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Abstract 
 
 
 
Resorcylic acid lactones (RALs) are biologically active polyketide natural products with 
typically a large macrocyclic ring fused to a resorcylic unit.
i
 This thesis outlines novel 
biomimetic syntheses of such natural products utilizing intramolecular capture of acylketenes 
for macrolactonization and subsequent transannular aromatization to form resorcylic cores in 
a one-pot procedure. This strategy is sufficiently concise for analogue synthesis and therefore 
has potential use for pharmaceutical applications. 
 
One of the RAL family, namely (S)-zearalenone (5), was successfully synthesized following 
our developed strategy. The key acylketene precursor 3 was prepared in eight steps from 
norbonene 1 via alkene 2 in excellent E/Z selectivity. Thermolysis of 3 provided macrocycle 
4 by retro-Diel-Alder fragmentation which in turn underwent ketal deprotection and 
transannular aromatization to give the natural product 5 in high yields.
ii
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Following the successful synthesis of (S)-zearalenone (5), this methodology was applied to a 
more complex target, LL-Z1640-2 (9). The synthesis of diketo-dioxinone 7 was achieved via 
Weinreb amide 6 in eight steps. The key transformations included selective Lindlars 
reduction of alkyne 6 and the incorporation of keto-dioxinone unit 10 by dianion chemistry. 
Upon heating a hydroxy-keto-dioxinone 7, macrocyclic triketo-ester was generated which 
smoothly aromatized to afford resorcylate 8 in a one-pot procedure. Further three steps of 
manipulation on resorcylate 8 furnished TAK-kinase inhibitor 9.
iii
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Extensive studies have been carried out towards the racemic synthesis of dimeric 
dihydroisocoumarin, known as tragoponol (16). Our aim included the use of inter- and intra-
molecular ketene trapping which would be followed by two separate aromatizations to 
construct its dilactone structure. The left hand side resorcylate unit rac-14 was synthesized in 
seven steps starting from commercially available keto-ester 11 through a ketene trapping 
and an aromatization sequence utilizing diketo-dioxinone rac-12 and alcohol rac-13. The 
incorporation of keto-dioxinone unit was achieved by C-acylation of dilithium enolate 
derived from keto-dioxinone 10 with Weinreb amide rac-14 to give diketo-dioxinone rac-15 
in high yield.  
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The final part of this thesis describes the studies carried out on a recently isolated RAL called 
paecilomycin B (21). A unique tetrahydropyran unit within the macrocyle is one of its 
attractive structural features. The key precursors 18 were successfully synthesized in five 
steps from alcohol 17. The introduction of four stereogenic centres was controlled by a 
diastereoselective aldol reaction, a CBS-reduction, and a directed epoxidation of an allylic 
alcohol. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(i) Schirmer, A.; Kennedy, J.; Murli, S.; Reid, R.; Santi, D. V. PNAS, 2006, 103, 4234. 
(ii) Miyatake-Ondozabal, H.; Barrett, A. G. M. Tetrahedron 2010, 66, 6331.                                                                                                                                                                                                                                  
(iii) Miyatake-Ondozabal, H.; Barrett, A. G. M. Org. Lett. 2010, 12, 5573. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
6 
 
Acknowledgments 
 
 
First of all, I would like to thank Professor Anthony G. M. Barrett for giving me the 
opportunity to work in his group, for his advice and guidance throughout my PhD studies and 
providing me an extremely exciting and challenging project.  
 
I am grateful for the resorcylate group, past and present: To begin with, Bhavesh. You have 
been a great friend as well as a competitive lab partner. Without you, my PhD would have 
been a boring part of my life and I am thankful for your “ Five reactions a day rule ” which 
gave me a lot of motivation; Ismael, Christoph, and Jeff. I appreciated all the help and 
support you have given me during my PhD studies; Katie, Pete, Jacques, Marianne, Laclef, 
Jens, Frauke, Tim, Rosa and Jenny. Thank you all for your motivated discussions as well as 
being great team members. I would like to further express my thanks to Jacques. You have 
been a constant amusement (the dancing was my favourite part) and I thank you for your 
friendship. 
 
Particular thanks to my team of proof-readers; Bhavesh, Dil, Aniello, Paul, Jens, Matt, Katie, 
Pete and Okanya. I very much appreciated your efforts. If you need any Japanese lessons in 
the future, please do not hesitate. 
 
I would like to acknowledge all the current and past members of Barrett and Fuchter group 
for their supports and guidance in the laboratory and also making the year incredibly 
enjoyable. Special thanks to Jean-Noel, Max, Aniello, Paul, Matt, Marta, Maria, Simon, 
Jullien, Matthias, Dil, Basti, Darunne and Lauriane for bringing extra fun into the lab, and 
also into my day-to-day life.   
 
I would also like to thank our administrative assistant, Rachael, for being always helpful and 
professional. I am thankful for EPSRC for funding, Pete Haycock and Dick Sheppard for 
NMR, John Barton for mass spectrometry, Andrew White for X-ray analysis, and Stephen 
Boyer for microanalysis.  
 
I would like to say a big thank you to my previous industrial supervisor Antonio, who 
encouraged me to undertake my PhD studies and has been an inspirational medicinal chemist. 
 
Finally, I would like to express my gratitude towards my family without whom I would not be 
in this position today. They have provided me a huge unconditional support, not only 
financially but also emotionally. Thank you so much for bearing up on my studies for 27 
years!   
 
To my other half, Edytka, your constant support as well as your unconditional love have 
helped me to overcome difficult moments throughout my studies. I believe there is no such 
word that is sufficient to thank you. 
7 
 
Abbreviations 
 
 
25
D][  optical rotation 
Å Angstrom (10
-10
 m) 
Ac  acetyl 
Acac     acetylacetonate 
Ac2O              acetic anhydride 
Anal.  analysis 
app.  apparent 
aq.  aqueous 
br  broad  
Boc                           tert-butyloxycarbonyl 
Bn   benzyl  
Bu  butyl  
ºC                                 degrees Celsius 
CAL-B Candida Antarctica lipase B  
cat.                      catalytic 
CBS  Corey-Bakshi-Shibata 
CDI              carbonyldiimidazole 
CHCl3        chloroform 
CH2Cl2 dichloromethane 
CI  chemical ionization 
CSA   camphor sulphonic acid 
  chemical shift  
d doublet 
DCC                                       N,N'-dicyclohexylcarbodiimide 
dd  doublet of doublet 
ddd  doublet of doublet of doublet 
DDQ  2,3-dichloro-5,6-dicyano-1,4-benzoquinone 
DEAD              diethyl azodicarboxylate 
DIAD               diisopropyl azodicarboxylate  
DIBAL-H                              diisobutylaluminium hydride 
DIPEA                                   N,N-diisopropylethylamine 
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DMAP  4-dimethylaminopyridine 
DMF                                      N,N-dimethylformamide 
DMP                                      Dess-Martin periodinane 
DMSO                                    dimethyl sulfoxide 
dr                              diastereomeric ratio 
dt                  doublet of triplet  
dq                                           doublet of quartet 
EDC                                       1-ethyl-3-(3-dimethylaminopropyl)carbodiimide 
e.e.                                          enantiomeric excess 
EI                 electron ionization 
Elem.                                      elemental 
EOM                     ethoxymethyl 
eq.                                    equivalent 
ES                                    electrospray 
Et                                     ethyl 
Et3N                                       triethylamine 
Et2O                                    diethyl ether 
EtOAc                                    ethyl acetate 
EtOH                                    ethanol 
FVP              flash vacuum pyrolysis 
h                                    hour 
HMDS                                    bis(trimethylsilyl)amine 
HMPA                         hexamethylphosphoramide 
HRMS                                    high resolution mass spectrometry  
Hz                                    Hertz 
i                                              iso 
IC50              half maximal inhibitory cocentration 
IR  infrared spectroscopy 
J                                    coupling constant 
KOH   potassium hydroxide  
LDA                                       lithium diisopropylamine 
LG   leaving group  
LiHMDS lithium hexamethyl disilazide 
μ                                   micro 
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m                                     multiplet 
M                          molar 
Me                                     methyl 
MeOH  methanol 
min                                         minute(s) 
mL                         millilitre(s) 
mmol                   millimole(s) 
mol                                         mole(s) 
MOM  methoxymethyl 
Mp.                        melting point 
MS           mass spectrometry 
MW                                        microwave irradiation 
m/z  mass to charge ratio 
n                           nano 
NaH   sodium hydride 
NaOH   sodium hydroxide   
N2                         nitrogen gas 
NMR                           nuclear magnetic resonance  
Nu    nucleophile 
o  ortho 
PCC              pyridinium chlorochromate 
PE              petroleum ether 
PG  general protecting group 
pH  potential hydrogen 
Ph                                    phenyl 
PhMe                       toluene 
Piv                       pivaloyl 
PKS  polyketide synthase 
PMB  p-methoxybenzyl 
ppm                                    parts per million 
PPTS                       pyridinium para-toluenesulfonate 
Pr   propyl 
p-TSA   para-toluenesulfonic acid 
Py.  pyridine 
10 
 
PyBOP benzotriazol-1-yl-oxytripyrrolidinophosphonium   
                                    hexafluorophosphate 
q                                    quartet 
R                         general substituent 
RAL  resorcylic acid lactone 
RCM                    ring-closing metathesis 
Rf                              retention factor 
s                                              singlet 
SAE     Sharpless asymmetric epoxidation 
st  sextet 
t                                              triplet 
TBAF    tetra-n-butylammonium fluoride 
TBDPSCl tert-butyl(chloro)diphenylsilane 
TBS  tert-butyldimethylsilane  
td  triplet of doublet 
Tf  trifluoromethanesulfonyl (triflic) 
TFA  trifluoroacetic acid 
THF  tetrahydrofuran  
TIPSCl triisopropylsilyl chloride 
TLC  thin layer chromatography 
TMS  trimethylsilyl 
UV              Ultra-violet 
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1. General Introduction 
 
1.1 Resorcylic Acid Lactones (RALs) 
 
Polyketide natural products with a large macrocyclic ring fused to 6-alkyl-2,4-
dihydroxybenzoic acid or β-resorcylate unit 22 (Figure 1) are known as resorcylic acid 
lactones (RALs).
1
 They exhibit a range of biological activities including anti-malarial and 
anti-cancer properties as illustrated below.
2
 Due to their unique biological activities, the 
organic chemistry community gained deep interest in this class of natural products in the 
early 1990s.
2
  
 
 
                      
  
 
 
 
 
 
 
 
 
 
 
 
 
FIGURE 1. Examples of related resorcyclic acid lactones (5), (9), (21), (23), (24), and (25) 
 
(S)-Zearalenone (5) is a potent anabolic and estrogenic mycotoxin,
3
 isolated in 1962 from the 
microfungus Fusarium graminearum. Radicicol (23) is a potent and selective inhibitor of 
HSP90 whereas three other resorcylic natural products aigialomycin D (25), hypothemycin 
(24) and LL-Z1640-2 (9) are known for their anti-malarial and kinase inhibition activities, 
respectively.
2
 Paecilomycin B (21) has been recently isolated in 2010, and possesses a unique 
tetrahydropyran ring within its macrocycle along with a moderate antiplasmodial activity 
19 
 
against Plasmodium falciparum lines 3D7 (a chloroquine-susceptive line).
4
 The total 
synthesis of natural products (5), (9), (23), (24), and (25) has been published using 
conventional synthetic strategies, some of which will be discussed in the following chapters.
2
  
 
1.2 Biosynthesis of polyketides and RALs 
 
The biosynthesis of many aromatic units found in nature involves the condensation of acetate 
and malonate units. The biosynthesis of polyketides was investigated by Robinson and Birch 
in the late 1940s and early 1950s to explore the mechanistic details of the biosynthetic 
process.
5,6
    
 
A theory was subsequently established which shows that the polyketide chains are built by 
the condensation of coenzyme A esters 26 with malonyl coenzyme A units 27 (Scheme 1). 
This step is an entropically driven process where the loss of carbon dioxide promotes 
Claisen-type condensation to produce β-keto thioester 28. The process is then repeated where 
thioester 28 undergoes further condensation with another malonyl coenzyme A unit 27 to 
give 3,5-diketo thioester 29, followed by another condensation to construct 3,5,7-triketo 
thioester 30 and to build the polyketide chains.
6
 
 
 
 
 
 
 
 
 
 
 
SCHEME 1. Biosynthesis of polyketide chain 
 
In general, RALs are biosynthesized by large multidomain enzymes that iteratively catalyze 
the condensation of nine units of thioacetates or malonates.
2
 Different modules can further 
process the product of each condensation to reduce or dehydrate the β-ketone. The proposed 
20 
 
biosynthesis of zearalenone is illustrated below where two polyketide synthases (PKSs) are 
involved (Scheme 2). The first is said to be responsible for the assembly of the first five 
acetate units with the appropriate carbonyl reductions. The second performs the remaining 
condensations without carbonyl reductions to construct the polyketide fragment 31. This 
fragment is highly reactive and undergoes an aromatization followed by cyclization on the 
second PKS to release the lactone 32.
2
  
 
 
 
 
 
SCHEME 2. Proposed generic biosynthesis of zearalenone 32 
 
1.3 Conventional synthetic strategy for the synthesis of RALs 
 
Traditionally, many of these resorcylate natural products including (S)-zearalenone (5), 
radicicol (23), hypothemycin (24), aigialomycin D (25), and LL-Z1640-2 (9) have been 
synthesized utilizing an aromatic building block such as resorcylic acid 33, orsellinic acid 34, 
or their derivatives (Figure 2).
2,7
 
 
 
 
 
FIGURE 2.  Aromatic starting materials for the conventional synthesis of resorcylates 
 
1.3.1 Traditional synthesis of DL-zearalenone rac-(5) 
 
The first total synthesis of DL-zearalenone rac-(5) was reported in 1968 by Harrison et al..
7
 
Their brief synthetic strategy is outlined below with key disconnections (Scheme 3). The 
aromatic fragment was constructed using aromatic building block 35 and the other two 
intermediates 36 and 37 formed the macrocycle using a Michael addition, 
macrolactonization, and a Wittig reaction.
 
 
21 
 
 
 
 
 
 
SCHEME 3. Harrison retrosynthesis of DL-zearalenone rac-(5) 
 
The most recent synthesis of (S)-zearalenone (5) by Barrett and co-workers will be discussed 
in the following chapter. 
 
1.3.2 Traditional synthesis of radicicol (23) – 1st generation 
 
Due to its unique and powerful biological activity, radicicol (23) has been the subject of a 
significant synthetic study and several total syntheses have been reported to date.
2,8,9,10,11
   
One of the 1
st
 generation total syntheses, by Lett et al., is illustrated below along with main 
disconnections (Scheme 4).
8 
The key bond formation consisted of palladium catalyzed Stille 
coupling, between isocoumarin 38 and stannane 39, and Mitsunobu macrolactonization to 
construct the macrocylic core. These synthetic approaches well-addressed two main 
challenges found in the synthesis of radicicol (23). These included: i) the presence of strained 
and therefore sensitive allylic epoxide; ii) the enone functionality which was readily enolised 
at the benzylic position to form isocoumarin.  
 
 
 
 
 
 
 
SCHEME 4. Main disconnections of radicicol (23) by Lett et. al.
8
 
 
The synthesis began with prop-2-yn-1-ol (40) which underwent a series of derivatizations to 
provide alcohol 41 in 68% over four steps (Scheme 5). Reduction with lithium aluminium 
hydride was followed by a Sharpless asymmetric epoxidation and Swern oxidation to give 
aldehyde 42 in a moderate yield of 68% over three steps. Stannane 43 was then installed to 
22 
 
furnish an advanced intermediate 39 (Scheme 4) after MOM-protection and TBS-
deprotection. Stille coupling was performed using chloride 38 (Scheme 4) to give 
isocoumarin 44 in high yield. DIBAL-H reduction of the isocoumarin moiety was followed 
by a Pinnick (Lindgren) oxidation and Mitsunobu cyclization to form the macrocycle 45 in 
39% yield over three steps. The final steps included TBS-protection, –OMOM elimination, 
and deprotection chemistry to provide radicicol (23) in 25% yield over four steps (Scheme 5). 
 
 
 
 
 
 
 
 
 
 
SCHEME 5. 1
st
 Generation synthesis of radicicol (23) 
 
1.3.3 Traditional synthesis of radicicol (23) – 2nd generation 
 
In 2002, a further modification was carried out, by Tinchkowski and Lett, on the 1
st
 
generation synthesis of radicicol (23).
10 
The main disconnections were identical however a 
Stille coupling was replaced by a Suzuki coupling in order to avoid tin contamination. More 
importantly, the final elimination step was successfully improved by the formation of 
mesylate leaving group to facilitate the process, hence enhancing the overall yield (Scheme 
6).  
The same aldehyde 42 was synthesized and used in lithiated alkyne 46 addition followed by 
deprotection and protection chemistry to produce alkyne 47 in good yield. Hydroboration and 
a Suzuki coupling reaction were then performed to join the two main fragments and 
Mitsunobu macrolactonization gave resorcylate 48 in 18% yield over five steps. The ortho-
phenol protection and PMB deprotection resulted in allylic alcohol 49 which was 
subsequently converted to its mesylate derivative and eliminated to give radicicol (23) in an 
23 
 
excellent yield of 60% over five steps. With this modification, the yield of elimination step 
was improved by 60%. 
 
 
 
 
 
 
 
 
SCHEME 6. 2
st
 Generation synthesis of radicicol (23) by Tinchkowski and Lett.
10 
 
1.3.4 First total synthesis of aigialomycin D (25) via Diel-Alder reaction 
 
An elegant total synthesis of aigialomycin D (25) was reported by Danishefsky et al. in 2001, 
where the aromatic ring was constructed by a late stage Diels-Alder reaction.
9
 This synthesis 
also highlighted the efficient protection of alkyne functionality as a cobalt complex in order 
to facilitate ring closing metathesis (RCM). The key disconnections are shown below 
(Scheme 7). The precursor 51 for Diels-Alder reaction was prepared from four simple starting 
materials 52. 
 
 
 
 
 
 
SCHEME 7. Key disconnections of aigialomycin D (25) by Danishefsky et al.
9 
 
The required stereochemistry of the diol was derived from D-deoxyribose (53) (Scheme 8). 
Four steps derivatization of 53 resulted in alcohol 54 in 33% yield. Parikh-Doering oxidation 
was followed by a Reformatsky reaction, TBS protection and Piv deprotection to afford 
alkyne 56 in 78% yield over four steps. The RCM precursor 57 was prepared from 56 by four 
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steps transformation including oxidation, a Wittig olefination, carbonylation and Mitsunobu 
esterification in 73% yield. The alkyne functionality was then efficiently protected as a cobalt 
complex using cobalt octacarbonyl, prior to RCM. Deprotection with cerium ammonium 
nitrate (CAN) and Diels-Alder reaction with diene 50 (Scheme 7) gave resorcylate 58 in 
excellent yield of 60% over four steps. Aigialomycin D (25) was synthesized following 
phenol protection, TBS deprotection, OTBS elimination and global deprotection in 44% 
yield over four steps (Scheme 8).   
 
 
 
 
 
 
  
 
 
 
 
SCHEME 8. The total synthesis of aigialomycin D (25) via a Diels-Alder reaction 
 
1.4 Development of aromatization methods of triketo-esters 
 
Whilst several total syntheses of RALs have been reported, low overall yields were still 
observed particularly due to unexpected difficulties concerning the protecting groups on the 
phenols and in particular, their removal. The macrolactonization and esterification steps have 
also proven to be difficult due to the deactivation of the reacting carbonyl centre by the 
resorcinol ring. Several new cyclization methodologies have been developed in order to 
address the issue, including Mitsunobu macrolactonization,
12
 Corey–Nicolaou 
macrolactonization
13
 and Masamune’s thioester-lactonization.14 Nevertheless, deprotection of 
the phenol groups was still found to be problematic and the yields of prior steps had to be 
improved. This led to investigation into an alternative synthetic strategy where the aromatic 
ring is introduced at a later stage of the synthesis with no need of protection on the 
resorcylate unit. 
25 
 
In the 1970s, inspired by the polyketide biosynthesis of resorcylates, Harris et al. published 
some pioneering research illustrating that simple polyketides such as 60 can undergo 
aromatization between pH 4 and 12 (Scheme 9).
5
 An example is given below where 3,5,7-
triketo ester 60 was synthesized by a self-condensation of methyl acetoacetate 59, and 
subsequently underwent aromatization under either acidic or basic conditions to give 
resorcylate 61 (Scheme 9).
5 
The reaction conditions were later optimised by Barrett et al. and 
the best yield of 72% was obtained with the use of pH 9.2 buffer.
15  
  
 
 
 
 
 
SCHEME 9. Synthesis of resorcylate 61 via aromatization of methyl acetoacetate 60  
 
Harris et al. also discovered that alternative cyclizations of triketo-ester 60 were possible 
depending on reaction conditions (Scheme 10). The first cyclization was a result of 
Dieckmann cyclization rather than aldol condensation under strongly basic conditions to give 
resorcinol 62. The last two cyclizations of triketo-ester 60 can also occur either under 
strongly acidic conditions or treatment with acetic anhydride to give 4-pyrone 63 and 4-
hydroxy-2-pyrone 64 respectively.  
 
 
 
 
 
 
 
 
 
 
SCHEME 10. Three other possible cyclizations of triketo-ester 60   
 
Despite the fact that these procedures have demonstrated their potential utility for various 
ring construction, a few disadvantages still remain unsolved. The use of harsh reaction 
conditions to perform the aldol-dehydration reaction, as well as the tolerability and instability 
26 
 
issues of the synthesized triketo-ester are the most problematic, particularly in natural product 
and analogue synthesis. Hence, a search into appropriate masking group for the tri-keto 
functionality was essential in order to overcome these issues. 
 
1.5 Dioxinone as masked carbonyl groups and its applications in natural 
product synthesis  
 
In 1984, Hyatt et al. showed that 2,2,6-trimethyl-4H-1,3-dioxin-4-one 65 can be opened at 
elevated temperatures with nucleophiles such as alcohols, amines and thiols to provide -
keto-esters, -keto-amides or -keto-thio-esters, respectively.16 This reaction occurred via a 
retro-Diels-Alder reaction of dioxinone 65 to form the reactive acetylketene intermediate 66, 
which was trapped with a nucleophile to give the desired product 67 (Scheme 11).  
 
 
 
 
SCHEME 11. Nucleophilic opening of dioxinone XX 
 
With this methodology in hand, Sasaki and co-workers reported a facile synthesis of 
substituted tetronic acid, ()-carlosic acid (72), in 1990 (Scheme 12).17 A mixture of 
secondary alcohol 68 and alkyl-dioxinone 69 was heated at reflux to smoothly give -keto-
ester 70 in 93% yield. Subsequent treatment with tetrabutylammonium fluoride (TBAF) as a 
mild base gave tetronic acid 71 via a Dieckmann condensation. Finally, acidic hydrolysis of 
ester 71 resulted in the formation of natural product 72 in 56% yield. 
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SCHEME 12. Synthesis of ()-carlosic acid (72) by an intermolecular capture of acylketene 
 
Acylketenes are excellent 4  components for inverse electron demand hetero-Diels-Alder 
reactions. Its wide synthetic utility has been demonstrated by many researchers.
18
 
An expedient synthesis of A-B spiroketal fragment 77 of spongistatin was reported by 
Crimmins and Smith in 2006 (Scheme 13).
19
 1,3-Dioxinone 73 was heated in the presence of 
electron-rich vinyl ether 74 to undergo [4 + 2] cycloaddition to give cycloadduct 75 in high 
yield. Acid-catalyzed elimination of 1-butanol was followed to afford 4-pyranone 76 in 65% 
over two steps. A further five steps derivatization of 76 led to the construction of spiroketal 
intermediate 77.  
 
 
 
 
 
 
 
 
 
 
 
 
 
SCHEME 13. Synthesis of 4-pyranone 76 by [4 + 2] cycloaddition of acylketene intermediate 
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1.6 Discovery of diketo-dioxinones as resorcylate precursors 
 
Inspired by the work of Hyatt, the Barrett group discovered that the key triketo-esters 79, 
precursors of resorcylates 22, could be synthesized from diketo-dioxinones 78 (Scheme 14).
20
 
Diketo-dioxinones 78 underwent thermal decomposition to generate the reactive ketene 
intermediates which were trapped by alcohols to give triketo-esters 79. The aromatization 
reaction was performed by adding cesium carbonate to initiate the base-catalyzed aldol 
condensation and this was followed by the addition of excess acetic acid to promote the 
dehydration providing resorcylates 22 in good yields.   
 
 
 
 
SCHEME 14. The use of diketo-dioxinones 78 as precursors of resorcylates 22 
 
This methodology has therefore enabled quick access to a wide range of triketo-esters 79 
which were smoothly aromatized under mild conditions to give various resorcylate units 22 
in two steps. 
 
1.7 Application of late-stage aromatization approach to natural product 
synthesis  
 
With the use of this biomimetic methodology, Barrett and co-workers have successfully 
completed the total synthesis of several natural products including aigialomycin D (25), 
marine antifungal agent 15G256 (80) and cytotoxin cruentaren A (81) (Figure 3).20,21,22  
 
                
                 
 
 
 
 
 
FIGURE 3. 15G256 (80) and cruentaren A (81)  
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1.7.1 Biomimetic synthesis of marine antifungal agent 15G256 (80)  
 
In 2008, the total synthesis of marine antifungal agent 15G256(80) was achieved via a late-
stage aromatization approach.
20 
The synthesis highlighted the stability of delicate 
functionality to the generation of the resorcylate units by cyclization and aromatization 
(Scheme 15). The necessary diketo-dioxinone unit 85 was synthesized using a new acylation 
method. Sequential C-acylation of silyl-enol ether 82 with acid chloride 83a and acid chloride 
83b in the presence of magnesium chloride gave diketo-ester dioxinone 85 in excellent 
yields. Palladium catalyzed deallylation reaction was performed in a good yield to reveal 
diketo-dioxinone (R)-86 in 89% yield. The following reaction involved the thermolysis of 
diketo-dioxinone (R)-86 to generate the corresponding ketene in toluene which was 
efficiently trapped in an intermolecular fashion with alcohol 87. The resulting triketo-ester 
was aromatized using potassium carbonate and methanoic hydrogen chloride sequentially to 
provide 15G256 monomer unit 88 (75%). 
 
 
 
 
 
 
 
 
 
 
SCHEME 15. Synthesis of resorcylate building block 88 using a late-stage aromatization 
 
The same approach was utilized to construct the appropriate monomer resorcylate units, 89 
and 91, to complete the synthesis (Scheme 16). The phenol unit was protected as benzyl ether 
90 in 92% yield, which was subjected to silyl deprotection and a Yamaguchi esterification 
with another monomer unit 91 to furnish bis-resorcylate 92 in 73% yield over two steps. 
Another palladium deallylation was performed to give the corresponding carboxylic acid 93 
(87%) which was elaborated further to generate 15G256 (80) in five steps. 
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SCHEME 16. Synthesis of 15G256 (80)  
 
1.7.2 Biomimetic synthesis of cruentaren A (81)  
 
This is one of the most recent natural product synthesis accomplished by Barrett et al. in 
2012.
21 
The complex structural features of Cruentaren A (81) include eight stereogenic 
centres with a relatively large amide side chain attached to 12-membered macrocycle. This 
synthesis overcame the previous synthetic problems encountered by Maier et al. and F rstner 
et al..
23,24
 These included: i) deactivation and steric hindrance of carbonyl functionality by the 
phenol ring, leading to low yields on the macrolactonization step; ii) the formation of the 
undesired 6-membered lactone under basic or acidic conditions.  
 
The key transformations are shown below (Scheme 17). Thermolysis of diketo-dioxinone 94 
at 100 ºC in a sealed tube generated the corresponding ketene, which was trapped by alcohol 
95 and subsequently aromatized to give resorcylate 96 in 74% yield over two steps. The 
phenol 96 was protected as the dimethyl ether by the reaction with methyl iodide, followed 
by ring-closing alkyne metathesis with F rstner molybdenum nitride precatalyst 97 to give 
macrolactone 98 in 62% over two steps. The last steps included incorporation of the amide 
side chain, deprotections and Lindlar reduction to furnish cruentaren A (81) in 21% yield 
over seven steps.    
 
 
31 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
SCHEME 17. Synthesis of cruentaren A (81)  
 
The late-stage aromatization strategy has proven to be extremely suitable for the synthesis of 
related resorcylate products providing high yields for intermolecular ketene trapping and 
aromatization and demonstrated the large applicability of its synthetic utility. 
 
1.8 Efficient synthesis of keto-dioxinones and diketo-dioxinones 
 
Keto- and diketo-dioxinone derivatives are essential fragments for the synthesis of RALs in 
the biomimetic methodology developed by Barrett and co-workers. Therefore, extensive 
effort has been invested to design the most efficient and flexible synthesis of these fragments. 
 
1.8.1 Various methodologies for the synthesis of keto-dioxinones 
 
In 1991, the first selective example of keto-dioxinone synthesis was reported by Kaneko et al. 
using C-acylation chemistry (Scheme 18).
25
 They showed that dioxinone 65 can be 
deprotonated under strongly basic conditions in the presence of hexamethylphosphoramide 
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(HMPA) to generate lithium enolate 99 which further reacted with acid chloride 100 to 
provide keto-dioxinone 101 in a moderate yield. A possible side reaction, O-acylation, was 
successfully prevented by using 0.5 equivalent of acid chloride 100 along with more than 
50% recovery of starting material 65. The keto-dioxinone 101 was utilized as a precursor for 
the enantioselective synthesis of (S)- and (R)-6-(2,3-dihydroxypropyl)-l,3-dioxin-4-ones 102. 
 
 
 
 
 
SCHEME 18. Synthesis of keto-dioxinone 101 
 
The importance of using half of an equivalent of the acid chloride for selective C-acylation 
was further highlighted by the following example by Kaneko and co-workers (Scheme 19).
26
  
The treatment of lithium enolate 99, derived from 65, with one equivalent of acid chloride 
103 resulted in exclusive formation of O-acylated product 104 in 43% yield. In comparison, 
the use of 0.5 equivalent of acid chloride 103 gave the desired C-acylated product 105 in 48% 
yield.  
 
 
 
 
 
 
 
 
SCHEME 19. A example of O-acylation and C-acylation of dioxinone 65 
 
After a decade, Tadano et al. developed a two-step methodology for keto-dioxinone 
synthesis, which consisted of a Mukaiyama type aldolisation and subsequent Dess-Martin 
oxidation (Scheme 20).
27
 The trimethylsilyl-enol ether 106 was reacted with aldehyde 107 
mediated by trifluoroboron diethyletherate as a Lewis acid to provide hydroxy-dioxinone 
108. The oxidation with Dess-Martin periodinane (DMP) gave keto-dioxinone 109 in 
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reasonable yield of 67% over two steps. A successful synthesis of (+)-macquarimicin was 
later achieved using 109 as a key building block.         
 
 
 
 
 
 
 
SCHEME 20. A two-step synthesis of keto-dioxinone 109  
 
An analogous approach was later applied to the biomimetic total synthesis of (S)-zearalenone 
(5) by Barrett and co-workers in 2008 (Scheme 21).
20 
Investigation into various Lewis acids 
were carried out for the aldolisation, however trifluroboron diethyletherate gave the best 
results of 61% yield over titanium and aluminium based Lewis acids. DMP oxidation of 
hydroxy-dioxinone 111 gave keto-dioxinone 112 in 82% yield after TBS deprotection.  
A detailed synthesis of (S)-zearalenone (5) will be discussed in the following chapter. 
 
 
 
 
 
 
SCHEME 21. Synthesis of keto-dioxinone 112 via a Mukaiyama aldolisation 
 
In 2005, Katritzky et al. devised an alternative electrophile for C-acylation of lithium enolate 
of dioxinone 65.
28
 They reported that acylbenzotriazoles were an excellent replacement for 
acid chlorides since they are easier to handle and more tolerant towards sensitive functional 
groups present in the molecule. For example, lithium enolate of dioxinone 65 was subjected 
to acylation with acylbenzotriazole 113 to give keto-dioxinone 105 in an improved yield of 
65% (Scheme 22). It is also noteworthy that O-acylation was minimized using the 
benzotriazole derivative even though 0.89 equivalent of the electrophile was used. 
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SCHEME 22. Synthesis of keto-dioxinone 105 using acylbenzotriazole 113 
 
Recently, Barrett et al. published the total synthesis of (+)-montagnetol (117) utilizing C-
acylation of dioxinone 65 with acylbenzotriazole 115 as one of the key transformations 
(Scheme 23).
29
 Dioxinone 65 was heated at 90 ºC to undergo a retro-Diels-Alder reaction, 
and the generated ketene 66 was trapped with benzotriazole 114 to form amide 115. 
Treatment with lithium enolate of 65 gave diketo-dioxinone 116 in 43% yield over three 
steps.  
 
 
 
 
 
 
 
 
SCHEME 23. Synthesis of acylbenzotriazole 115 and diketo-dioxinone 116 
 
Acylimidazoles can also be used as electrophiles during this transformation. This was proved 
through the successful total synthesis of antibiotic fungal metabolites ent-W1278A (119), ent-
W1278B (120) and ent-W1278C (121) by Barrett and co-workers in 2009 (Scheme 24).
30
 
Lithium enolate of dioxinone 65 was generated using lithium bis-(trimethylsilyl)amide 
(LiHMDS) and quenched with acylimidazole 118 to afford keto-dioxinone 10 in 64% yield. 
The use of zinc chloride, as a Lewis acid, was essential to drive the reaction towards C-
acylation over O-acylation. The downside of these reaction conditions included the use of 3.0 
equivalents of dioxinone 65 to fully consume acylimidazole 118 (1 equivalent).   
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SCHEME 24. Synthesis of keto-dioxinone 10 using acylimidazole 118  
 
In order to address the over-usage of dioxinone 65 in the previous synthesis of keto-
dioxinone 10, Patel and Barrett further optimized the conditions and managed to improve the 
yield as well as starting material ratios (Scheme 25).
31
  The reaction was carried out at higher 
temperature and transmetalation of lithium enolate with diethyl zinc was crucial to obtain a 
high conversion. The synthesis was also applicable to multi-gram scale, giving yields of 67 – 
70%.   
 
 
 
 
 
SCHEME 25. An improved synthesis of keto-dioxinone 10 mediated by diethyl zinc  
 
1.8.2 Efficient preparation of diketo-dioxinones via Claisen type condensation 
 
An example of diketo-dioxinone synthesis is illustrated in the biomimetic synthesis of 
15G256(80) (Scheme 15 in section 1.7.1). The allyl ester side chain was initially installed 
in order to facilitate C-acylation of keto-dioxinone 84 over O-acylation using magnesium 
chloride. The diketo-dioxinone (R)-86 was then revealed by deallylation using 
tetrakis(triphenylphosphine)palladium. This strategy was also applied to the total synthesis of 
aigialomycin D (25) by Calo and Barrett.
22 
 
 
Soon after, a direct functionalization of keto-dioxinone 10 was developed by Poeverlein and 
Barrett in 2009 (Scheme 26).
30
 This is one of the most efficient and straightforward methods 
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to access diketo-dioxinone frameworks. Keto-dioxinone 10 was treated with 2 equivalents of 
lithium diisopropylamide (LDA) at 20 ºC to generate dilithium dienolate 122 as a reactive 
intermediate. Subsequent addition of Weinreb amide 123 achieved the Claisen-condensation 
at the least hindered site to provide diketo-dioxinone (S)-86 in 70% yield. The use of acid 
chlorides instead of Weinreb amides gave complex mixtures of byproducts due to O-
acylation as a side reaction.  
 
 
 
 
 
 
 
SCHEME 26. Synthesis of diketo-dioxinone (S)-86 via dilithium enolate intermediate 122 
 
The enolate dianion chemistry of keto-dioxinone 10 was further investigated by Patel and 
Barrett, particularly the use of diethyl zinc for transmetalation of dilithium enolate 122. In 
2011, they reported that C-acylation of keto-dioxinone 10 can indeed be attained using highly 
functionalized Weinreb amides such as 124 with the aid of diethyl zinc as an additive 
(Scheme 27).
31 
The produced diketo-dioxinone 125 was subjected to base-induced 
aromatization to give isopropylidene-protected resorcylate 126 in 72% yield over two steps. 
The use of acylimidazoles as electrophiles was also described and comparable yields were 
obtained.
31
 Without the use of diethyl zinc in the crossed Claisen reaction, the overall yield (2 
steps) was considerably decreased to 0  25%. A possible explanation for this effect includes 
the reduced basicity of the resulting dilithium zincate relative to the dilithium systems.  
 
 
 
 
 
 
 
 
SCHEME 27. Synthesis of a functionalized diketo-dioxinone 125 mediated by diethyl zinc 
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1.9 Discovery of macrolactonization using dioxinone precursors and its 
applications   
 
The first macrolactonization, based on intramolecular capture of acylketenes, was discovered 
by Boeckmann in 1989 (Scheme 28).
32
 Hydroxy-dioxinone 127 was heated in toluene to 
generate hydroxy-ketene 128 via a retro-Diels Alder reaction which was trapped in situ by the 
pendant alcohol to provide (+)-diplodialide A (129) in 68% yield. A dilute reaction 
conditions were crucial to avoid polymeric byproduct derived from intermolecular capture of 
the acylketene intermediate 128.  
 
 
 
 
SCHEME 28. Macrolactonization based on intramolecular ketene trapping by Boeckmann  
Boeckmann et al. also pioneered the use of acylketene intermediates with secondary amines 
to form macrolactams. For instance, 16-membered lactam was successfully synthesized in the 
total synthesis of antibiotic natural product (+)-ikarugamycin (133) (Scheme 29).
33
 
Thermolysis of amino-dioxinone 130 under dilute conditions gave lactam 131 in 77% yield 
which was followed by base treatment to form protected pyrrolidine-dione 132. Final 
deprotection with trifluoroacetic acid gave the natural product 133 in 55% yield. 
 
 
 
 
 
 
 
 
 
 
 
 
SCHEME 29. Boeckmann’s synthesis of (+)-ikarugamycin (133)  
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Intramolecular captures of acylketenes are especially useful in organic synthesis as they 
enable us to access medium and large rings which are often problematic using traditional 
methods particularly on strained substrates. 
This powerful strategy was later applied to the synthesis of antitumor agent callipeltoside A 
(137) by Trost et al. in 2002 (Scheme 30).
34
 The key transformation involved the thermal 
decomposition of hydroxy-dioxinone 134 to afford the macrolide 135 in 82% yield. Silyl 
protecting groups were removed using HF∙pyridine and this was followed by acid catalyzed 
hemiketal formation to give tetrahydropyran 136 in 91% yield over two steps. Intermediate 
136 was then converted to callipeltoside A (137) in just three steps in 59% yield.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
SCHEME 30. Trost’s synthesis of callipeltoside (137)  
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Aim of the project 
 
Several resorcylate natural products were successfully synthesized using biomimetic late-
stage aromatization strategy as described in the previous sections. They all incorporated an 
intermolecular ketene trapping step by the appropriate alcohol to give the key triketo-ester 
fragment. 
 
This project was established to investigate intramolecular ketene trapping, rather than 
intermolecular, on hydroxy-diketo-dioxinone intermediates 140 (Scheme 31). This should 
provide a route to triketo-ester macrocycles 139 which could undergo transannular 
aromatization to form macrocylic resorcylate 138. This strategy can be seen as a combination 
of Boeckmann’s macrolactonization and Barrett’s biomimetic late-stage aromatization. 
Transannular aromatization itself is also a challenge since this type of transformation has 
never been described in the literature.   
 
 
 
 
 
 
 
SCHEME 31. Generic synthetic strategy for macrocyclic resorcylates using transannular aromatization 
 
Four natural products were chosen as targets to explore the feasibility as well as applicability 
of this methodology (Figure 4). The preliminary studies were carried out on the total 
synthesis of (S)-zearalenone (5) and later applied to more complex natural products such as 
LL-Z1640-2 (9), tragoponol (16), and paecilomycin B (21). 
 
 
 
 
 
 
FIGURE 4. Resorcylate natural product targets (5), (9), (16), and (21)  
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CHAPTER TWO: 
 
RESULTS AND DISCUSSION 
 
-(S)-ZEARALENONE- 
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2.  (S)-Zearalenone 
 
2.1 Isolation, structure and biological properties 
 
(S)-Zearalenone (5) is a secondary metabolite isolated in 1962 and its anabolic properties 
have been used as a bovine growth stimulant (Figure 5).
3 
Its structure as well as its natural 
(S)-configuration were confirmed by Urry et al. in 1966.
35
 At present, (S)-zearalenone (5) is 
manufactured industrially via fermentation. One of its derivatives, zeranol (141), is marketed 
under the trade name Ralgro
®
 as an anabolic growth stimulant for cattle.
36
  
 
 
 
 
FIGURE 5. (S)-Zearalenone (5) and its derivative zeranol (141) 
 
It is believed that its estrogen agonistic properties are the product of a direct interaction on 
the estrogen receptor in competition with 17-estradiol
37
 and that the macrocycle of 
zearalenone was able to adopt a conformation which mimics the one of the steroid.
38
 (S)-
Zearalenone (5) is also a mycotoxin which has also been shown to have antibacterial 
properties.
36,39
 
 
2.2 Previous synthesis utilizing a late-stage aromatization  
 
In 2008, (S)-zearalenone (5) was successfully synthesized by Barrett et al. using inter-
molecular ketene trapping, biomimetic aromatization and ring-closing metathesis (RCM).
20 
The key disconnections are shown on the following scheme (Scheme 32). (S)-Zearalenone (5) 
was constructed utilizing RCM on resorcylate 142 which was generated by a late-stage 
aromatization of triketo ester 143. Thermal decomposition of diketo-dioxinone fragment 145 
generated the reactive ketene intermediate which was trapped in an intermolecular fashion 
with the enantiomerically pure secondary alcohol 144 to synthesize triketo ester 143. 
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SCHEME 32. Previous retrosynthesis of (S)-zearalenone (5) via a late-stage aromatization 
 
The enantiomerically enriched alcohol (S)-144 was prepared in four sequential steps from 
(±)-5-hexanolide 146 (Scheme 33). Lactone 146 was treated with Grignard reagent 147 and 
converted to the corresponding acetate 148 using acetic anhydride in 71% yield over two 
steps. Ketal protection was performed under Dean-Stark conditions using ethylene glycol 
followed by acetyl hydrolysis to give ketal rac-144 in 85% yield. The last step involved 
kinetic resolution with CAL-B lipase and vinyl acetate to obtain alcohol (S)-144 in an 
excellent enantiomeric excess (e.e.).
20 
The undesired (R)-enantiomer 149 was recycled by 
three step procedure using Mitsunobu reaction to regenerate (S)-enantiomer (S)-144 in 70% 
yield over three steps.  
 
          
 
 
 
 
 
 
 
 
 
 
 
SCHEME 33. Synthesis of enantiomerically enriched alcohol (S)-144 by a kinetic resolution 
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The diketo-dioxinone 145 was prepared in seven steps with an overall yield of 21% (Scheme 
34).
20
 The aldehyde 110 was synthesized following a literature procedure via intermediates 
152 and 153, where high yields were observed over three steps.
40
 This was followed by 
vinylogous Mukaiyama-aldol addition of the silyl-enolate 82 with aldehyde 110 to give the 
coupling partner 111 in 61% yield. The product was then oxidized under Dess-Martin 
conditions, followed by TBS deprotection providing hydroxy-keto-dioxinone 112 in 82% 
yield. The last step employed another Dess-Martin oxidation to give diketo-dioxinone 145 in 
52% yield.    
 
 
 
 
 
 
 
 
 
SCHEME 34. Synthesis of diketo-dioxinone 145 via a Mukaiyama type aldolisation 
 
In the final step, diketo-dioxinone 145 was heated in toluene at 110 ºC to induce a retro-
hetero-Diels-Alder reaction where by the resulting ketene was trapped by alcohol (S)-144  
(Scheme 35).
16 
The reactive triketo ester intermediate 143 was smoothly aromatized to give 
resorcylate 142 in 82% yield over two steps. RCM of alkene 142 using second generation 
Hoveyda-Grubbs catalyst gave (S)-zearalenone (5) in 71% yield. 
 
 
 
 
 
 
 
 
 
SCHEME 35. Synthesis of (S)-zearalenone (5) using RCM for macrolactonization 
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2.3 Total synthesis of (S)-zearalenone (5) via intramolecular ketene 
trapping and transannular aromatization 
 
2.3.1 Retrosynthetic strategy I  
 
Our initial retrosynthesis is shown below (Scheme 36). It was envisaged that both macrocyle 
and resorcylate unit could be synthesized from diketo-dioxinone 154 following 
intramolecular ketene trapping, transannular aromatization and ketal deprotection. A Claisen 
condensation using dianion chemistry of keto-dioxinone 10 with Weinreb amide 155 should 
generate the acylketene precursor 154 after silyl deprotection. The Weinreb amide 155 may 
be prepared from alkene 157 via two step procedure including ozonolysis and a Horner-
Wadworth-Emmons type reaction. The literature known fragment 157 will be synthesized 
following a reported procedure.  
 
 
 
 
 
 
 
 
 
 
 
 
SCHEME 36.  Retrosynthetic strategy I of (S)-zearalenone (5)  
 
2.3.1.1 Synthesis of Weinreb amide 155 
 
The enantiomerically pure alcohol (S)-144 was synthesized following the procedure 
described in section 2.2, in an overall yield of 30% (Scheme 33).
20 
The protection of alcohol 
(S)-144 was necessary to avoid deprotonation during the Horner-Wadworth-Emmons 
reaction. The treatment of (S)-144 with triisopropylsilyl chloride (TIPSCl) in 
dichloromethane provided alkene 157 in 68% yield (Scheme 37). Ozonolysis was then 
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performed on the terminal alkene 157 following the method described by Molander et al.
41
 to 
generate the corresponding aldehyde 156 in a yield of 70%. The last step employed the 
Horner-Wadsworth-Emmons reaction as described by Netz et al.,
42
 using phosphite 158 and 
sodium hydride to yield the desired ,-unsaturated Weinreb amide 155 in 80% yield. 
 
 
 
 
 
 
 
 
 
 
SCHEME 37.  Synthesis of Weinreb amide 155 
 
2.3.1.2 Synthesis of keto-dioxinone 10 
 
Keto-dioxinone 10 was prepared by the method developed within the group (Scheme 38).
222  
The lithium enolate 99 derived from dioxinone 65 was formed and acylated using acetyl 
chloride 159 to afford the desired product 10 in 55% yield. The use of 0.6 equivalent of acid 
chloride 159 was crucial to minimize the formation of O-acylated product 160.   
 
 
 
 
 
SCHEME 38. Synthesis of acyl dioxinone 10 
 
2.3.1.3 Towards the synthesis of hydroxy-diketo-dioxinone 154 
 
The acylation using keto-dioxinone 10 has been extensively studied within the group, and 
promising results were obtained when reacted with Weinreb amides.
30,31
 Initially, as a model 
studies, the keto-dioxinone 10 was treated with 2.1 equivalents of LDA at –78 ºC to form the 
dianion intermediate 122 which was trapped by different Weinreb amides (Scheme 39). The 
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use of simple Weinreb amide 161 gave diketo-dioxinone 116 in an excellent yield of 90% 
whereas unsaturated Weinreb amide 162 gave product 145 in a poor yield of 10 – 20%.  In 
the latter case, approximately 10 – 20% of Michael addition product was also observed as one 
of several byproducts. 
 
 
 
 
 
 
 
 
 
SCHEME 39. Reaction of dianion 122 with Weinreb amides 161 and 162 
 
Despite the poor yield of this acylation using ,-unsaturated Weinreb amide 162, it was 
thought that the Michael addition may be minimized by increasing the steric hindrance of the 
substituent, and therefore improve the yield of this transformation. Hence, the acylation of 
Weinreb amide 155 was attempted following identical conditions used for the synthesis of 
dioxinone 145 (Scheme 40). However, the reaction gave numerous byproducts with no sign 
of diketo-dioxinone 163. 
 
 
 
 
 
 
 
SCHEME 40. Acylation of keto-dioxinone 10 with Weinreb amide 155 
 
It is believed that the dianion 122 may be too reactive at this temperature and therefore gave 
rise to unwanted byproducts. In order to investigate its reactivity, a range of conditions were 
attempted (Table 1). A combination of sodium hydride with n-butyllithium was used instead 
of two equivalent of LDA to avoid the generation of free amine in the reaction mixture which 
could have caused side reactions.  
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    Entry Base Time (h) Temperature (°C) Yield (%) S.M. Recovered (%) 
       a        LDA 0.5 78 to 30  10 Decomposition 
       b        LDA 0.5 78  0 95 
       c 
    i) NaH 
ii) n-BuLi 
0.5 0 °C to 78 °C 10 Decomposition 
       d 
    i) NaH 
ii) n-BuLi 
2 0 °C to 30 °C 0 Decomposition 
 
TABLE 1. Investigated conditions for the acylation of keto-dioxinone 10 with Weinreb amide 155 
  
In most of the attempts, the temperature was controlled below 30 ºC to minimize the 
formation of byproducts. However, none of the reactions showed a clean conversion to the 
desired product 163. Nevertheless, the two best results (Entry a and c) were obtained using 
LDA at 78 ºC to 30 ºC, and sodium hydride and n-butyllithium at 0 ºC to 78 ºC 
respectively. Unfortunately, these reaction outcomes were not reproducible and the desired 
product was isolated only once in 10% yield. According to set of conditions (b), it suggested 
that the temperature must be between 78 ºC and 30 ºC to induce the reaction, otherwise the 
dianion 122 seemed to be not sufficiently reactive. A longer reaction time (Entry d) resulted 
in a less clean reaction and no desired product was obtained.    
 
In addition to the non-reproducibility and low yieldng of these reactions, another problem 
was observed during silica gel column chromatography. Diketo-dioxinone fragments such as 
163 readily undergoes aromatization under slightly acidic (silica) or basic conditions to give 
isopropylidene-protected resorcylate 164 (Scheme 41) as previously described by Barrett et 
al. (Scheme 27).
31 
In fact, upon purification on silica gel, roughly 5% of aromatized product 
164 was isolated from the reaction conditions (b). 
 
 
 
 
SCHEME 41. Unwanted aromatization of diketo-dioxinone 163 on silica 
 
These synthetic problems led us to investigate an alternative route to obtain hydroxy-diketo-
dioxinone 154. 
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2.3.2 Retrosynthetic strategy II 
 
This proposed strategy for the synthesis of diketo-dioxinone 154 makes use of Wittig-Horner 
type reaction on aldehyde 156 to generate the required alkene 165 (Scheme 42). The C-
acylation of dioxinone 65 with acyl imidazole derived from ester 165 should provide the 
coupling product 154 after deprotections (thioketal and TIPS). During this synthesis, the 
appropriate ketone will have to be protected as a thioketal to enable purification by silica gel 
column chromatography without aromatization. The phosphonate 166 could be prepared from 
-chloro-ketoester 167 via a Michaelis-Arbuzov reaction. 
 
 
 
 
 
 
 
 
 
 
 
 
SCHEME 42. Retrosynthetic strategy II of hydroxy-diketo-dioxinone 154 
 
2.3.2.1 Synthesis of phosphonate 166 
 
A one-pot method reported by Corbel et al.
43
 was carried out to synthesize the desired 
intermediate 170 in 20% yield over three steps (Scheme 43). The initial step involved 
condensation of 167 with methyl hydrazinecarboxylate in diethyl ether and ethanol to form 
imine 168. This step was necessary in order to avoid Perkow reaction on the ketone. The next 
step consisted of a Michaelis-Arbuzov reaction to successfully synthesize the corresponding 
phosphonate 169. Subsequent treatment with aqueous HCl induced the hydrazinecarboxylate 
deprotection and provided phosphonate 170 in 20% yield, similar to reported value. The low 
overall yield was explained by the loss of material during the work-up procedure as described 
by Corbel et al..
43 
The thioketal protection was initially carried out using aluminium 
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trichloride as a Lewis acid but resulted in a mixture of mono and bis-protected products.
44
 
This was improved by following Barros’s procedure45 using boron trifluoride diethyl etherate 
to provide exclusively the desired product 166 in 84% yield. 
 
 
 
 
 
 
 
 
 
SCHEME 43. Synthesis of phosphonate 166 
 
2.3.2.2 Towards the synthesis of alkene 165 
 
The next step required a selective formation of (E)-alkene 165 using aldehyde 156 and 
phosphonate 166. Initial studies were carried out using 3-phenylpropanal 172 as a model 
substrate in place of valuable aldehyde 156. The standard Horner-Wadsworth-Emmons 
conditions reported by Netz et al.
42 
were initially attempted using 2 equivalents of sodium 
hydride in THF at 0 ºC (Scheme 44).  It was anticipated that this would generate the reactive 
dianion 171 and hence react selectively with aldehyde 172 to afford olefin 173. 
Unfortunately, the reaction resulted in over six unknown products from which the desired 
product 173 was not isolated after purification.       
 
 
 
 
 
 
 
 
 
SCHEME 44. Towards the synthesis of model alkene 173  
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The first concern was the incomplete deprotonation of phosphonate 166. The formation of 
such species has been reported in the literature and it is proposed that use of 
hexamethylphosphoramide (HMPA) is essential for a complete deprotonation. An example is 
given below where -keto ester 170 was treated either with sodium hydride or LDA and 
HMPA to form the dianion 174 and subsequently reacted with aldehyde 175 to give alkene 
176 in 90% yield (Scheme 45).
46, 47
 
 
 
 
 
 
SCHEME 45.  Synthesis of alkene 176 via the formation of dianion 174 using HMPA 
 
Consequently, these conditions were applied on thio-ketal protected phosphonate 166 and 
aldehyde 172 (Scheme 46). For reference purposes, -keto ester 170 was also subjected to 
these conditions. The reaction of phosphonate 166 with aldehyde 172 in the presence of 
HMPA resulted in complete decomposition with no sign of product 173. On the other hand, 
identical reaction contions using -keto ester 170 provided the expected product 177 in a 
reasonable yield of 70%, in a 2:1 ratio of keto/enol forms. 
 
 
   
      
 
 
 
 
SCHEME 46. Synthesis of alkenes 173 and 177  
 
Further investigation on the unsuccessful conversion from 166 to 173 was carried out. A 
possible explanation for this could have been due to the instability of the dianion formed 
during the reaction. This was demonstrated through an experiment where by the phosphonate 
166 was treated with LDA and HMPA in THF at 78 ºC and immediately quenched with 
water. As a result, over five products were observed by TLC analysis with no trace of starting 
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material 166 suggesting the instability of dianion species. Due to this unrewarding step, 
retrosynthetic strategy III was proposed and pursued. 
 
2.3.3 Retrosynthetic strategy III  
 
The third strategy utilizes cross-metathesis, between terminal alkenes (S)-144 and 178, as the 
key step to construct diketo-dioxinone 154 after ketal deprotection (Scheme 47). A ketal-
keto-dioxinone 178 may be synthesized via C-acylation of dioxinone 65 using activated ester 
179. 
 
 
 
 
 
 
 
 
 
 
 
 
 
SCHEME 47. Retrosynthetic strategy III of hydroxy-diketo-dioxinone 154 
 
Three approaches were considered towards the synthesis of ketal 2 (Scheme 48). The first is 
to perform a Wittig reaction on aldehyde 180 to generate alkene 2. As a second option, 
elimination of sulfoxide 181 was also considered as a masked alkene functionality.  Another 
masking group is the norbonene unit, cycloaddition adduct 182 should undergo a retro-Diels-
Alder reaction at high temperature to generate the desired alkene 2.  
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SCHEME 48. Retrosynthesis of activated ketal-ester 179 
 
2.3.3.1 Towards the synthesis of alkene 2 using a Wittig olefination 
 
The synthesis of aldehyde precursor 185 is described below (Scheme 49). The first step was a 
nucleophilic substitution by deprotonated benzyl alcohol to give 183 in a yield of only 10%. 
This was accompanied by the formation of byproduct 186 in 10% yield. This was formed as a 
result of a self-condensation of keto-ester 167 which explained the poor yield of this step. 
The selective ketal protection of keto-ester 183 resulted in a transformation with a yield of 
65%. During the course of this reaction, decarboxylation as well as transesterification by 
ethylene glycol were observed as side reactions. The removal of the benzyl group with 
hydrogenation provided alcohol 185 in high yield. 
    
 
 
 
 
 
 
 
 
 
SCHEME 49. Synthesis of primary alcohol 185 
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Several methods were attempted in order to synthesize the corresponding aldehyde 180. 
Swern oxidation was initially employed following the procedure of Burgada et al. (Scheme 
50).
48
  However, only the cyclized product 187 was isolated in 50% yield with recovery of 
starting material 185. 
 
 
 
 
 
SCHEME 50. Swern oxidation on alcohol 185 
 
Consequently, both Moffatt and pyridinium chlorochromate (PCC) oxidations were 
performed utilizing the procedure described by Deslongchamps et al.
49
 and Herdewijn et 
al..
50
 In both cases, only lactone 187 was isolated as the major component. These outcomes 
displayed the ease of the undesired cyclization process. In fact, the cyclization of 185 was 
observed in the absence of a solvent at room temperature after ten hours. 
 
The reluctance of alcohol 185 to undergo oxidation led to pursue the next strategy option. 
 
2.3.3.2 Synthesis of alkene 2 via a sulphoxide elimination 
 
This proposed synthesis makes use of thermal sulfoxide elimination to reveal the required 
terminal alkene 2. The desired sulfoxide 181 was synthesized in four steps in an overall yield 
of 24% (Scheme 51). The first step involved a conjugate addition of thiophenol 188 to ethyl 
acrylate 189. The reaction was carried out as described by Khan et al.
51
 where perchloric acid 
was used as a catalyst. A Claisen condensation on ester 190 using ethyl acetate 150 gave -
keto ester 191 in 84% yield. The ketal protection using ethylene glycol and p-TSA affored 
ketal 192 in a moderate yield of 50% due to partial decarboxylation and transesterification by 
ethylene glycol. The oxidation step using sodium periodate was performed in a mixture of 
water and methanol to yield sulfoxide 181 in an excellent yield of 99%.  
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SCHEME 51. Synthesis of alkene 2 
 
The next step was the thermal elimination of sulfoxide 181 to generate the alkene 2. This 
reaction was optimized by investigating several conditions to give the best yield of 77% 
(Table 2). 
 
TABLE 2. Optimization of thermal sulfoxide elimination 
 
All the reactions were conducted under microwave conditions. In general, longer reaction 
times gave higher yields. However in reaction (d), a poor yield of 28% was observed due to 
partial decomposition of product 2. The reaction in xylene (Entry g) gave the best yield of 
77% with no sign of decomposition. The use of stoichiometric amount of pyridine as a base 
proved to be effective to trap the sulfenic acid formed and therefore avoid further 
decomposition.
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Although the desired alkene 2 was successfully synthesized, this route was rather long and 
non-scalable. This led us to finding a shorter and scalable route as an alternative. 
Entry Solvent Base Temperature (ºC) Time (h) Yield (%) 
a chloroform - 95 0.5 0 
b toluene - 130 0.5 10 
c toluene - 130 3 30 
d toluene - 130 7 28 
e toluene pyridine 130 3 30 
f xylene pyridine 145 0.5 30 
g xylene pyridine 145 1.5 77 
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2.3.3.3 An improved synthesis of alkene 2 via a retro-Diels-Alder reaction 
A new synthetic route to alkene 2 was proposed where flash vacuum pyrolysis (FVP) is 
employed to induce a retro-Diels-Alder reaction of norbonene unit (Scheme 52).   
 
Norbonene-2-carboxylic acid (1) was treated with carbodiimidazole (CDI) in THF and 
subsequently reacted with the lithium enolate of ethyl acetate 150 to provide -keto ester 193 
in 85% yield. Three equivalents of ethyl acetate were required in this transformation due to 
deprotonated ethyl acetate being consumed by deprotonation of acidic protons on the product 
193. The ketal protection of 193 was carried out using ethylene glycol, p-TSA and ethyl 
orthoformate to give ketal 194 in 82% yield. In contrast, the standard ketal protection using 
Dean-Stark conditions gave only 15% of desired product 194 along with decarboxylation and 
transesterification as side reactions. Flash vacuum pyrolysis (FVP) was then performed using 
a Carbolite furnace at 580 ºC under 0.18 mbar pressure to yield olefin 2 in 70%.
53
  FVP was 
performed twice on 15 g scale and reproducible yields of 70% were obtained. 
 
 
 
 
 
SCHEME 52. Synthesis of alkene 2 via a flash vacuum pyrolysis 
This new strategy resulted in a better overall yield of 49% over three steps to synthesize the 
desired intermediate 2. 
 
2.3.3.4 Synthesis of hydroxy-diketo-dioxinone 154 
 
Two approaches were considered to construct hydroxy-diketo-dioxinone 154 (Scheme 53).  
The first involved a cross-metathesis followed by alkylation with dioxinone 65 whereas the 
second approach reversed the order of the steps; alkylation followed by a cross-metathesis.  
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SCHEME 53.  Two proposed synthetic approaches for the preparation of diketo-dioxinone 154 
 
2.3.3.4.1 Approach I 
 
The synthesis of olefin 195 was carried out via cross-metathesis between two terminal 
alkenes 157 and 2 (Scheme 54). The procedure was followed as described by Grubbs et. al..
54
  
The use of second generation Grubbs catalyst 197 afforded the coupling product 195 in a 
moderate yield of 60% with 10% recovery of unreacted 2. A dimerization of terminal alkene 
157 was also observed as a side reaction in 15% yield. The use of second generation 
Hoveyda-Grubbs catalyst 196 gave a lower yield of 40% and increased the formation of 157 
dimer. The ester hydrolysis was performed using 5% sodium hydroxide solution in ethanol to 
produce carboxylic acid 198 in 89% yield. 
 
 
 
 
 
 
 
 
 
SCHEME 54. Synthesis of carboxylic acid 198 
57 
 
Having acid 198 in hand, various leaving groups were investigated for the acylation with 
dioxinone 65. The following table shows the attempted leaving groups along with their 
reaction conditions (Table 3). 
 
 
 
 
 
Entry R Temperature (ºC) Time (h) Yield (%) 
a Cl 78 0.5 0 
b 
 
78 0.5 0 
c 
 
25 0.5 0 
 
TABLE 3. C-Acylation of dioxinone 65 with different electrophiles 199 
 
The corresponding acid chloride was synthesized using oxalyl chloride with a catalytic 
amount of dimethylformamide (DMF) in dichloromethane. The acylation reaction with 65 
however resulted in immediate decomposition. This in turn led us to investigate into less 
reactive electrophile such as imidazole and benzotriazole derivatives. The imidazole 
derivative was synthesized using CDI in THF whereas benzotriazole derivative was obtained 
via an EDC coupling reaction. Unfortunately, both reactions with lithium enolate of 
dioxinone 65 gave numerous unknown products with no trace of product 200. We 
anticipitated that these unsuccessful reactions are due to molecular complexity of the 
substrate during the alkylation step.  
 
2.3.3.4.2 Approach II 
 
Hence, an alternative route was designed where the alkylation is carried out at earlier stage in 
the synthesis. Thus, the alkylation of the activated ester of 2, rather than 195, was 
investigated (Scheme 55). 
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Hydrolysis of 2 was carried out using potassium hydroxide in ethanol. The corresponding 
free carboxylic acid was obtained by adjusting the aqueous pH to 3. An accurate pH 
adjustment was required to obtain a high yield since slight excess of acid resulted in 
deprotection of ketal group and polymerization was observed in some cases. The carboxylic 
acid was activated as its benzotriazole derivative using EDC hydrochloride salt to give acyl 
benzotriazole 201 in 70% yield over two steps. The choice of this leaving group arose from 
the fact that successful alkylation between dioxinone 65 and benzotriazole derivatives have 
been previously documented.
55
 The alkylation with lithium enolate derived from dioxinone 
65 in the presence of zinc chloride gave keto-dioxinone 178 in a satisfying yield of 63%. The 
use of zinc chloride was considered to reduce the O-acylation by coordination to the oxygen 
as a Lewis acid.
30
 In fact, the equivalent reaction without the zinc chloride resulted in yields 
between 35 – 50%. The cross-metathesis between alkenes 178 and (S)-144 proceeded with 
excellent E/Z selectivity and gave the desired olefin 3 in 75% yield. Pleasingly, no protection 
of hydroxyl functionality was required during this transformation.   
 
 
 
 
 
 
 
 
 
 
SCHEME 55. Synthesis of hydroxy-diketal-dioxinone 3 by a cross-metathesis 
 
2.3.3.5 Synthesis of (S)-zearalenone (5) 
 
The final steps involved macrocyclization via intramolecular ketene trapping and subsequent 
ketal deprotection and transannular aromatization to form the resorcylate unit (Scheme 56). 
The hydroxy-acylketene precursor 3 was subjected to ketene trapping conditions in toluene to 
give the desired macrocycle 4 in an excellent yield of 83%. The reaction was carried out 
under dilute conditions to prevent intermolecular side-reactions. A mild ketal deprotection 
was performed on macrocycle 4 to generate triketo-ester macrocycle 202 as a reaction 
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intermediate (triketo-esters are known to be unstable). The 
1
H NMR of 202 showed a 
complex mixture of enol and keto forms as expected. Transannular aromatization using 
cesium carbonate and acidification afforded (S)-zearalenone (5) in a gratifying yield of 55% 
over two steps. 
 
 
 
 
 
 
 
SCHEME 56. Synthesis of (S)-zearalenone (5) utilizing transannular aromatization 
 
2.4 Conclusion 
 
In summary, we report a novel synthesis of (S)-zearalenone (5) utilizing intramolecular 
capture of acylketene to form triketo ester macrolide, and transannular aromatization to form 
the resorcylate unit.
56
 The use of FVP enabled multi-gram preparation of the key cross 
metathesis partner 2. It is noteworthy that the late transformations of our synthesis closely 
mimic the biosynthesis of resorcylate natural products. Its applicability will be further 
explored through the synthesis of more complex natural product such as LL-Z1640-2 (9).  
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CHAPTER THREE: 
 
RESULTS AND DISCUSSION 
 
-LL-Z1640-2- 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
61 
 
3.  LL-Z1640-2 
 
3.1 Isolation, structure and biological properties 
 
LL-Z1640-2 (9) was first reported in 1978 by Ellestad et al.,
57
 however no significant 
biological activity was discovered until in 2003 (Figure 6). Like other members of the RALs 
family, LL-Z1640-2 (9) targets the ATP-binding pockets of kinases, additionally an 
irreversible and highly selective TAK1 inhibitor (IC50 = 8.1 nM).
2 
TAK1 is a MAPKKK 
involved in the p38 signalling cascade for pro-inflammation signals such as cytokines. The 
selectivity profile of this compound appeared to be promising, showing 50-fold selectivity 
over other MAP kinases including MEK1 (411 nM) and no inhibitory effects were observed 
on MEKK1, ASKN and MKK4.
58
 It has also been proven that cis-enone functionality within 
LL-Z1640-2 (9) is essential for the TAK1 inhibition. This is demonstrated by its cis-enol 
derivative, LL-Z1640-4 (203), which is inactive as TAK1 inhibitor however exhibit both 
antiviral and antiprotozoan activity (Figure 6). 
 
 
 
 
 
 
 
 
FIGURE 6. LL-Z1640-2 (9) and LL-Z1640-4 (203) 
 
 
 
3.2 First total synthesis of LL-Z1640-2 (9) 
 
The first synthesis was achieved by Tatsuta and co-workers in 2001.
59
 A brief retrosynthesis 
is illustrated below (Scheme 57). Due to likely isomerisation of the cis-enone to its trans-
isomer, this functionality was incorporated in the last step via selective allylic oxidation. 
They envisioned forming the macrocycle via a Mukaiyama macrocyclization which led to 
intermediate 204. The (Z)-alkene was synthesized by a Corey-Fuchs reaction followed by 
Lindlar hydrogenation of the resulting alkyne. A Sonogashira coupling was utilized to attach 
the required side chain on the aromatic unit and the carbonate portion was removed by -allyl 
reduction.  
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SCHEME 57. Retrosynthesis of LL-Z1640-2 (9) by Tatsuta et al.
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The required stereochemistry of the two alcohols present in the final product was envisaged 
to originate from D-ribose (206). Hence, alkyne 207 was derived from D-ribose (206) in six 
steps with an overall yield of 36% (Scheme 58). Subsequent engagement in a Sonogashira 
coupling to iodobenzoate 208 was followed by MOM protection to give fully protected 
resorcylate 205 in 83% yield over two steps. The next five steps involved Lindlar 
hydrogenation, -allyl reduction, deprotection, Swern oxidation and a Corey-Fuchs reaction 
to afford dibromo-alkene 209 in very high yield. Further extension of the side chain was 
achieved by alkylation using propylene oxide. Lindlar hydrogenation of the resulting alkyne 
gave (Z)-olefin which was in turn saponified with sodium hydroxide to give cyclization 
precursor 204. The Mukaiyama macrolactonization using pyridinium salt 210 gave the 
desired macrocycle which was further elaborated to give LL-Z1640-2 (9) in 10% yield over 
six steps. It is worth noting that this particular macrolactonization is impressive since the 
secondary alcohol had to react with a 2,6-disubstituted benzoate.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
SCHEME 58. The first synthesis of LL-Z1640-2 (9) 
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3.3 Total synthesis of LL-Z1640-2 (9) via intramolecular ketene trapping   
and transannular aromatization 
 
3.3.1 Retrosynthetic strategy I  
 
Our initial retrosynthesis takes advantage of ketal-keto-dioxinone 178, used in the total 
synthesis of (S)-zearalenone (5) (Scheme 59). LL-Z1640-2 (9) should be available by 
performing intramolecular ketene trapping, deprotections and transannular aromatization on 
hydroxy-keto-dioxinone 211. The cross-metathesis between two main building blocks 178 
and 212 could be followed by partial hydrogentation of the resulting alkyne and PMB 
deprotection to provide dioxinone fragment 211.  
 
 
 
 
 
 
 
 
 
SCHEME 59. Retrosynthetic strategy I of LL-Z1640-2 (9) 
 
The desired alkene 212 could be obtained from aldehyde 213 following Wittig olefination 
(Scheme 60). The propargylic ketone unit should be accessible via addition of lithiated 
acetylene 214 on Weinreb amide 215. Oxidation of the primary alcohol 216 to the 
corresponding acid could follow by Weinreb amide formation to provide 215. A reduction of 
acetonide 218 would result in diol 217 which may be further elaborated to 216 by a selective 
protection of the less hindered alcohol. It was envisaged that the required stereochemistry of 
the natural product would come from the deoxy sugar, 2-deoxy-D-ribose (53).  
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SCHEME 60. Retrosynthetic analysis of terminal alkene 212  
 
3.3.1.1 Synthesis of Weinreb amide 215 
 
The desired acetonide 218 was synthesized in 70% yield following the procedure described 
by Barbat et al. (Scheme 61).
60
  Subsequent reduction using lithium aluminium hydride 
provided the diol 217 in 95% yield. The selective protection of the less hindered alcohol was 
carried out using tert-butyldiphenysilyl chloride (TBDPSCl) to give the desired product 216 
in 53% yield.
61
 During this transformation, the increase in reaction concentration not only led 
to a better yield in general but also reduced formation of bis-protected by-product. The next 
step utilized a Parikh-Doering oxidation on primary alcohol 216 to generate the 
corresponding aldehyde 220 in 80% yield. Further derivatization was executed by Pinnick 
oxidation and an amide coupling reaction using PyBOP 221 to give Weinreb amide 215 in 
70% yield over two steps. 
 
 
 
 
 
 
 
 
 
SCHEME 61. Synthesis of Weinreb amide 215 
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3.3.1.2 Synthesis of alkyne 214 
 
The synthesis of acetylene fragment 214 was carried out following the method described by 
Lett et al. (Scheme 62).
62
 (S)-Ethylene oxide (223) was treated with lithiated TMS-acetylene 
derived from 224 to yield the secondary alcohol 225 in 70%.
62,63 
PMB-protection using 
acetimidate 226 and TMS-deprotection under basic conditions provided alkyne 214 in 70% 
yield over two steps. 
 
 
 
 
 
 
SCHEME 62. Synthesis of alkyne 214 
 
3.3.1.3 Towards the synthesis of propargylic ketone 212 
 
Having synthesized Weinreb amide 215 and alkyne 214, the coupling step was performed 
using n-butyllithium in THF (Scheme 63). A procedure described by Brummond et al. was 
followed.
64
 The reaction initially resulted in a low yield of 30% however it was later 
optimized to provide the propargylic ketone 227 in 80% yield. The deprotonation of the 
acetylene 214 was found to be relatively slow and therefore longer reaction time gave 
increased yields. The deprotection of the TBDPS group was attempted using 
tetrabutylammonium fluoride (TBAF) however immediate decomposition was observed. 
Most likely due to the propargylic ketone functionality being labile under basic conditions.  
  
 
 
 
 
SCHEME 63. Towards the synthesis of alcohol 228 
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3.3.2 Retrosynthetic strategy II 
 
This strategy consists of a Wittig olefination at early stage in the synthesis to incorporate the 
alkene unit (Scheme 64). The propargylic ketone 212 could be synthesized from the primary 
alcohol 230 following the same strategy as mentioned before via the formation of Weinreb 
amide 229. A Wittig reaction on acetonide 218 should generate the desired alkene 230. This 
alternative route turned out to be more efficient and a much shorter route to obtain the desired 
product 212. 
 
 
 
 
SCHEME 64. An improved retrosynthetic analysis of terminal alkene 212  
 
3.3.2.1 Synthesis of propargylic ketone 212  
 
The 5-step synthesis of propargylic ketone 212 is illustrated below (Scheme 65). Wittig 
olefination on acetonide 218 proceeded successfully to give olefin 230 in 66% yield. Parikh-
Doering oxidation was followed by Pinnick oxidation and an amide coupling using PyBOP 
221 to yield the desired Weinreb amide 229 in 60% over there steps. The coupling step with 
acetylene 214 gave alkyne 212 in an excellent and reproducible yield of 80% on a gram scale.   
 
 
 
 
 
 
 
 
 
 
SCHEME 65. Synthesis of propargylic ketone 212 
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3.3.2.2 Towards the synthesis of ketal-keto-dioxinone 211  
 
The synthesis of dioxinone fragment 232 was then attempted by cross-metathesis between 
olefins 212 and 178 (Scheme 66). It was anticipated that the presence of the propargylic 
ketone unit may interfere with the ruthenium catalyst and therefore make the catalyst less 
available to the alkene. Intramolecular enyne metathesis was also taken into consideration as 
a potential side reaction. In fact, the use of either second generation Hoveyda-Grubbs or 
Grubbs catalysts gave no formation of product 232 and both reactants were recovered with no 
sign of dimerization. The reaction was also performed at 60 ºC in toluene however a similar 
outcome was observed. The terminal alkene 212 was also treated with methyl acrylate under 
identical conditions but the desired coupling product was not observed. 
 
 
 
 
 
 
 
SCHEME 66. Towards the synthesis of ketal-keto-dioxinone 232 
 
In order to assess whether the propargylic ketone unit was interfering with the ruthenium 
catalyst, the following cross-metathesis was carried out using alkenes 230 and 178 (Scheme 
67). As a result, dioxinone 233 was isolated in 53% yield with recovery of approximately 
35% of unreacted alkene 178.   
 
 
 
 
 
SCHEME 67. Synthesis of dioxinone 233 
 
This outcome suggested that the propargylic ketone may indeed be interfering with the 
catalyst and therefore the triple bond was masked as a cobalt complex 234 (Scheme 68). This 
idea was inspired by Danishefsky et al.
9 
where they applied this strategy to perform ring-
closing metathesis in the presence of a propargylic ketone (refer to Chapter I, sub-section 
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1.3.4). The corresponding cobalt complex 234 was synthesized in a high yield of 93% using 
dicobalt octacarbonyl. It was then subjected to cross-metathesis with olefin 178 however both 
alkenes were left unreacted after prolonged heating at reflux (45 h). 
 
 
 
 
 
 
 
 
 
SCHEME 68. Towards the synthesis of cobalt complex 235 
 
Due to these synthetic difficulties, an alternative route to hydroxy-diketo-dioxinone fragment 
was proposed. 
 
3.3.3 Retrosynthetic strategy III 
 
Our final approach takes advantage of the efficient C-acylation of keto-dioxinone (refer to 
Chapter I, sub-section 1.8.2) with an appropriate Weinreb amide using dienolate chemistry. 
Based on this strategy, a new retrosynthesis was envisaged as followed (Scheme 69). LL-
Z1640-2 (9) should be available following selective methylation, global deprotection, and 
selective allylic oxidation of resorcylate 236. We considered that the resorcylate unit could be 
constructed via intramolecular capture of an acylkenene, derived from dioxinone 237, and 
late-stage transannular aromatization. Subsequent hydrogenation using Lindlars conditions 
should yield resorcylate 236. The diketo-dioxinone 237 may be accessible by C-acylation of 
keto-dioxinone 10 with Weinreb amide 238 via the formation of dilithium enolate. 
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SCHEME 69. Retrosynthetic strategy III of LL-Z1640-2 (9)  
 
3.3.3.1 Synthesis of Weinreb amide 238  
 
Weinreb amides 243 and 244 were synthesized in five steps from acetonide 218 (Scheme 70). 
Lactol 218 was subjected to Wittig olefination with (carbethoxymethylene)triphenyl-
phosphorane to generate -unsaturated ester 239 with excellent E:Z selectivity. Following 
Parikh-Doering oxidation, aldehyde 240 was obtained and subsequent treatment with lithiated 
alkyne 214 followed by protection of the resulting propargylic alcohol gave alkynes 241 and 
242 in 25% and 55%, respectively. The two esters 241 and 242 were then transformed into 
Weinreb amides 243 and 6 in excellent yields. Since the preparation of the ethoxymethylether 
(EOM) derivative 6 resulted in higher overall yield than tri-isopropylsilyl (TIPS) derivative 
243, this substrate was taken forward in the synthesis. 
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SCHEME 70.  Synthesis of Weinreb amides 243 and 6 
 
3.3.3.2 Towards the synthesis of resorcylate 247 Approach I 
 
The alkylation of Weinreb amide 6 using keto-dioxinone 10 was performed following a 
methodology developed within the group (refer to Chapter I, sub-section 1.7.2). The dilithium 
dienolate derived from keto-dioxinone 10 was transmetalated with diethyl zinc in situ and 
reacted with Weinreb amide 6 to give diketo-dioxinone 244 in a modest yield of 31% 
(Scheme 71). The best conversion and yield were observed when 2.4 equivalents of 10 were 
used. Paramethoxybenzyl (PMB) deprotection was carried out using 2,3-dichloro-5,6-
dicyano-1,4-benzoquinone (DDQ) in dichloromethane to afford the acylketene precursor 245. 
The intermediate 245 was then taken to undergo ketene trapping and transannular 
aromatization to give resorcylate 246 in a pleasing yield of 24% over three steps. The 
hydrogenation of alkyne 246 under Lindlar conditions gave no sign of desired product 247 
and unreacted starting material was recovered. This outcome is believed to be because of the 
phenol functionality interfering with palladium during the reaction. It was therefore planned 
to perform the hydrogenation at an earlier stage in the synthesis.    
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SCHEME 71. Towards the synthesis of resorcylate 247 – Approach I 
 
3.3.3.3 Synthesis of resorcylate 247 Approach II 
 
Lindlar reduction of alkyne 6 provided solely the desired Z-alkene 248 in 91% yield (Scheme 
72). Alkylation of Weinreb amide 248 with a dianion enolate derived from keto-dioxinone 
10, followed by PMB deprotection provided the coupling product 7 in an excellent yield of 
48% over two steps. The transmetalation of dilithium enolate using diethyl zinc was essential 
for complete consumption of Weinreb amide 248 and also minimized the formation of the 
Michael addition adduct. In fact, in the absence of diethyl zinc, the reaction proceeded in 
18% yield. In addition, the purification of diketo-dioxinone 7 on silica gave no aromatized 
product, on the contrary to the previous result found during the synthesis of (S)-zearalenone 
(5). This is likely due to the additional steric hindrance of the side chain preventing 
aromatization. Thermolysis of diketo-dioxinone 7 resulted in the generation of its 
corresponding acylketene which was efficiently trapped by the alcohol. Subsequent 
aromatization gave the desired resorcylate 247 in a satisfying yield of 55% over three steps.  
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SCHEME 72. Synthesis of resorcylate 247 – Approach II 
 
3.3.3.4 Towards the synthesis of resorcylate 247 Approach III 
 
In parallel, an alternative strategy was also suggested with the aim to improve the overall 
yield of the synthesis of diketo-dioxinone 237. This approach was inspired by the work 
discovered within the group (refer to Chapter I, sub-section 1.7.1) where selective C-6 
alkylation of keto-dioxinone 84 could be achieved using a mild base with the appropriate acid 
chloride 249 (Scheme 73).
20 
The palladium mediated deallylation followed by PMB 
deprotection could generate the desired coupling product 237. 
 
 
 
 
 
 
SCHEME 73. An alternative retrosynthesis of diketo-dioxinone 237 
 
The synthesis of keto-ester dioxinones 252 and 253 was attempted following the method 
described by Barrett et al..
20
 The hydrolysis of both esters 241 and 242 proceeded in 
moderate yields of 35 and 65%, respectively (Scheme 74). Different bases were investigated 
for hydrolysis, however no improvement was observed in any cases. The formation of the 
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corresponding acid chlorides with oxalyl chloride was followed by selective C-6 alkylation of 
dioxinone 84, however desired products 252 and 253 were not obtained. Decomposition was 
observed where R = EOM, and an intramolecular Michael addition was observed where R = 
TIPS (Scheme 74).  
 
 
 
 
 
 
 
 
 
 
 
 
SCHEME 74. Towards the synthesis of diketo-ester dioxinones 252 and 253 
 
3.3.3.5 Synthesis of LL-Z1640-2 (9)  
 
Consequently, approach II proved to be the best route to synthesize the diketo-dioxinone 
fragment as well as the resorcylate core. The synthesis of LL-Z1640-2 (9) was completed 
following three steps from resorcylate 247 (Scheme 75). Regioselective methylation was 
achieved utilizing methyl iodide in acetone to give resorcylate 254 in 78% yield. Global 
deprotection using polymer-supported sulfonic acid in MeOH gave the triol intermediate 
which in turn underwent allylic oxidation with Dess-Martin periodinane (DMP) to give LL-
Z1640-2 (9) in 66% yield over two steps. It is noteworthy that longer reaction time on allylic 
oxidation step resulted in a mixture of over-oxidized products. 
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SCHEME 75. Synthesis of LL-Z1640-2 (9) 
 
3.4 Conclusion 
 
In summary, we report a 15-step biomimetic total synthesis of TAK-kinase inhibitor LL-
Z1640-2 (9) without the use of phenolic protection.
65
 The preparation of diketo-dioxinone 
fragment 7 was performed via C-acylation of keto-dioxinone 10 with an appropriate Weinreb 
amide 248 in good yield. The noteworthy steps also include the use of intramolecular ketene 
trapping and transannular aromatization of triketo-ester macrocycle in a one-pot procedure to 
build the resorcylic core 247 in high yields. Further elaboration of its applications will be 
explored towards the synthesis of dimeric resorcylate, tragoponol (16). 
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CHAPTER FOUR: 
 
RESULTS AND DISCUSSION 
 
        -TRAGOPONOL- 
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4. Tragoponol 
 
4.1 Isolation, structure and biological properties 
 
Tragoponol (16) was initially isolated from the roots of Tragopon porrifolius in Spain in 
2003, and later re-isolated in Italy in 2007.
66,67
  This natural product is the first known 
dimeric dihydroisocoumarin featuring a 7,8,15,16-tetrahydrodibenzo[c,i][1,7]dioxacyclodod 
ecine-5,13-dione ring system (Figure 7). The analysis of the circular dichroism of tragoponol 
(16) revealed that both stereogenic centres were (S)-configurations.
67
 The most similar known 
natural product would be lisianthioside (256) which is a dimeric secoiridoid glycoside. 
Tragopon porrifolius also yielded glucosides 257 and 258 along with monomeric 
dihydroisocoumarine, thunberginol C (259). During NMR characterization of 16, degradation 
was observed in DMSO-d6 forming its benzoic acid derivative 255. The biological activity of 
this natural product is still unknown however, its interesting structural features attracted our 
attention towards total synthesis. There is no reported synthesis of tragoponol (16) to date.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FIGURE 7. Tragoponol (16), degradated product 255, lisianthioside (256) 
glucosides 257, 258, and thunberginol C (259) 
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4.2 Towards the total synthesis of tragoponol (16) via inter- and intra 
molecular capture of acylketenes and aromatizations 
 
4.2.1 Retrosynthetic strategy I  
 
Tragoponol (16) was chosen as a new target as it was a suitable substrate for applications of 
inter- and intra-molecular ketene trappings which could then followed by two separate 
aromatizations to construct its dilactone structure.  
Our first retrosynthesis is illustrated below where two key building blocks (S)-261 and (S)-
262 are used as advanced intermediates (Scheme 76). It was envisaged that tragoponol (16) 
could be obtained from hydroxy-diketo-dioxinone 260 following intramolecular ketene 
trapping and transannular aromatization. We also aimed to synthesize the left hand side 
resorcylate utilizing a ketene-trapping and aromatization sequence. The use of phenyl-keto-
dioxinone (S)-261 was proposed as it is known to decompose at lower temperature (~ 65 ºC) 
to generate the corresponding ketene via a retro-Diels Alder reaction. This context will be 
discussed in the next section. This approach should allow us firstly to achieve the selective 
intermolecular ketene trapping between (S)-261 and (S)-262, which in turn could aromatize to 
form the first resorcylate unit. 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
SCHEME 76. Retrosynthetic strategy I of tragoponol (16) 
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The diketo-dioxinones (S)-261 and (S)-262 should be accessible via C-acylation of keto-
dioxinones 263 and 10 with appropriate Weinreb amides (S)-264 and (S)-265 (Scheme 77). 
To start with, the synthesis will be carried out as racemate in order to optimize the best 
synthetic route. 
 
 
 
 
 
 
 
 
SCHEME 77. Retrosynthesis of diketo-dioxinones (S)-261 and (S)-262 
 
4.2.1.1 Various rates of dioxinone fragmentation depending on C-2 substituents 
 
In 2009, Barrett and co-workers showed that the rate of dioxinone fragmentation was 
enhanced by introducing aromatic substituents on the C-2 position.
30 
The extent of acylketene 
formation from dioxinones 267, 65, 268, and 269 were investigated as followed (Scheme 78). 
As a result, a range of yields from 5% to 95% was observed when the reaction was stopped 
after 1.5 hours. The authors speculated that nearly complete retro-Diels-Alder reaction and 
ketene trapping was observed using dioxinone 269 due to the overlap of the phenyl π-system 
with σ* of the O-CO during the fragmentation. 
   
 
 
 
 
 
 
 
 
 
 
 
SCHEME 78. Conversion efficiencies for ketene generation and trapping 
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The drawback of diphenyl-dioxinone 269 lied on its instability even at room temperature. 
Purification by silica gel column chromatography resulted in major decomposition via retro-
Diels–Alder reaction. This led us to use phenyl-dioxinone 268 instead which is easier to 
handle and relatively stable at room temperature. 
 
4.2.1.2 Synthesis of phenyl-keto-dioxinone 263  
 
The synthesis keto-dioxinone 263 was carried out following a literature procedure (Scheme 
79).
30
 The initial condensation step resulted in a moderate yield of 33% and reproducible 
yields were observed on scale-up. Some decomposition of 268 was observed during silica gel 
column chromatography reflecting the poor yielding of this step. The phenyl-keto-dioxinone 
263 was synthesized by acylation of lithiated dioxinone 268 with acetyl chloride at 78 oC in 
a yield of 40%. 
 
 
 
 
 
SCHEME 79. Synthesis of phenyl-keto-dioxinone 263 
 
4.2.1.3 Synthesis of phenyl-diketo-dioxinone rac-261  
 
 
The diketo-dioxinone rac-261 was successfully prepared in five steps from commercially 
available starting material (Scheme 80). The β-keto-ester 11 was treated with boron 
tribromide in dichloromethane to give phenol 272 in 90% yield. Subsequent sodium 
borohydride reduction gave the corresponding alcohol 273 in a reasonable yield of 60%. A 
bis-silyl protection and nucleophilic substitution by amine 222 resulted in Weinreb amide 
rac-264 in 74% over two steps. The alkylation with the dianion derived from phenyl-keto-
dioxinone 263 gave the desired coupling product rac-261 in an excellent yield of 74%. The 
use of diethyl zinc as well as higher reaction concentration increased the reaction rate and full 
conversion was observed after 2 hours at 5 oC. 
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SCHEME 80. Synthesis of diketo-dioxinone rac-261 
 
4.2.1.4 Synthesis of diketo-dioxinone rac-262  
 
In a similar manner, diketo-dioxinone rac-262 was prepared in four steps from 11 (Scheme 
81). Sodium borohydride reduction on β-ketoester 11 generated the corresponding alcohol 
274 in 77% yield. Following silyl protection and ester activation, Weinreb amide rac-265 
was prepared in an excellent yield of 94% over two steps. The C-acylation of dilithium 
dienolate derived from keto-dioxinone 10, with rac-265 gave the desired diketo-dioxinone 
275 in a high yield of 85%. In the absence of diethyl zinc, the reaction proceeded in 69% 
yield with approximately 10% recovery of starting material illustrating the importance as an 
additive. The silyl deprotection was achieved using hydrogen fluoride in pyridine to provide 
the secondary alcohol rac-262, which was directly used in the next step due to instability 
issues. It was essential to perform the silyl deprotection under neutral conditions otherwise 
aromatization was observed specially in slightly basic conditions (e.g. use of 
tetrabutylammonium fluoride (TBAF)). 
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SCHEME 81. Synthesis of diketo-dioxinone rac-262 
 
4.2.1.5 Towards the synthesis of tragoponol (16)  
 
Both diketo-dioxinones rac-261 and rac-262 in hand, the initial selective intermolecular 
ketene trapping was attempted followed by an aromatization (Scheme 82). The first step was 
carried out in toluene at 78 ºC to provide the penta-ketone 276 as an intermediate. In the next 
step, we intended to selectively aromatize the triketo-ester unit over the diketo-dioxinone 
fragment. Unfortunately, the subsequent treatment with cesium carbonate in methanol 
followed by acidification gave no desired product 277. Instead, three possible byproducts 
278, 279 and 280 were identified by mass spectrometry. These byproduct formations were 
most likely as a result of undesired –OTBS elimination under acidic conditions along with 
aromatization of diketo-dioxinone unit to form isopropylidene-protected resorcylates.  
 
As a consequence, an alternative approach was investigated where the second diketo-
dioxinone unit is introduced at a later stage after the initial resorcylate formation. A milder 
aromatization was also required to avoid –OTBS elimination. 
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SCHEME 82. Towards the synthesis of resorcylate 277 and associated byproducts 278, 279, and 280 
 
4.2.2 Retrosynthetic strategy II  
 
This approach utilized the same acylketene precursor 260 as strategy I to synthesize 
tragoponol (16). We thought to incorporate the second keto-dioxinone unit at a later stage via 
C-acylation of keto-dioxinone 10 with Weinreb amide (S,S)-281 (Scheme 83). The silyl 
deprotection of the resulting diketo-dioxinone could provide the key intermediate 260. The 
left hand side resorcylate (S,S)-281 should be accessible utilizing intermolecular ketene 
trapping and aromatization between diketo-dioxinone (S)-12 and alcohol (S)-13. A seek for 
mild aromatization conditions will be required for this step to avoid the formation of 
aforementioned byproducts. 
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SCHEME 83. Retrosynthetic strategy II of tragoponol (16) 
 
4.2.2.1 Synthesis of Weinreb amide rac-13 and diketo-dioxinone rac-12 
 
The previously prepared Weinreb amide rac-265 (refer to sub-section 4.2.1.4) was reacted 
with tetrabutylammonium fluoride (TBAF) to afford alcohol rac-13 in 98% yield (Scheme 
84). Diketo-dioxinone moiety rac-12 was obtained by C-acylation of keto-dioxinone 10, via 
dianion, with Weinreb amide rac-264 (refer to sub-section 4.2.1.3 for its preparation) in 89% 
yield. 
 
 
 
 
 
 
 
 
 
SCHEME 84. Synthesis of building blocks rac-13 and rac-12 
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4.2.2.2 Synthesis of resorcylate rac-281 using mild aromatization conditions 
 
The first example of aromatization of a triketo-ester under neutral conditions was established 
by Basset and Barrett in 2010.
29
 The diketo-dioxinone 116 was heated in the presence of 
molecular sieves and methanol in a sealed tube to give resorcylate 61 in 82% yield (Scheme 
85). The acyl-ketene is trapped in situ by the methanol and subsequently aromatized in one-
pot procedure. These conditions were then applied to our substrate with the aim to achieve 
aromatization without undesired –OTBS elimination. 
 
 
 
 
SCHEME 85. The aromatization of triketo-ester under neutral conditions
29
 
 
Hence, diketo-dioxinone rac-12 and alcohol rac-13 was subjected to neutral aromatization 
conditions to give resorcylate rac-14 in 37% yield (Scheme 86). The formation of desired 
product was accompanied with byproduct 282 (25%) as a result of benzylic dehydration of 
starting material rac-13. 
 
 
 
 
 
 
 
 
SCHEME 86. The ketene trapping-aromatization of diketo-dioxinone rac-12 under neutral conditions  
 
We believed that this may be avoided by firstly performing the ketene trapping to consume 
rac-13 in the absence of molecular sieves. Once the triketo-ester is formed, it would be 
subjected to mild aromatization conditions to generate the required resorcylate. As a 
consequence, the following experiment was designed (Scheme 87). The initial acylketene 
capture in toluene was followed by neutral aromatization to give an improved yield of 45% 
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with no dehydrated byproduct 282. However, transesterification of triketo-ester by methanol 
was now observed to give 283 in 20% yield.   
 
 
 
 
 
 
 
 
SCHEME 87. Synthesis of resorcylate rac-14 and transesterified byproduct 283 
 
Although a moderate yield was observed using this procedure, a further improvement was 
crucial for scale-up purposes. This was achieved by minimizing the transesterification of 
triketo-ester intermediate using a mixture of iso-propanol and methanol (Scheme 88). The 
reaction now proceeded in a satisfying yield of 81% with a trace amount of byproduct 284, 
presumable due to less nucleophilicity of bulky proton source, iso-propanol. 
 
 
 
 
 
 
 
 
SCHEME 88. An improved synthesis of resorcylate rac-14 using a mixture of iso-propanol and methanol 
 
The synthesis of resorcylate rac-281 was completed by a regioselective methylation (Scheme 
89). Phenol rac-14 was treated with methyl iodide and potassium carbonate in acetone to 
smoothly furnish mono-protected resorcylate rac-281 in 80% yield.  
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SCHEME 89. Synthesis of Weinreb amide rac-281 
 
4.2.2.3  Synthesis of diketo-dioxinone rac-15Incorporation of the second keto-
dioxinone unit 
 
For the next step, the C-acylation of keto-dioxinone 10 with Weinreb amide rac-281 was 
attempted (Scheme 90). Unfortunately, the reaction resulted in the recovery of both starting 
materials with no formation of diketo-dioxinone rac-285. It was speculated that dilithium 
enolate was consumed on deprotonation of free phenol rather than alkylation, and therefore 
both phenols were protected to assess this hypothesis.   
 
 
 
 
 
 
 
   
 SCHEME 90. Towards the synthesis of diketo-dioxinone rac-285 
 
The bis-methylation of resorcylate rac-14 was carried out with an excess of methyl iodide to 
give product rac-286 in 71% yield (Scheme 91). The alkylation of keto-dioxinone 10, via 
dianion formation, with Weinreb amide rac-286 was now successful, giving diketo-dioxinone 
rac-15 in a gratifying yield of 76%. We planned to perform a regioselective demethylation 
using boron trichloride at a later stage to obtain the necessary mono-methylated resorcylate. 
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  SCHEME 91. Synthesis of diketo-dioxinone rac-15 
 
4.2.2.4 Towards the synthesis of tragoponol (16) via transannular aromatization 
  
 
The final steps involved silyl deprotections, intramolecular capture of acylketene for 
macrolactonization and transannular aromatization to form the dimeric dihydroisocoumarin 
unit. The table below shows the different conditions attempted for the silyl deprotection of 
diketo-dioxinone rac-15 (Table 4).  
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*    calculated by 1H NMR analysis of the crude material 
Table 4. Attempted conditions for the synthesis of alcohol rac-287 
 
The use of hydrogen fluoride (Entry a) initially gave desired product rac-287 however an 
immediate 6-membered lactonization occurred to give compound rac-289 in 50% yield. The 
silyl deprotection was also attempted using a Lewis acid, zirconium tetrachloride (Entry b), 
resulting only in recovery of starting material rac-15. The treatment of resorcylate rac-15 
with TBAF (Entry c) underwent selective deprotection of phenolic silyl group to give 
compound rac-288 in a quantitative yield. The best result was obtained utilizing 
hexafluorosilicic acid (Entry d) to achive selective silyl deprotection of secondary over 
phenolic alcohol. These conditions gave desired product rac-287 and lactonized compound 
rac-289 in 1:1 ratio.  
 
The 1:1 mixture of compound rac-287 and rac-289 was subsequently subjected to 
intramolecular ketene trapping under dilute conditions as illustrated below (Scheme 92). 
Unfortunately, the desired macrocycle 290 was not formed but instead, a facile 6-membered 
    Entry Reagent          Time (h) Yield(A:B:C) (%)*
 
  Recovered rac-15 (%) 
       a    HF.py.              2.0 0:0:50 0 
       b     ZrCl4              7.5  100 
       c     TBAF              1.0 0:100:0 0 
       d     H2SiF6              1.5 50:0:50 0 
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lactonization occurred to give dihydroisocoumarin rac-289 in 65% yield. After numerous 
attempts on ketene trapping step, the formation of byproduct rac-289 could not be 
suppressed. The ease of this lactonization can be rationalized by its entropy driven process as 
well as thermodynamically stable 6-memebered rather than 16-membered lactone formation.  
 
 
 
 
 
 
SCHEME 92. Towards the synthesis of triketo-ester macrocycle 290 
 
Firstly, we aimed to prevent the formation of lactone rac-289 during the first deprotection 
step. Therefore, it was proposed to seek for an alternative protecting group where it could be 
deprotected under mild and neutral conditions to minimize the acid-catalyzed lactonization.  
 
Consequently, both benzyl and PMB protecting groups were chosen since hydrogenation 
could be used for their deprotections under neutral conditions. 
 
4.2.3 Retrosynthetic strategy III 
 
Our third approach comprises identical synthetic strategy as II, however altering the 
protecting group from silyl to benzyl/paramethoxy benzyl group (Scheme 93). The building 
blocks (S,S)-291 and (S,S)-292 will be synthesized as racemates following similar 
transformation sequence as described in previous sub-sections. 
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SCHEME 93. Retrosynthetic analysis III of tragoponol (16) 
 
4.2.3.1 Synthesis of diketo-dioxinones rac-293 and rac-294 
 
The required Weinreb amides rac-300 and rac-301 were obtained in five steps starting from 
commercial source (Scheme 94). The demethylation with boron tribromide was followed by 
silyl protection to provide keto ester 295 in 90% over two steps. The ketone reduction with 
sodium borohydride gave alcohol rac-296 in a moderate yield of 67%. The benzyl protection 
was performed in the presence of triflic acid and acetimidate 297 (conditions A) whereas 
PMB protection was achieved using camphorsulfonic acid (CSA) and acetimidate 226 
(conditions B) to yield ethers rac-298 and rac-299 in 62% and 70%, respectively. The 
corresponding Weinreb amides rac-300 and rac-301 were prepared using N,O-
dimethylhydroxylamine hydrochloride 222 and iso-propyl magnesium chloride in good 
yields.  
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SCHEME 94. Synthesis of Weinreb amides rac-300 and rac-301  
 
The key fragments rac-293 and rac-294 were constructed through the dianion chemistry of 
keto-dioxinone 10 with appropriate Weinreb amides rac-300 and rac-301 in satisfying yields 
of 89% and 80%, respectively (Scheme 95).  
 
 
 
 
 
 
SCHEME 95. Synthesis of diketo-dioxinones rac-293 and rac-294 
 
4.2.3.2 Synthesis of resorcylates rac-291 and rac-292 using mild aromatization 
conditions 
 
The acylketene precursors rac-293 and rac-294 were separately treated with alcohol rac-13 
in toluene at elevated temperature to generate triketo-ester intermediates (Scheme 96). These 
in turn were subjected to mild aromatization conditions in a sealed tube affording resorcylates 
rac-291 and rac-292 in pleasing yields of 62% and 58%. Only a trace amount of 
transesterification of triketo-ester by methanol was observed in both cases. 
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SCHEME 96. Synthesis of resorcylates rac-291 and rac-292 under neutral conditions 
 
4.2.3.3 Synthesis of diketo-dioxinones rac-304 and rac-305 Incorporation of the 
second keto-dioxinone unit 
 
Having synthesized the western part of resorcylates rac-291 and rac-292, the phenol 
functionalities were protected using excess methyl iodide in acetone to give methyl-ethers 
rac-302 and rac-303 in 69% and 73% yield, respectively (Scheme 97). The crossed 
condensation of keto-dioxinone 10 mediated by diethyl zinc resulted in coupling products 
rac-304 and rac-305 in excellent yields of 62% and 72%.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
SCHEME 97. Synthesis of diketo-dioxinones rac-304 and rac-305  
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4.2.3.4 Towards the synthesis of tragoponol (16) using rac-304 as a precursor  
 
The next step involved benzyl deprotection to generate hydroxy-acylketene precursor rac-287 
which in turn would undergo macrolactonization and transannular aromatization. The benzyl 
deprotection of dioxinone rac-304 was attempted under standard hydrogenation conditions 
using palladium on charcoal (Scheme 98). As a result, the starting material rac-304 not only 
underwent benzyl deprotection but also benzyl ester cleavage to give two fragments 306 and 
307 in quantitative yields. A transfer hydrogenation using cyclohexadiene was also 
performed providing a limited amount of hydrogen source in order to induce selectivity. 
However no reaction was observed and starting materials were recovered.  
 
Due to difficulties found on benzyl deprotection, the work was focused on the deprotection of 
PMB derivative rac-305. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
SCHEME 98. Towards the synthesis of alcohol rac-287 from resorcylate rac-304 
 
4.2.3.5 Towards the synthesis of tragoponol (16) using rac-305 as a precursor  
 
The PMB deprotection was executed using DDQ as an oxidant under neutral conditions 
(Scheme 99). Unfortunately, an immediate 6-membered lactonization of intermediate rac-287 
was observed once again resulting in dihydroisocoumarin rac-289 and diketo-dioxinone rac-
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262 in total of 65% yield. These results suggested that fragmentation occurs even under 
neutral conditions at low temperature and proved to be extremely challenging to prevent this 
process. These issues have led us to investigate an alternative towards the synthesis of 
tragoponol (16). 
 
 
 
 
 
 
 
 
 
 
 
 
SCHEME 99. Towards the synthesis of alcohol rac-287 from resorcylate rac-305 
 
4.2.4 Retrosynthetic strategy IV 
 
To address the issue of 6-membered lactone formation, we designed a new retrosynthesis 
where both resorcylate units are constructed at a late stage in the synthesis (Scheme 100). The 
cyclic hexa-keto-diester 308 should undergo double transannular aromatization to provide the 
dihydroisocoumarin system which could be further transformed to give tragoponol (16). The 
macrocycle 308 may be elaborated from diketal intermediate 309 following a mild ketal 
deprotection. For the synthesis of 309, ketal-dioxinones 310 and 311 could firstly undergo 
selective ketene trapping followed by silyl deprotection and the resulting hydroxy-dioxinone 
may be subjected to second ketene trapping in an intramolecular manner to give macrolide 
309. 
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SCHEME 100. Retrosynthetic analysis IV of tragoponol (16) 
 
 
The proposed racemic retrosynthesis of ketal-dioxinone 311 is illustrated as followed 
(Scheme 101). The ketene precursor rac-311 should be available by non-classical Wittig 
reaction
68
 between phosphonium salt 312 and Weinreb amide rac-265 and subsequent silyl 
deprotection. Two approaches were considered for the synthesis of 312. The -chloro-keto-
dioxinone 101 could be subjected to ketal protection and treated with triphenyl phosphine to 
give 312. As a second option, lithium enolate derived from dioxinone 65 may undergo 
conjugate addition to ketal phosphonium triflate salt 314 to generate phosphorane 313 which 
could also be employed in the non-classical Wittig reaction. 
 
 
 
 
 
 
 
 
96 
 
 
 
 
 
 
 
 
 
 
 
SCHEME 101. Retrosyntheses of ketal-dioxinone rac-311 and ketal phosphonium salt 312 
 
4.2.4.1 Towards the synthesis of ketal-dioxinone rac-311 Approach I 

he -chloro-keto-dioxinone 101 was prepared following a literature procedure using HMPA 
as a co-solvent in 23% yield (Scheme 102).
69
 Approximately 65% of unreacted starting 
material was recovered during this transformation. A number of conditions were examined 
for the ketal protection however resulted in either recovery of starting material or 
decomposition (Table 5). Due to reluctance of ketone 101 undergoing ketal protection, the 
work was focused on the second approach. 
 
 
 
 
SCHEME 102. Towards the synthesis of -chloro-ketal-dioxinone 315 
 
TABLE 5. Attempted conditions for the ketal protection of 101 
Entry Reagents solvent Temperature (°C) Results 
a HOCH2CH2OH, p-TSA, HC(OEt)3 PhMe 23 Decomposition 
b HOCH2CH2OH, TMSCl CH2Cl2 23 S.M. recovered 
c HOCH2CH2OH, (CO2H)2 MeCN 23 S.M. recovered 
d TMSOCH2CH2OTMS, TMSOTf CH2Cl2 78 S.M. recovered 
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4.2.4.2 Towards the synthesis of ketal-dioxinone rac-311 Approach II 
 
The ketal phosphonium triflate salt 314 was synthesized following a known protocol in three 
steps (Scheme 103).
70
 The synthesis began with triflation of trifluoroethanol 316 with triflic 
anhydride to give triflate 317 which in turn reacted with triphenyl phosphine to provide 
phosphonium salt 318 in 22% over two steps. The final step consisted of ketal formation 
under basic conditions to afford desired intermediate 314 in 38% yield, comparable to 
reported value. 
 
 
 
 
 
SCHEME 103. Synthesis of ketal phosphonium triflate salt 314   
 
The next step involved a conjugate addition of lithium enolate derived from dioxinone 65 to 
ketal phosphonium salt 314. Since there is no example of such transformation in the 
literature, the reaction was performed using LiHMDS to form the enolate as usual and reacted 
with 314 at 78 ºC (Scheme 104). Starting material was consumed in three hours however, no 
sign of desired product 313 was observed. The major byproduct may have been the formation 
of 7-membered vinyl phosphonate 319 through ketal opening and formation of P-O bond. 
The 
1
H NMR analysis as well as mass spectrometry suggests its formation however clean 
isolation was not possible even after several attempts of recrystallization and therefore its 
structure could not be unambiguously verified. Due to this unrewarding step, we sought a 
new retrosynthesis of ketal-dioxinone rac-311 without the use of non-classical Wittig 
reaction.  
 
 
 
 
 
SCHEME 104. Towards the synthesis of phosphorane 313 via a conjugate addition 
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4.2.4.3 A new approach for the synthesis of ketal-dioxinone rac-311 Approach III 
 
For this strategy, it was proposed to utilize acylketene acetal as an alternative Michael 
acceptor. The fact that acylketene acetals are previously reported in the literature to undergo 
1,4-addition reactions drove our attention.
71
 The main disconnection for this approach is 
shown in scheme 105. We aimed to synthesize ketal keto-dioxinone rac-311 via the reaction 
of lithium enolate derived from dioxinone 65 with acylketene acetal 320. The base-mediated 
cyclization of -keto ester 321 should provide the required Michael acceptor 320. A 
transesterification of ester 322 with chloro-ethanol could result in cyclization precursor 321.  
 
 
 
 
 
 
 
 
 
 
SCHEME 105. Retrosynthesis of ketal keto-dioxinone rac-311 via acylketene acetal 320    
 
4.2.4.3.1 Synthesis of acylketene acetal 320 
 
Having synthesized Weinreb amide rac-265 (refer to sub-section 4.2.1.4), it was subjected to 
Claisen condensation using a lithium enolate derived from ethyl acetate to give -keto ester 
322 in 81% yield (Scheme 106). A triphenylphosphine catalyzed transesterification of 322 
using chloro-ethanol gave ester 321 in 64% yield.
72
 During the course of this reaction, 
byproduct 323 (17%) was also isolated as a result of thermal –OTBS elimination. The 
cyclization of -keto ester 321 was achieved via the formation of its enolate using potassium 
carbonate to provide acylketene acetal 320 in an excellent yield of 90%.
71
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SCHEME 106. Synthesis of acylketene acetal 320 
    
4.2.4.3.2 Towards the synthesis of ketal-dioxinone rac-311 Approach III 
 
According to the literature, simple acylketene acetyl such as 324 underwent conjugate 
addition reaction with hard nucleophiles (EtLi, t-BuLi, n-BuLi, C6H5Li) to give the 
corresponding ketal-ketones in moderate yields (Scheme 107).
71
 No evidence of 1,2-addition 
was observed and hydrolyzed starting materials (resulting from the work-up) were the only 
other isolated products.
71  
 
 
 
 
 
 
SCHEME 107. Synthesis of various ketal-ketones via conjugate addition reaction 
 
We anticipitated that similar chemistry should be applicable to our substrate using lithiated 
dioxinone 65 as a nucleophile. Thus, lithium enolate of dioxinone 65 was treated with 
acylketene acetal 320 at 78 to 23 ºC (Scheme 108). Disappointingly, it resulted in no sign of 
reaction and starting materials were recovered. 
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SCHEME 108. Towards the synthesis of ketal-keto-dioxinone 325 
 
In order to facilitate 1,4-addition by the lithium enolate, the use of copper iodide was also 
examined giving solely recovery of starting materials. The transmetalation of the lithium 
enolate with diethyl zinc was also investigated with the aim to increase the nucleophilicity to 
initiate the reaction (Scheme 109). Unfortunately, these conditions promoted exclusively 1,2-
addition as expected resulting in the formation of byproduct 326 (39%) after dehydration and 
hydrolysis of the ketal unit.  
 
 
 
 
 
 
 
SCHEME 109. Towards the synthesis of ketal-keto-dioxinone 325 mediated by diethyl zinc 
 
4.2.4.4 Towards the synthesis of ketal-dioxinone rac-311 Approach IV 
 
After several unsuccessful attempts on 1,4-addition reaction using dioxinone 65 and 
acylketene acetal 320, it was proposed that dioxinone radical such as 327 could be utilized 
instead to undergo radical coupling with acylketene acetal 320 to generate the key ketal keto-
dioxinone rac-311 after silyl deprotection (Scheme 110). The free radical 327 may be 
prepared by a Barton decarboxylation of ester 328. This should in turn be available from 
benzyl ester dioxinone 330 by deprotection and N,N'-dicyclohexylcarbodiimide (DDC) 
coupling with 2-mercaptopyridine N-oxide 329. 
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SCHEME 110. Retrosynthesis of ketal-dioxinone rac-311 via a Barton-decarboxylation    
 
4.2.4.4.1 Towards the synthesis of Barton-ester 328  
 
The compound 334 was prepared in three steps starting from commercially available 
carbobenzyloxy chloride 331 (Scheme 111). The carbamate 332 was prepared following a 
literature procedure in 82% yield.
73
 The C-acylation of dioxinone 65 was carried out using 
LiHMDS as a base to give ester dioxinone 330 in a reasonable yield of 44%. We also 
observed acylation at C-2 position in this case giving rise to dioxinone 333 in 17% yield. 
Interestingly, these ratios were inversed when diethyl zinc was employed in the reaction. 
Further investigation will be required to obtain a concrete rationalisation behind this 
outcome. The debenzylation was performed under hydrogenation conditions to give the 
corresponding carboxylic acid 334 in a good yield. The final DCC coupling using 2-
mercaptopyridine N-oxide 329 resulted in an immediate decomposition and starting material 
was not recovered. The reaction was also carried out via the formation of acid chloride 
followed by the treatment with 2-mercaptopyridine sodium salt 335 however it also led to 
decomposition. It is predicted that neither activated carboxylic acid of dioxinone 334 nor 
Barton ester 328 were sufficiently stable for isolation.  
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SCHEME 111. Towards the synthesis of Barton ester 328    
 
4.3 Conclusion 
 
To summarize, we report three main approaches towards the synthesis of tragoponol (16). An 
advanced acylketene precursors rac-15, rac-304 and rac-305 have been synthesized using an 
efficient C-acylation of keto-dioxinones as well as mild aromatization conditions. During the 
deprotection step prior to ketene trapping, we encountered a facile 6-membered lactonization 
which could not be suppressed in many attempted conditions. We also examined four 
strategies in order to synthesize ketal-dioxinone fragment rac-311 to address the issue of 
undesired lactonization. The non-classical Wittig approach was not promising due to 
unexpected difficulties on ketal protection of keto-dioxinone 101. Although acylketene acetyl 
320 was successfully synthesized in minimum steps, the following 1,4-addition reaction with 
dioxinone 65 gave disappointing results. The synthesis of Barton-ester dioxinone 328 will be 
investigated within the group in the future and extensive research will be necessary to achieve 
our goal. 
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CHAPTER FIVE: 
 
RESULTS AND DISCUSSION 
 
     -PAECILOMYCIN B- 
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5. Paecilomycin B 
 
5.1 Isolation, structure and biological properties 
 
In 2010, six newRALs, named paecilomycin A – F, were isolated from the mycelia solid 
culture of Paecilomyces sp. SC0924 (Figure 8).
4
 Their structures were elucidated by 
extensive NMR analysis as well as single-crystal X-ray studies.
4
 In terms of their biological 
activities paecilomycin A (336), B (21) and E (339) exhibit antiplasmodial activity against 
Plasmodium falciparum line 3D7 with IC50 values of 0.78 μM, 3.8 μM, and 20.0 nM 
respectively. On the other hand, dihydroisobenzofuranone derivatives (337) and (338) are 
both inactive (IC50 > 50 μM). Among these new RAL derivatives, a unique structural feature 
of paecilomycin B (21) is noticeable. This natural product is the first RAL possessing a 
tetrahydropyran unit within the 14-membered macrocycle. Due to its appealing molecular 
complexity, we planned to apply our biomimetic approach for its total synthesis. There is no 
reported synthesis of paecilomycins B (21) to date.  
 
 
 
 
 
 
 
 
 
 
 
 
 FIGURE 8. Paecilomycins A – F 
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5.2 Towards the total synthesis of paecilomycin B (21) via intra-molecular 
capture of acylketene and transannular aromatization 
 
5.2.1 Retrosynthetic strategy I  
 
Our initial retrosynthetic analysis of paecilomycin B (21) is illustrated below (Scheme 112). 
The final steps will involve regioselective methylation and global deprotection of resorcylate 
341 to furnish the natural product 21. The aromatic unit could be constructed using our 
methodology on hydroxy-ketene precursor 342 which may undergo deprotection, 
intramolecular capture of acylketene and transannular aromatization. We envisaged that keto-
dioxinone unit 10 could be incorporated on Weinreb amide 343 via dianion chemistry to give 
diketo-dioxinone 342. 
 
 
 
 
 
 
 
 
 
 
 
 
SCHEME 112. Retrosynthetic strategy I of paecilomycin B (21)  
 
Due to the rare substitution pattern of tetrahydropyran 343, a novel retrosynthesis was 
designed where no monosaccharide was utilized as a precursor (Scheme 113). The Weinreb 
amide 343 should be accessible from carboxylic acid 344 by an amide coupling reaction. A 
deprotection of protecting group (2) followed by oxidation of tetrahydropyran 345 may 
generate the required acid 344. We aimed to incorporate the side chain 346 via cross-
metathesis with alkene 347. The tetrahydropyran unit may be constructed from allylic 
epoxide 348 following acetonide deprotection and a favourable 6-exo-tet cyclization through 
epoxide opening. A directed epoxidation of enantiometically enriched allylic alcohol 349 
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could lead to epoxide 348 in high selectivity. The syn-diol moiety 349 should be available 
from extended enone 350 by a Corey-Bakshi-Shibata reduction. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
SCHEME 113. Retrosynthesis of tetrahydropyran unit 343 
 
There were two proposed approaches for the synthesis of enone 350 (Scheme 114). Firstly, 
the reaction between Weinreb amide 351 and 1-bromo-diene 352 using a halogen-lithium 
exchange should provide 350. The activation of ester 353 should provide the Weinreb amide 
351. It was envisaged that the chilarity of hydroxy-ester 353 may be introduced by a 
diastereoselective aldol reaction between (S)-glyceraldehyde acetonide (354) and the lithium 
enolate derived from ethyl acetate 150. Alternatively, extended enone 350 should also be 
available by an aldol reaction between (S)-glyceraldehyde acetonide (354) and the lithium 
enolate of enone 355 which would result in a synthesis two steps shorter as compared with 
the first approach. 
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SCHEME 114. Two proposed approaches for the synthesis of enone 350  
 
5.2.1.1 Synthesis of alkene 346  
 
Cross metathesis partner 346 was successfully synthesized in two steps following a procedure 
described by Figueroa et al. (Scheme 115).
74
 (S)-Propylene oxide (223) was treated with 
vinyl cuprate in THF to generate enantiomerically enriched alcohol 356. The resulting 
hydroxyl group was protected as its PMB derivative using acetimidate 226 to give PMB-ether 
346 in 58% yield over two steps. 
 
 
 
 
 
SCHEME 115. Synthesis of alkene 346 
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5.2.1.2 Synthesis of Weinreb amide 366 Approach I 
 
The first asymmetric induction was planned to originate from a diastereoselective aldol 
reaction on (S)-glyceraldehyde acetonide (354). In 1980, Heathcock and co-workers reported 
an elegant procedure involving the use of aldehyde 357 with the lithium enolate of methyl 
ester 358 to undergo aldol reaction in good yields as well as diastereoselectivity (Scheme 
116).
75
 
 
 
 
 
 
 
SCHEME 116. Diastereoselective aldol reaction demonstrated by Heathcock et al.
75
 
 
The diastereoselective outcome of this aldol reaction was thus predicted from a nucleophilic 
attack as illustrated in Felkin-Ann model 360 (Scheme 117).
75 
The model 360 was drawn 
assuming that the alkoxy substituent is the “ large ” and “ EWG ” substituent on the 
asymmetric carbon. 
 
 
 
 
SCHEME 117. Felkin-Ann model 360  
 
Following this efficient aldol reaction, we successfully applied it to our synthesis. Weinreb 
amide 366 was synthesized in five steps starting from L-(+)-Gulonic acid gamma-lactone 
(362) (Scheme 118). Acetonide 363 was prepared from diol 362 using 2-methoxypropene 
219 and p-TSA in 64% yield. The oxidative cleavage with sodium periodate resulted in the 
formation of (S)-glyceraldehyde acetonide (354) which was in turn reacted with the lithium 
enolate derived from ethyl acetate, to give aldol adduct 364 in 25% yield with acceptable 
diastereomeric ratio of 7.2:1 by 
1
H NMR analysis. Due to the instability of aldehyde 354, 
some decomposition was observed during the work-up procedure and reflected the poor 
overall yield. The next step involved silyl protection and a Weinreb amide formation using 
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iso-propyl magnesium chloride and amine 222 to provide compound 366 in pleasing yield of 
67% over two steps. 
 
 
 
 
 
 
 
 
 
 
 
SCHEME 118. Synthesis of Weinreb amide 366 
 
5.2.1.3 Towards the synthesis of enone 370 Approach I 
 
Having synthesized the required Weinreb amide 366, the synthesis towards (E)-1-bromo-
diene 352 was investigated (Scheme 119). Crotonaldehyde (367) was treated with carbon 
tetrabromide and triphenylphosphine to undergo a Corey-Fuchs reaction to generate 1,1-
dibromo diene 368 in 37% yield. Mono-debromination of 368 was initially attempted with 
zinc and acetic acid however no desired product 369 was obtained. Instead, the use of 
diethylphosphite and sodium hydride gave mono-bromide 369 as a 1:1 mixture of E/Z 
isomers. Subsequent isomerisation using sodium hydroxide in ethanol gave exclusively (E)-
alkene 352 in 37% over two steps. These procedures were carried out following a reported 
procedure by Tokuda et al. and Hayashi et al..
76
 
 
 
 
 
 
 
 
 
SCHEME 119. Synthesis of (E)-1-bromo-diene 352 
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A number of conditions were examined for the synthesis of 370 (Table 6). Initially, halogen-
lithium exchange was performed using n-BuLi (Entry a) however no reaction was observed. 
The use of t-BuLi (Entry b) with the aim to facilitate the lithiation afforded no desired 
product but byproduct 371 in 60% yield. The formation of the standard Grignard reagent  
(Entry c) as well as the “ turbo-Grignard ” reagent (Entry d) were examined and resulted in 
either decomposition or recovery of starting materials.  
 
 
 
 
 
TABLE 6. Attempted conditions for the synthesis of enone 370 
 
According to the outcomes from Entry (a) and (b), it was suggested that (E)-1-bromo-diene 
352 may be not sufficiently reactive towards lithiation. As a consequence, the synthesis of the 
corresponding iodo derivative was investigated in order to overcome this issue (Scheme 120). 
A procedure described by Concellón et al. was followed to synthesize E/Z mixture of 1-iodo-
diene 374 (Scheme 120).
77
 A lithiated di-iodomethane was reacted with crotonaldehyde (367) 
to generate alcohol 372. Subsequent acetylation with acetic anhydride gave acetate 373 in 
83% yield over two steps. The reductive elimination of 373 with samarium(II) and di-
iodomethane gave alkene 374 as a 2:3 mixture of E/Z isomers in 24% yield. Due to its low 
boiling point, a large proportion of the product was lost during the work-up procedure 
resulting in poor yield. Nevertheless, the isomerization step was attempted under previously 
mentioned conditions. Disappointingly, the reaction gave a trace of desired (E)-alkene 375 
along with major decomposition. 
 
 
 
Entry Reagents solvent Temperature (°C) Results 
a n-BuLi THF 78 No reaction 
b t-BuLi Et2O 78 Byproduct 371 (60%) 
c Mg THF 70 Decomposition 
d i-PrMgCl, CuCl THF 23          S.M. recovered 
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SCHEME 120. Towards the synthesis of (E)-1-iodo-diene 375 
 
5.2.1.4 The synthesis of enone 370 Approach II 
 
An alternative route was established and successfully applied to the synthesis of enone 370. 
Crotonaldehyde (367) was subjected to Wittig olefination to give diene 355 in 48% yield 
(Scheme 121).
78
  
 
 
 
SCHEME 121. Synthesis of keto-diene 355 
 
An improved one-step synthesis of (S)-glyceraldehyde acetonide (354) from commercially 
available (R)-()-2,2-dimethyl-1,3-dioxolane-4-methanol (17) was carried out by Swern 
oxidation (Scheme 122). The oxidation step was followed by an aldol reaction with the 
enolate derived from ketone 355 to pleasingly afford hydroxy-ketone 376 (38%) in good 
diastereoselectivity of 7.2:1 by 
1
H NMR analysis. The TBS protection was performed using 
TBSCl and imidazole to give the desired enone 370 in 91% yield.    
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SCHEME 122. Synthesis of enone 370 
 
5.2.1.5 The synthesis of allylic alcohol 380 Approach II 
 
The introduction of the third stereogenic centre was planned to be achieved by a CBS 
reduction. This approach was inspired from the work published by Hanessian and co-workers 
on the total synthesis of jerangolid A.
79
 The key CBS reduction of hydroxy-ketone 377, as 
part of its synthesis, is shown below (Scheme 123). The use of (R)-Me-CBS catalyst 
combined with borane-dimethyl sulphide complex resulted in moderate yield of 63% with an 
excellent diastereoselectivity. The syn configuration of diol 378 was determined by 
13
C NMR 
analysis of its acetonide derivative.
79
  
 
 
 
 
SCHEME 123. Diastereoselective synthesis of allylic alcohol 378 by Hanessian et al.
79
  
 
Thus, this procedure was applied to our substrate 370 (Scheme 124). The treatment of ketone 
370 with borane-THF complex and (R)-Me-CBS catalyst (379) gave syn-allylic alcohol 380 
in 90% yield with high diastereoselectivity of 95:5, analyzed by 
1
H NMR of the crude 
material.  
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SCHEME 124. Synthesis of allylic alcohol 380 
 
The formation of the syn-diol was unambiguously proved by derivatization to its acetonide 
derivative as illustrated below (Scheme 125). The silyl deprotection of 380 with TBAF 
proceeded smoothly to give diol 381 which was in turn protected as an acetonide to give 382 
in 50% yield over two steps. The 
13
C NMR analysis showed a clear indication for syn 
configuration, giving the quaternary carbon shift at below  100 ppm as well as newly formed 
acetonide methyl carbons at  19.9 and 30.0 ppm.79  
 
 
 
 
 
SCHEME 125. Synthesis of acetonide 382 
 
5.2.1.6 Towards the synthesis of tetrahydropyran 19  
 
The next step consisted of directed epoxidation and acetonide deprotection to undergo a 6-
exo-tet cyclization to form the tetrahydropyran core. Initially, a Sharpless epoxidation was 
performed to incorporate the required epoxide unit however it resulted in a rather poor yield 
with a long reaction time. As a consequence, a vanadium based directed epoxidation was 
carried out as an alternative and resulted in a 5:1 ratio of diastereoisomers 383 in an excellent 
yield of 86% (Scheme 126). These inseparable isomers were subsequently subjected to two 
different silyl protections to give bis-silylated products 384 and 385 in 65% and 86% yield 
respectively, at which point the diastereoisomers were separable by column chromatography. 
Several acetonide deprotections were examined at this stage, including the use of BrØnsted 
acids (HCl, TFA) and Lewis acids (FeCl3-SiO2, In(OTf)3, TMSOTf). Unfortunately, most of 
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the attempted conditions resulted either in decomposition or unknown byproduct formation 
with no sign of product 19. The use of tin(II) chloride in dichloromethane did promote 
acetonide deprotection however, it reacted further to give 5,6-bicycles 386 (38%) and 387 
(48%) as byproducts. Interestingly, the use of tin(II) chloride dihydrate with 384 gave 82% 
yield of bicycle 386 (Scheme 19).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
SCHEME 126. Towards the synthesis of tetrahydropyran 19 
 
The absolute configuration and structure of bicycle 386 were determined by single-crystal X-
ray crystallography of its 3,5-dinitrobenzoyl derivative 388 (Scheme 127). Additionally, this 
X-ray structure in turn confirmed the correct absolute configuration of allylic alcohol 380. 
 
 
 
 
 
 
 
SCHEME 127. Synthesis of 3,5-dinitrobenzoyl derivative 388 for X-ray crystallography 
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A suggested mechanism for the formation of bicycle 394 is illustrated below (Scheme 128). 
Initial deprotection of the acetonide group by tin(II) chloride gave diol intermediate 389, 
which underwent Lewic acid catalyzed epoxide opening giving stabilized carbocation 390. 
Subsequent 1,2-hydride shift occurred generating dihydroxy-ketone intermediate 391 which 
in turn cyclized to form tetrahydropyran 392. The Lewis acid-promoted rearrangement of 
optically active epoxy silyl ethers has been previously studied by Yamamoto et al.
80
 and they 
also reported the anti-migration of the hydride shift to the epoxide moiety in a concerted 
manner. The last steps included the formation of oxonium ion intermediate 393 inducing 
elimination of the –OLA unit and proceeded through 5-endo cyclization with the primary 
alcohol and silyl deprotection to give 5,6-system 394. Further mechanistic studies are 
required to confirm this route, and will be carried out in the near future.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
SCHEME 128. The proposed mechanism for the formation of bicycle 394 
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5.2.2 Retrosynthetic strategy II 
 
According to our proposed mechanism for the formation of bicycle 394, a need for protection 
of the primary alcohol was apparent. Additionally, the use of Lewis acid for acetonide 
deprotection had to be avoided to prevent the undesired rearrangement of epoxy silyl ether 
fragment. Consequently, an alternative route was established for the synthesis of 
tetrahydropyran 395 (Scheme 129). With the appropriate protection of primary alcohol, 396 
should undergo base-induced 6-exo-tet ring closing to form tetrahydropyran 395 in the 
absence of Lewis acid. The directed epoxidation of enantiomerically enriched allylic alcohol 
397 may lead to the generation of epoxide 396 with high diastereoselectivity. Diol 399 could 
be subjected to a selective protection of primary alcohol and PG3-deprotection to produce the 
epoxidation precursor 397. The acetonide deprotection could then be carried out at earlier 
stage on 400 to furnish diol 399. 
 
 
 
 
 
 
 
 
 
 
 
 
 
SCHEME 129. Retrosynthetic strategy II of tetrahydropyran unit 395 
 
5.2.2.1 Synthesis of diol 404 
 
The synthesis began with previously synthesized starting material 376 (Scheme 130). The 
silyl protection of alcohol 376 proceeded smoothly to give 401 in 90% yield. Following the 
previous success of the CBS reduction, identical conditions were employed to afford syn-
allylic alcohol 402 in an excellent yield of 82% with high diastereoselectivity of 10:1 by 
1
H 
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NMR analysis of the crude material. The resulting hydroxyl functionality was protected as 
pivalate ester 403 in 72% yield. Deprotection of acetonide group was carried out using p-
TSA in methanol to give 50% yield of diol 404 along with 13% of starting material 403. 
Longer reaction time led to formation of byproducts 405 and 406 as a result of pivaloyl 
deprotection and cyclization at the allylic position. An additional optimization study is 
required in order to improve the overall yield of this transformation however, due to limited 
amount of time, the material was taken forward in the synthesis.  
 
 
 
 
 
 
 
 
 
 
 
 
 
SCHEME 130. Synthesis of diol 404 
 
5.2.2.2 Synthesis of allylic epoxide 409 
 
The 6-exo-tet cyclization precursor 409 was successfully prepared in three steps from diol 
404 (Scheme 131). Regioselective protection of diol 404 was performed with chloromethyl 
methyl ether (MOMCl) in the presence of Hünig’s base to give ether 407 in 80% yield. The 
pivaloyl deprotection with diisobutylaluminium hydride (DIBAL-H) gave diol 408 as a key 
intermediate. The final directed epoxidation was executed utilizing vanadyl acetylacetonate 
and t-butylperoxide to furnish cyclization precursor 409 in a gratifying yield of 69% over two 
steps with good diastereoselectivity of 4.8:1 by 
1
H NMR analysis. The next step will consist 
of 6-exo-tet cyclization to form the tetrahydropyran 410. This step is still to be investigated in 
the near future within the group.  
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SCHEME 131. Synthesis of allylic epoxide 409 
 
5.3 Conclusion 
 
To conclude, we report two main synthetic studies carried out towards the synthesis of 
paecilomycin B (21). The 6-exo-tet cyclization precursors 384 and 385 were successfully 
synthesized through a series of transformations, including a diastereoselective aldol reaction, 
a CBS reduction and a directed epoxidation. During the cyclization attempt, a unique 5,6-
bicycle byproducts 386 and 387 were isolated. The absolute configuration and structure of 
386 were determined by single-crystal X-ray crystallography of its acetonide derivative 388. 
Following the lastest retrosynthetic strategy, a promising route was established for the 
synthesis of cyclization precursor 409 where primary alcohol is appropriately protected to 
avoid the formation of the bicycle. The key tetrahydropyran formation step will be 
investigated in the near future in the group.  
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EXPERIMENTAL 
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6. Experimental  
 
6.1 General Procedures 
6.1.1 Instrumental Procedures 
 
Melting points: obtained using a Reichert-Thermovar melting point apparatus and are 
uncorrected.  
 
Infrared spectra: obtained using a Mattson 5000 FTIR apparatus with automatic background 
subtraction. Indicative features of each spectrum are given with adsorptions (max) reported 
in wavenumbers (cm
-1
).  
 
Proton nuclear magnetic resonance spectra (
1
H NMR): recorded at 400 MHz on Bruker 
DRX-400 spectrometers or at 500 MHz on a Bruker AM 500m spectrometer. Chemical shifts 
() are quoted in parts per million (ppm) and referenced to the residual solvent peak (7.26 
ppm for CHCl3).  
 
Carbon nuclear magnetic resonance spectra (
13
C NMR): recorded at 100 MHz on Bruker 
DRX-400 spectrometers or at 125 MHz on a AM 500 spectrometer. Chemical shifts () are 
quoted in ppm and referenced to the residual solvent peak (77.0 ppm for CHCl3). Spectra 
recorded at 500 MHz (
1
H NMR) and 125 MHz (
13
C NMR) were carried out by the Imperial 
College Department of Chemistry NMR Service.  
 
Mass spectrometry: low and high resolution mass spectra (EI, CI, ESI) were recorded by 
Imperial College Mass Spectrometry Service using a Micromass Platform II and 
Micromass AutoSpec-Q spectrometer.  
 
Microanalysis: determined by the London Metropolitan University Analytical Service.  
 
Optical Rotations: recorded at 25 ºC on a Perkin-Elmer 241 Polarimeter with a path length of 
1 dm, using the 589.3 nm D-line of sodium. Concentrations (c) are quoted in g/100 mL.  
 
X-ray Diffraction: X-ray diffraction data were recorded by the Imperial College Department 
of Chemistry X-ray diffraction service. 
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6.1.2 General Experimental Procedures 
 
Reaction Procedures: All reactions were carried out in flame-dried or oven-dried glassware 
in an atmosphere of dry nitrogen or argon unless otherwise stated. For the purpose of this 
thesis, room temperature was taken as 23 ºC where no external heating or cooling was 
applied and temperatures other than this were recorded as the bath temperature, unless 
otherwise stated. Prolonged periods of vessel cooling were attained by the use of CryoCool 
apparatus.  
 
Solvents and reagents: All solvents and reagents were obtained from commercial suppliers 
and used without further purification unless otherwise stated. The following reaction solvents 
were distilled under nitrogen: Et2O and THF from sodium benzophenone ketyl; PhMe from 
sodium; CH2Cl2, MeOH, pyridine and Et3N from CaH2. H2O refers to distilled H2O.  
 
Chromatography: Flash column chromatography was performed using Merck silica gel 60, 
particle size 40-63 mm unless otherwise stated. Thin layer chromatography (TLC) was 
performed on pre-coated aluminium backed or glass backed plates (Merck Kieselgel 60 
F254), visualisation was accomplished by UV light (254 nm).  
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6.2 Procedures and compound characterization 
 
General procedure for the synthesis of lithium diisopropylamide (LDA)  
 
A solution of di-iso-propylamine (1 eq.) in THF was cooled to 78 ºC using a dry ice/acetone 
bath. n-Butyllithium (1.6 M in hexane, 1.1 eq.) was added dropwise and the resulting solution 
was stirred for 20 min at 78 ºC before use as described. 
 
(S)-Triisopropyl(5-(2-(pent-4-enyl)-1,3-dioxolan-2-yl)pentan-2-yloxy)silane 157 
 
 
 
  
To a stirred solution of alcohol (S)-144 (700 mg, 3.1 mmol) and imidazole (418 mg, 6.1 
mmol) in CH2Cl2 (6.5 mL) at 0 ºC, TIPSCl (0.72 ml, 3.4 mmol) was added and stirred at 23 
ºC for 15 h. The precipitate was removed by filtration and the filtrate was partitioned between 
H2O (5 mL) and CH2Cl2 (25 mL).  The organic layer was dried (MgSO4), rotary evaporated 
and chromatographed (Et2O/PE 1:19) to afford protected alcohol 157 (809 mg, 68%) as a 
colourless oil: Rf 0.65 (Et2O/PE 1:19); IR max (neat) 2944 (s), 2867 (s), 1718 (w), 1463 (m), 
1375 (w), 1135 (m), 1056 (m), 883 (m), 676 (m) cm
-1
; 
1
H NMR (400 MHz, CDCl3)  5.85 – 
5.78 (m, 1H, -CH2CHCH2), 5.05 – 4.96 (m, 2H, -CH2CHCH2), 3.94 (br. s, 5H, -OCH2CH2O-
, CH3CH-OSi(iPr)3), 2.09 – 2.04 (m, 2H, -CH2CHCH2), 1.67 – 1.38 (m, 10H), 1.17 (d, J = 
6.0 Hz, 3H, CH3CH-OSi(iPr)3), 1.07 (s, 21H, CH3CH-OSi(iPr)3); 
13
C NMR (100 MHz, 
CDCl3)  138.7, 114.6, 111.7, 68.5, 64.9 (2C), 40.1, 37.4, 36.6, 33.9, 23.5, 23.1, 19.7, 18.1 
(6C), 12.5 (3C); MS (ESI) m/z 385 (M + H)
+
, 407 (M + Na)
+
. 
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(S)-4-(2-(4-(Triisopropylsilyloxy)pentyl)-1,3-dioxolan-2-yl)butanal 156 
 
 
 
A solution of alkene 157 (1 g, 2.6 mmol) and a catalytic amount of NaHCO3 (21 mg, 0.26 
mmol) in CH2Cl2 / MeOH (1:1, 25 mL) was cooled to 78 ºC.  Oxygen was bubbled through 
the mixture for 15 min and followed by ozone for 2 h, by which time the blue colour 
persisted.  Oxygen gas was then bubbled through until the solution became colourless and 
excess Me2S (0.95 mL, 13 mmol) was added at 78 ºC. The resulting mixture was stirred for 
2 h at 23 ºC. The volatiles were evaporated and the residue was chromatographed (EtOAc/PE 
1:9 to 1:4) to afford aldehyde 156 (701 mg, 70%) as a colourless oil: Rf 0.43 (EtOAc/PE 1:4); 
IR max (neat) 2944 (s), 2867 (s), 1710 (s), 1463 (m), 1376 (w), 1247 (w), 1135 (m), 1058 
(s), 883 (m), 676 (m) cm
-1
; 
1
H NMR (400 MHz, CDCl3)  9.79 (s, 1H, -CH2CHO), 3.96 (br. 
s, 5H, -OCH2CH2O-, CH3CH-OSi(iPr)3), 2.52 – 2.42 (m, 2H, -CH2COH), 1.78 – 1.38 (m, 
10H), 1.18 (d, J = 6.0 Hz, 3H, CH3CH-OSi(iPr)3), 1.08 (s, 21H, CH3CH-OSi(iPr)3); 
13
C 
NMR (100 MHz, CDCl3)  202.5, 111.4, 68.5, 64.9 (2C), 43.9, 40.1, 37.4, 36.3, 23.5, 19.7, 
19.1, 18.2 (6C), 12.5 (3C); MS (ESI) m/z 409 (M + Na)
+
. 
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 (S,E)-N-Methoxy-N-methyl-6-(2-(4-(triisopropylsilyloxy)pentyl) 
-1,3-dioxolan-2-yl)hex-2-enamide 155 
 
 
 
 
 
Sodium hydride (60% in mineral oil, 55 mg, 2.3 mmol) was prewashed with pentane (20 mL) 
and suspended in Et2O (10 mL).  Horner-Wittig reagent 158 (435 mg, 2.0 mmol) was added 
dropwise and the resulting mixture was stirred for 45 min at 0 ºC. A solution of aldehyde 156 
(685 mg, 1.8 mmol) in Et2O (2 mL) was added dropwise into the cloudy mixture and stirred 
for 1.5 h at 23 ºC.  The reaction was quenched by addition of H2O (5 mL) and the aqueous 
layer was extracted with Et2O (20 mL × 2). The combined organic layers were dried 
(MgSO4), rotary evaporated and chromatographed (EtOAc/PE 1:9 to 1:4) to afford Weinreb 
amide 155 (678 mg, 80%) as an amber oil: Rf  0.32 (EtOAc/PE 3:7); IR max (neat) 2942 (s), 
2865 (s), 2360 (m), 2341 (m), 1666 (s), 1637 (m), 1461 (m), 1376 (m), 1135 (m), 1056 (m), 
997 (m), 883 (m), 676 (m) cm
-1
; 
1
H NMR (400 MHz, CDCl3)  6.99 (dt, J = 15.6 Hz, 6.8 
Hz, 1H, -CH2CHCHCO-), 6.42 (d, J = 15.2 Hz, 1H, CH2CHCHCO), 3.94 (br. s, 5H, -
OCH2CH2O-, CH3CH-OSi(iPr)3), 3.71 (s, 3H, -OCH3), 3.25 (s, 3H, -NCH3), 2.29 – 2.23 (m, 
2H, -CH2CHCHCO), 1.68 – 1.40 (m, 10H), 1.17 (d, J = 6.0 Hz, 3H, CH3CH-OSi(iPr)3), 1.07 
(s, 21H, CH3CH-OSi(iPr)3); 
13
C NMR (100 MHz, CDCl3)  167.0, 147.4, 118.8, 111.5, 
68.5, 64.5 (2C), 61.6, 40.1, 37.4, 36.7, 32.6, 29.7, 23.5, 22.6, 19.6, 18.2 (6C), 12.5 (3C); MS 
(ESI) m/z 494 (M + Na)
+
, 472 (M + H)
+
. 
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6-((1Z, 5E)-2-Hydroxy-4-oxo-9-(2-((S)-4-(triisopropylsilyloxy)pentyl)-1,3-dioxolan-2-
yl)nona-1,5-dienyl)-2,2-dimethyl-4H-1,3-dioxin-4-one 163 
 
 
 
 
Keto-dioxinone 10 (157 mg, 0.8 mmol) was added into a solution of LDA (1.7 mmol) in THF 
(4 mL) at 78 ºC and stirred for 45 min.  A precipitate was formed and red-orange colour 
persisted. A solution of Weinreb amide 155 (135 mg, 0.3 mmol) in THF (0.5 mL) was then 
added dropwise at 30 ºC and further stirred for 25 min.  The reaction was quenched by the 
addition of 1 M aq. HCl solution (5 mL) and the aqueous layer was extracted with Et2O (20 
mL × 2). The combined organic layers were dried (MgSO4), rotary evaporated and 
chromatographed (EtOAc/PE 1:9 to 3:7) to afford diketo-dioxinone 163 (8.8 mg, 5%) as an 
amber oil: Rf 0.81 (EtOAc/PE 3:2); 
1
H NMR (400 MHz, CDCl3) 14.81 (s, 1H, enol OH), 
6.96 – 6.88 (m, 1H, CH2CHCHCO-), 5.86 (d, J = 15.6 Hz, 1H, CH2CHCHCO), 5.52 (s, 1H, -
C(OH)CHCOCHCO2-), 5.42 (s, 1H, -C(OH)CHCOCHCO2-), 3.95 (br. s, 5H, -OCH2CH2O-, 
CH3CH-OSi(iPr)3), 3.29 (s, 2H, CH2C(OH)CHCOCHCO2-), 2.31 – 2.24 (m, 2H, -
CH2CHCHCO), 1.72 (s, 6H, -OC(CH3)2O-), 1.66 – 1.40 (m, 10H), 1.17 (d, J = 6.0 Hz, 3H, 
CH3CH-OSi(iPr)3), 1.07 (s, 21H, CH3CH-OSi(iPr)3). Due to the lack of the amount of 
material, further analysis of this compound was not possible.  
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Ethyl 4-(diethoxyphosphoryl)-3-oxobutanoate 170
43
 
 
 
 
 
 
 
 
 
To a stirred solution of methyl hydrazinecarboxylate (4.5 g, 50 mmol) in Et2O (50 mL) and 
EtOH (8 mL) at 23 ºC, ethyl 4-chloroacetoacetate 167 (8.2 g, 50 mmol) was added dropwise 
over 15 min and the resulting mixture was stirred for 4 h. The solvent was rotary evaporated 
to afford 168 as a yellow solid (12.8 g). This material was placed under vacuum for 15 h and 
subsequently used in the next step without further purification. The hydrazone intermediate 
168 (12.5 g) was added dropwise to a solution of triethyl phosphate (8.7 g, 52.5 mmol) in 
PhMe (50 mL) at reflux and stirred for 4.5 h. The red-brown solution was rotary evaporated 
and partitioned between H2O (50 mL) and CHCl3 (25 mL). The aqueous layer was extracted 
with CHCl3 (25 mL × 3) and the combined organic layers were dried (MgSO4) and rotary 
evaporated to give phosphonate 169 as a red-brown oil. This material was then treated with 3 
M aq. HCl solution (30 mL) in acetone (30 mL) and stirred for 5 h at 23 ºC. The solvent was 
rotary evaporated and the aqueous layer was extracted with CHCl3 (25 mL × 4). The 
combined organic layers were dried (MgSO4), rotary evaporated and chromatographed 
(EtOAc/PE 1:1 to 4:1) to afford phosphonate 170 (2.67 g, 20% over 3 steps) as a red-orange 
oil: Rf 0.61 (EtOAc); IR max (neat) 2984 (m), 2911 (m), 1713 (s), 1394 (m), 1363 (m), 1240 
(m), 1016 (s), 957 (s), 819 (m) cm
-1
; 
1
H NMR (400 MHz, CDCl3)  4.25 – 4.14 (m, 6H, -
OCH2CH3, -PO(OCH2CH3)2), 3.69 (s, 2H, EtOCOCH2-), 3.29 (d, J = 22.4 Hz, 2H, 
CH2PO(OEt)2), 1.37 (t, J = 6.8 Hz, 6H, -PO(OCH2CH3)2), 1.30 (t, J = 7.2 Hz, 3H, -
OCH2CH3); 
13
C NMR (100 MHz, CDCl3)  194.7, 166.8, 62.8, 62.7, 61.5, 49.6, 42.5 (d, Jpc 
= 126.8 Hz), 16.3 (2C), 14.1; MS (ESI) m/z 555 (2M + Na)
+
, 289 (M + Na)
+
, 267 (M + H)
+
. 
This data is in accordance with the literature.
43
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Ethyl 2-(2-((diethoxyphosphoryl)methyl)-1,3-dithiolan-2-yl)acetate 166 
 
 
 
A solution of phosphonate 170 (500 mg, 1.9 mmol) in CH2Cl2 (2.5 mL) was cooled to 0 ºC 
and stirred for 10 min.  Boron trifluoride diethyl etherate (0.24 ml, 1.9 mmol) was added 
dropwise maintaining the internal temperature at 0 ºC. 1,2-Ethanedithiol (0.16 ml, 1.9 mmol) 
was then added dropwise over 30 min. The resulting mixture was stirred at 23 ºC for 3 h. The 
volatiles were evaporated under reduced pressure and the residue was chromatographed 
(EtOAc/PE 1:1 to 7:3) to afford dithiane 166 (845 mg, 84%) as a pale yellow oil: Rf 0.70 
(EtOAc); IR max (neat) 2981 (m), 2926 (m), 1729 (s), 1391 (m), 1339 (m), 1243 (s), 1174 
(s), 1050 (s), 1020 (s), 953 (s) cm
-1
; 
1
H NMR (400 MHz, CDCl3)  4.20 – 4.07 (m, 6H, -
OCH2CH3, -PO(OCH2CH3)2), 3.40 – 3.28 (m, 4H, -SCH2CH2S-), 3.36 (s, 2H, EtOCOCH2-), 
3.03 (d, J = 18.0 Hz, 2H, -CH2PO(OEt)2), 1.33 (t, J = 7.2 Hz, 6H, -PO(OCH2CH3)2), 1.28 (t, 
J = 7.2 Hz, 3H, -OCH2CH3); 
13
C NMR (100 MHz, CDCl3)  170.6, 61.9 (2C), 61.6 (d, Jpc = 
3.2 Hz), 60.6, 47.9, 39.7 (2C), 39.4 (d, Jpc = 131.7 Hz), 16.4 (2C), 14.2; MS (ESI) m/z 707 
(2M + Na)
+
, 365 (M + Na)
+
, 343 (M + H)
+
. 
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Ethyl 4-(benzyloxy)-3-oxobutanoate 183
81
 
 
 
 
 
 
 
Sodium hydride (60% in mineral oil, 1.9 g, 79 mmol) was prewashed with pentane (30 ml) 
and suspended in THF (60 mL).  A mixture of benzyl alcohol (7.5 mL, 73 mmol) and ethyl 4-
chloroacetoacetate 167 (8.3 mL, 61 mmol) was then added at 23 ºC and stirred for 8 h at 40 
ºC.  The reaction was quenched by the addition of saturated aq. NH4Cl solution (20 mL) and 
the aqueous layer was acidified to pH 2 using 3 M aq. HCl solution. The resulting aqueous 
layer was extracted with EtOAc (60 mL × 2) and the combined organic layers were dried 
(MgSO4), rotary evaporated and chromatographed (Et2O/PE 1:19 to 1:4) to afford keto-ester 
183 (1.44 g, 10%) as an amber oil: Rf 0.30 (Et2O/PE 1:9); IR max (neat) 2982 (m), 1721 (s), 
1454 (w), 1369 (m), 1317 (m), 1096 (s), 1027 (s), 739 (s), 698 (s) cm
-1
; 
1
H NMR (400 MHz, 
CDCl3)  7.40 – 7.35 (m, 5H, ArH), 4.62 (s, 2H, -CH2OCH2Ph), 4.20 (q, J = 7.2 Hz, 2H, -
OCH2CH3), 4.17 (s, 2H, -CH2OCH2Ph-), 3.57 (s, 2H, -COCH2CO-), 1.27 (t, J = 6.8 Hz, -
OCH2CH3); 
13
C NMR (100 MHz, CDCl3)  201.8, 167.0, 136.9, 128.6 (2C), 128.2, 127.9 
(2C), 74.8, 73.5, 61.5, 46.1, 14.1; MS (ESI) m/z 495 (2M + Na)
+
. This data is in accordance 
with the literature.
81
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Ethyl 2-(2-(benzyloxymethyl)-1,3-dioxolan-2-yl)acetate 184 
 
 
 
 
 
 
 
To a stirred solution of keto-ester 183 (500 mg, 2.19 mmol) and ethylene glycol (0.24 mL, 
4.24 mmol) in PhMe (3.5 mL), p-TSA (30 mg, 0.15 mmol) was added at 23 ºC. The resulting 
mixture was heated at reflux under Dean-Stark conditions for 6.5 h. The reaction was 
quenched by the addition of saturated aq. NaHCO3 solution (3 mL) and the aqueous layer was 
extracted with EtOAc (10 mL × 2). The combined organic layers were dried (MgSO4), rotary 
evaporated and chromatographed (Et2O/PE 3:17 to 1:1) to afford ketal 184 (400 mg, 65%) as 
a pale yellow oil: Rf 0.21 (Et2O/PE 1:9); IR max (neat) 2895 (m), 1732 (s), 1370 (m), 1182 
(s), 1096 (s), 1035 (s), 950 (m) cm
-1
; 
1
H NMR (400 MHz, CDCl3)  7.36 – 7.28 (m, 5H, 
ArH), 4.62 (s, 2H, -OCH2Ph), 4.15 (q, J = 6.8 Hz, 2H, -OCH2CH3), 4.07 – 3.99 (m, 4H, -
OCH2CH2O-), 3.60 (s, 2H, -CH2OCH2Ph), 2.82 (s, 2H, -COCH2CO2Et), 1.26 (t, J = 7.2 Hz, -
OCH2CH3); 
13
C NMR (100 MHz, CDCl3)  169.4, 138.1, 128.4 (2C), 127.7, 127.6 (2C), 
107.9, 73.6, 72.0, 65.5 (2C), 60.6, 40.5, 14.2; MS (ESI) m/z 303 (M + Na)
+
. 
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Ethyl 2-(2-(hydroxymethyl)-1,3-dioxolan-2-yl)acetate 185 
 
 
 
 
To a stirred solution of ketal 184 (100 mg, 0.36 mmol) in MeOH (1 mL), palladium on 
charcoal (9.5 mg, 0.09 mmol) was added and the mixture stirred for 18 h under a hydrogen 
atmosphere using a balloon. The mixture was filtered through celite and the filtrate was 
rotary evaporated to afford primary alcohol 185 (62 mg, 90%) as a colourless oil. This 
material was used in the following step without further purification: Rf 0.41 (Et2O); IR max 
(neat) 3505 (m), 2899 (m), 1729 (s), 1372 (m), 1030 (s) cm
-1
; 
1
H NMR (400 MHz, CDCl3)  
4.18 (q, J = 7.2 Hz, 2H, -OCH2CH3), 4.10 – 4.02 (m, 4H, -OCH2CH2O-), 3.71 (s, 2H, 
HOCH2-), 2.78 (s, 2H, EtO2CCH2-), 2.22 (br. s, 1H, -OH), 1.29 (t, J = 7.2 Hz, -OCH2CH3); 
13
C NMR (100 MHz, CDCl3)  169.6, 108.2, 75.3, 60.9 (2C), 40.5, 38.7, 14.2. 
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Ethyl 3-(phenylthio)propanoate 190
51
 
 
 
 
 
To a stirred solution of ethyl acrylate 189 (21.6 mL, 200 mmol) and thiophenol 188 (22.6 
mL, 220 mmol) in CH2Cl2 (200 mL) at 23 ºC, aq. HClO4 (0.5 mol %) was added dropwise 
and stirred for 53 h. The reaction mixture was directly loaded on silica gel column and 
chromatographed (Et2O/PE 1:19) to afford ethylester 190 (25.2 g, 60%) as a colourless oil:  
Rf 0.40 (Et2O/PE 1:4); IR max (neat) 2981 (m), 1729 (s), 1583 (m), 1370 (m), 1241 (s), 1177 
(s), 1024 (m), 737 (s) cm
-1
; 
1
H NMR (400 MHz, CDCl3)  7.41 – 7.22 (m, 5H, ArH), 4.17 
(q, J = 7.2 Hz, 2H, -OCH2CH3), 3.20 (t, J = 7.6 Hz, 2H, PhSCH2-), 2.67 – 2.63 (t, J = 7.6 Hz, 
2H, - PhSCH2CH2-), 1.28 (t, J = 7.2 Hz, -OCH2CH3); 
13
C NMR (100 MHz, CDCl3)  171.8, 
135.3, 130.1 (2C), 129.0 (2C), 126.6, 60.8, 34.5, 29.1, 14.2; MS (CI) m/z 228 (M NH4)
+
, 
210 (M); HRMS (CI): (M  NH4)
+
, found 228.1067; C11H18NO2S requires 228.1058. This 
data is in accordance with the literature.
51
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Ethyl 3-oxo-5-(phenylthio)pentanoate 191 
 
 
 
 
 
Ethyl acetate 150 (10 mL, 112 mmol) was added dropwise into a solution of LDA (112 
mmol) in THF (60 mL) at 78 ºC and stirred for 30 min. Ethyl 3-(phenylthio)propanoate 190 
(7.5 g, 36 mmol) was added slowly and the reaction mixture was warmed to 23 ºC over 4 h.  
The reaction was quenched by the addition of H2O (30 mL) and the aqueous layer was 
acidified to pH 1 using 3 M aq. HCl solution. The resulting aqueous layer was extracted with 
Et2O (50 mL × 2) and the combined organic layers were dried (MgSO4), evaporated under 
reduced pressure and chromatographed (Et2O/PE 1:19 to 1:4) to afford -ketoester 191 (7.62 
g, 84%) as an amber oil: Rf 0.22 (Et2O/PE 20:80); IR max (neat) 2981 (m), 1718 (s), 1368 
(m), 1177 (s), 1024 (s), 739 (s), 691 (s) cm
-1
; 
1
H NMR (400 MHz, CDCl3)  7.39 – 7.21 (m, 
5H, ArH), 4.20 (q, J = 7.2 Hz, 2H, -OCH2CH3), 3.45 (s, 2H, -COCH2CO-), 3.18 (t, J = 7.2 
Hz, 2H, PhSCH2-), 2.90 (t, J = 7.2 Hz, 2H, - PhSCH2CH2-), 1.28 (t, J = 7.2 Hz, -OCH2CH3); 
13
C NMR (100 MHz, CDCl3)  200.9, 166.8, 135.4, 129.7 (2C), 129.1 (2C), 126.5, 61.5, 
49.4, 42.6, 27.3, 14.1; MS (ESI) m/z 275 (M + Na)
+
. 
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Ethyl 2-(2-(2-(phenylthio)ethyl)-1,3-dioxolan-2-yl)acetate 192 
 
 
 
 
 
 
To a mixture of -ketoester 191 (240 mg, 0.95 mmol) and ethylene glycol (0.1 mL, 2 mmol) 
in PhMe (1.8 mL), p-TSA (13 mg, 0.07 mmol) was added at 23 ºC. The resulting mixture was 
heated at reflux under Dean-Stark conditions for 4 h. The reaction was quenched by the 
addition of saturated aq. NaHCO3 solution (3 mL) and the aqueous layer was extracted with 
EtOAc (10 mL × 2). The combined organic layers were dried (MgSO4), rotary evaporated 
and chromatographed (Et2O/PE 1:9 to 1:4) to afford ketal 192 (140 mg, 50%) as a colourless 
oil: Rf 0.12 (Et2O/PE 1:4); IR max (neat) 2980 (m), 1730 (s), 1439 (m), 1214 (s), 1090 (s), 
1030 (s), 949 (m), 737 (s) cm
-1
; 
1
H NMR (400 MHz, CDCl3)  7.37 – 7.17 (m, 5H, ArH), 
4.16 – 4.13 (q, J = 7.2 Hz, 2H, -OCH2CH3), 4.08 – 3.99 (m, 4H, -OCH2CH2O-), 3.05 – 3.01 
(m, 2H, PhSCH2-), 2.68 (s, 2H, -CH2CO2Et), 2.25 – 2.20 (m, 2H, PhSCH2CH2-), 1.26 (t, J = 
7.2 Hz, -OCH2CH3); 
13
C NMR (100 MHz, CDCl3)  169.1, 136.4, 128.9 (2C), 128.7 (2C), 
125.8, 108.5, 65.3 (2C), 60.7, 42.9, 37.4, 27.2, 14.2; MS (ESI) m/z 319 (M + Na)
+
; HRMS 
(ESI): (M + Na)
+
, found 319.0970;
 
C15H20NaO4S requires 319.0980. 
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Ethyl 2-(2-(2-(phenylsulfinyl)ethyl)-1,3-dioxolan-2-yl)acetate 181 
 
 
 
 
 
 
To a stirred solution of sulfide 192 (68 mg, 0.23 mmol) in MeOH (1.1 mL) at 0 ºC, saturated 
aq. NaIO4 solution (0.5 mL, 0.32 mmol) was added dropwise over 10 min. A thick white 
precipitate was immediately formed and the ice bath was removed. The resulting mixture was 
stirred further for 13 h at 23 ºC. The reaction mixture was diluted with H2O (0.5 mL) and the 
aqueous layer was extracted with EtOAc (10 mL × 2). The combined organic layers were 
dried (MgSO4) and rotary evaporated to afford sulphoxide 181 (71 mg, 99%) as a pale yellow 
oil. This material was used in the following step without further purification: Rf 0.10 (Et2O); 
IR max (neat) 2987 (m), 2896 (w), 1733 (s), 1488 (w), 1043 (s) cm-1; 1H NMR (400 MHz, 
CDCl3)  7.66 – 7.51 (m, 5H, ArH), 4.12 (q, J = 7.2 Hz, 2H, -OCH2CH3), 4.04 – 3.95 (m, 
4H, -OCH2CH2O-), 3.00 – 2.88 (m, 2H, PhSCH2-), 2.62 (s, 2H, -CH2CO2Et), 2.33 – 2.25 (m, 
1H, - PhSCH2CH2-), 2.13 – 2.05 (m, 1H, - PhSCH2CH2-), 1.23 (t, J = 7.2 Hz, -OCH2CH3); 
13
C NMR (100 MHz, CDCl3)  168.9, 143.6, 131.1, 129.2 (2C), 124.2 (2C), 108.1, 65.2 
(2C), 60.8, 51.2, 42.9, 29.8, 14.1; MS (ESI) m/z 647 (2M + Na)
+
, 335 (M + Na)
+
. 
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Ethyl 2-(2-vinyl-1,3-dioxolan-2-yl)acetate 2 
 
 
 
A solution of sulphoxide 181 (1.2 g, 3.85 mmol) and anhydrous pyridine (0.47 mL, 7 mmol) 
in anhydrous xylene (10 mL) was irradiated under microwave conditions (300w, 145 ºC) for 
1.5 h. The volatiles were evaporated under reduced pressure and the residue was 
chromatographed (Et2O/PE 1:9 to 1:4) to afford olefin 2 (551 mg, 77%) as a pale yellow oil: 
Rf 0.22 (Et2O/PE 1:4); IR max (neat) 2982 (m), 1733 (s), 1369 (m), 1208 (s), 1174 (s), 1032 
(s), 947 (m) cm
-1
; 
1
H NMR (400 MHz, CDCl3)  5.92 (dd, J = 17.2, 10.6 Hz, 1H, CH2CHC-
), 5.47 (dd, J = 17.1, 1.7 Hz, 1H, CH2CHC-), 5.22 (dd, J = 10.6, 1.5 Hz, 1H, CH2CHC-), 4.17 
(q, J = 7.2 Hz, 2H, -OCH2CH3), 4.05 – 3.91 (m, 4H, -OCH2CH2O-), 2.79 (s, 2H, -
CH2CO2Et), 1.27 (t, J = 7.2 Hz, -OCH2CH3); 
13
C NMR (100 MHz, CDCl3)  168.9, 136.6, 
116.1, 106.4, 64.8 (2C), 60.6, 43.9, 14.2; MS (ESI) m/z 187 (M + H)
+
; HRMS (ESI): (M + 
H)
+
, found 187.0962;
 
C9H15O4 requires 187.0970. 
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Ethyl 3-((1R,4R)-bicyclo[2.2.1]hept-5-en-2-yl)-3-oxopropanoate 193 
 
 
 
    
 
To a stirred solution of norbonene-2-carboxylic acid 1 (22.1 mL, 181.2 mmol) in THF (600 
mL) at 23 ºC, carbodiimidazole (32.3 g, 199 mmol) was added in portion. The resulting 
mixture was stirred at 23 ºC for 18 h. The solvent was reduced to approximately 60 mL in 
volume and this clear pale yellow solution was subsequently used in the next step.  
Meanwhile, ethyl acetate 150 (53 mL, 544 mmol) was added dropwise to a solution of LDA 
(544 mmol) in THF (600 mL) at –78 ºC and allowed to stir for 30 min. The prepared solution 
in THF (60 mL) containing acyl imidazolide intermediate was then added and the resulting 
mixture was stirred for 20 min. The reaction mixture was then allowed to warm to 23 ºC over 
2.5 h. The reaction was quenched by the addition of 1 M aq. HCl solution and the aqueous 
layer was extracted with Et2O (200 mL × 2). The combined organic layers were washed with 
saturated aq. NaHCO3 solution (100 mL × 3) and dried (MgSO4). Evaporation under reduced 
pressure afforded -ketoester 193 (32 g, 85%) as a dark orange oil. This material was used in 
the following step without further purification: Rf 0.24 (endo), 0.28 (exo) (Et2O/PE 1:4); IR 
max (neat) 2977 (m), 1740 (s), 1707 (s), 1367 (m), 1337 (m), 1307 (m), 1252 (m), 1093 (s), 
1030 (s), 715.7 (s) cm
-1
; 
1
H NMR (400 MHz, CDCl3)  endo 6.21 (dd, J = 5.6, 3.1 Hz, 1H, -
C=CHC-), 5.90 (dd, J = 5.7, 2.7 Hz, 1H, -CHC=C), 4.22 (q, J = 7.2 Hz, 2H, -OCH2CH3), 
3.53 (d, J = 15.2 Hz, 1H, -OCH2CO2Et), 3.46 (d, J = 15.2 Hz, 1H, -OCH2CO2Et), 3.28 (br. s, 
1H, bridge-H), 3.21 – 3.18 (m, 1H, -CHCOCH2CO2Et), 2.95 (br. s, 1H, bridge-H), 1.85 – 
1.78 (m, 1H), 1.56 – 1.35  (m, 3H), 1.30 (t, J = 7.2 Hz, -OCH2CH3);  exo  6.20 (dd, J = 5.6, 
2.9 Hz, 1H, -C=CHC-), 6.14 (dd, J = 5.6, 3.1 Hz, 1H, -CHC=C-), 4.23 (q, J = 7.2 Hz, 2H, -
OCH2CH3), 3.58 (d, J = 15.2 Hz, 1H, -OCH2CO2Et), 3.54 (d, J = 15.4 Hz, 1H, -
OCH2CO2Et), 3.06 (br. s, 1H, bridge-H), 2.95 (br. s, 1H, bridge-H), 2.53 – 2.49 (m, 1H, -
CHCOCH2CO2Et), 1.94 (m, 1H), 1.43 – 1.33 (m, 3H), 1.31 (t, J = 7.2 Hz, -OCH2CH3); 
13
C 
NMR (100 MHz, CDCl3)  endo 203.0, 167.4, 138.1, 131.1, 61.3, 52.0, 49.9, 48.7, 45.9, 
42.7, 27.6, 14.1; MS (EI) m/z 208 (M
+
); HRMS (EI): (M
+
), found 208.1098; C12H16O3 
requires 208.1099; Elem. Anal.: found C, 69.18; H, 7.74; C12H16O3 requires C, 69.21; H, 
7.74%.    
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Ethyl 2-(2-((1R,4R)-bicyclo[2.2.1]hept-5-en-2-yl)-1,3-dioxolan-2-yl)acetate 194 
 
 
 
 
 
 
To a mixture of β-keto ester 193 (16 g, 76.9 mmol), ethylene glycol (12.9 mL, 231 mmol) 
and p-TSA (1.5 g, 7.7 mmol) in PhMe (160 mL), triethyl orthoformate (38.4 mL, 231 mmol) 
was added dropwise at 23 ºC and stirred for 18 h. The solvent was evaporated under reduced 
pressure and the residue was chromatographed (Et2O/PE 10:90 to 1:4) to afford ketal 194 
(15.9 g, 82%) as a colourless oil: Rf 0.20 (endo), 0.24 (exo) (Et2O/PE 1:4); IR max (neat) 
2974 (m), 1733 (s), 1369 (m), 1332 (m), 1217 (m), 1091 (m), 1043 (s), 719 (s) cm
-1
; 
1
H 
NMR (400 MHz, CDCl3)  endo 6.14 (dd, J = 5.6, 3.1 Hz, 1H, -C=CHC-), 5.94 (dd, J = 5.7, 
2.7 Hz, 1H, -CHC=C), 4.18 (q, J = 7.2 Hz, 2H, -OCH2CH3), 4.09 – 3.90 (m, 4H, -
OCH2CH2O-), 2.99 (br. s, 1H), 2.81 (br. s, 1H), 2.75 – 2.71 (m, 1H), 2.64 (s, 2H, -
CH2CO2Et), 1.91 – 1.85 (m, 1H), 1.41 – 1.38 (m, 1H), 1.29 (t, J = 7.2 Hz, -OCH2CH3), 1.27 -
1.26 (m, 1H), 0.99 (ddd, J = 11.3, 8.1, 2.5 Hz, 1H); exo  6.19 (dd, J = 5.6, 2.9 Hz, 1H, -
C=CHC-), 6.11 (dd, J = 5.6, 3.1 Hz, 1H, -CHC=C-), 4.17 (q, J = 7.2 Hz, 2H, -OCH2CH3), 
4.11 – 3.94 (m, 4H, -OCH2CH2O-), 2.87 (br. s, 1H, bridge-H), 2.82 (br. s, 1H, bridge-H), 
2.72 (d, J = 14.2 Hz, 1H, -CH2CO2Et), 2.67 (d, J = 14.2 Hz, 1H, -CH2CO2Et), 1.96 – 1.92 
(m, 1H), 1.69 (br. d, J = 8 Hz, 1H), 1.57 – 1.53 (m, 2H),  1.32 – 1.30 (m, 1H), 1.28 (t, J = 7.2 
Hz, -OCH2CH3); 
13
C NMR (100 MHz, CDCl3)  endo 169.7, 135.9, 132.4, 110.4, 65.5, 64.4 
60.4, 50.4, 46.1, 44.1, 43.2, 42.3, 28.3, 14.2; exo 169.7, 137.8, 137.2, 111.1, 65.6, 64.9, 60.5, 
46.6, 46.0, 43.5, 43.1, 41.6, 28.3, 14.1; MS (EI) m/z 252 (M
+
); HRMS (EI): (M
+
), found 
252.1359; C14H20O4 requires 252.1362; Elem. Anal.: found C, 66.56; H, 7.91; C14H20O4 
requires C, 66.65; H, 7.99%.    
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Ethyl 2-(2-vinyl-1,3-dioxolan-2-yl)acetate 2 
 
 
 
Flash vacuum pyrolysis (FVP) was carried out on norbonene 194 (24 g, 95 mmol) using a 
carbolite furnace at 580 ºC under 0.18 mbar pressure. The material collected on the cooling 
trap was chromatographed (Et2O/PE 1:9 to 1:4) to afford olefin 2 (12 g, 70%) as a pale 
yellow oil: Rf 0.22 (Et2O/PE 1:4); IR max (neat) 2982 (m), 1733 (s), 1369 (m), 1208 (s), 
1174 (s), 1032 (s), 947 (m) cm
-1
; 
1
H NMR (400 MHz, CDCl3)  5.92 (dd, J = 17.2, 10.6 Hz, 
1H, CH2CHC-), 5.47 (dd, J = 17.1, 1.7 Hz, 1H, CH2CHC-), 5.22 (dd, J = 10.6, 1.5 Hz, 1H, 
CH2CHC-), 4.17 (q, J = 7.2 Hz, 2H, -OCH2CH3), 4.05 – 3.91 (m, 4H, -OCH2CH2O-), 2.79 
(s, 2H, -CH2CO2Et), 1.27 (t, J = 7.2 Hz, -OCH2CH3); 
13
C NMR (100 MHz, CDCl3)  168.9, 
136.6, 116.1, 106.4, 64.8 (2C), 60.6, 43.9, 14.2; MS (ESI) m/z 187 (M + H)
+
; HRMS (ESI): 
(M + H)
+
, found 187.0962;
 
C9H15O4 requires 187.0970. 
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(S,E)-Ethyl2-(2-(5-(2-(4-(triisopropylsilyloxy)pentyl)-1,3-dioxolan-2- 
yl)pent-1-enyl)-1,3-dioxolan-2-yl)acetate 195 
 
 
 
 
 
 
 
To a stirred solution of alkenes 2 (100 mg, 0.49 mmol) and 157 (188 mg, 0.49 mmol) in 
CH2Cl2 (4 mL), Grubbs catalyst II (21 mg, 0.025 mmol) was added in one portion and the 
resulting mixture was heated at reflux for 18 h. The solvent was evaporated under reduced 
pressure and the residue was chromatographed (Et2O/PE 3:7 to 1:1) to afford olefin 195 (159 
mg, 60%) as a pale yellow oil: Rf 0.51 (Et2O/PE 1:1); 
1
H NMR (400 MHz, CDCl3)  5.90 
(dt, J = 15.2, 6.8 Hz, 1H, -CH2CHCHC-), 5.54 (d, J = 16.0 Hz, 1H, -CH2CHCHC-), 4.18 (q, 
J = 7.2 Hz, 2H, -OCH2CH3), 4.04 – 3.90 (m, 4H, -OCH2CH2O-), 3.95 (s, 5H, -SiOCH-, -
OCH2CH2O-), 2.79 (s, 2H, -CH2CO2Et), 2.09 – 2.07 (m, 2H, -CH2CHCHC-), 1.64 – 1.42 (m, 
10H), 1.29 (t, J = 7.2 Hz, 3H, -OCH2CH3), 1.19 (d, J = 6 Hz, 3H, CH3CH-), 1.01 (s, 21H, 
CH3CH-OSi(iPr)3); 
13
C NMR (100 MHz, CDCl3)  169.0, 132.3, 128.8, 111.6, 106.4, 68.5, 
64.9 (2C), 64.7 (2C), 60.5, 44.3, 40.1, 37.4, 36.7, 31.9, 23.5, 23.2, 19.7, 18.1 (6C), 14.2, 12.5 
(3C); MS (ESI) m/z 565 (M + Na)
+
; HRMS (ESI): (M + Na)
+
, found 565.3525; 
C29H54NaO7Si requires 565.3537. 
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(S,E)-2-(2-(5-(2-(4-(Triisopropylsilyloxy)pentyl)-1,3-dioxolan-2-yl)pent-1-enyl)-1,3-
dioxolan-2-yl)acetic acid 198 
 
 
 
 
A solution of ethylester 195 (140 mg, 0.25 mmol) and 5% aq. NaOH solution (1.6 mL) in 
absolute EtOH (0.8 mL) was stirred for 1 h at 50 ºC. The mixture was washed with Et2O (3 
mL) and the aqueous layer was acidified to pH 1 using 1 M aq. HCl solution. The resulting 
aqueous layer was extracted with Et2O (10 mL × 2) and the combined organic layers were 
dried (MgSO4) and rotary evaporated to afford carboxylic acid 198 (114 mg, 89%) as a 
colourless viscous oil. This material was used in the following step without further 
purification: Rf 0.22 (Et2O); IR max (neat) 2943 (s), 2866 (s), 1678 (s), 1463 (m), 1253 (m), 
1059 (s), 883 (s) cm
-1
; 
1
H NMR (400 MHz, CDCl3)  5.94 (dt, J = 15.6, 6.8 Hz, 1H, -
CH2CHCHC-), 5.46 (d, J = 15.6 Hz, 1H, -CH2CHCHC-), 4.10 – 3.96 (m, 4H, -OCH2CH2O-
), 3.95 (s, 5H, -SiOCH-, -OCH2CH2O-), 2.85 (s, 2H, -CH2CO2H), 2.11 – 2.06 (m, 2H, -
CH2CHCHC-), 1.62 – 1.39 (m, 10H), 1.19 (d, J = 6 Hz, 3H, CH3CH-), 1.00 (s, 21H, CH3CH-
OSi(iPr)3; 
13
C NMR (100 MHz, CDCl3)  172.2, 133.2, 128.0, 111.6, 106.3, 68.5, 64.9 
(2C), 64.7 (2C), 43.7, 40.1, 37.4, 36.6, 31.8, 23.5, 23.1, 19.6, 18.2 (6C), 12.5 (3C); MS (ESI) 
m/z 537 (M + Na)
+
, 515 (M + H)
+
; HRMS (ESI): (M + H)
+
, found 515.3391; C27H51O7Si 
requires 515.3404. 
 
. 
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Potassium 2-(2-vinyl-1,3-dioxolan-2-yl)acetate 411 
 
  
 
 
To a stirred solution of ethylester 2 (2 g, 10.8 mmol) in EtOH (10 mL), a solution of KOH 
(950 mg, 17 mmol) in EtOH (10 mL) was added and the resulting mixture was stirred for 1.5 
h at 45 ºC. The volatile was evaporated under reduced pressure to afford a sticky yellow 
solid. Trituration with Et2O (20 mL) provided the potassium salt 411 (1.82 g, 86%) as a white 
solid: 
1
H NMR (400 MHz, D2O)  5.95 (dd, J = 17.3, 10.7 Hz, 1H, CH2CHC-), 5.45 (dd, J = 
17.3, 1.1 Hz, 1H, CH2CHC-), 5.30 (dd, J = 10.7, 1.2 Hz, 1H, CH2CHC-), 4.08 – 3.96 (m, 4H, 
-OCH2CH2O-), 2.68 (s, 2H, -CH2C-); 
13
C NMR (100 MHz, D2O)  179.7, 138.6, 118.8, 
109.7, 66.8 (2C), 48.9. 
 
 
2-(2-Vinyl-1,3-dioxolan-2-yl)acetic acid 412 
 
 
 
 
 
Potassium salt 411 (900 mg, 4.6 mmol) was dissolved in H2O (15 mL) and the aqueous was 
acidified to pH 3 using 1 M aq. HCl solution. The resulting aqueous layer was extracted with 
Et2O (25 mL × 2) and the combined organic layers were dried (MgSO4) and rotary 
evaporated to afford carboxylic acid 412 (726 mg, 90%) as a colourless oil. This material was 
used in the following step without further purification. Due to its instability at room 
temperature, carboxylic acid 412 was only characterized by 
1
H NMR analysis: Rf 0.16 
(Et2O); 
1
H NMR (400 MHz, CDCl3)  5.90 (dd, J = 17.2, 10.6 Hz, 1H, CH2CHC-), 5.50 (dd, 
J = 17.2, 1.3 Hz, 1H, CH2CHC-), 5.26 (dd, J = 10.4, 1.4 Hz, 1H, CH2CHC-), 4.08 – 3.94 (m, 
4H, -OCH2CH2O-), 2.86 (s, 2H, -CH2C-). 
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1-(1H-Benzo[d][1,2,3]triazol-1-yl)-2-(2-vinyl-1,3-dioxolan-2-yl)ethanone 201 
 
 
 
 
 
 
 
To a solution of acid 412 (600 mg, 3.8 mmol) and EDC hydrochloride salt (800 mg, 4.18 
mmol) in CH2Cl2 (15 mL), a solution of benzotriazole 114 (500 mg, 4.18 mmol) in CH2Cl2 (3 
mL) was added dropwise at 23 ºC and stirred for 18 h. The mixture was diluted with CH2Cl2 
(30 mL) and washed with 1 M aq. HCl solution (15 mL), and with pH 9 buffer solution (30 
mL × 2). The organic layer was dried (MgSO4) and evaporated under reduced pressure to 
afford acyl triazole 201 (807 mg, 82%) as a white solid: Rf 0.67 (Et2O/PE 1:1); Mp; 97 – 101 
ºC; IR max (neat) 1743 (s), 1621 (w), 1375 (s), 1367 (s), 1195 (s), 1172 (s), 1059 (s) cm-1; 
1
H NMR (400 MHz, CDCl3)  8.34 (d, J = 8.4 Hz, 1H, ArH), 8.15 (d, J = 8.4 Hz, 1H, ArH), 
7.70 – 7.67 (m, 1H, ArH), 7.56 – 7.52 (m, 1H, ArH), 6.08 (dd, J = 17.2, 10.6 Hz, 1H, 
CH2CHC-), 5.56 (dd, J = 17.1, 1.7 Hz, 1H, CH2CHC-), 5.29 (dd, J = 10.6, 1.5 Hz, 1H, 
CH2CHC-), 4.11 – 3.97 (m, 4H, -OCH2CH2O-), 3.96 (s, 2H, -CH2C); 
13
C NMR (100 MHz, 
CDCl3)  167.7, 146.3, 136.4, 131.1, 130.4, 126.2, 120.2, 116.7, 114.6, 106.7, 65.0 (2C), 
43.8; MS (EI) m/z 259 (M
+
); HRMS (EI): (M
+
), found 259.0955; C13H13N3O3 requires 
259.0957; Elem. Anal.: found C, 60.27; H, 5.13; N, 16.26; C13H13N3O3 requires C, 60.22; H, 
5.05; N, 16.21%. 
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2,2-Dimethyl-6-(2-oxo-3-(2-vinyl-1,3-dioxolan-2-yl)propyl)-4H-1,3-dioxin-4-one 178 
 
 
 
 
 
 
Dioxinone 65 (540 mg, 3.8 mmol) in THF (2 mL) was added dropwise to a solution of 
LiHMDS (3.8 mmol) in THF (15 mL) at –78 ºC and the resulting amber solution was stirred 
for an hour at aforementioned temperature. Zinc chloride (1 M in Et2O; 3.8 mL) was 
subsequently added and stirred further for 15 min. Acyl triazole 201 (350 mg, 1.27 mmol) in 
THF (2 mL) was then added dropwise and the mixture was warmed to 0 ºC over 1.5 h. The 
reaction mixture gradually turned bright yellow with time. The reaction was quenched by the 
addition of saturated aq. NH4Cl solution (20 mL) and the aqueous layer was acidified to pH 2 
using 1 M aq. HCl solution. The resulting aqueous layer was extracted with Et2O (25 mL × 2) 
and dried (MgSO4), evaporated under reduced pressure and chromatographed (Et2O/PE 1:1 to 
1:0) to afford ketal-keto-dioxinone 178 (225 mg, 63%) as an amber oil:  Rf 0.35 (Et2O); IR 
max (neat) 2994 (w), 1719 (s), 1637 (m), 1391 (m), 1374 s, 1271 (m), 1200 (s), 1013 (s) cm-
1
; 
1
H NMR (400 MHz, CDCl3)  5.79 (dd, J = 17.3, 10.7 Hz, 1H, CH2CHC-), 5.45 (dd, J = 
17.3, 1.1 Hz, 1H, CH2CHC-), 5.34 (s, 1H, -OCCHCO2-), 5.26 (dd, J = 10.7, 1.2 Hz, 1H, 
CH2CHC), 4.04 – 3.92 (m, 4H, -OCH2CH2O-), 3.50 (s, 2H, -CH2C(O)CH2- ), 2.92 (s, 2H, -
CH2C(O)CH2-), 1.73 (s, 6H, CH3 × 2); 
13
C NMR (100 MHz, CDCl3)  199.5, 164.7, 160.8, 
136.2, 116.8, 107.2, 106.5, 96.8, 64.6 (2C), 51.3, 48.2, 25.1 (2C); MS (ESI) m/z 565 (2M + 
H)
+
, 587 (2M + Na)
+
; HRMS (ESI): (2M +H)
+
, found 565.2271; C28H37O12 requires 
565.2285; Elem. Anal.: found C, 59.67, H, 6.37; C14H18O6 requires C, 59.57; H, 6.43%.  
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(S,E)-6-(3-(2-(5-(2-(4-Hydroxypentyl)-1,3-dioxolan-2-yl)pent-1-enyl)-1,3-dioxolan-2-yl)-2-
oxopropyl)-2,2-dimethyl-4H-1,3-dioxin-4-one 3 
 
 
 
 
 
 
A stirred solution of alkene 178 (75 mg, 0.27 mmol) and Grubbs catalyst II (24 mg, 0.03 
mmol) in CH2Cl2 (3 mL) was heated at reflux, at which point a solution of alcohol (S)-144 
(122 mg, 0.54 mmol) in CH2Cl2 (1 mL) was added dropwise over 10 min. The resulting 
mixture was continued to heat at reflux for 18 h. The solvent was evaporated under reduced 
pressure and the residue was chromatographed (Et2O/PE 1:0 to EtOAc/PE 4:1) to afford keto-
dioxinone 3 (98 mg, 75%) as a dark brown oil: Rf  0.17 (Et2O); 
25
D][  +3.6 (c 1.0 CH2Cl2); IR 
max (neat) 3458 (m), 1720 (s), 1638 (m), 1391 (m), 1374 (m), 1271 (m), 1202 (s), 1015 (s) 
cm
-1
; 
1
H NMR (400 MHz, CDCl3)  5.85 (dt, J = 15.5, 6.9 Hz, 1H, -CHCCHC-), 5.40 (d, J 
= 15.5 Hz, 1H, -CHCCHC-), 5.34 (s, 1H, -OCCHCO2-), 4.01 – 3.90 (m, 8H, -OCH2CH2O- × 
2), 3.85 – 3.78 (m, 1H, -CH-OH), 3.49 (s, 2H, -CH2COCH2-), 2.89 (s, 2H, -CH2COCH2-), 
2.09 – 2.04 (m, 2H, -CH2CHCCHC- ), 1.73 (s, 6H, CH3 × 2), 1.66 – 1.42 (m, 10H), 1.21 (d, J 
= 6.1 Hz, 3H, CH3-); 
13
C NMR (100 MHz, CDCl3)  199.7, 164.8, 160.8, 132.9, 128.5, 
111.5, 107.1, 106.5, 96.7, 67.9, 64.9 (2C), 64.5 (2C), 51.7, 48.1, 39.4, 36.9, 36.5, 31.7, 25.0 
(2C), 23.5, 23.0, 20.0; MS (ESI) m/z 505 (M + Na)
+
; HRMS (ESI): (M + Na)
+
, found 
505.2397; C25H38NaO9 requires 505.2414; Elem. Anal.: found C, 62.10; H, 8.03; C25H38O9 
requires C, 62.22; H, 7.94%. 
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Macrocycle 4 
 
 
 
 
 
A solution of dioxinone 3 (30 mg, 0.06 mmol) in PhMe (1.5 mL) was added dropwise into 
PhMe (4.5 mL) at reflux over 40 min. The resulting mixture was heated at reflux for 15 min.  
The solvent was evaporated under reduced pressure and the residue was chromatographed 
(Et2O) to afford the macrocyle 4 (21 mg, 83%) as a colourless oil and used immediately in 
the following step: Rf 0.69 (Et2O); MS (ESI) m/z 425 (M + H)
+
, 447 (M + Na)
+
; HRMS 
(ESI): (M + H)
+
, found 425.2169; C22H32O8 requires 425.2175. 
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(S)-Zearalenone (5) 
 
 
 
 
 
 
 
 
A solution of macrocycle 4 (70 mg, 0.15 mmol) in acetone (0.81 mL) and H2O (0.5 mL) was 
treated with p-TSA (30 mg, 0.15 mmol) and stirred for 3 h at 23 ºC. Additional H2O (3 mL) 
was added and the aqueous layer was extracted with Et2O (10 mL × 2). The combined 
organic layers were dried (MgSO4) and evaporated under reduced pressure to give a bright 
yellow oil. This material was dissolved in MeOH (4 mL) and subsequently treated with 
Cs2CO3 (455 mg, 1.4 mmol) at 23 ºC. The reaction mixture immediately turned dark yellow 
and was allowed to stir for 45 min. Acetic acid (0.25 mL, 4.2 mmol) was then added and 
stirred further for 18 h. 2 M aq. HCl solution (3 mL) was added and allowed to stir further for 
1.5 h. The solvent was removed by evaporation under reduced pressure and the residue was 
partitioned between EtOAc (15 mL) and H2O (10 mL). The organic layer was washed with 
H2O (5 mL × 2), dried (MgSO4), rotary evaporated and chromatographed (Et2O/PE 3:5 to 
1:1) to afford (S)-zearalenone (5) (26.2 mg, 55% over 3 steps) as a white solid: Rf 0.38 
(Et2O/PE 1:1); Mp 162 – 163 
o
C, lit.
82
 164 – 166; 25D][ 130.0 (c 0.45 MeOH); lit.
83 134.0 
(c 1.0 MeOH); IR max (neat) 3306 (m), 1689 (s), 1645 (s), 1618 (s), 1579 (s), 1312 (s), 1260 
(s), 1195 (s), 1167 (s), 1143 (s), 1101 (s), 1074 (m) cm
-1
; 
1
H NMR (400 MHz, CDCl3)  
12.09 (s, 1H, ArOH), 7.05 (dd, J = 15.3, 1.7, 1H, ArCHCH-), 6.44 (d, J = 2.5 Hz, 1H, ArH), 
6.39 – 6.38 (d, J = 2.5 Hz, 1H, ArH), 5.75 – 5.68 (m, 1H, ArCHCH-), 5.37 (br. s, 1H, 
ArOH), 5.07 – 4.99 (m, 1H, -CO2CH-), 2.89 (ddd, J = 18.6, 12.1, 2.1 Hz, 1H), 2.67 – 2.62 
(m, 1H), 2.42 – 2.38 (br. m, 1H), 2.42 – 2.38 (br. m, 4H), 1.85 – 1.74 (m, 2H), 1.73 – 1.63 
(m, 2H), 1.58 – 1.48 (m, 1H), 1.41 (d, J = 6.1 Hz, 3H, CH3-); 
13
C NMR (100 MHz, CDCl3) 
 211.7, 171.3, 165.5, 160.6, 144.0, 133.2, 132.5, 108.4, 103.9, 102.5, 73.5, 42.9, 36.7, 34.7, 
31.0, 22.3, 21.0, 20.8; MS (ESI) m/z 319 (M + H)
+
; HRMS (ESI): (M + H)
+
, found 
319.1540; C18H23O5 requires 319.1545; Elem. Anal.: found C, 68.03; H, 7.00; C18H22O5 
requires C, 67.91; H, 6.97%. The 
1
H NMR and 
13
C NMR spectra (Appendix 2) were identical 
with those reported in the literature.
20
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(S)-5-(Trimethylsilyl)pent-4-yn-2-ol 225
62,63
 
 
 
 
 
 
A solution of ethynyltrimethylsilane 224 (7.5 mL, 55 mmol) in Et2O (80 mL) was cooled to 
78 ºC and stirred for 10 min. n-Butyllithium (1.6 M in hexane; 34 mL) was then added 
dropwise and the resulting mixture was stirred for an hour at the aforementioned temperature.  
(S)-Ethylene oxide (223) (3.66 mL, 52 mmol) was subsequently added followed by dropwise 
addition of BF3∙Et2O (6.5 mL, 52.4 mmol). The resulting colourless solution was warmed to 
0 ºC over 4 h with stirring. The reaction was quenched by addition of H2O (20 mL) and the 
aqueous layer was extracted with Et2O (40 mL × 2). The combined organic layers were dried 
(MgSO4), rotary evaporated and chromatographed (Et2O/PE 1:9 to 1:3) to afford alcohol 225 
(5.67 g, 70%) as a colourless liquid: Rf 0.25 (Et2O/PE 1:3); 
25
D][ 13.5 (c 1.5 CHCl3); lit.
84 
13.5 (c 3.0 CHCl3); IR max (neat) 3351 (m), 2963 (m), 2176 (s), 1248 (s), 1032 (s), 836 (s) 
cm
-1
; 
1
H NMR (400 MHz, CDCl3)  4.01 – 3.93 (m, 1H, -CH-OH), 2.49 – 2.35 (m, 1H, -
CH2-), 2.49 – 2.35 (m, 1H, -CH2-), 1.96 (br. s, 1H, OH), 1.28 (d, J = 6 Hz, 3H, -CH3), 0.19 
(s, 9H, Si(CH3)3); 
13
C NMR (100 MHz, CDCl3)  103.2, 87.6, 66.2, 30.5, 22.2, 0.3, 0.2, 0.1; 
MS (CI) m/z 174 (M + NH4)
+
; HRMS (CI): (M + NH4)
+
, found 174.1316; C8H20NOSi 
requires 174.1314; Elem. Anal.: found C, 61.40; H, 10.20; C8H16OSi requires C, 61.48; H, 
10.32%. This data is in accordance with the literature.
62,63
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4-Methoxybenzyl 2,2,2-trichloroacetimidate 226
85
 
 
 
 
 
 
 
 
Sodium hydride (60% in mineral oil, 487 mg, 12.7 mmol) was suspended in Et2O (20 ml) and 
(4-methoxyphenyl)methanol 414 (7 g, 50.7 mmol) was added dropwise at 0 ºC. The resulting 
cloudy mixture was stirred for 30 min at 23 ºC. Trichloroacetonitrile 413 (5.1 mL, 50.7 
mmol) was then added dropwise and the reaction mixture gradually turned yellow-orange.  
The reaction was complete by TLC analysis after 3 h of stirring at 23 ºC and quenched by 
addition of saturated aq. NH4Cl solution (15 mL). The aqueous layer was extracted with Et2O 
(30 mL × 2) and the combined organic layers were dried (MgSO4) and evaporated under 
reduced pressure to afford trichloroacetimidate 226 (13.9 g, 98%) as a red-orange oil. This 
material was used in the following step without further purification: 
1
H NMR (400 MHz, 
CDCl3)  8.39 (br. s, 1H, NH), 7.41 (d, J = 8.4 Hz, 2H, ArH), 6.95 (d, J = 8.8 Hz, 2H, ArH), 
5.31 (s, 2H, ArCH2-), 3.85 (s, 3H, CH3). This data is in accordance with the literature.
85
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(S)-1-Methoxy-4-((pent-4-yn-2-yloxy)methyl)benzene 214
62
 
 
 
 
 
 
 
 
 
To a stirred solution of alcohol 225 (2.5 g, 16 mmol) in CH2Cl2 (50 mL) at 23 ºC, a solution 
of trichloroacetimidate 226 (6.8 g, 24 mmol) in CH2Cl2 (10 mL) was added dropwise 
followed by addition of CSA (560 mg, 0.15 mmol). The resulting yellow mixture was stirred 
for 18 h. The reaction was quenched by addition of saturated aq. NH4Cl solution (15 mL) and 
the aqueous layer was extracted with Et2O (50 mL × 2). The combined organic layer was 
dried (MgSO4) and evaporated under reduced pressure to afford a yellow oil. This material 
was subsequently dissolved in MeOH (80 mL) and treated with K2CO3 (2.1 g, 19 mmol) at 23 
ºC. The resulting suspension was stirred for 18 h and the reaction was quenched by addition 
of H2O (25 mL). The aqueous layer was extracted with Et2O (35 mL × 3) and the combined 
organic layer was dried (MgSO4), rotary evaporated and chromatographed (Et2O/PE 3:97 to 
1:9) to afford alkyne 214 (2.28 g, 70% over 2 steps) as a colourless oil: Rf 0.45 (Et2O/PE 1:9); 
25
D][  6.7 (c 1.9 CHCl3); lit.
86
 6.5 (R-isomer, c 1.04 CHCl3); IR max (neat) 2979 (m), 2936 
(m), 1612 (m), 1512 (s), 1244 (s), 1095 (s), 1032 (s) cm
-1
; 
1
H NMR (400 MHz, CDCl3)  
7.31 (d, J  = 8.8 Hz, 2H, ArH), 6.91 (d, J  = 8.8 Hz, 2H, ArH), 4.52 (s, 2H, ArCH2-), 3.83 (s, 
3H, -OCH3), 3.75 – 3.67 (m, 1H, -CHOCH2Ar), 2.55 – 2.49 (ddd, J = 16.4, 4.8, 2.4 Hz, 1H, -
CH2CCH), 2.41 – 2.34 (ddd, J = 16.8, 6.4, 2.8 Hz, 1H, -CH2CCH), 2.04 – 2.03 (t, J = 2.4 Hz, 
1H, -CH2CCH), 1.33 – 1.32 (d, J = 6.4 Hz, 3H, -CH3); 
13
C NMR (100 MHz, CDCl3)  
159.2, 130.6, 129.2 (2C), 113.8 (2C), 81.3, 72.8, 70.4, 69.9, 55.3, 26.0, 19.5; MS (EI) m/z 
204 (M
+
); HRMS (CI): (M
+
), found 204.1142; C13H16O2 requires 204.1150; Elem. Anal.: 
found C, 76.50; H, 7.79; C13H16O2 requires C, 76.44; H, 7.90%.  
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(3aR,7aS)-2,2-Dimethyltetrahydro-3aH-[1,3]dioxolo[4,5-c]pyran-6-ol 218
60
 
 
 
 
 
 
 
 
  
2-Deoxy-D-ribose (53) (8 g, 60 mmol) was dissolved in DMF (100 mL) and dried CaSO4 (2 
g, 14.8 mmol) was added. The resulting suspension was cooled to 0 ºC and 2-
methoxypropene 219 (5.7 mL, 60 mmol) was added followed by catalytic amount of p-TSA 
(40 mg, 0.2 mmol). The mixture was stirred at 0 ºC for an hour at which additional 2-
methoxypropene 219 (5.7 mL, 60 mmol) was added dropwise and stirred further for 2 h at 0 
ºC. Na2CO3 (8 g, 75 mmol) was then added and stirred for 30 min at 23 ºC. The reaction 
mixture was filtered and the volatiles were evaporated under reduced pressure to afford 
acetonide 218 (7.1 g, 68%) as a pale yellow oil. Silica gel column chromatography on 
acetonide 218 resulted in signs of decomposition; hence this material was subsequently used 
in the following step without further purification: Rf 0.32 (Et2O). 
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2-((4S,5R)-5-(Hydroxymethyl)-2,2-dimethyl-1,3-dioxolan-4-yl)ethanol 217
61
 
 
 
 
 
 
  
 
To a stirred suspension of LiAlH4 (150 mg, 3.9 mmol) in THF (6 mL) at 0 ºC, a solution of 
acetonide 218 (480 mg, 2.8 mmol) in THF (6 mL) was added dropwise and stirred for 2 h at 
23 ºC. The reaction was quenched sequentially with H2O (0.5 mL), 15% aq. NaOH solution 
(0.5 mL) and H2O (0.5 mL). The reaction mixture was then poured into Et2O (10 mL) and 
stirred further for 30 min. The insoluble material was removed by filtration through celite and 
the solvents were evaporated under reduced pressure to afford diol 217 (443 mg, 90%) as a 
pale yellow oil. This material was used in the next step without further purification; Rf 0.10 
(EtOAc/PE 1:3): 
1
H NMR (400 MHz, CDCl3)  4.38 – 4.33 (m, 1H, HOCH2CHO-), 4.22 – 
4.19 (m, 1H, -OCHCH2CH2COH), 3.87 – 3.76 (m, 2H, HOCH2CHO-), 3.69 – 3.61 (m, 2H, -
CH2CH2OH), 2.43 (br. s, 2H, -OH × 2), 1.88 – 1.80 (m, 2H, -CH2CH2OH), 1.47 (s, 3H, -
CH3), 1.38 (m, 3H, -CH3); 
13
C NMR (100 MHz, CDCl3)  108.1, 77.9, 75.5, 61.2, 60.3, 
31.5, 28.1, 25.5; MS (ESI) m/z 199 (M + Na)
+
. This data is in accordance with the 
literature.
61
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((4R,5S)-5-(2-(tert-Butyldiphenylsilyloxy)ethyl)-2,2-dimethyl- 
1,3-dioxolan-4-yl)methanol 216
61
 
 
 
 
 
 
 
To a stirred solution of diol 217 (2.4 g, 13.6 mmol) and imidazole (1.57 g, 23 mmol) in DMF 
(5 mL) at 23 ºC, TBDPSCl (2.5 mL, 9.7 mmol) was added dropwise. Exothermic reaction 
was observed as half amount of TBDPSCl was added. The reaction mixture was stirred for 4 
h at 23 ºC. The reaction mixture was diluted with EtOAc (30 mL) and the reaction was 
quenched with saturated aq. NH4Cl solution (15 mL). The aqueous layer was extracted with 
EtOAc (30 mL × 2), dried (MgSO4), rotary evaporated and chromatographed (Et2O/PE 1:3 to 
1:1) to afford mono-protected diol 216 (2.98 g, 53%) as a colourless oil: Rf 0.63 (Et2O/PE 
2:1); 25D][ 5.0 (c 2.0 CHCl3); IR max (neat) 3450 (m), 2931 (m), 1427 (m), 1378 (m), 1369 
(m), 1216 (s), 1107 (s), 1082 (s), 1043 (s) cm
-1
; 
1
H NMR (400 MHz, CDCl3)  7.70 – 7.67 
(m, 4H, ArH), 7.45 – 7.38 (m, 6H, ArH), 4.44 – 4.40 (m, 1H, HOCH2CHO-), 4.20 – 4.16 (m, 
1H, -OCHCH2CH2COSi-), 3.84 – 3.80 (m, 2H, HOCH2CHO-), 3.63 – 3.59 (m, 2H, -
CH2CH2OSi-), 1.85 – 1.80 (m, 2H, -CH2CH2COSi-), 1.60 (br. s, 1H, -OH), 1.47 (s, 3H, -
CH3), 1.39 (s, 3H, -CH3), 1.07 (s, 9H, -SiC(CH3)3); 
13
C NMR (100 MHz, CDCl3)  135.6 
(2C), 135.5 (2C), 133.6, 133.5, 129.6 (2C), 127. 7 (2C), 127.6 (2C), 107.9, 77.8, 73.8, 61.8, 
61.0, 31.7, 28.2, 26.8 (3C), 25.4, 19.1; MS (ESI) m/z 415 (M + H)
+
; HRMS (ESI): (M + H)
+
, 
found 415.2294; C24H35O4Si requires 415.2305. This data is in accordance with the 
literature.
61
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(4S,5S)-5-(2-(tert-Butyldiphenylsilyloxy)ethyl)-2,2-dimethyl 
-1,3-dioxolane-4-carbaldehyde 220 
 
 
 
 
 
 
To a stirred solution of alcohol 216 (50 mg, 0.12 mmol) and Et3N (0.08 mL, 0.6 mmol) in 
CH2Cl2/DMSO (4:1 v/v, 1.5 mL) at 0 ºC, SO3.pyridine complex (67 mg, 0.4 mmol) was 
added in one portion.  The resulting mixture was stirred for 45 min at 23 ºC. The mixture was 
diluted with EtOAc (25 mL) and washed with H2O (10 mL × 2), saturated aq. NaHCO3 
solution (10 mL × 2) and brine (10 mL × 2). The combined organic layers were dried 
(MgSO4), rotary evaporated and chromatographed (EtOAc/PE 1:19 to 3:17) to afford 
aldehyde 220 (40 mg, 80%) as a colourless oil: Rf 0.48 (EtOAc/PE 1:4); IR max (neat) 2931 
(m), 1732 (m), 1472 (m), 1427 (s), 1218 (s), 1105 (s), 1082 (s) cm
-1
; 
1
H NMR (400 MHz, 
CDCl3)   9.68 (d, J = 3.4 Hz, 1H, -CHO), 7.70 – 7.68 (m, 4H, ArH), 7.48 – 7.40 (m, 6H, 
ArH), 4.69 – 4.63 (m, 1H, OHCCHO-), 4.30 (dd, J = 6.8, 3.4 Hz, 1H, -OCHCH2CH2OSi-), 
3.86 – 3.83 (m, 2H, -CH2CH2OSi-), 1.98 – 1.90 (m, 1H, -CH2CH2COSi-), 1.75 – 1.67 (m, 
1H, -CH2CH2COSi-), 1.60 (s, 3H, -CH3), 1.45 (s, 3H, -CH3), 1.08 (s, 9H, -SiC(CH3)3); 
13
C 
NMR (100 MHz, CDCl3)  202.3, 135.6 (2C), 135.5 (2C), 133.6 (2C), 129.7 (2C), 127.7 
(2C), 127.6 (2C), 110.5, 81.9, 75.1, 60.5, 32.4, 27.6, 26.8 (3C), 25.4, 19.2; MS (ESI) m/z 413 
(M + H)
+
; HRMS (ESI): (M + H)
+
, found 413.2149; C24H33O4Si requires 413.2148; Elem. 
Anal., found C, 69.81; H, 7.75; C24H32O4Si requires C, 69.86; H, 7.82. 
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(4S,5S)-5-(2-(tert-Butyldiphenylsilyloxy)ethyl)-N-methoxy-N,2,2- 
trimethyl-1,3-dioxolane-4-carboxamide 215 
 
 
 
 
 
 
 
 
 
To a solution of aldehyde 220 (100 mg, 0.24 mmol) in H2O (1 mL) and acetone (1 mL) at 0 
ºC, 2-methyl-2-butene (0.46 mL, 4.33 mmol), NaH2PO4.2H2O (75 mg, 0.48 mmol) and 
NaClO2 (54 mg, 0.6 mmol) were added successively with vigorous stirring. The resulting 
yellow solution was stirred for 30 min at 23 ºC. The aqueous layer was extracted with EtOAc 
(15 mL × 2), dried (MgSO4) and rotary evaporated to give the corresponding acid as a 
colourless gum. This material was used in the following step without further purification. 
 
To a stirred solution of corresponding carbocylic acid (102 mg, 0.24 mmol), N,O-
dimethylhydroxylamine hydrochloride salt 222 (28 mg, 0.29 mmol) and PyBOP (131 mg, 
0.25 mmol) in CH2Cl2 (5 mL) at 0 ºC, DIPEA (0.13 mL, 0.7 mmol) was added and stirred for 
2 h at 23 ºC. The reaction mixture was diluted with Et2O (20 mL) and washed successively 
with 1 M aq. HCl solution (10 mL × 3), saturated aq. NaHCO3 solution (10 mL × 3), and 
brine (10 mL × 3). The combined organic layers were dried (MgSO4), rotary evaporated and 
chromatographed (Et2O/PE 3:7 to 1:1) to afford Weinreb amide 215 (79 mg, 70% over 2 
steps) as a colourless oil: Rf 0.70 (Et2O); 
25
D][ 45.0 (c 0.93 CHCl3); IR max (neat) 2932 
(m), 1687 (s), 1427 (m), 1378 (m), 1218 (m), 1108 (s), 1082 (s) cm
-1
; 
1
H NMR (400 MHz, 
CDCl3) 7.72 – 7.68 (m, 4H, ArH), 7.46 – 7.38 (m, 6H, ArH), 4.99 (d, J = 6.4 Hz, 1H, 
(OMe)MeNCOCHO-), 4.73 (ddd, J = 10.2, 6.8, 2.9 Hz 1H, -OCHCH2CH2OSi-), 3.92 – 3.86 
(m, 1H, -CH2CH2OSi-), 3.83 – 3.78 (m, 1H, -CH2CH2OSi-), 3.72 (s, 3H, -NOCH3), 3.20 (s, 
3H, -NCH3), 1.80 – 1.72 (m, 1H, -CH2CH2COSi-), 1.71 – 1.63 (m, 1H, -CH2CH2COSi-), 
1.60 (s, 3H, -CH3), 1.43 (s, 3H, -CH3), 1.08 (s, 9H, -SiC(CH3)3); 
13
C NMR (100 MHz, 
CDCl3)  170.5, 135.6 (2C), 135.5 (2C), 133.9, 133.8, 129.6, 129.5, 127.6 (4C), 109.9, 75.6, 
74.0, 61.1, 60.6, 33.5, 32.3, 27.4, 26.8 (3C), 25.8, 19.2; MS (ESI) m/z 494 (M + Na)
+
; 
HRMS (ESI): (M + H)
+
, found 472.2515; C26H38NO5Si requires 472.2519; Elem. Anal., 
found C, 66.11; H, 7.99; N, 2.94; C26H37NO5Si requires C, 66.21; H, 7.91; N, 2.97%. 
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(S)-1-((4S,5S)-5-(2-(tert-Butyldiphenylsilyloxy)ethyl)-2,2-dimethyl- 
1,3-dioxolan-4-yl)-5-(4-methoxybenzyloxy)hex-2-yn-1-one 227 
 
 
 
 
 
 
 
To a stirred solution of alkyne 214 (104 mg, 0.5 mmol) in THF (2.7 mL) at 78 ºC, n-
butyllithium (1.6 M in hexane; 0.32 mL) was added dropwise and the resultant was stirred for 
1.5 h at 0 ºC. The reaction mixture was re-cooled to78 ºC and a solution of Weinreb amide 
215 (160 mg, 0.34 mmol) in THF (1 mL) was added dropwise. The reaction mixture was 
allowed to warm to 0 ºC and stirred for 2 h. The reaction was quenched by the addition of 
saturated aq. NH4Cl solution (10 mL) and the aqueous layer was extracted with Et2O (15 mL 
× 2). The combined organic layers were dried (MgSO4), rotary evaporated and 
chromatographed (Et2O/PE 1:9 to 1:4) to afford propargylic ketone 227 (167 mg, 80%) as a 
colourless oil: Rf 0.26 (Et2O/PE 1:4); 
25
D][ 8.0 (c 0.50 CHCl3); IR max (neat) 2931 (m), 
2860 (m), 2211 (m), 1667 (s), 1513 (s), 1427 (w), 1246 (s), 1212 (s), 1080 (s) cm
-1
; 
1
H NMR 
(400 MHz, CDCl3)  7.70 – 7.66 (m, 4H, ArH), 7.46 – 7.38 (m, 6H, ArH), 7.27 (d, J = 7.8 
Hz, 2H, ArH), 6.87 (d, J = 7.3 Hz, 2H, ArH), 4.73 (ddd, J = 10.3, 7.3, 3.4Hz, 1H, -
SiOCH2CH2CHO-), 4.53 – 4.50 (d, J = 7.3Hz, 1H, -OCHCOCC-), 4.49 (app. d, J = 1.9 Hz, 
2H, -OCH2Ar), 3.88 – 3.84 (m, 2H, -SiOCH2CH2-), 3.80 (s, 3H, -OCH3), 3.78 – 3.73 (m, 1H, 
CH3CHO-), 2.70 (dd, J = 17.2, 4.9 Hz, 1H, -CCCH2-), 2.55 (dd, J = 17.2, 7.3 Hz, 1H, -
CCCH2-), 2.01 – 1.93 (m, 1H, -SiOCH2CH2-), 1.73 – 1.66 (m, 1H, -OSiCH2CH2-), 1.62 (s, 
3H, -CH3), 1.41 (s, 3H, -CH3), 1.31 (d, J = 6.4 Hz, 3H, CH3CH-), 1.07 (s, 9H, -SiC(CH3)3); 
13
C NMR (100 MHz, CDCl3)  186.9, 159.3, 135.6 (2C), 135.5 (2C), 133.7 (2C), 130.2, 
129.7, 129.6, 129.2 (2C), 127.7 (2C), 127.6 (2C), 113.9 (2C), 110.6, 95.7, 83.2, 81.6, 74.7, 
72.3, 70.6, 60.5, 55.3, 32.9, 27.1, 27.0, 26.8 (3C), 25.3, 19.9, 19.2; MS (ESI) m/z 615 (M + 
H)
+
; HRMS (ESI): (M + H)
+
, found 615.3144; C37H46O6Si requires 615.3142. 
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((4R,5S)-5-Allyl-2,2-dimethyl-1,3-dioxolan-4-yl)methanol 230
87
 
 
 
 
 
 
 
Methylene-triphenylphosphine (5.1 g, 14.4 mmol) was dried in a round bottom flask using a 
heat gun for 10 min. THF (60 mL) was added and cooled to 0 ºC. NaHMDS (1 M in THF; 
13.6 mL) was added dropwise over 5 min and yellow precipitate was formed. The resulting 
mixture was warmed to 23 ºC and stirred for 1 h. The mixture was re-cooled to 78 ºC at 
which a solution of acetonide 218 (1 g, 5.8 mmol) in THF (5 mL) was added over 10 min.  
The resulting mixture was allowed to slowly warm to 0 ºC over 2 h and stirred for 15 h at 23 
ºC. The reaction was quenched by the addition of saturated aq. NH4Cl solution (25 mL) and 
the aqueous layer was extracted with EtOAc (30 mL × 2). The combined organic layers were 
dried (MgSO4), rotary evaporated and chromatographed (Et2O/PE 3:7 to 3:2) to afford alkene 
230 (658 mg, 66%) as a colourless oil: Rf  0.72 (Et2O); 
25
D][ 55.4 (c 1 CHCl3); lit.
87 
+54.8 (c 
0.26 CHCl3); IR max (neat) 3448 (m), 3089 (w), 2936 (m), 1642 (m), 1369 (s), 1216 (s), 
1037 (s) cm
-1
; 
1
H NMR (400 MHz, CDCl3)  5.92 – 5.82 (m, 1H, -CHC=CH2), 5.20 – 5.13 
(m, 2H, -CHC=CH2), 4.31 – 4.26 (m, 1H, HOCH2CHO-), 4.21 (app. q, J = 5.4 Hz, 1H, -
OCHCH2CHC=CH2), 3.68 (d, J = 5.4 Hz, 2H, HOCH2CHO-), 2.48 – 2.28 (m, 2H, -
CH2CHC=CH2), 1.82 (br. s, 1H, HO-), 1.51 (s, 3H, -CH3), 1.40 (s, 3H, -CH3); 
13
C NMR 
(100 MHz, CDCl3)  134.2, 117.4, 108.2, 77.8, 76.2, 61.6, 33.6, 28.1, 25.4; MS (CI) m/z 173 
(M + H)
+
; HRMS (CI): (M + H)
+
, found 173.1178; C9H17O3 requires 173.1178; Elem. Anal., 
found C, 62.69; H, 9.31; C9H16O3 requires C, 62.77; H, 9.36%. This data is in accordance 
with the literature.
87
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(4S,5S)-5-Allyl-N-methoxy-N,2,2-trimethyl-1,3-dioxolane-4-carboxamide 229 
 
 
 
 
 
 
 
To a stirred solution of alcohol 230 (1.5 g, 8.7 mmol) and Et3N (6 mL, 43 mmol) in 
CH2Cl2/DMSO (4:1 v/v, 105 mL) at 0 ºC, SO3.pyridine complex (4.8 g, 30 mmol) was added 
in one portion.  The resulting mixture was stirred for 1 h at 23 ºC. The reaction mixture was 
diluted with EtOAc (100 mL) and washed with H2O (20 mL × 2), saturated aq. NaHCO3 
solution (20 mL× 2) and brine (20 mL × 2). The combined organic layers were dried 
(MgSO4) and rotary evaporated to afford aldehyde 231 as a pale yellow oil. This material was 
used in the following step without further purification. 
 
Aldehyde 231 was dissolved in acetone (26 mL) and H2O (26 mL) and cooled to 0 ºC. 2-
Methyl-2-butene (16 mL, 157 mmol), NaH2PO4.2H2O (2.7 g, 17 mmol) and NaClO2 (2.4 g, 
22 mmol) were added successively with vigorous stirring. The resulting yellow solution was 
stirred for 2 h at 23 ºC. The aqueous layer was extracted with EtOAc (30 ml × 2), dried 
(MgSO4) and rotary evaporated to give the corresponding carboxylic acid as a pale yellow 
oil. This material was subsequently used in the following step without further purification. 
 
To a stirred solution of carboxylic acid, N,O-dimethylhydroxylamine hydrochloride salt 222 
(1 g, 10.5 mmol) and PyBOP (4.7 g, 9.2 mmol) in CH2Cl2 (20 mL) at 0 ºC, DIPEA (4.5 mL, 
26 mmol) was added and stirred for 15 h at 23 ºC. The reaction mixture was diluted with 
Et2O (60 mL) and washed successively with 1 M aq. HCl solution (15 mL × 3), saturated aq. 
NaHCO3 solution (15 mL × 3), and brine (15 mL × 3). The combined organic layers were 
dried (MgSO4), rotary evaporated and chromatographed (Et2O/PE 2:3 to 7:3) to afford 
Weinreb amide 229 (1.2 g, 60% over 3 steps) as a white solid: Rf  0.43 (Et2O); Mp 88 – 91 
ºC; 25D][ .0 (c 0.45 CHCl3); IR max (neat) 2987 (w), 2944 (w), 1659 (s), 1375 (m), 1363 
(m), 1218 (m), 1166 (m), 1067 (s) cm
-1
; 
1
H NMR (400 MHz, CDCl3)  5.90 – 5.80 (m, 1H, -
CHC=CH2), 5.16 – 5.10 (m, 2H, -CHC=CH2), 4.98 (d, J = 6.8 Hz, 1H, (OMe)MeNCOCHO-
), 4.46 (app. q, J = 6.8 Hz, 1H, -OCHCH2CHC=CH2), 3.74 (s, 3H, -NOCH3), 3.33 (s, 3H, -
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NCH3), 2.28 – 2.25 (m, 2H, -OCHCH2CHC=CH2), 1.66 (s, 3H, -CH3), 1.42 (s, 3H, -CH3); 
13
C NMR (100 MHz, CDCl3)  169.9, 134.2, 117.3, 110.0, 77.1, 75.5, 61.2, 35.4, 32.3, 27.4, 
25.7; MS (ESI) m/z 252 (M + Na)
+
, 481 (2M + Na)
+
; HRMS (ESI): (M + Na)
+
, found 
252.1206; C11H19NNaO4 requires 252.1212; Elem. Anal., found C, 57.61; H, 8.26; N, 6.14; 
C11H19NO4 requires C, 57.62; H, 8.35; N, 6.11%. 
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(S)-1-((4S,5S)-5-Allyl-2,2-dimethyl-1,3-dioxolan-4-yl)-5- 
(4-methoxybenzyloxy)hex-2-yn-1-one 212 
 
 
 
 
 
 
 
To a stirred solution of alkyne 229 (602 mg, 2.95 mmol) in THF (18 mL) at 78 ºC, n-
butyllithium (1.6 M in hexane; 1.84 mL) was added dropwise and the resultant was stirred for 
1.5 h at 0 ºC. The reaction mixture was re-cooled to78 ºC and a solution of Weinreb amide 
214 (520 mg, 2.27 mmol) in THF (2 mL) was added dropwise. The reaction mixture was 
allowed to warm to 0 ºC and stirred for 2 h. The reaction was quenched by the addition of 
saturated aq. NH4Cl solution (20 mL) and the aqueous layer was extracted with Et2O           
(25 mL × 2). The combined organic layers were dried (MgSO4), rotary evaporated and 
chromatographed (Et2O/PE 1:5 to 3:7) to afford propargylic ketone 212 (675 mg, 80%) as a 
colourless gum: Rf  0.65 (Et2O/PE 1:1); 
25
D][ .9 (c 0.53 CHCl3); IR max (neat) 2988 (m), 
2938 (m), 2210 (s), 1666 (s), 1612 (m), 1513 (s), 1245 (s), 1213 (s), 1080 (s), 1032 (s) cm
-1
; 
1
H NMR (400 MHz, CDCl3)  7.29 (d, J = 8.4 Hz, 2H, ArH), 6.90 (d, J = 8.4 Hz, 2H, 
ArH), 5.89 – 5.83 (m, 1H, -CHC=CH2), 5.18 – 5.12 (m, 2H, -CHC=CH2), 4.57 (d, J = 7.2 
Hz, 1H, -OCHCOCC-), 4.51 (app. d, J = 3.2 Hz, 2H, -OCH2Ar), 4.49 – 4.43 (m, 1H, -
OCHCH2CHC=CH2), 3.83 (s, 3H, -OCH3), 3.81 – 3.76 (m, 1H, -CH3CH-), 2.76 – 2.70 (dd, J 
= 17.2, 5.6 Hz, 1H, -COCCCH2-), 2.62 – 2.56 (dd, J = 17.2, 6.8 Hz, 1H, -COCCCH2-), 2.46 
– 2.40 (m, 1H, , -OCHCH2CHC=CH2), 2.34 – 2.26 (m, 1H, -CH2CHC=CH2), 1.66 (s, 3H, -
CH3), 1.42 (s, 3H, -CH3), 1.34 (d, J = 6.4Hz, 3H, -CHCH3); 
13
C NMR (100 MHz, CDCl3)  
186.5, 159.3, 133.9, 130.2, 129.2 (2C), 117.7, 113.9 (2C), 110.8, 95.9, 83.1, 81.6, 77.8, 72.3, 
70.6, 55.3, 34.6 (2C), 27.0, 25.3, 19.9; MS (ESI) m/z 395 (M + Na)
+
; HRMS (ESI): (M + 
Na)
+
, found 395. 1831; C22H28NaO5 requires 395.1834; Elem. Anal., found C, 70.99; H, 
7.50; C22H28O5 requires C, 70.94; H, 7.58%.  
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Cobalt complex 234 
 
 
 
 
 
 
To a stirred solution of alkyne 212 (40 mg, 0.107 mmol) in PhMe (5 mL), dicobalt 
octacarbonyl (57 mg, 0.151 mmol) was added and stirred for 45 min at 23 ºC.  The mixture 
was filtered through neutral alumina, rotary evaporated and the residue was chromatographed 
(Et2O/PE 3:17 to 3:7) to afford cobalt complex 234 (65.5 mg, 93%) as a red-brown oil: Rf 
0.81 (Et2O/PE 1:1); IR max (neat) 2925 (m), 1956 (m), 1712 (s), 1604 (m), 1446 (s), 1255 
(s), 1105 (s) cm
-1
 
1
H NMR (400 MHz, CDCl3)  7.27 (bd, 2H, ArH), 6.90 (d, 2H, ArH), 
5.85 (bm, 1H, -CHC=CH2), 5.12 (m, 2H, -CHC=CH2), 4.89 (m, 1H), 4.59 (m, 1H), 4.47 (m, 
2H), 3.83 (br. s, 4H), 3.23 – 3.10 (bm, 2H), 2.38 – 2.19 (bm, 2H, -CH2CHC=CH2), 1.58 (br. 
s, 3H, -CH3), 1.36 (br. s, 3H, -CH3), 1.29 (br. s, 3H, -CHCH3); MS (ESI) m/z 681 (M + 
Na)
+
; HRMS (ESI): (M + H)
+
, found 659. 0377; C28H29Co2O11 requires 659.0374. 
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(E)-Ethyl 4-((4S,5R)-5-(hydroxymethyl)-2,2-dimethyl- 
1,3-dioxolan-4-yl)but-2-enoate 239 
 
 
 
 
 
 
A solution of Lactol 218 (4.3 g, 24.7 mmol) and (carbethoxymethylene)triphenylphosphorane 
(12.9 g, 37.0 mmol) in THF (120 mL) was heated to reflux for 15 h. Rotary evaporation and 
flash chromatography (Et2O/PE 1:1) then provided ,-unsaturated ester 239 (4.80 g, 80%) 
as a colourless liquid: Rf 0.23 (Et2O/PE 1:1); 
25
D][  23.5 (c 1.0, CHCl3); IR max (neat) 3460 
(m), 1716 (s), 1655 (m), 1163 (s), 1037 (s) cm
-1
; 
1
H NMR (400 MHz, CDCl3)  6.98 (dt, J = 
15.6, 7.3 Hz, 1H, -HC=CHCO2Et), 5.94 (dt, J = 15.6, 1.5, 1H, -HC=CHCO2Et), 4.35 – 4.30 
(m, 1H,), 4.25 – 4.22 (m, 1H), 4.21 (q, J = 7.8 Hz, 2H, -CO2CH2CH3), 3.68 (d, J = 5.4 Hz, 
2H, HOCH2-), 2.60 – 2.43 (m, 2H, -CH2HC=CHCO2Et ), 1.99 (br. s, 1H, OH), 1.50 (s, 3H, -
CH3), 1.39 (s, 3H, -CH3), 1.31 (t, J = 7.3 Hz, 3H, -CO2CH2CH3); 
13
C NMR (100 MHz, 
CDCl3)  166.2, 144.5, 123.6, 108.5, 77.5, 75.3, 61.4, 60.3, 32.4, 27.9, 25.3, 14.2; MS (ESI) 
m/z 267 (M + Na)
+
; HRMS (ESI): (M + Na)
+
, found 267.1199; C12H20NaO5 requires 
267.1208. 
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(E)-Ethyl 4-((4R,5R)-5-((5S)-1-(ethoxymethoxy)-5-(4-methoxybenzyloxy) 
hex-2-ynyl)-2,2-dimethyl-1,3-dioxolan-4-yl)but-2-enoate 242 
 
 
 
 
 
 
To a stirred solution of alcohol 239 (3.5 g, 14.3 mmol) and Et3N (9.8 mL, 70.3 mmol) in 
DMSO/CH2Cl2 (1:4 v/v, 140 mL) at 0 ºC, SO3.pyridine complex (7.9 g, 49.8 mmol) was 
added. After warming to 23 ºC, the stirred for 1 h and EtOAc (350 mL) was added and the 
separated organic layer was washed sequentially with H2O (100 mL × 3), saturated aq. 
NaHCO3 solution (100 mL × 2) and brine (100 mL × 3). The resulting organic layer were 
dried (MgSO4) and rotary evaporated to give aldehyde 240 (3.2 g) as a yellow oil, which was 
used in the following step without further purification. n-Butyllithium (1.54 M in hexane; 
12.5 mL) was added to a stirred solution of alkyne 214 (4.09 g, 20.0 mmol) in THF (35 mL) 
at 78 ºC. After stirring for 1 h, aldehyde 240 (3.2 g) in THF (10 mL) was added dropwise 
over 5 min and the stirred for 1.5 h at 78 ºC. Saturated aq. NH4Cl solution (80 mL) was 
added and the aqueous layer was extracted with Et2O (100 mL × 3). The combined organic 
layers were dried (MgSO4) and rotary evaporated to give propargylic alcohol intermediate 
(7.6 g) as a bright yellow oil. This material was used in the next step of the reaction sequence 
without further purification. i-Pr2NEt (15 mL, 86.0 mmol) and EOMCl (8 mL, 86.0 mmol) 
were then added to propargylic alcohol (7.6 g) in CH2Cl2 (100 mL) at 0 ºC and the mixture 
was stirred for 3 h at 23 ºC. The reaction was quenched with saturated aq. NH4Cl solution (80 
mL) and the aqueous layer was extracted with Et2O (100 mL × 3). The combined organic 
layers were dried (MgSO4), rotary evaporated and chromatographed (Et2O/PE 1:3 to 1:2) to 
give protected propargylic alcohol 242 (4.0 g, 58% over 3 steps) as a pale yellow oil: Rf 0.55 
(Et2O/PE 1:1); 
25
D][  (c 1.0, CHCl3); IR max (neat) 1717 (s), 1655 (w), 1513 (s), 1369 
(m), 1246 (s), 1095 (s), 1027 (s) cm
-1
; 
1
H NMR (400 MHz, CDCl3)  7.29 (d, J = 8.8 Hz, 
0.8H, ArH), 7.28 (d, J = 8.8 Hz, 1.2H, ArH), 7.06 – 6.98 (m, 1H, -HC=CHCO2Et), 6.90 (d, J 
= 8.8 Hz, 0.8H, ArH), 6.89 (d, J = 8.8 Hz, 1.2H, ArH), 5.94 (dt, J = 15.6, 1.5 Hz, 0.4H, -
HC=CHCO2Et), 5.91 (dt, J = 15.6, 1.5 Hz, 0.6H, -HC=CHCO2Et), 5.02 (d, J = 6.8 Hz, 0.4H, 
-OCH2O-), 5.01 (d, J = 6.8 Hz, 0.6H, -OCH2O-), 4.79 (d, J = 6.8 Hz, 0.6H, -OCH2O-), 4.71 
(d, J = 6.8 Hz, 0.4H, -OCH2O-), 4.51 – 4.49 (m, 2H, -CH2Ar), 4.47 – 4.28 (m, 3H), 4.22 (q, J 
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= 7.8 Hz, 2H, -CO2CH2CH3), 3.83 (s, 3H, -OCH3), 3.78 – 3.54 (m, 3H), 2.72 – 2.49 (m, 3H), 
2.44 (ddd, J = 7.3, 2.0, 2.0 Hz, 0.6H), 2.40 (ddd, J = 7.3, 2.0, 2.0 Hz, 0.4H), 1.52 (s, 1.2H, -
CCH3), 1.51 (s, 1.8H, -CCH3), 1.39 (s, 1.8H, -CCH3), 1.38 (s, 1.2H, -CCH3), 1.33 – 1.29 (m, 
6H), 1.26 – 1.19 (m, 3H) (d.r = 3:2); 13C NMR (100 MHz, CDCl3)  166.3, 159.1, 145.3, 
130.5, 129.2 (2C), 123.4, 113.8 (2C), 109.4, 108.8, 92.5, 85.7, 85.4, 79.1, 78.7,  76.0, 75.7, 
73.1, 72.8, 70.3, 65.6, 64.9, 64.3, 63.7, 60.3, 55.3, 33.1, 32.5, 28.0, 27.5, 26.5, 26.3, 25.7, 
25.4, 19.8, 15.1, 15.0, 14.3 (contains both diastereoisomers); MS (ESI) m/z 527 (M + Na)
+
; 
HRMS (ESI): (M + Na)
+
, found 527.2612; C28H40NaO8 requires 527.2621; Elem. Anal., 
found C, 66.74; H, 7.99; C28H40O8 requires C, 66.65; H, 7.99%. 
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(E)-Ethyl 4-((4R,5R)-5-((S)-5-(4-methoxybenzyloxy)-1-(triisopropylsilyloxy)hex- 
2-ynyl)-2,2-dimethyl-1,3-dioxolan-4-yl)but-2-enoate 241 
 
 
 
 
 
 
Save for the use of TIPSOTf/2,6-lutidine instead of EOMCl/i-Pr2NEt, protected propargylic 
alcohol 241 (370 mg, 25% over 3 steps, colourless oil) was prepared in accordance to 
procedure described above for the synthesis of protected propargylic alcohol 242: Rf 0.75 
(Et2O/PE 1:1); 
25
D][ 32.0 (c 1.20 CHCl3); IR max (neat) 1720 (s), 1655 (m), 1613 (m), 1513 
(m), 1246 (s), 1084 (s), 1058 (s), 1038 (s) cm
-1
; 
1
H NMR (400 MHz, CDCl3)  7.29 – 7.27 
(d, J = 8.8 Hz, 0.6H, ArH), 7.28 – 7.27 (d, J = 8.8 Hz, 1.4H, ArH), 7.07 – 7.00 (dt, J = 15.6, 
6.8 Hz, 1H, -HC=CHCO2Et), 6.90 – 6.88 (d, J = 8.8 Hz, 0.6H, ArH), 6.90 – 6.87 (d, J = 8.8 
Hz, 1.4H, ArH), 5.93 – 5.89 (br. d, , J = 15.6 Hz, 1H, -HC=CHCO2Et), 4.68 – 4.67 (m, 
0.3H), 4.58 – 4.57 (m, 0.7H), 4.50 (s, 0.6H, -CH2Ar), 4.49 (s, 1.4H, -CH2Ar), 4.32 – 4.38 (m, 
1H), 4.20 (q, J = 6.8 Hz, 2H, -CO2CH2CH3), 4.20 – 4.14 (m, 1H), 3.82 (s, 3H, -OCH3), 3.69 
– 3.62 (m, 1H), 2.80 – 2.52 (m, 3H), 2.41 – 2.34 (m, 1H), 1.50 (s, 2.1H, -CCH3), 1.49 (s, 
0.9H, -CCH3), 1.36 (s, 3H, -CCH3), 1.33 – 1.28 (m, 6H, -CHCH3, -OCH2CH3), 1.13 – 1.09 
(m, 21H, -OSi(iPr)3) (d.r = 7:3); 
13
C NMR (100 MHz, CDCl3)  166.4, 159.1, 146.0, 130.6, 
129.1 (2C), 123.1, 113.8 (2C), 108.9, 108.7, 83.9, 83.8, 80.8, 80.6, 80.2, 80.1, 76.2, 73.0, 
70.3, 63.1, 62.7, 60.2, 55.3, 33.4, 32.7, 27.9, 27.6, 26.4, 26.3, 25.5, 19.8, 18.1, 17.9 (6C), 
14.3, 12.6, 12.2 (3C) (contains both diastereoisomers); MS (ESI) m/z 625 (M + Na)
+
; HRMS 
(ESI): (M + Na)
+
, found 625.3544; C34H54NaO7Si requires 625.3537; Elem. Anal., found C, 
67.84; H, 9.04; C34H54O7Si requires C, 67.74; H, 9.03%. 
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(E)-4-((4R,5R)-5-((5S)-1-(Ethoxymethoxy)-5-(4-methoxybenzyloxy)hex-2-ynyl)-2,2-
dimethyl-1,3-dioxolan-4-yl)-N-methoxy-N-methylbut-2-enamide 6 
 
 
 
 
 
i-PrMgCl (2 M in THF; 10.7 mL) was added to N,O-dimethylhydroxylamine hydrochloride 
salt 222 (928 mg, 9.52 mmol) and ester 242 (2.4 g, 4.76 mmol) in THF (50 mL) at ºC 
and stirred for 45 min. The reaction was quenched with saturated aq. NH4Cl solution (40 mL) 
and the aqueous layer was extracted with Et2O (40 mL × 3). The combined organic layers 
were dried (MgSO4), rotary evaporated and chromatographed (EtOAc/PE 1:2 to 1:1) to give 
Weinreb amide 6 (1.97 g, 80%) as a colourless oil: Rf 0.30 (EtOAc/PE 1:1); 
25
D][ 22.0 (c 
0.50, CHCl3); IR max (neat) 1665 (m), 1634 (m), 1613 (m), 1513 (m), 1378 (s), 1245 (m), 
1096 (s), 1064 (s), 1026 (s) cm
-1
; 
1
H NMR (400 MHz, CDCl3)  7.29 (d, J = 8.8 Hz, 0.8H, 
ArH), 7.28 (d, J = 8.8 Hz, 1.2H, ArH), 7.08 – 7.00 (m, 1H, -HC=CHCON-), 6.89 (d, J = 8.8 
Hz, 2H, ArH), 6.56 – 6.52 (br. d, J = 15.6 Hz, 0.4H, -HC=CHCON-), 6.54 – 6.49 (br. d, J = 
15.6 Hz, 0.6H, -HC=CHCON-), 5.03 (d, J = 6.8 Hz, 0.4H, -OCH2O-), 5.02 (d, J = 6.8 Hz, 
0.6H, -OCH2O-), 4.79 (d, J = 6.8 Hz, 0.6H, -OCH2O-), 4.72 (d, J = 6.8 Hz, 0.4H, -OCH2O-), 
4.51 – 4.49 (m, 2H, -CH2Ar), 4.48 – 4.22 (m, 3H), 3.83 (s, 3H, -OCH3), 3.78 – 3.54 (m, 3H), 
3.72 (s, 1.2H, -NOCH3), 3.71 (s, 1.8H, -NOCH3), 3.27 (s, 3H, -NCH3), 2.77 – 2.53 (m, 3H), 
2.44 (ddd, J = 7.3, 2.0, 2.0 Hz, 0.6H), 2.40 (ddd, J = 7.3, 2.0, 2.0 Hz, 0.4H), 1.52 (s, 1.2H, -
CCH3), 1.51 (s, 1.8H, -CCH3), 1.38 (s, 1.8H, -CCH3), 1.37 (s, 1.2H, -CCH3), 1.33 – 1.29 (m, 
3H), 1.25 – 1.20 (m, 3H) (d.r = 3:2); 13C NMR (100 MHz, CDCl3)  166.6, 159.2, 143.8, 
143.7, 130.6, 129.2 (2C), 120.8, 120.7, 113.8 (2C), 109.2, 108.7, 92.5, 85.6, 85.3, 79.1, 78.7, 
76.1, 75.9, 73.1, 72.8, 70.3, 65.7, 64.9, 64.2, 63.7, 61.7, 55.3, 33.3, 32.6, 32.4, 27.9, 27.4, 
26.5, 26.3, 25.7, 25.3, 19.8, 15.1 (contains both diastereoisomers); MS (ESI) m/z 542 (M 
Na)+; HRMS (ESI): (M H)+, found 520.2902; C28H42NO8 requires 520.2910; Elem. 
Anal., found C, 64.82; H, 7.84; N, 2.61; C28H41NO8 requires C, 64.72; H, 7.95; N, 2.70%. 
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6-((2Z,5E)-7-((4R,5R)-5-((S)-1-(ethoxymethoxy)-5-(4-methoxybenzyloxy)hex-2-ynyl)-2,2-
dimethyl-1,3-dioxolan-4-yl)-2-hydroxy-4-oxohepta-2,5-dienyl)-2,2-dimethyl-4H-1,3-dioxin-
4-one 244 
 
 
 
The keto-dioxinone 10 (149 mg, 0.81 mmol) in THF (1.5 mL) was added dropwise to a 
stirred solution of LDA (1.67 mmol) in THF (10 mL) at 78 ºC and stirred for 1.5 h. Yellow 
precipitate was formed after 10 min of stirring. Diethylzinc solution (1 M in hexane; 1.65 
mL) was added dropwise and stirred for 20 min. The mixture was warmed to 25 ºC and 
Weinreb amide 6 (140 mg, 0.27 mmol) in THF (2 mL) was added quickly. The mixture was 
immediately warmed to 10 ºC and stirred for 2.5 h. The reaction was quenched with 
saturated aq. NH4Cl solution (10 mL) was added and the aqueous layer was acidified to pH 
12 using 1 M aq. HCl solution and the resulting aqueous layer was extracted with EtOAc 
(15 mL × 2). The combined organic layers were dried (MgSO4), rotary evaporated and 
chromatographed (EtOAc/PE 1:3 to 1:2) to give diketo-dioxinone 244 (53 mg, 31%) as a 
yellow oil: Rf 0.73 (EtOAc/PE 1:1); IR max (neat) 1779 (s), 1724 (s), 1639 (m), 1373 (m), 
1273 (m), 1156 (w), 1013 (m) cm
-1
; 
1
H NMR (400 MHz, CDCl3)  14.8 (br. s, 1H, enol -
OH), 7.29 – 7.26 (m, 2H, ArH), 7.01 – 6.90 (m, 1H, -HC=CHCOC=CO-), 6.89 (d, J = 8.8 
Hz, 2H, ArH), 5.95 (d, J = 15.6 Hz, 0.4H, -HC=CHCOC=CO-), 5.91 (d, J = 15.6 Hz, 0.6H, -
HC=CHCOC=CO-), 5.54 (s, 0.4H, enol -HC=COH), 5.52 (s, 0.6H, enol -HC=COH), 5.42 (s, 
1H, -OCCHCO2-), 5.02 (d, J = 6.8 Hz, 0.4H, -OCH2O-), 5.01 (d, J = 6.8 Hz, 0.6H, -OCH2O-
), 4.79 (d, J = 6.8 Hz, 0.6H, -OCH2O-), 4.72 (d, J = 6.8 Hz, 0.4H, -OCH2O-), 4.50 – 4.49 (m, 
2H), 4.45 – 4.22 (m, 3H), 3.82 (s, 3H, -OCH3), 3.78 – 3.57 (m, 3H), 3.29 (s, 2H, -CH2), 2.74 
– 2.70 (m, 1H), 2.60 – 2.52 (m, 2H), 2.47 – 2.40 (m, 1H), 1.72 (s, 6H, dioxinone -CH3 × 2), 
1.52 (s, 1.2H, -CCH3), 1.51 (s, 1.8H, -CCH3), 1.39 (s, 1.2H, -CCH3), 1.38 (s, 1.8H, -CCH3), 
1.30 – 1.20 (m, 6H, -CHCH3, -OCH2CH3) (d.r = 2:3); 
13
C NMR (100 MHz, CDCl3)  193.1 
(2C), 177.1, 165.1, 159.2, 142.2, 130.4, 129.2 (2C), 126.9, 126.7, 113.8 (2C), 109.4, 108.9, 
107.2, 99.4, 96.4, 96.3, 92.5, 85.7, 85.5, 76.1, 75.9, 73.1, 72.8, 70.3, 65.6, 64.8, 64.2, 63.7, 
55.3, 44.9, 43.5, 33.6, 33.1, 29.7, 28.0, 27.5, 26.4, 26.3, 25.7, 25.0 (2C), 19.7, 15.1, 15.0 
(contains both diastereoisomers, keto-form); MS (ESI) m/z 665 (M Na)+; HRMS (ESI): 
(M Na)+, found 665.2932; C35H46NaO11 requires 665.2938. 
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(E)-4-((4R,5R)-5-((5S,Z)-1-(Ethoxymethoxy)-5-(4-methoxybenzyloxy)hex-2-enyl)-2,2-
dimethyl-1,3-dioxolan-4-yl)-N-methoxy-N-methylbut-2-enamide 248 
 
 
 
 
 
 
A solution of Weinreb amide 6 (1.4 g, 2.38 mmol) and quinoline (0.28 mL, 2.38 mmol) in 
EtOAc (45 mL) was degassed using nitrogen for 10 min. Lindlar catalyst (232 mg, 10%wt) 
was added and the resulting mixture was stirred under hydrogen atmosphere for 2 h. The 
reaction mixture was filtered through Celite, rotary evaporated and the residue was 
chromatographed (EtOAc/PE 1:2 to 1:1) to give Z-alkene 248 (1.27 g, 91%) as a pale yellow 
oil: Rf 0.30 (EtOAc/PE 1:1); 
25
D][ 22.4 (c 1.00, CHCl3); IR max (neat) 1665 (m), 1634 (m), 
1613 (m), 1513 (m), 1378 (s), 1246 (m), 1071 (m), 1061 (s), 1028 (s) cm
-1
; 
1
H NMR (400 
MHz, CDCl3)  7.29 – 7.26 (m, 2H, ArH), 7.09 – 6.94 (m, 1H, -HC=CHCON-), 6.88 (d, J = 
8.8 Hz, 2H, ArH), 6.53 (d, J = 15.6 Hz, 0.5H, -HC=CHCON-), 6.47 (d, J = 15.6 Hz, 0.5H, -
HC=CHCON-), 5.91 – 5.83 (m, 1H, -CH2HC=CHCHO-), 5.41 (ddd, J = 11.2, 9.3, 1.5 Hz, 
1H, -CH2HC=CHCHO-), 4.71 – 4.69 (m, 1H), 4.71 – 4.69 (m, 0.5H), 4.55 – 4.38 (m, 3H), 
4.55 – 4.38 (m, 0.5H), 4.36 – 4.32 (m, 0.5H), 4.17 – 4.09 (m, 1H), 4.17 – 4.09 (m, 0.5H), 
3.82 (s, 3H, -OCH3), 3.78 – 3.49 (m, 3H), 3.72 (s, 1.5H, -NOCH3), 3.69 (s, 1.5H, -NOCH3), 
3.26 (s, 1.5H, -NCH3), 3.25 (s, 1.5H, -NCH3), 2.72 – 2.31 (m, 4H, CH2 × 2), 1.50 (s, 1.5H, -
CCH3), 1.43 (s, 1.5H, -CCH3), 1.36 (s, 1.5H, -CCH3), 1.34 (s, 1.5H, -CCH3), 1.24 – 1.18 (m, 
6H, -CHCH3, -OCH2CH3) (d.r = 1:1); 
13
C NMR (100 MHz, CDCl3)  166.6, 159.1, 144.1, 
143.8, 133.2, 132.6, 130.9, 130.8, 129.1 (2C), 128.0, 126.4, 120.8, 120.7, 113.8 (2C), 108.7, 
108.3, 92.5, 91.8, 91.5, 79.9, 78.6, 76.4, 75.9, 74.2, 73.9, 70.1, 69.5, 69.1, 64.2, 63.3, 61.7, 
55.3, 35.3, 34.9, 33.1, 32.4, 27.9, 27.8, 25.8, 25.4, 19.7, 15.1 (contains both 
diastereoisomers); MS (ESI) m/z 544 (M Na)+; HRMS (ESI): (M H)+, found 522.3063; 
C28H44NO8 requires 522.3067; Elem. Anal., found C, 64.61; H, 8.21; N, 2.59; C28H43NO8 
requires C, 64.47; H, 8.31; N, 2.69%. 
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6-((2Z,5E)-7-((4R,5R)-5-((5S,Z)-1-(Ethoxymethoxy)-5-hydroxyhex-2-enyl)-2,2-dimethyl-
1,3-dioxolan-4-yl)-2-hydroxy-4-oxohepta-2,5-dienyl)-2,2-dimethyl-4H-1,3-dioxin-4-one 7 
 
 
 
 
 
 
 
The keto-dioxinone 10 (1.06 g, 5.76 mmol) in THF (5 mL) was added dropwise to a stirred 
solution of LDA (11.96 mmol) in THF (30 mL) at 78 ºC. After stirring for 1.5 h, yellow-
orange mixture was treated with diethylzinc solution (1 M in hexane; 12 mL) and stirred for 
another 20 min. The mixture was then warmed to 25 ºC and Weinreb amide 248 (1.20 g, 
2.30 mmol) in THF (5 mL) was added quickly. The resulting mixture was immediately 
warmed to 5 ºC and stirred for 2.5 h. The reaction was quenched with saturated aq. NH4Cl 
solution (30 mL) where the aqueous layer was acidified to pH 12 using 1 M aq. HCl 
solution. The separated aqueous layer was extracted with EtOAc (25 mL × 2) and the 
combined organic layers were dried (MgSO4), rotary evaporated and chromatographed 
(EtOAc/PE 1:2) to give a 1:1 mixture of keto-dioxinone 10 and the coupling product (1.15 g) 
as a yellow oil. This material was used in the next step of reaction sequence without further 
purification. DDQ (400 mg, 1.76 mmol) was added to a stirred solution dioxinones (1.15 g) 
in CH2Cl2 (35 mL) containing pH 7-buffer solution (3 drops) at 0 ºC. After stirring for 3 h, 
the reaction was quenched with saturated aq. Na2S2O3 solution (30 mL) and the aqueous layer 
was extracted with EtOAc (40 mL × 3). The combined organic layers were dried (MgSO4), 
rotary evaporated and chromatographed (EtOAc/PE 4:1 to 1:0) to give diketo-dioxinone 7 
(580 mg, 48% over 2 steps) as a bright yellow oil: Rf 0.53 (EtOAc); 
25
D][ 39.2 (c 1.1, 
CHCl3); IR max (neat) 3460 (w), 1723 (s), 1639 (m), 1580 (s), 1374 (s), 1273 (m), 1204 (m), 
1015 (s), 907 (s), 726 (s) cm
-1
; 
1
H NMR (400 MHz, CDCl3)  14.8 (br. s, 1H, enol -OH), 
7.04 – 6.90 (m, 1H, -HC=CHCOC=CO-), 5.97 (d, J = 15.6 Hz, 1H, -HC=CHCOC=CO-), 
5.92 – 5.89 (m, 1H, -CH2HC=CHCHO-), 5.57 (s, 0.6H, enol -HC=COH), 5.56 (s, 0.4H, enol 
-HC=COH), 5.55 – 5.45 (m, 1H, -CH2HC=CHCHO-), 5.42 (s, 1H, -OCCHCO2-), 4.80 (d, J 
= 7.3 Hz, 0.6H, -OCH2O-), 4.77 (d, J = 7.3 Hz, 0.4H, -OCH2O-), 4.71 (d, J = 6.8 Hz, 0.4H, -
OCH2O-), 4.61 (d, J = 7.3 Hz, 0.6H, -OCH2O-), 4.56 – 4.51 (m, 1H), 4.37 – 4.32 (m, 0.6H), 
4.25 – 4.22 (m, 0.4H), 4.20 – 4.17 (m, 0.4H), 4.12 (dd, J = 8.8, 5.9 Hz, 0.6H), 3.98 – 3.88 (m, 
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1H), 3.78 – 3.54 (m, 2H), 3.30 (s, 1.2H, -CH2), 3.29 (s, 0.8H, -CH2), 2.70 – 2.64 (m, 1H), 
2.59 – 2.49 (m, 1H), 2.38 – 2.35 (m, 2H), 1.72 (s, 6H, dioxinone -CH3 × 2), 1.51 (s, 1.2H, -
CCH3), 1.45 (s, 1.8H, -CCH3), 1.39 (s, 1.2H, -CCH3), 1.36 (s, 1.8H, -CCH3), 1.26 – 1.21 (m, 
6H, -CHCH3, -OCH2CH3) (d.r = 3:2); 
13
C NMR (100 MHz, CDCl3)  193.0 (2C), 177.2, 
165.1, 160.7, 142.3, 133.1, 132.4, 129.7, 127.2, 126.9, 108.6, 107.1, 99.3, 96.4, 92.1, 91.7, 
79.6, 78.4, 76.4, 75.9, 69.6, 69.2, 67.1, 64.1, 63.5, 44.9, 37.4, 37.3, 33.6, 33.5, 27.8, 25.7, 
25.4, 24.9 (2C), 23.3, 22.9, 15.0 (contains both diastereoisomers, keto-form); MS (ESI) m/z 
547 (M Na)+; HRMS (ESI): (M  H)+, found 525.2706; C27H41O10 requires 525.2700. 
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(3aS,5Z,8S,15E,17aS)-4-(Ethoxymethoxy)-11,13-dihydroxy-2,2,8-trimethyl-7,8,17,17a-
tetrahydro-3aH-benzo[c][1,3]dioxolo[4,5-h][1]oxacyclotetradecin-10(4H)-one 247 
 
 
 
 
 
The diketo-dioxinone 7 (200 mg, 0.38 mmol) in PhMe (10 mL) was added dropwise to PhMe 
(40 mL) at reflux over 20 min and stirred for 1 h. The solvent was rotary evaporated and the 
resulting residue was dissolved in MeOH (45 mL) and treated with Cs2CO3 (2 g, 6.1 mmol) 
and the dark yellow mixture was stirred for 30 min. AcOH (7 mL) was then added and stirred 
further for 3.5 h at 23 ºC. The volatiles were removed by rotary evaporation and the residue 
was partitioned between EtOAc (50 mL) and H2O (30 mL). The separated organic layer was 
washed with saturated aq. NaHCO3 solution (30 mL), dried (MgSO4), rotary evaporated and 
chromatographed (EtOAc/PE 1:3 to 1:2) to give resorcylate 247 (90 mg, 55% over 3 steps, dr 
= 2:1) as a white solid: Rf 0.74 (EtOAc/PE 1:1); Mp 52 – 55 ºC; IR max (neat) 3303 (m), 
1643 (s), 1610 (s), 1582 (m), 1447 (m), 1380 (m), 1255 (s), 1162 (s), 1106 (s), 1015 (s), 968 
(m), 842 (s) cm
-1
; MS (ESI) m/z 447 (M ); HRMS (ESI): (M H)-, found 447.2024; 
C24H31O8 requires 447.2019; Elem. Anal., found C, 64.37; H, 7.03; C24H32O8 requires C, 
64.27; H, 7.19%.  
 
More polar diastereomer (Major) - 25D][ 6.6 (c 0.33, CHCl3); 
1
H NMR (400 MHz, CDCl3) 
 12.02 (br. s, 1H, OH), 7.08 (d, J = 15.2 Hz, 1H, ArCH=CH-), 6.38 (d, J = 2.4 Hz, 1H, 
ArH), 6.35 (d, J = 2.4 Hz, 1H, ArH), 6.09 – 6.03 (m, 1H), 5.99 – 5.94 (m, 1H), 5.80 (ddd, J = 
15.2, 10.3, 4.4 Hz, 1H, ArCH=CH-), 5.54 (br. s, OH), 5.40 – 5.37 (m, 1H, ArCO2CHCH3-), 
4.77 – 4.74 (m, 1H), 4.71 (d, J = 7.3 Hz, 1H, -OCH2O-), 4.61 (d, J = 6.8 Hz, 1H, -OCH2O-), 
4.52 – 4.47 (m, 2H), 3.68 – 3.51 (m, 2H, -OCH2OCH2CH3), 2.82 – 2.66 (m, 3H), 2.47 – 2.42 
(m, 1H), 1.56 (s, 3H, -CCH3), 1.49 (d, J = 5.8 Hz, 3H, ArCO2CHCH3-), 1.41 (s, 3H, -CCH3), 
1.15 (t, J = 7.3 Hz, 3H, -OCH2OCH2CH3); 
13
C NMR (100 MHz, CDCl3)  171.0, 165.4, 
160.7, 143.2, 133.3, 130.4, 129.4, 126.6, 108.3, 107.6, 103.9, 102.6, 93.7, 78.2, 75.4, 72.0, 
71,6, 63.8, 35.9, 33.5, 29.7, 26.9, 24.3, 18.6, 14.9. 
 
Less polar diastereomer (Minor) - 25D][ 95.5 (c 0.45, CHCl3); 
1
H NMR (400 MHz, CDCl3)  
12.06 (s, 1H, OH), 6.98 (d, J = 16.1 Hz, 1H, ArCH=CH-), 6.37 (d, J = 2.4 Hz, 1H, ArH), 
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6.32 (d, J = 2.4 Hz, 1H, ArH), 6.12 (br. s, OH), 5.75 – 5.69 (m, 2H), 5.50 – 5.45 (m, 1H), 
5.22 – 5.16 (m, 1H, ArCO2CHCH3-), 4.85 (d, J = 6.8 Hz, 1H, -OCH2O-), 4.75 (d, J = 6.8 Hz, 
1H, -OCH2O-), 4.72 – 4.68 (m, 1H), 4.22 – 4.15 (m, 2H), 3.86 – 3.63 (m, 2H, -
OCH2OCH2CH3), 3.04 (dt, J = 16.6, 10.8 Hz, 1H), 2.81 – 2.73 (m, 1H), 2.58 – 2.52 (m, 1H), 
2.38 – 2.30 (m, 1H), 1.54 (s, 3H, -CCH3), 1.45 (d, J = 5.8 Hz, 3H, ArCO2CHCH3-), 1.42 (s, 
3H, -CCH3), 1.29 – 1.28 (m, 3H, -OCH2OCH2CH3); 
13
C NMR (100 MHz, CDCl3)  171.4, 
165.4, 160.8, 144.2, 133.9, 132.9, 129.5, 126.9, 109.3, 108.9, 102.9, 102.6, 91.7, 81.0, 73.1, 
68.1, 63.5, 35.1, 34.9, 29.7, 27.3, 26.0, 21.0, 15.0. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
172 
 
(3aS,5Z,8S,15E,17aS)-4-(Ethoxymethoxy)-11-hydroxy-13-methoxy-2,2,8-trimethyl-
7,8,17,17a-tetrahydro-3aH-benzo[c][1,3]dioxolo[4,5-h][1]oxacyclotetradecin-10(4H)-one 
254 
 
 
 
 
 
 
MeI (40 L, 0.71 mmol) in acetone (1 mL) was added to a solution of resorcylate 247 (80 
mg, 0.18 mmol) and K2CO3 (49 mg, 0.36 mmol) in acetone (12 mL) and heated to reflux for 
4 h. H2O (20 mL) was added to the ensuing reaction mixture and the aqueous layer was 
extracted with Et2O (20 mL × 2). The combined organic layers were dried (MgSO4), rotary 
evaporated and chromatographed (EtOAc/PE 1:4) to give resorcylate 254 (65 mg, 78%) as a 
colourless gum: Rf 0.55 (EtOAc/PE 1:2); 
25
D][  (c 1.0, CHCl3); IR max (neat) 1643 (s), 
1608 (s), 1575 (m), 1442 (w), 1379 (m), 1318 (m), 1257 (s), 1212 (s), 1160 (s), 1043 (s) cm
-1
; 
1
H NMR (400 MHz, CDCl3)  12.09 (br. s, 1H, OH), 12.04 (br. s, 1H, OH), 7.09 (dd, J = 
17.1, 2.0 Hz, 1H, ArCH=CH-), 6.99 (br. d, J = 16.1 Hz, 1H, ArCH=CH-), 6.44 (d, J = 2.9 
Hz, 1H, ArH), 6.42 (d, J = 2.9 Hz, 1H, ArH), 6.41 (d, J = 2.4 Hz, 1H, ArH), 6.38 (d, J = 2.4 
Hz, 1H, ArH), 6.08 – 5.94 (m, 2H), 5.83 – 5.73 (m, 2H), 5.73 – 5.69 (m, 1H), 5.51 – 5.46 (m, 
1H), 5.43 – 5.37 (m, 1H, ArCO2CHCH3-), 5.23 – 5.16 (m, 1H, ArCO2CHCH3-), 4.82 (d, J = 
7.3 Hz, 1H, -OCH2O-), 4.75 (d, J = 7.3 Hz, 1H, -OCH2O-), 4.74 – 4.64 (m, 3H), 4.60 (d, J = 
6.8 Hz, 1H), 4.53 – 4.46 (m, 2H), 4.22 – 4.08 (m, 2H), 3.84 (s, 3H, -OCH3), 3.83 (s, 3H, -
OCH3), 3.69 – 3.48 (m, 4H), 3.05 (dt, J = 16.1, 10.7 Hz, 1H), 2.84 – 2.65 (m, 4H), 2.62 – 
2.56 (m, 1H), 2.46 – 2.39 (m, 1H), 2.36 – 2.30 (m, 1H), 1.56 (s, 3H, -CCH3), 1.54 (s, 3H, -
CCH3), 1.48 (d, J = 6.8 Hz, 3H, ArCO2CHCH3-), 1.48 (d, J = 6.8 Hz, 3H, ArCO2CHCH3-), 
1.40 (s, 6H), 1.28 (t, J = 7.3 Hz, 3H, -OCH2OCH2CH3), 1.13 (t, J = 7.3 Hz, 3H, -
OCH2OCH2CH3) (d.r = 7:4); 
13
C NMR (100 MHz, CDCl3) 171.1, 165.5, 164.1, 142.6, 
133.6, 133.4, 133.0, 130.3, 129.6, 127.1, 126.6, 109.1, 108.1, 107.4, 103.7, 100.1, 100.0, 
99.1, 93.8, 78.2, 75.4, 71.9, 71.5, 63.7, 63.4, 55.4, 35.9, 35.1, 34.7, 33.5, 26.9, 24.3, 18.6, 
15.0, 14.9 (contains both diastereoisomers); MS (ESI) m/z 463 (M )+, 485 (M + Na)+; 
HRMS (ESI): (M H)+, found 463.2349; C25H35O8 requires 463.2332. 
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LL-Z1640-2 (9) 
 
 
 
 
 
 
 
 
Polymer supported sulfonic acid (69.4 mg, 0.96 mmol) was added to resorcylate 254 (37 mg, 
0.08 mmol) dissolved in MeOH (5 mL) and heated to 50 ºC for 45 min. The resulting 
reaction mixture was filtered and the solvent was rotary evaporated to give a pale brown solid 
(26 mg), which was subsequently used in the next step of reaction sequence without further 
purification. Dess-Martin periodinane (38 mg, 0.089 mmol) was added to a solution of allylic 
alcohol intermediate (26 mg) in CH2Cl2 (5 mL) at 23 ºC. The mixture was stirred for 8 min 
where the reaction was then quenched by the addition of H2O (5 mL). The aqueous layer was 
extracted with EtOAc (15 mL × 2) and the combined organic layers were dried (MgSO4), 
rotary evaporated and chromatographed (EtOAc/PE 4:1 to 1:0) to give  LL-Z1640-2 (9) (19 
mg, 66% over 2 steps) as a white solid: Rf 0.42 (EtOAc); Mp 167 – 168 ºC, lit.
57
 172 – 176 
ºC; 25D][ 73.5 (c 0.33, MeOH), lit.
57
 75.9 (MeOH); IR max (neat) 3465 (w), 3298 (w), 
1682 (m), 1645 (s), 1606 (s), 1574 (s), 1416 (m), 1378 (m), 1318 (s), 1251 (s), 1213 (s), 1203 
(s), 1161 (s), 1045 (s), 1026 (s), 830 (m) cm
-1
; 
1
H NMR (400 MHz, CDCl3)  12.12 (br. s, 
1H, OH), 6.87 (d, J = 15.6 Hz, 1H, ArCH=CH-), 6.40 (d, J = 2.4 Hz, 1H, ArH), 6.38 (d, J = 
2.4 Hz, 1H, ArH), 6.33 (dd, J = 11.2, 2.4 Hz, 1H, -CH2CH=CHO-), 6.20 (td, J = 11.2, 2.4 
Hz, 1H, -CH2CH=CHO-), 5.98 (ddd, J = 15.2, 10.2, 4.4 Hz, 1H, ArCH=CH-), 5.28 – 5.21 
(m, 1H, ArCO2CHCH3-), 4.51 (br. s, 1H), 3.99 – 3.98 (br. m, 1H), 3.81 (s, 3H, -OCH3), 3.73 
(br. d, J = 5.4 Hz, 1H), 3.57 (dt, J = 17.1, 11.2 Hz, 1H), 2.51 (dq, J = 17.1, 2.4 Hz, 1H), 2.43 
– 2.35 (br. s, 1H), 2.25 – 2.09 (m, 2H, CH2), 1.47 (d, J = 6.4 Hz, 3H, ArCO2CHCH3-); 
13
C 
NMR (125 MHz, CDCl3) 199.1, 171.3, 165.9, 164.2, 147.3, 143.1, 132.9, 130.2, 125.3, 
108.2, 103.4, 100.2, 80.7, 73.7, 73.6, 55.4, 37.5, 37.0, 20.7; MS (ESI) m/z 363 (M )+; 
HRMS (ESI): (M H)+, found 363.1444; C19H23O7 requires 363.1444. The 
1
H NMR and 
13
C 
NMR spectra (Appendix 3 and 4) were identical with those of an authentic sample purchase 
from the Aldrich Chemical Co. 
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3-(Allyloxy)-3-oxopropanoic acid 417
20
 
 
 
 
 
Meldrum’s acid 415 (20 g, 139 mmol) in allyl alcohol (40 mL) was gently heated to reflux 
for 12 h. Excess allyl alcohol 416 was then removed by rotary evaporation and the resulting 
residue was dissolved in MeOH (60 mL), and aq. NH3 (50% v/v; 7 mL) was added. After 15 
min, the reaction mixture was rotary evaporated and the residue was washed with a mixture 
of PE and Et2O (1:1 v/v, 15 mL × 2) and dissolved in H2O (100 mL). The mixture was 
acidified to pH 4 with 1 M aq. HCl and aqueous layer was extracted with Et2O (40 mL × 3). 
The combined organic layers were washed with brine (30 mL), dried (MgSO4) and rotary 
evaporated to afford monoallyl malonate intermediate 417 (12.1 g, 61%) as a yellow oil. This 
material was used in the next step of reaction sequence without further purification. 
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Allyl 4-(2,2-dimethyl-4-oxo-4H-1,3-dioxin-6-yl)-3-oxobutanoate 84
20
 
 
 
 
 
 
 
Oxalyl chloride (1.1 mL, 12.5 mmol) and DMF (1 drop) were added to a stirred solution of 3-
(allyloxy)-3-oxopropanoic acid (417) (1.5 g, 10.4 mmol) in CH2Cl2 (20 mL) at 0 ºC. After 
warming to 23 ºC, the mixture was stirred for 2 h. The volatiles were removed by rotary 
evaporation giving the corresponding acid chloride intermediate as a dark red oil (1.5 g).  
 
Dioxinone 65 (5.2 g, 36.5 mmol) in THF (10 mL) was added dropwise to a solution of 
LiHMDS (35.4 mmol) in THF (70 mL) at 78 ºC and ensuing mixture was stirred for 1 h. 
The acid chloride intermediate (1.5 g) in THF (10 mL) was then added dropwise to the 
mixture and stirred further for 2 h at 78 ºC. The reaction was quenched with saturated aq. 
NH4Cl solution (100 mL) and the resulting aqueous layer was acidified to pH 3 using 1 M aq. 
HCl solution. The separated aqueous layer was extracted with EtOAc (80 mL × 3), and the 
combined organic layers were dried (MgSO4), rotary evaporated and chromatographed 
(EtOAc/PE 1:3 to 1:2) to give keto-dioxinone 84 (480 mg, 18%) as a yellow oil: Rf 0.50 
(EtOAc/PE 1:1); IR max (neat) 1722 (s), 1638 (s), 1375 (m), 1271 (m), 1199 (m), 1014 (s) 
cm
-1
; 
1
H NMR (400 MHz, CDCl3) 5.91 (ddd, J = 16.4, 11.1, 5.8 Hz, 1H, -HC=CH2), 5.37 
(s, 1H, -COCH=COCCH2-), 5.33 (d, J = 16.4 Hz, 1 H, -HC=CH2), 5.29 (d, J = 11.1 Hz, 1H, 
-HC=CH2), 4.65 (d, J = 5.8 Hz, 2H, -OCH2CH=CH2), 3.62 (s, 2H, CH2), 3.54 (s, 2H, CH2), 
1.72 (s, 6H, CH3 × 2); 
13
C NMR (100MHz, CDCl3) 195.5, 166.1, 163.5, 160.5, 131.2, 
119.4, 107.4, 97.2, 66.4, 49.0, 47.0, 25.0 (2C); HRMS (ESI): (M + H)
+
, found 269.1035; 
C13H17O6 requires 269.1026. This data is in accordance with the literature.
20
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2,6-Dimethyl-2-phenyl-4H-1,3-dioxin-4-one 268
30
 
 
 
 
 
 
 
 
t-Butylacetoacetate 270 (16 mL, 96.4 mmol) was cooled to 10 ºC, and acetophenone 271 
(22.5 mL, 193 mmol) in acetic anhydride (32 mL) was added. After 10 min of stirring, conc. 
sulphuric acid (5.05 mL, 96.4 mmol) was added and the mixture was warmed to 0 ºC. After 
stirring for 15 h, the dark-brown coloured mixture was poured in a cooled saturated aq. 
K2CO3 solution (100 mL) where the resulting aqueous layer was extracted with EtOAc      
(450 mL × 2). The combined organic layers were dried (MgSO4), rotary evaporated and 
chromatographed (Et2O/PE 3:17) to afford phenyl-dioxinone 268 (6.4 g, 33%) as a white 
powder: Rf 0.52 (Et2O/PE  3:7); IR max (neat) 1713 (s), 1636 (m), 1384 (s), 1354 (s), 1173 
(s), 975 (m), 832 (s) cm
-1
; 
1
H NMR (400 MHz, CDCl3)  7.49 – 7.47 (m, 2H, ArH), 7.40 – 
7.38 (m, 3H, ArH), 5.19 (s, 1H, -O2CCHCO-), 2.03 (s, 3H, -CH3), 1.91 (s, 3H, -CH3); 
13
C 
NMR (100 MHz, CDCl3)  169.1, 161.4, 140.5, 129.1, 128.6 (2C), 124.9 (2C), 106.6, 96.6, 
29.5, 20.1; MS (ESI) m/z 205 (M H)+; HRMS (ESI): (M H)+, found 205.0868. C12H13O3 
requires 205.0865. This data is in accordance with the literature.
30
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
177 
 
2-Methyl-6-(2-oxopropyl)-2-phenyl-4H-1,3-dioxin-4-one 263
30
 
 
 
 
 
 
A stirred solution of HMDS (1.13 mL, 5.39 mmol) in THF (15 mL) was cooled to 78 ºC and 
treated with n-Butyllithium (1.6 M in hexanes; 3.37 mL). After stirring for 30 min, phenyl-
dioxinone 268 (1 g, 4.9 mmol) in THF (2 mL) was added dropwise and the resulting yellow 
solution was stirred at 78 ºC for another 1 h. Acetyl chloride (0.21 mL, 2.94 mmol) was then 
added slowly and the resulting mixture was stirred for 2 h. The reaction was quenched with 
saturated aq. NH4Cl solution (20 mL) and the separated aqueous layer was extracted with 
Et2O (40 mL × 2). The combined organic layers were dried (MgSO4), rotary evaporated and 
chromatographed (Et2O/PE 7:13) to afford keto-dioxinone 263 (290 mg, 40%) as an off-
white solid: Rf 0.34 (Et2O/PE 1:1); Mp 35 – 36 ºC; IR max (neat) 1731 (s), 1711 (s), 1631 
(m), 1385 (s), 1357 (m), 1241 (m), 1169 (s), 977 (s), 773 (s), 704 (s) cm
-1
; 
1
H NMR (400 
MHz, CDCl3) 7.49 – 7.47 (m, 2H, ArH), 7.41 – 7.39 (m, 3H, ArH), 5.35 (s, 1H, -
O2CCHCO-), 3.35 (d, J = 4.4 Hz, 2H, -CH2), 2.21 (s, 3H, -COCH3), 1.94 (s, 3H, -CH3); 
13
C 
NMR (100 MHz, CDCl3)  200.5, 164.4, 160.7, 139.7, 129.3, 128.6 (2C), 125.1 (2C), 107.2, 
98.7, 48.5, 29.9, 29.1; MS (ESI) m/z 247 (M H)+; HRMS (ESI): (M H)+, found 
247.0976; C14H15O4 requires 247.0970. This data is in accordance with the literature.
30
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6-(2-Oxopropyl)-2,2-diphenyl-4H-1,3-dioxin-4-one 418 
 
 
 
 
Save for the use of di-phenyl-dioxinone 269 instead of phenyl-dioxinone 268, keto-dioxinone 
418 (100 mg, 29%, amber oil) was prepared following a procedure described above for the 
synthesis of keto-dioxinone 263: Rf 0.45 (EtOAc/PE 1:1); IR max (neat) 1726 (s), 1626 (s), 
1588 (m), 1362 (s), 1203 (s), 1059 (s) cm
-1
; 
1
H NMR (400 MHz, CDCl3) 7.55 – 7.54 (m, 
4H, ArH), 7.41 – 7.39 (m, 6H, ArH), 5.45 (s, 1H, -O2CCHCO-), 3.45 (s, 2H, -CH2), 2.24 (s, 
3H, -CH3); 
13
C NMR (100 MHz, CDCl3)  200.4, 164.4, 160.3, 139.0 (2C), 129.5 (2C), 
128.6 (4C), 126.1 (4C), 99.3, 95.3, 48.6, 30.3; MS (ESI) m/z 309 (M H)+; HRMS (ESI): 
(M H)+, found 309.1132; C19H17O4 requires 309.1127.    
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Ethyl 3-(4-hydroxyphenyl)-3-oxopropanoate 272
88
 
 
 
 
 
 
 
BBr3 (2.17 mL, 22.5 mmol) was added to a stirred solution of ethyl 3-(4-methoxyphenyl)-3-
oxopropanoate (11) (2.5 g, 11.26 mmol) in CH2Cl2 (70 mL) at 78 ºC. After stirring for 1.5 h 
at 15 ºC, additional BBr3 (2.17 mL, 22.5 mmol) was added to the reaction mixture and 
stirred for another 2 h. The reaction was quenched with MeOH (5 mL) and saturated aq. 
NaHCO3 solution (40 mL). The separated aqueous layer was extracted with CH2Cl2 (50 mL × 
2) and the combined organic layers were dried (MgSO4), rotary evaporated and 
chromatographed (Et2O/PE 3:7) to afford phenol 272 (2.1 g, 90%) as a white solid: Rf 0.38 
(Et2O/PE 1:1); IR max (neat) 3321 (s), 1694 (s), 1670 (s), 1606 (s), 1580 (s), 1519 (m), 1336 
(m), 1279 (m), 1211 (s), 1163 (s), 1022 (s), 844 (s) cm
-1
; 
1
H NMR (400 MHz, CDCl3)  7.88 
(d, J = 8.8 Hz, 2H, ArH), 6.96 (br. s, 1H, -OH), 6.92 (d, J = 8.8 Hz, 2H, ArH), 4.25 (q, J = 
7.3 Hz, 2H, -CO2CH2CH3), 3.99 (s, 2H, -CH2), 1.28 (t, J = 7.3 Hz, 3H, -CO2CH2CH3); 
13
C 
NMR (100 MHz, CDCl3)  191.6, 168.3, 161.3, 131.3 (2C), 128.7, 115.7 (2C), 61.7, 45.7, 
14.0; MS (CI) m/z 209 (M H)+, 226 (M NH4)
+
; HRMS (ESI): (M H)+, found 209.0811; 
C11H13O4 requires 209.0814. No characterization given in the reference. 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
180 
 
3-(tert-Butyldimethylsilyloxy)-3-(4-(tert-butyldimethylsilyloxy) 
phenyl)-N-methoxy-N-methylpropanamide rac-264 
 
 
 
 
 
 
 
NaBH4 (100 mg, 2.6 mmol) was added in one portion to a stirred solution of β-ketoester 272 
(500 mg. 2.4 mmol) in EtOH (12.5 mL) at 0 ºC and stirred for 3 h. Following TLC analysis, 
the reaction was then quenched with saturated aq. NH4Cl solution (20 mL). The separated 
aqueous layer was extracted with EtOAc (30 mL × 2), and the combined organic layers were 
dried (MgSO4) and rotary evaporated to afford β-hydroxy-ester 273 as a colourless oil (485 
mg). This material was used in the following step without further purification. 
 
TBSCl (907 mg, 6 mmol) in CH2Cl2 (2 mL) was added to a stirred solution of β-hydroxy 
ester 273 (485 mg) and imidazole (600 mg, 8.8 mmol) in CH2Cl2 (10 mL) at 23 ºC and stirred 
for 18 h. Saturated aq. NH4Cl solution (20 mL) was added and the aqueous layer was 
extracted with CH2Cl2 (25 mL × 2). The combined organic layers were dried (MgSO4) and 
rotary evaporated to afford bis-TBS-protected ester intermediate (1.13 g) as a colourless oil. 
This material was used in the following step without further purification. 
 
To a stirred solution of N,O-dimethylhydroxylamine hydrochloride salt 222 (466 mg, 4.80 
mmol) and  ester (1.13 g) in THF (18 mL) at  ºC, i-PrMgCl (2 M in THF; 6.0 mL) was 
added and stirred for 25 min at ºC. The reaction was quenched with saturated aq. NH4Cl 
solution (40 mL) and the aqueous layer was extracted with Et2O (25 mL × 3). The combined 
organic layers were dried (MgSO4), rotary evaporated and chromatographed (Et2O/PE 1:3) to 
afford Weinreb amide rac-264 (489 mg, 45% over 3 steps) as a colourless oil: Rf 0.14 
(Et2O/PE 1:4); IR max (neat) 1662 (m), 1608 (m), 1509 (s), 1472 (m), 1251 (s), 1078 (s), 912 
(s), 831 (s), 776 (s) cm
-1
; 
1
H NMR (400 MHz, CDCl3)  7.24 (d, J = 8.8 Hz, 2H, ArH), 6.80 
(d, J = 8.8 Hz, 2H, ArH), 5.21 (dd, J = 9.3, 4.4 Hz, 1H, ArCHO-), 3.67 (s, 3H, -NOCH3), 
3.20 (s, 3H, -NCH3), 3.09 – 3.03 (m, 1H, -CH2), 2.49 (dd, J = 14.2, 3.9 Hz, 1H, -CH2), 0.99 
(s, 9H, -(CH3)3), 0.85 (s, 9H, -(CH3)3), 0.21 (s, 6H, -Si-CH3 × 2), 0.03 (s, 3H, -Si-CH3), 
0.13 (s, 3H, -Si-CH3); 
13
C NMR (100 MHz, CDCl3)  171.8, 154.8, 137.6, 126.9 (2C), 
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119.7 (2C), 71.8, 61.3, 43.1, 31.9, 25.7 (3C), 25.6 (3C), 18.2, 18.1, 3.5, 4.4, 4.8, 5.1; 
MS (ESI) m/z 476 (M Na)+; HRMS (ESI): (M Na)+, found 476.2628; C23H43NNaO4Si2 
requires 476.2628; Elem. Anal., found C, 61.97; H, 9.50; N, 2.94; C23H43NO4Si2 requires C, 
60.88; H, 9.55; N, 3.09%. 
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(Z)-6-(6-(tert-Butyldimethylsilyloxy)-6-(4-(tert-butyldimethylsilyloxy)phenyl)-2-hydroxy-4-
oxohex-2-enyl)-2-methyl-2-phenyl-4H-1,3-dioxin-4-one rac-261 
 
 
 
 
 
 
 
The phenyl-keto-dioxinone 263 (50 mg, 0.20 mmol) in THF (0.4 mL) was added dropwise to 
a solution of LDA (0.425 mmol) in THF (1.3 mL) at 78 ºC. After stirring for 1 h, the 
resulting dark orange-yellow mixture was treated with diethylzinc solution (1 M in hexane; 
0.425 mL) and stirred for another 20 min at 78 ºC. The mixture was then warmed to 25 ºC 
and Weinreb amide rac-264 (38 mg, 0.085 mmol) in THF (0.3 mL) was added quickly. The 
ensuing mixture was immediately warmed to 5 ºC and stirred for another 2 h. The reaction 
mixture was quenched with saturated aq. NH4Cl solution (10 mL) and the aqueous layer was 
acidified to pH 12 using 1 M aq. HCl solution. The resulting aqueous layer was extracted 
with EtOAc (15 mL × 2) and the combined organic layers were dried (MgSO4), rotary 
evaporated and chromatographed (Et2O/PE 1:4)  to afford diketo-dioxinone rac-261 (40 mg, 
74%) as a yellow oil: Rf 0.40 (Et2O/PE 1:4); IR max (neat) 1744 (s), 1607 (s), 1509 (s), 1377 
(m), 1252 (s), 1080 (s), 910 (s), 833 (s), 776 (s) cm
-1
;  
1
H NMR (400 MHz, CDCl3) 15.1 
(br. s, 1H, enol -OH), 7.47 – 7.45 (m, 2H, ArH), 7.40 – 7.37 (m, 3H, ArH), 7.21 (d, J = 7.8 
Hz, 1H, ArH), 7.19 (d, J = 7.8 Hz, 1H, ArH)  6.81 (d, J = 7.8 Hz, 2H, ArH), 5.53 (s, 0.5H, 
enol -HC=COH), 5.49 (s, 0.5H, enol -HC=COH), 5.33 (s, 1H, -O2CCHCO-), 5.05 (dd, J = 
9.3, 4.4 Hz, 1H, ArCHO-), 3.22 (s, 1H, -CH2), 3.21 (s, 1H, -CH2), 2.68 – 2.50 (m, 2H, -CH2), 
1.93 (s, 1.5H, -CH3), 1.92 (s, 1.5H, -CH3), 1.01 (s, 4.5H, -(CH3)3), 1.00 (s, 4.5H, -(CH3)3), 
0.84 (s, 4.5H, -(CH3)3), 0.83 (s, 4.5H, -(CH3)3), 0.22 (s, 3H, -Si-CH3), 0.21 (s, 3H, -Si-CH3), 
0.02 (s, 3H, -Si-CH3), 0.17 (s, 1.5H, -Si-CH3), 0.18 (s, 1.5H, -Si-CH3) (contains two 
rotamers); 
13
C NMR (100 MHz, CDCl3)  189.9, 189.6, 188.2, 187.9, 165.2, 160.7, 155.1, 
139.8, 136.9, 129.2, 128.6, 128.5, 126.8 (2C), 125.1 (2C), 119.9 (2C), 107.2, 101.8, 98.4, 
72.0, 49.4, 49.3, 43.9, 43.7, 30.3, 29.3, 29.2, 25.7 (6C), 18.2, 18.1, 4.4 (2C), 4.7, 5.3 
(contains two rotamers); MS (ESI) m/z 661 (M Na)+; HRMS (ESI): (M )+, found 
639.3163; C35H50NaO7Si2 requires 639.3173. 
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Ethyl 3-hydroxy-3-(4-methoxyphenyl)propanoate 274
89
 
 
 
 
 
 
 
 
 
NaBH4 (416 mg, 11 mmol) was added in one portion to a stirred solution of ester 11 (2.22 g. 
10 mmol) in EtOH (50 mL) at 0 ºC and stirred for 2 h. The reaction was then quenched with 
saturated aq. NH4Cl solution (50 mL) and the separated aqueous layer was extracted with 
EtOAc (50 mL × 2). The combined organic layers were dried (MgSO4), rotary evaporated 
and chromatographed (Et2O/PE 3:7) to afford β-hydroxy-ester 274 (1.7 g, 77%) as a 
colourless oil: Rf 0.48 (Et2O/PE 50:50); IR max (neat) 3452 (s), 1715 (s), 1609 (m), 1377 
(m), 1239 (m), 1161 (m), 1076 (m), 1035 (s), 814 (m) cm
-1
; 
1
H NMR (400 MHz, CDCl3)  
7.32 (d, J = 8.8 Hz, 2H, ArH), 6.91 (d, J = 8.3 Hz, 2H, ArH), 5.13 – 5.09 (m, 1H, ArCHO-), 
4.20 (q, J = 7.8 Hz, 2H, -CO2CH2CH3), 3.83 (s, 3H, -OCH3), 3.22 (d, J = 3.4 Hz, 1H, -OH), 
2.78 (dd, J = 16.1, 9.3 Hz, 1H, -CH2), 2.69 (dd, J = 16.1, 3.4 Hz, 1H, -CH2), 1.30 (t, J = 6.8 
Hz, 3H, -CO2CH2CH3); 
13
C NMR (100 MHz, CDCl3)  172.5, 159.2, 134.7, 126.9 (2C), 
113.9 (2C), 69.9, 60.8, 55.3, 43.3, 14.2; MS (CI) m/z 242 (M NH4)
+
; HRMS (CI): (M 
H4)
+
, found 242.1399; C12H20NO4 requires 242.1392; Elem. Anal., found C, 64.38; H, 
7.16; C12H16O4 requires C, 64.27; H, 7.19%. This data is in accordance with the literature.
89
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3-(tert-Butyldimethylsilyloxy)-N-methoxy-3-(4-methoxyphenyl)- 
N-methylpropanamide rac-265 
 
 
 
 
 
 
 
 
 
TBSCl (707 mg, 4.69 mmol) in CH2Cl2 (5 mL) was added to a stirred solution of β-hydroxy 
ester 274 (700 mg, 3.13 mmol) and imidazole (468 mg, 6.88 mmol) in CH2Cl2 (14 mL) at 23 
ºC and stirred for 18 h. The reaction was quenched with saturated aq. NH4Cl solution (20 
mL) and the separated aqueous layer was extracted with CH2Cl2 (25 mL × 2). The combined 
organic layers were dried (MgSO4) and rotary evaporated to give TBS-protected ester (1 g) as 
a colourless oil. This material was used in the following step without further purification. 
 
To a stirred solution of N,O-dimethylhydroxylamine hydrochloride salt 222 (173 mg, 1.78 
mmol) and protected ester (1 g) in THF (10 mL) at ºC, i-PrMgCl (2 M in THF; 2.00 mL) 
was added and stirred for 25 min at ºC. The reaction was quenched with saturated aq. 
NH4Cl solution (25 mL) and the separated aqueous layer was extracted with Et2O (25 mL × 
3). The combined organic layers were dried (MgSO4), rotary evaporated and 
chromatographed (Et2O/PE 1:1) to afford Weinreb amide rac-265 (1.04 g, 94%) as a 
colourless oil: Rf 0.13 (Et2O/PE 1:1); IR max (neat) 1658 (s), 1612 (m), 1512 (s), 1463 (m), 
1384 (m), 1246 (s), 1076 (s), 1034 (m), 828 (s), 776 (s) cm
-1
; 
1
H NMR (400 MHz, CDCl3)  
7.32 (d, J = 8.3 Hz, 2H, ArH), 6.87 (d, J = 8.3 Hz, 2H, ArH), 5.23 (dd, J = 8.8, 4.4 Hz, 1H, 
ArCHO-), 3.83 (s, 3H, -OCH3), 3.68 (s, 3H, -NOCH3), 3.20 (s, 3H, -NCH3), 3.03 (m, 1H, -
CH2), 2.48 (dd, J = 14.6, 4.4 Hz, 1H, -CH2), 0.86 (s, 9H, -(CH3)3), 0.04 (s, 3H, -Si-CH3), 
0.11 (s, 3H, -Si-CH3); 
13
C NMR (100 MHz, CDCl3)  171.7, 158.7, 137.0, 127.0 (2C), 
113.5 (2C), 71.7, 61.3, 55.2, 43.2, 31.9, 25.7 (3C), 18.1, 4.7, 5.1; MS (ESI) m/z 376 (M 
Na)+; HRMS (ESI): (M Na)+, found 376.1917; C18H31NNaO4Si requires 376.1920; 
Elem. Anal., found C, 61.27; H, 8.94; N, 3.84; C18H31NO4Si requires C, 61.15; H, 8.84; N, 
3.96%.    
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 (Z)-6-(6-(tert-Butyldimethylsilyloxy)-2-hydroxy-6-(4-methoxyphenyl)-4-oxohex-2-enyl)-
2,2-dimethyl-4H-1,3-dioxin-4-one 275 
 
 
 
 
 
 
 
 
 
The keto-dioxinone 10 (114 mg, 0.62 mmol) in THF (0.5 mL) was added dropwise to a 
stirred solution of LDA (1.3 mmol) in THF (3 mL) at 78 ºC. After stirring for 1 h, a dark 
orange-yellow precipitate was formed and diethylzinc solution (1 M in hexane; 1.3 mL) was 
added dropwise and stirred further for 20 min. The mixture was then warmed to 25 ºC and 
Weinreb amide rac-265 (100 mg, 0.28 mmol) in THF (0.5 mL) was added quickly to the 
ensing mixture and immediately warmed to 5 ºC. After stirring for 2 h, the reaction was 
quenched with saturated aq. NH4Cl solution (15 mL) and the aqueous layer was acidified to 
pH 12 using 1 M aq. HCl solution. The resulting aqueous layer was extracted with EtOAc 
(25 mL × 2) and the combined organic layers were dried (MgSO4), rotary evaporated and 
chromatographed (Et2O/PE 1:1) to afford diketo-dioxinone 275 (115 mg, 85%) as a yellow 
oil: Rf 0.45 (Et2O/PE 1:1); IR max (neat) 2954 (m), 2930 (m), 1729 (s), 1607 (s), 1512 (s), 
1373 (s), 1246 (s), 1077 (s), 1014 (s), 829 (s) cm
-1
; 
1
H NMR (400 MHz, CDCl3)  15.1 (br. 
s, 1H, enol -OH), 7.26 (d, J = 8.9 Hz, 2H, ArH), 6.88 (d, J = 8.9 Hz, 2H, ArH), 5.56 (s, 1H, 
enol -HC=COH), 5.40 (s, 1H, -O2CCHCO-), 5.08 (dd, J = 8.9, 3.9 Hz, 1H, ArCHO-), 3.83 (s, 
3H, -OCH3), 3.22 (s, 2H, -CH2), 2.63 (dd, J = 14.0, 8.9 Hz, 1H, -CH2), 2.54 (dd, J = 14.0, 4.4 
Hz, 1H, -CH2), 1.71 (s, 6H, dioxinone -CH3 × 2), 0.85 (s, 9H, -(CH3)3), 0.01 (s, 3H, -Si-
CH3), 0.16 (s, 3H, -Si-CH3); 
13
C NMR (100 MHz, CDCl3)  189.0 (2C), 164.9, 160.6, 
158.9, 136.3, 126.9 (2C), 113.8 (2C), 107.1, 101.7, 96.4, 71.9, 55.2, 49.5, 43.6, 25.7 (3C), 
25.0, 24.9, 18.1, 4.7, 5.3 (keto-form); MS (ESI) m/z 499 (M Na)+; HRMS (ESI): (M 
Na)+, found 499.2107; C25H36NaO7Si requires 499.2128; Elem. Anal., found C, 63.15; H, 
7.65; C25H36O7Si requires C, 63.00; H, 7.61%.    
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3-Hydroxy-N-methoxy-3-(4-methoxyphenyl)-N-methylpropanamide rac-13
90
 
 
 
 
 
 
TBAF (17 mL, 18.0 mmol) was added to Weinreb amide rac-265 (3 g, 8.4 mmol) in THF 
(130 mL) and stirred for 8 h at 23 ºC. The reaction was quenched with H2O (150 mL) and the 
separated aqueous layer was extracted with EtOAc (200 mL × 2). The combined organic 
layers were dried (MgSO4), rotary evaporated and chromatographed (Et2O/PE 7:3) to afford 
alcohol rac-13 (1.5 g, 75%) as a white solid: Rf 0.19 (EtOAc/PE 1:1); Mp 30 – 32 ºC; IR 
max (neat) 3424 (s), 2971 (w), 1629 (s), 1509 (s), 1440 (m), 1384 (m), 1237 (s), 1063 (s), 826 
(s) cm
-1
; 
1
H NMR (400 MHz, CDCl3)  7.35 (d, J = 8.3 Hz, 2H, ArH), 6.91 (d, J = 8.3 Hz, 
2H, ArH), 5.12 (dt, J = 9.3, 2.9 Hz, 1H, ArCHO-), 4.18 (d, J = 2.9 Hz, 1H, -OH), 3.83 (s, 
3H, -OCH3), 3.66 (s, 3H, -NOCH3), 3.23 (s, 3H, -NCH3), 2.89 – 2.76 (m, 2H, -CH2); 
13
C 
NMR (100 MHz, CDCl3)  173.3, 159.0, 135.2, 127.0 (2C), 113.8 (2C), 69.8, 61.3, 55.3, 
40.4, 31.9; MS (ESI) m/z 262 (M Na)+; HRMS (ESI): (M Na)+, found 262.1060; 
C12H17NNaO4 requires 262.1055; Elem. Anal., found C, 60.34; H, 7.29; N, 5.66; C12H17NO4 
requires C, 60.24; H, 7.16; N, 5.85%. This data is in accordance with the literature.
90
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(Z)-6-(6-(tert-Butyldimethylsilyloxy)-6-(4-(tert-butyldimethylsilyloxy)phenyl)-2-hydroxy-4-
oxohex-2-enyl)-2,2-dimethyl-4H-1,3-dioxin-4-one rac-12 
 
 
 
 
 
 
Save for the use of Weinreb amide rac-264 instead of rac-265, diketo-dioxinone rac-12 (2.25 
g, 89%, yellow solid) was prepared following the conditions described for the synthesis of 
diketo-dioxinone 275: Rf 0.70 (Et2O/PE 1:1); Mp 59 – 61 ºC; IR max (neat) 2957 (m), 2935 
(m), 1733 (s), 1609 (s), 1505 (m), 1371 (s), 1250 (s), 1084 (s), 834 (s) cm
-1
; 
1
H NMR (400 
MHz, CDCl3)  15.12 (br. s, 1H, enol -OH), 7.19 (d, J = 8.3 Hz, 2H, ArH), 6.81 (d, J = 8.3 
Hz, 2H, ArH), 5.57 (s, 1H, enol -HC=COH), 5.41 (s, 1H, -O2CCHCO-), 5.05 (dd, J = 8.8, 3.9 
Hz, 1H, ArCHO-), 3.21 (s, 2H, -CH2), 2.63 (dd, J = 14.1, 9.3 Hz, 1H, -CH2), 2.54 (dd, J = 
13.2, 3.9 Hz, 1H, -CH2), 1.71 (s, 6H, dioxinone -CH3 × 2), 0.99 (s, 9H, -(CH3)3), 0.83 (s, 9H, 
-(CH3)3), 0.20 (s, 6H, -Si-CH3 × 2), 0.03 (s, 3H, -Si-CH3), 0.18 (s, 3H, -Si-CH3); 
13
C 
NMR (100 MHz, CDCl3)  189.1 (2C), 164.9, 160.7, 155.0, 136.9, 126.8 (2C), 119.9 (2C), 
107.1, 101.1, 96.5, 72.0, 49.4, 43.6, 25.7 (6C), 25.0, 24.9, 18.2, 18.1, -4.4 (2C), -4.7, -5.3 
(keto-form); MS (ESI) m/z 599 (M Na)+; HRMS (ESI): (M Na)+, found 599.2857; 
C30H48NaO7Si2 requires 599.2836; Elem. Anal., found C, 62.34; H, 8.44; C30H48O7Si2 
requires C, 62.46; H, 8.39%.   
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3-(Methoxy(methyl)amino)-1-(4-methoxyphenyl)-3-oxopropyl 2-(2-(tert-butyldimethy 
lsilyloxy)-2-(4-(tert-butyldimethylsilyloxy)phenyl)ethyl)-4,6-dihydroxybenzoate rac-14 
 
 
 
 
 
 
 
 
 
A solution of diketo-dioxinone rac-12 (1.85 g, 3.2 mmol) and alcohol rac-13 (0.9 g, 3.8 
mmol) in PhMe (5 mL) was added to PhMe (35 mL) at reflux and stirred for 1 h. The solvent 
was removed by rotary evaporation and the residue was dissolved in CH2Cl2 (18 mL), i-PrOH 
(2.5 mL) and MeOH (2.5 mL) in a sealed tube. The resulting mixture was heated at 100 ºC 
for 2.5 h in the presence of molecular sieves 4 Å (powder - preactivated). Rotary evaporation 
and silica gel column chromatography (Et2O/PE 3:7 to 1:1) gave resorcylate rac-14 (1.88 g, 
81%) as a off-white solid: Rf 0.48 (EtOAc/PE 1:1); Mp 51 – 53 ºC; IR max (neat) 3300 (m), 
2957 (m), 2933 (m), 1643 (s), 1612 (s), 1509 (s), 1247 (s), 1167 (s) cm
-1
; 
1
H NMR (500 
MHz, CDCl3)  11.24 (br. s, 1H, -OH), 10.69 (br. s, 1H, -OH), 7.45 – 7.41 (m, 4H, ArH), 
7.02 (d, J = 9.8 Hz, 2H, ArH), 6.96 – 6.89 (m, 6H, ArH), 6.72 (d, J = 8.3 Hz, 2H, ArH), 6.71 
(d, J = 8.3 Hz, 2H, ArH), 6.56 (dd, J = 7.8, 5.9 Hz, 1H, ArCO2CH-), 6.46 (dd, J = 8.8, 5.9 
Hz, 1H, ArCO2CH-), 6.32 – 6.30 (m, 4H, ArH), 5.82 (br. s, 1H, -OH), 5.70 (br. s, 1H, -OH), 
4.71 (dd, J = 9.8, 3.4 Hz, 1H, ArCHO-), 4.53 (dd, J = 9.8, 2.4 Hz, 1H, ArCHO-), 3.80 (s, 6H, 
-OCH3 × 2), 3.64 (s, 3H, -NOCH3), 3.55 (s, 3H, -NOCH3), 3.43 (dd, J = 13.7, 2.9 Hz, 1H, -
CH2), 3.35 (s, 3H, -NCH3), 3.34 (dd, J = 12.7, 2.9 Hz, 1H, -CH2), 3.27 (m, 2H, -CH2), 3.19 
(s, 3H, -NCH3), 3.12 – 3.07 (m, 2H, -CH2), 3.06 – 3.00 (m, 1H, -CH2), 2.93 (dd, J = 13.2, 
10.3 Hz, 1H, -CH2), 1.02 (s, 9H, -(CH3)3), 1.01 (s, 9H, -(CH3)3), 0.72 (s, 9H, -(CH3)3), 0.71 
(s, 9H, -(CH3)3), 0.22 (s, 6H, -Si-CH3 × 2), 0.21 (s, 6H, -Si-CH3 × 2), -0.35 (s, 3H, -Si-CH3), 
-0.37 (s, 3H, -Si-CH3), -0.38 (s, 3H, -Si-CH3), -0.39 (s, 3H, -Si-CH3) (d.r = 1:1); 
13
C NMR 
(125 MHz, CDCl3) 170.7, 170.5, 169.7, 168.9, 164.4, 163.2, 159.8, 159.7, 159.5, 154.5, 
154.4, 144.5, 144.2, 138.4, 138.3, 131.4, 131.1, 128.4 (2C), 128.3 (2C), 126.9 (2C), 126.8 
(2C), 119.6 (2C), 119.5 (2C), 114.1 (4C), 113.6, 112.8, 107.2, 106.1, 101.8, 75.6, 74.9, 73.4, 
73.2, 61.3, 61.2, 55.2, 46.6, 46.1, 38.3, 38.2, 32.1, 30.3, 25.7 (12C), 18.2, 17.9, -4.4 (2C), -
5.1, -5.2, -5.4, -5.5 (contains both diastereoisomers); MS (ESI) m/z 762 (M Na)+; HRMS 
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(ESI): (M Na)+, found 762.3487; C39H57NNaO9Si2 requires 762.3470; Elem. Anal., found 
C, 63.43; H, 7.67; N, 1.87; C39H57NO9Si2 requires C, 63.30; H, 7.76; N, 1.89%.  
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3-(Methoxy(methyl)amino)-1-(4-methoxyphenyl)-3-oxopropyl 2-(2-(tert-butyldimethylsilyl 
oxy)-2-(4-(tert-butyldimethylsilyloxy)phenyl)ethyl)-6-hydroxy-4-methoxybenzoate rac-286 
 
 
 
 
 
 
 
 
 
 
 
MeI (2.7 mL, 43.3 mmol) in acetone (2 mL) was added to a solution of resorcylate rac-14 
(800 mg, 1.1 mmol) and K2CO3 (747 mg, 5.4 mmol) in acetone (38 mL) and heated to reflux 
for 2 h. The volatiles were removed by rotary evaporation and H2O (40 mL) was added. The 
separated aqueous layer was extracted with Et2O (50 mL × 2) and the combined organic 
layers were dried (MgSO4), rotary evaporated and chromatographed (Et2O/PE 1:2 to 1:1) to 
afford resorcylate rac-286 (575 mg, 71%) as a white solid. Two diastereoisomers (dr = 1:1) 
were separated by trituration using cold hexanes: Rf 0.48 (EtOAc/PE 1:1); IR max (neat) 
2959 (w), 2931 (m), 1720 (s), 1656 (m), 1608 (s), 1471 (s), 1255 (s) cm
-1
; HRMS (ESI): (M 
Na)+, found 790.3815; C41H61NNaO9Si2 requires 790.3783; Elem. Anal., found C, 64.22; 
H, 8.05; N, 1.84; C41H61NO9Si2 requires C, 64.11; H, 8.00; N, 1.82%.  
 
 Diastereosiomer І – white solid; Mp 114 – 116 ºC; 1H NMR (400 MHz, CDCl3)  7.47 (d, J 
= 8.8 Hz, 2H, ArH), 6.99 (d, J = 8.8 Hz, 2H, ArH), 6.88 (d, J = 8.3 Hz, 2H, ArH), 6.71 (d, J 
= 8.3, 2H, ArH), 6.48 (t, J = 6.8 Hz, 1H, ArCO2CH-), 6.34 (d, J = 1.9 Hz, 1H, ArH), 6.31 (d, 
J = 1.9 Hz, 1H, ArH), 4.78 (dd, J = 9.7, 3.4 Hz, 1H, ArCHO-), 3.82 (s, 3H, -OCH3), 3.79 (s, 
3H, -OCH3), 3.78 (s, 3H, -OCH3), 3.63 (s, 3H, -NOCH3), 3.30 (dd, J = 16.1, 7.8 Hz, 1H, -
CH2), 3.16 (s, 3H, -NCH3), 2.96 (dd, J = 16.1, 6.4 Hz, 1H, -CH2), 2.78 (dd, J = 13.2, 3.4 Hz, 
1H, -CH2), 2.61 (dd, J = 13.2, 9.8 Hz, 1H, -CH2), 1.01 (s, 9H, -(CH3)3), 0.77 (s, 9H, -
(CH3)3), 0.21 (s, 6H, -Si-CH3 × 2), -0.32 (s, 6H, -Si-CH3 × 2); 
13
C NMR (100 MHz, CDCl3) 
170.5, 167.3, 160.6, 159.3, 158.1, 154.2, 139.6, 138.4, 132.3, 128.4 (2C), 126.6 (2C), 119.3 
(2C), 116.9, 113.7 (2C), 108.3, 97.1, 74.7, 73.0, 61.2, 55.8, 55.3, 55.2, 45.9, 39.0, 32.0, 25.8 
(6C), 18.2, 18.0, -4.4 (2C), -5.2, -5.5.  
 
Diastereosiomer ІІ – colourless gum; 1H NMR (400 MHz, CDCl3)  7.51 (d, J = 8.3 Hz, 2H, 
ArH), 6.93 – 6.90 (m, 4H, ArH), 6.70 (d, J = 8.8, 2H, ArH), 6.53 (t, J = 6.4 Hz, 1H, 
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ArCO2CH-), 6.34 (d, J = 1.9 Hz, 1H, ArH), 6.32 (d, J = 1.9 Hz, 1H, ArH), 4.62 (dd, J = 9.8, 
2.9 Hz, 1H, ArCHO-), 3.80 (s, 3H, -OCH3), 3.79 (s, 3H, -OCH3), 3.77 (s, 3H, -OCH3), 3.64 
(s, 3H, -NOCH3), 3.29 (dd, J = 16.1, 7.8 Hz, 1H, -CH2), 3.12 (s, 3H, -NCH3), 2.98 – 2.92 (m, 
2H, -CH2), 2.61 (dd, J = 13.2, 9.8 Hz, 1H, -CH2), 1.01 (s, 9H, -(CH3)3), 0.76 (s, 9H, -
(CH3)3), 0.21 (s, 6H, -Si-CH3 × 2), -0.35 (s, 3H, -Si-CH3), -0.36 (s, 3H, -Si-CH3); 
13
C NMR 
(100 MHz, CDCl3) 170.5, 167.2, 160.6, 159.4, 158.3, 154.2, 139.9, 138.3, 132.3, 128.6 
(2C), 126.7 (2C), 119.3 (2C), 116.7, 113.8 (2C), 108.5, 97.1, 74.9, 72.8, 61.2, 55.8, 55.3, 
55.2, 45.8, 39.0, 32.0, 25.8 (6C), 18.2, 18.0, -4.4 (2C), -5.2, -5.4; MS (ESI) m/z 790 (M 
Na)+. 
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 (Z)-6-(2,2-Dimethyl-4-oxo-4H-1,3-dioxin-6-yl)-5-hydroxy-1-(4-methoxyphenyl)-3-oxohex-
4-enyl 2-(2-(tert-butyldimethylsilyloxy)-2-(4-(tert-butyldimethylsilyloxy)phenyl)ethyl)-4,6-
dimethoxybenzoate rac-15 
 
 
 
 
 
 
 
 
 
 
 
 
Save for the use of Weinreb amide rac-286 (Diastereoisomer I) instead of rac-265, diketo-
dioxinone rac-15 (88 mg, 76%, yellow oil) was prepared following the conditions described 
for the synthesis of diketo-dioxinone 275: Rf 0.62 (EtOAc/PE 1:1); IR max (neat) 2954 (m), 
2855 (m), 1726 (s), 1605 (s), 1509 (s), 1251 (s), 1158 (m), 1081 (m), 910 (s), 834 (s) cm
-1
; 
1
H 
NMR (400 MHz, CDCl3)  15.0 (br. s, 1H, enol -OH), 7.40 (d, J = 8.8, 2H, ArH), 6.88 (d, J 
= 8.8 Hz, 2H, ArH), 6.85 (d, J = 8.8 Hz, 2H, ArH), 6.67 (d, J = 8.8 Hz, 2H, ArH), 6.39 – 
6.34 (m, 1H, ArCO2CH-), 6.34 (d, J = 1.9 Hz, 1H, ArH), 6.28 (m, 1H, ArH), 5.57 (s, 1H, 
enol -HC=COH), 5.37 (s, 1H, -O2CCHCO-), 4.76 – 4.74 (m, 1H, ArCHO-), 3.82 (s, 3H, -
OCH3), 3.78 (s, 3H, -OCH3), 3.74 (s, 3H, -OCH3), 3.20 (s, 2H, -CH2), 3.11 – 3.04 (m, 1H, -
CH2), 2.82 (d, J = 14.6, 4.9 Hz, 1H, -CH2), 2.62 – 2.55 (m, 2H, -CH2), 1.68 (s, 6H, dioxinone 
-CH3 × 2), 1.01 (s, 9H, -(CH3)3), 0.77 (s, 9H, -(CH3)3), 0.21 (s, 6H, -Si-CH3 × 2), -0.32 (s, 
3H, -Si-CH3), -0.34 (s, 3H, -Si-CH3) (d.r = 1:1); 
13
C NMR (100 MHz, CDCl3) 
C)167.4, 164.7, 160.7, 159.6, 157.9, 154.2, 139.2, 138.1, 131.3, 128.2 (2C), 126.5 
(2C), 119.3 (2C), 116.7, 113.9 (2C), 108.2, 107.1, 100.8, 97.0, 96.3, 77.2, 74.7, 72.7, 55.8, 
55.3, 55.2, 45.9, 44.5, 43.4, 25.8 (3C), 25.7 (3C), 24.9 (2C), 18.2, 18.0, -4.4 (2C), -5.2, -5.5 
(keto-form); MS (ESI) m/z 913 (M Na)+; HRMS (ESI): (M Na)+, found 913.4026; 
C48H66NaO12Si2 requires 913.3991.  
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Ethyl 3-(4-(tert-butyldimethylsilyloxy)phenyl)-3-oxopropanoate 295 
 
 
 
 
 
BBr3 (1 M in CH2Cl2; 135 mL) was added to a stirred solution of ester 11 (15 g, 67.6 mmol) 
in CH2Cl2 (420 mL) at 78 ºC and then warmed to 15 ºC. After stirring for 1.5 h, additional 
BBr3 (1 M in CH2Cl2; 67 mL) was added and the resulting mixture was stirred for another 2.5 
h. The reaction was quenched with MeOH (100 mL) and saturated aq. NaHCO3 solution (200 
mL). The separated aqueous layer was extracted with CH2Cl2 (350 mL × 2) and the combined 
organic layers were dried (MgSO4) and rotary evaporated to give the corresponding phenol 
intermediate (14 g), which was used in the next step of the reaction sequence without further 
purification. 
 
To a stirred solution of phenol (14 g) and imidazole (10.1 g, 148.1 mmol) in CH2Cl2 (200 
mL) at 23 ºC, TBSCl (15.3 g, 101 mmol) in CH2Cl2 (25 mL) was added and stirred for 18 h. 
The reaction was quenched with saturated aq. NH4Cl solution (150 mL) and the separated 
aqueous layer was extracted with CH2Cl2 (150 mL × 2). The combined organic layers were 
dried (MgSO4), rotary evaporated and chromatographed (Et2O/PE 1:4) to afford β-ketoester 
295 (21 g, 90% over 2 steps) as a yellow oil: Rf 0.72 (Et2O/PE 1:1); IR max (neat) 2957 (m), 
2933 (m), 2861 (m), 1741 (s), 1680 (s), 1597 (s), 1508 (s), 1263 (s), 1211 (m), 1166 (s), 906 
(s), 837 (s) cm
-1
; 
1
H NMR (400 MHz, CDCl3)  7.89 (d, J = 8.8 Hz, 2H, ArH), 6.91 (d, J = 
8.8 Hz, 2H, ArH), 4.23 (q, J = 6.8 Hz, 2H, -CO2CH2CH3), 3.96 (s, 2H, -CH2), 1.28 (t, J = 6.4 
Hz, 3H, -CO2CH2CH3), 1.01 (s, 9H, -(CH3)3), 0.26 (s, 6H, -Si-CH3 × 2); 
13
C NMR (100 
MHz, CDCl3)  191.1, 167.7, 160.8, 130.8 (2C), 129.6, 120.1 (2C), 61.4, 45.8, 25.5 (3C), 
18.2, 14.1, -4.3 (2C); MS (ESI) m/z 323 (M H)+; HRMS (ESI): (M H)+, found 323.1672; 
C17H27O4Si requires 323.1679; Elem. Anal., found C, 63.47; H, 8.08; C17H26O4Si requires C, 
63.32; H, 8.13%. 
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Ethyl 3-(4-(tert-butyldimethylsilyloxy)phenyl)-3-hydroxypropanoate rac-296 
 
 
 
 
 
 
 
NaBH4 (2.8 g, 74 mmol) was added in one portion to a stirred solution of β-ketoester 295 (20 
g, 62 mmol) in EtOH (300 mL) at 0 ºC. After stirring for 3 h, the reaction was quenched with 
saturated aq. NH4Cl solution (250 mL) and the separated aqueous layer was extracted with 
EtOAc (300 mL × 2). The combined organic layers were dried (MgSO4), rotary evaporated 
and chromatographed (Et2O/PE 1:3) to give β-hydroxy-ester rac-296 (13.3 g, 67%) as a 
colourless oil: Rf 0.53 (Et2O/PE 1:1); IR max (neat) 3455 (w), 2956 (m), 2931 (m), 2858 
(m), 1726 (m), 1608 (m), 1510 (s), 1463 (m), 1253 (s), 1194 (m), 1163 (m), 1036 (m), 911 
(s), 836 (s), 778 (s) cm
-1
; 
1
H NMR (400 MHz, CDCl3)  7.25 (d, J = 8.8 Hz, 2H, ArH), 6.83 
(d, J = 8.3 Hz, 2H, ArH), 5.08 (dd, J = 9.3, 3.9 Hz, 1H, ArCHO-), 4.19 (q, J = 7.3 Hz, 2H, -
CO2CH2CH3), 3.15 (br. s, 1H, -OH), 2.77 (dd, J = 16.1, 9.3 Hz, 1H, -CH2), 2.68 (dd, J = 
16.1, 9.3 Hz, 1H, -CH2), 1.28 (t, J = 6.8 Hz, 3H, -CO2CH2CH3), 1.00 (s, 9H, -(CH3)3), 0.22 
(s, 6H, -Si-CH3 × 2); 
13
C NMR (100 MHz, CDCl3)  172.4, 155.3, 135.3, 126.9 (2C), 120.0 
(2C), 70.0, 60.8, 25.7 (3C), 25.7, 18.2, 14.2, -4.4 (2C); Elem. Anal., found C, 63.06; H, 8.66; 
C17H28O4Si requires C, 62.92; H, 8.70%. Not stable under mass spectrometry conditions. 
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Ethyl 3-(benzyloxy)-3-(4-(tert-butyldimethylsilyloxy)phenyl)propanoate rac-298 
  
 
 
 
 
 
 
 
 
Triflic acid (0.12 mL, 0.15 mmol) was added to a stirred solution of β-hydroxy-ester rac-296 
(5 g, 15 mmol) and acetimidate 297 (7.6 g, 30.1 mmol) in CH2Cl2 (20 mL) and cyclohexane 
(37.5 mL) at 0 ºC. The resulting mixture was allowed to warm to 23 ºC and stirred for 18 h. 
The precipitate was filtered and the filtrate was diluted with Et2O (100 mL) and washed with 
saturated aq. NaHCO3 solution (50 mL). The organic layer was dried (MgSO4), rotary 
evaporated and chromatographed (Et2O/PE 1:19) to give ethylester rac-298 (4.0 g, 62%) as a 
colourless oil; Rf 0.76 (Et2O/PE 1:1); IR max (neat) 2955 (m), 2930 (m), 2859 (m), 1736 (s), 
1630 (s), 1606 (m), 1508 (s), 1472 (m), 1255 (s), 1163 (s), 1096 (m), 1028 (m), 910 (s), 837 
(s), 779 (s), 695 (s) cm
-1
; 
1
H NMR (400 MHz, CDCl3)  7.35 – 7.25 (m, 7H, ArH), 6.86 (d, J 
= 8.8 Hz, 2H, ArH), 4.81 (dd, J = 9.3, 4.9 Hz, 1H, ArCHO-), 4.45 (d, J = 11.7 Hz, 1H, 
ArCH2O-), 4.31 (d, J = 11.7 Hz, 1H, ArCH2O-), 4.19 – 4.10 (m, 2H, -CO2CH2CH3), 2.90 
(dd, J = 15.2, 8.8 Hz, 1H, -CH2), 2.62 (dd, J = 15.2, 5.4 Hz, 1H, -CH2), 1.23 (t, J = 7.3 Hz, 
3H, -CO2CH2CH3), 1.02 (s, 9H, -(CH3)3), 0.24 (s, 6H, -Si-CH3 × 2); 
13
C NMR (100 MHz, 
CDCl3)  170.9, 155.5, 138.3, 133.3, 128.3 (2C), 128.0 (2C), 127.8 (2C), 127.5, 120.1 (2C), 
77.5, 70.5, 60.5, 43.7, 25.7 (3C), 18.2, 14.2, -4.3 (2C); MS (ESI) m/z 437 (M Na)+; HRMS 
(ESI): (M Na)+, found 437.2129; C24H34NaO4Si requires 437.2124. Elem. Anal., found C, 
69.42; H, 8.19; C24H34O4Si requires C, 69.52; H, 8.27%. 
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1-(4-(tert-Butyldimethylsilyloxy)phenyl)-3-(methoxy 
(methyl)amino)-3-oxopropyl benzoate rac-300 
 
 
 
 
 
 
 
 
 
To a stirred solution of N,O-dimethylhydroxylamine hydrochloride salt 222 (256 mg, 2.62 
mmol) in THF (10 mL) at ºC, i-PrMgCl (2 M in THF; 2.62 mL) was added and then 
warmed to ºC. After stirring for 45 min, a solution of ethylester rac-298 (500 mg, 1.17 
mmol) in THF (2 mL) was added dropwise and the ensuing mixture was gradually warmed to 
ºC over a 40 min period. The reaction was then quenched with saturated aq. NH4Cl 
solution (30 mL) and the separated aqueous layer was extracted with Et2O (30 mL × 2). The 
combined organic layers were dried (MgSO4), rotary evaporated and chromatographed 
(Et2O/PE 1:2) to give Weinreb amide rac-300 (400 mg, 76%) as a colourless oil; Rf 0.31 
(Et2O/PE 1:1); IR max (neat) 2955 (m), 2931 (m), 2858 (m), 1662 (s), 1607 (s), 1508 (s), 
1471 (m), 1385 (m), 1255 (s), 1167 (m), 1092 (m), 1073 (m), 999 (m), 910 (s), 837 (s), 779 
(s), 696 (s) cm
-1
; 
1
H NMR (400 MHz, CDCl3)  7.35 – 7.27 (m, 7H, ArH), 6.86 (d, J = 8.8 
Hz, 2H, ArH), 4.92 (dd, J = 8.8, 5.9 Hz, 1H, ArCHO-), 4.43 (d, J = 11.2 Hz, 1H, ArCH2O-), 
4.35 (d, J = 11.2 Hz, 1H, ArCH2O-), 3.61 (s, 3H, -NOCH3), 3.19 (s, 3H, -NCH3), 3.17 – 3.12 
(br. m, 1H, -CH2), 2.67 (dd, J = 15.6, 4.9 Hz, 1H, -CH2), 1.02 (s, 9H, -(CH3)3), 0.24 (s, 6H, -
Si-CH3 × 2); 
13
C NMR (100 MHz, CDCl3)  171.6, 155.3, 138.5, 134.1, 128.2 (2C), 127.9 
(2C), 127.7 (2C), 127.4, 120.0 (2C), 77.7, 70.7, 61.3, 40.8, 32.0, 25.7 (3C), 18.2, -4.4 (2C); 
MS (ESI) m/z 452 (M Na)+; HRMS (ESI): (M Na)+, found 452.2224; C24H35NNaO4Si 
requires 452.2233. 
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3-(Methoxy(methyl)amino)-1-(4-methoxyphenyl)-3-oxopropyl 2-(2-(benzyloxy)-2-(4-(tert-
butyldimethylsilyloxy)phenyl)ethyl)-4,6-dihydroxybenzoate rac-291 
 
 
 
 
 
 
 
 
 
Save for the use of diketo-dioxinone rac-293 instead of rac-12, resorcylate rac-291 (470 mg, 
62%, off-white solid) was prepared following the conditions described for the synthesis of 
resorcylate rac-14: Rf 0.64 (EtOAc/PE 1:1); Mp 50 – 52 ºC; IR max (neat) 3252 (w), 2954 
(m), 2935 (m), 2859 (m), 1643 (s), 1611 (s), 1586 (m), 1510 (s), 1450 (m), 1389 (w), 1307 
(m), 1248 (s), 1167 (s), 1097 (m), 1004 (m), 909 (s), 833 (s), 780 (s), 697 (s) cm
-1
; 
1
H NMR 
(400 MHz, CDCl3)  11.47 (br. s, 1H, -OH), 11.29 (br. s, 1H, -OH), 7.33 (d, J = 8.8 Hz, 2H, 
ArH), 7.32 (d, J = 8.8 Hz, 2H, ArH), 7.30 – 7.24 (m, 6H, ArH), 7.16 – 7.12 (m, 4H, ArH), 
7.05 (d, J = 8.8 Hz, 2H, ArH), 7.00 (d, J = 8.8 Hz, 2H, ArH), 6.87 – 6.82 (m, 4H, ArH), 6.78 
(d, J = 8.3 Hz, 2H, ArH), 6.77 (d, J = 8.3 Hz, 2H, ArH), 6.50 – 6.47 (m, 1H, ArCO2CH-), 
6.44 (dd, J = 8.8, 4.9 Hz, 1H, ArCO2CH-), 6.26 (d, J = 2.4 Hz, 1H, ArH), 6.21 (d, J = 2.4 Hz, 
1H, ArH), 6.06 (d, J = 2.4 Hz, 1H, ArH), 5.94 (d, J = 2.4 Hz, 1H, ArH), 4.52 – 4.48 (m, 1H, 
ArCHO-), 4.42 – 4.38 (m, 1H, ArCHO-), 4.36 (d, J = 12.2 Hz, 1H, ArCH2O-), 4.33 (d, J = 
12.2 Hz, 1H, ArCH2O-), 4.15 (d, J = 12.2 Hz, 1H, ArCH2O-), 4.11 (d, J = 12.2 Hz, 1H, 
ArCH2O-), 3.82 (s, 3H, -OCH3), 3.78 (s, 3H, -OCH3), 3.69 – 3.61 (m, 1H, -CH2), 3.55 (s, 
3H, -NOCH3), 3.49 (s, 3H, -NOCH3), 3.48 – 3.45 (m, 1H, -CH2), 3.29 – 3.21 (m, 2H, -CH2), 
3.16 (s, 3H, -NCH3), 3.13 (s, 3H, -NCH3), 3.07 – 2.94 (m, 4H, -CH2 × 2), 1.03 (s, 9H, -
(CH3)3), 1.02 (s, 9H, -(CH3)3), 0.24 (s, 6H, -Si-CH3 × 2), 0.23 (s, 6H, -Si-CH3 × 2) – phenol 
OH not visible (d.r = 1:1); 
13
C NMR (100 MHz, CDCl3) 170.7, 170.6, 170.1, 170.0, 164.9, 
164.5, 160.5, 160.4, 159.6, 155.1, 143.3, 138.6, 138.5, 134.4, 131.3, 131.1, 128.3 (4C), 128.2 
(4C), 128.1, 127.7 (4C), 127.6 (4C), 127.4, 127.3, 119.9 (4C), 114.0 (4C), 112.8, 112.3, 
105.7, 105.5, 101.9, 101.8, 81.7, 81.0, 73.2, 70.1, 70.0, 61.3, 55.3, 44.2, 38.7, 38.5, 32.2, 25.7 
(6C), 18.2 (2C), -4.3 (4C) (contains both diastereoisomers); MS (ESI) m/z 738 (M Na)+; 
HRMS (ESI): (M Na)+, found 738.3093; C40H49NNaO9Si requires 738.3074; Elem. Anal., 
found C, 67.25; H, 6.76; N, 1.91; C40H49NO9Si requires C, 67.11; H, 6.90; N, 1.96%. 
198 
 
3-(Methoxy(methyl)amino)-1-(4-methoxyphenyl)-3-oxopropyl 2-(2-(benzyloxy)-2-(4-(tert-
butyldimethylsilyloxy)phenyl)ethyl)-4,6-dimethoxybenzoate rac-302 
 
 
 
 
 
 
 
 
 
 
 
Save for the use of resorcylater rac-291 instead of rac-14, bis-methylated resorcylate rac-302 
(215 mg, 69%, colourless gum) was prepared following the conditions described for the 
synthesis of resorcylate rac-286: Rf 0.60 (EtOAc/PE 1:1); IR max (neat) 2959 (m), 2938 (m), 
2861 (m), 1720 (s), 1669 (s,) 1604 (s), 1586 (s), 1509 (s), 1461 (m), 1421 (m), 1329 (m), 
1252 (s), 1201 (s), 1157 (s), 1091 (s), 1054 (s), 1000 (m), 911 (s), 832 (s) cm
-1
; 
1
H NMR 
(400 MHz, CDCl3)  7.46 (d, J = 8.3 Hz, 2H, ArH), 7.44 (d, J = 8.8 Hz, 2H, ArH), 7.30 – 
7.24 (m, 6H, ArH), 7.20 – 7.13 (m, 4H, ArH), 7.08 (d, J = 8.8 Hz, 2H, ArH), 6.99 (d, J = 8.8 
Hz, 2H, ArH), 6.90 – 6.85 (m, 4H, ArH), 6.77 (d, J = 8.3 Hz, 2H, ArH), 6.76 (d, J = 8.3 Hz, 
2H, ArH), 6.51 – 6.47 (m, 2H, ArCO2CH- × 2), 6.36 (d, J = 2.4 Hz, 1H, ArH), 6.34 (d, J = 
2.4 Hz, 1H, ArH), 6.29 (d, J = 2.4 Hz, 1H, ArH), 6.18 (d, J = 2.4 Hz, 1H, ArH), 4.49 (dd, J = 
8.8, 5.4 Hz, 1H, ArCHO-), 4.40 (dd, J = 8.8, 4.4 Hz, 1H, ArCHO-), 4.34 (d, J = 11.7 Hz, 1H, 
ArCH2O-), 4.32 (d, J = 11.7 Hz, 1H, ArCH2O-), 4.14 (d, J = 11.7 Hz, 1H, ArCH2O-), 4.13 
(d, J = 11.7 Hz, 1H, ArCH2O-), 3.80 (s, 3H, -OCH3), 3.79 (s, 6H, -OCH3× 2), 3.78 (s, 3H, -
OCH3), 3.70 (s, 3H, -OCH3), 3.67 (s, 3H, -OCH3), 3.62 (s, 6H, -NOCH3 × 2), 3.32 – 3.22 (m, 
2H, -CH2), 3.14 (s, 3H, -NCH3), 3.11 (s, 3H, -NCH3), 3.08 – 2.92 (m, 4H, -CH2 × 2), 2.88 
(dd, J = 14.2, 4.9 Hz, 1H, -CH2), 2.77 (dd, J = 14.2, 5.4 Hz, 1H, -CH2), 1.03 (s, 9H, -(CH3)3), 
1.02 (s, 9H, -(CH3)3), 0.24 (s, 12H, -Si-CH3 × 4) (d.r = 1:1); 
13
C NMR (100 MHz, CDCl3) 
170.5, 167.2, 167.1, 160.8, 159.4, 158.2, 158.0, 154.9, 139.5, 139.2, 138.9, 134.7, 132.2, 
132.1, 128.6 (2C), 128.5 (2C), 128.1 (4C), 127.8 (4C), 127.6, 127.5 (2C), 127.2, 127.1, 119.7 
(4C), 116.9, 116.8, 113.8 (2C), 113.7 (2C), 107.6, 107.4, 97.3, 97.2, 81.7, 81.5, 73.0, 72.9, 
70.6, 70.4, 61.2, 55.7 (2C), 55.3 (2C), 55.2, 55.1, 42.7, 39.1, 39.0, 38.9, 32.0, 30.3, 25.7 (6C), 
18.2 (2C), -4.4 (4C) (contains both diastereoisomers); MS (ESI) m/z 738 (M Na)+; HRMS 
(ESI): (M Na)+, found 766.3416; C42H53NNaO9Si requires 766.3387; Elem. Anal., found 
C, 68.01; H, 7.00; N, 1.73; C42H53NO9Si requires C, 67.81; H, 7.18; N, 1.88%. 
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6-(2,2-Dimethyl-4-oxo-4H-1,3-dioxin-6-yl)-1-(4-methoxyphenyl)-3,5-dioxohexyl 2-(2-
(benzyloxy)-2-(4-(tert-butyldimethylsilyloxy)phenyl)ethyl)-4,6-dimethoxybenzoate rac-304 
 
 
 
 
 
 
 
 
 
 
Save for the use of Weinreb amide rac-302 instead of rac-265, diketo-dioxinone rac-304 (81 
mg, 78%, yellow oil) was prepared following the conditions described for the synthesis of 
diketo-dioxinone 275: Rf 0.72 (EtOAc/PE 1:1); IR max (neat) 2954 (m), 2857 (m), 1724 (s), 
1603 (s), 1604 (s), 1510 (m), 1250 (s), 1201 (s), 1157 (s), 908 (s) cm
-1
; 
1
H NMR (400 MHz, 
CDCl3)  14.95 (br. s, 2H, enol -OH), 7.38 (d, J = 8.8 Hz, 2H, ArH), 7.35 (d, J = 8.8 Hz, 2H, 
ArH), 7.28 – 7.25 (m, 6H, ArH), 7.18 – 7.11 (m, 4H, ArH), 7.00 (d, J = 8.8 Hz, 2H, ArH), 
6.93 (d, J = 8.8 Hz, 2H, ArH), 6.87 (d, J = 8.8 Hz, 2H, ArH), 6.84 (d, J = 8.8 Hz, 2H, ArH), 
6.78 – 6.75 (m, 4H, ArH), 6.39 – 6.35 (m, 3H), 6.33 (d, J = 2.4 Hz, 1H, ArH), 6.26 (d, J = 
2.4 Hz, 1H, ArH), 6.16 (d, J = 2.4 Hz, 1H, ArH), 5.56 (s, 1H, -HC=COH), 5.53 (s, 1H, -
HC=COH), 5.35 (s, 1H, -O2CCHCO-), 5.23 (s, 1H, -O2CCHCO-), 4.42 (dd, J = 8.3, 4.4 Hz, 
1H, ArCHO-), 4.32 – 4.29 (m, 1H, ArCHO-), 4.31 (d, J = 11.7 Hz, 1H, ArCH2O-), 4.29 (d, J 
= 11.7 Hz, 1H, ArCH2O-), 4.09 (d, J = 11.7 Hz, 1H, ArCH2O-), 4.07 (d, J = 11.7 Hz, 1H, 
ArCH2O-), 3.80 (s, 3H, -OCH3), 3.78 (s, 3H, -OCH3), 3.75 (s, 6H, -OCH3 × 2), 3.70 (s, 3H, -
OCH3), 3.66 (s, 3H, -OCH3), 3.17 (s, 2H, -CH2), 3.13 (s, 2H, -CH2), 3.11 – 2.93 (m, 4H, -
CH2 × 2), 2.86 – 2.77 (m, 3H), 2.67 (dd, J = 13.7, 5.4 Hz, 1H, -CH2), 1.67 (s, 6H, dioxinone -
CH3 × 2), 1.66 (s, 6H, dioxinone -CH3 × 2), 1.02 (s, 9H, -(CH3)3), 1.01 (s, 9H, -(CH3)3), 0.23 
(s, 12H, -Si-CH3 × 4) (d.r = 1.1); 
13
C NMR (100 MHz, CDCl3) 188.4, 188.3, 188.2, 188.0, 
167.3, 167.2, 164.8, 160.9, 160.6, 159.6, 159.5, 158.2, 157.9, 155.0, 154.9, 139.4, 139.0, 
138.8, 138.7, 134.5, 134.4, 131.2, 131.1, 128.4 (2C), 128.3 (2C), 128.1 (4C), 127.7 (4C), 
127.5 (2C), 127.4 (2C), 127.3, 127.2, 119.8 (4C), 113.9 (2C), 113.8 (2C), 107.5, 107.3, 
107.1, 100.7, 97.2, 97.1, 96.4, 81.6, 81.4, 72.6, 72.5, 70.5, 70.3, 55.7, 55.3 (2C), 55.2, 55.1, 
44.5, 44.3 (2C), 43.2, 42.7, 25.7 (6C), 24.9 (4C), 18.2 (2C), -4.4 (4C) (contains both 
diastereoisomers, keto-form); MS (ESI) m/z 889 (M Na)+; HRMS (ESI): (M Na)+, found 
889.3593; C49H58NaO12Si requires 889.3596. 
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Ethyl 3-(4-(tert-butyldimethylsilyloxy)phenyl)-3-(4-methoxybenzyloxy)propanoate rac-299 
 
 
 
 
 
 
 
 
A solution of acetimidate 226 (7.0 g, 24.7 mmol) in CH2Cl2 (10 mL) was added dropwise to a 
stirred solution of alcohol rac-296 (4.0 g, 12.34 mmol) in CH2Cl2 (40 mL) at 23 ºC. The 
ensuing mixture was then treated with CSA (429 mg, 1.85 mmol) and the resulting yellow 
mixture was stirred for 18 h. The reaction was quenched with saturated aq. NH4Cl solution 
(50 mL) and the separated aqueous layer was extracted with Et2O (100 mL × 2). The 
combined organic layers were dried (MgSO4), rotary evaporated and chromatographed 
(Et2O/PE 1:3) to afford ethylester rac-299 (4.0 g, 70%) as a pale yellow oil: Rf 0.68 (Et2O/PE 
1:1); IR max (neat) 2954 (m), 2931 (m), 2858 (m), 1735 (s), 1609 (s), 1509 (s), 1472 (m), 
1368 (w), 1247 (s), 1166 (s), 1088 (m), 1058 (m), 1033 (s), 911 (s), 837 (s), 821 (s) cm
-1
; 
1
H 
NMR (400 MHz, CDCl3)  7.25 (d, J = 8.8 Hz, 2H, ArH), 7.20 (d, J = 8.8 Hz, 2H, ArH), 
6.87 (d, J = 8.8 Hz, 2H, ArH), 6.85 (d, J = 8.8 Hz, 2H, ArH), 4.79 (dd, J = 9.3, 4.9 Hz, 1H, 
ArCHO-), 4.38 (d, J = 11.2 Hz, 1H, ArCH2O-), 4.23 (d, J = 11.2 Hz, 1H, ArCH2O-), 4.25 – 
4.09 (m, 2H, -CO2CH2CH3), 3.82 (s, 3H, -OCH3), 2.87 (dd, J = 15.2, 9.3 Hz, 1H, -CH2), 2.60 
(dd, J = 15.2, 4.9 Hz, 1H, -CH2), 1.23 (t, J = 6.8 Hz, 3H, -CO2CH2CH3), 1.02 (s, 9H, -
(CH3)3), 0.24 (s, 6H, -Si-CH3 × 2); 
13
C NMR (100 MHz, CDCl3)  170.9, 159.1, 155.5, 
133.4, 130.3 129.4 (2C), 128.0 (2C), 120.0 (2C), 113.7 (2C), 77.2, 70.1, 60.4, 55.2, 43.7, 25.7 
(3C), 18.2, 14.2, -4.4 (2C); MS (ESI) m/z 467 (M Na)+; HRMS (ESI): (M Na)+, found 
467.2234; C25H36NaO5Si requires 467.2230; Elem. Anal., found C, 67.64; H, 8.23; 
C25H36O5Si requires C, 67.53; H, 8.16%. 
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3-(4-(tert-Butyldimethylsilyloxy)phenyl)-N-methoxy-3-(4-methoxybenzyloxy)-N-
methylpropanamide rac-301 
 
 
 
 
 
 
 
 
Save for the use of ester rac-299 instead of rac-298, Weinreb amide rac-301 (1.36 g, 69%, 
colourless oil) was prepared following the conditions described for the synthesis of Weinreb 
amide rac-300: Rf 0.22 (Et2O/PE 1:1); IR max (neat) 2959 (m), 2932 (m), 2861 (m), 1661 
(s), 1608 (s), 1508 (s), 1471 (m), 1463 (m), 1385 (m), 1249 (s), 1170 (s), 1080 (m), 1034 (m), 
910 (s), 836 (s), 822 (s), 779 (s) cm
-1
; 
1
H NMR (400 MHz, CDCl3)  7.29 (d, J = 8.8 Hz, 2H, 
ArH), 7.22 (d, J = 8.3 Hz, 2H, ArH), 6.87 (d, J = 8.8 Hz, 2H, ArH), 6.86 (d, J = 8.3 Hz, 2H, 
ArH), 4.91 (dd, J = 8.3, 4.9 Hz, 1H, ArCHO-), 4.37 (d, J = 11.2 Hz, 1H, ArCH2O-), 4.29 (d, 
J = 11.2 Hz, 1H, ArCH2O-), 3.82 (s, 3H, -OCH3), 3.60 (s, 3H, -NOCH3), 3.18 (s, 3H, -
NCH3), 3.14 – 3.10 (br. m, 1H, -CH2), 2.67 (dd, J = 15.6, 4.9 Hz, 1H, -CH2), 1.02 (s, 9H, -
(CH3)3), 0.24 (s, 6H, -Si-CH3 × 2); 
13
C NMR (100 MHz, CDCl3)  171.6, 159.0, 155.2, 
134.2, 130.6, 129.3 (2C), 127.9 (2C), 120.0 (2C), 113.6 (2C), 77.4, 70.3, 61.2, 55.2, 40.7, 
32.0, 25.6 (3C), 18.2, -4.3 (2C); MS (ESI) m/z 482 (M Na)+; HRMS (ESI): (M Na)+, 
found 482.2328; C25H37NNaO5Si requires 482.2338.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
202 
 
3-(Methoxy(methyl)amino)-1-(4-methoxyphenyl)-3-oxopropyl 2-(2-(4-(tert-butyld 
Imethylsilyloxy)phenyl)-2-(4-methoxybenzyloxy)ethyl)-4,6-dihydroxybenzoate rac-292 
 
 
 
 
 
 
 
 
 
 
 
 
Save for the use of diketo-dioxinone rac-294 instead of rac-12, resorcylate rac-292 (730 mg, 
58%, off-white solid) was prepared following the conditions described for the synthesis of 
resorcylate rac-14: Rf 0.60 (EtOAc/PE 1:1); Mp 50 – 52 ºC; IR max (neat) 3266 (w), 2959 
(m), 2933 (m), 2859 (m), 1644 (s), 1610 (s), 1586 (s), 1510 (s), 1453 (m), 1389 (w), 1246 (s), 
1169 (s), 1098 (m), 1031 (m), 1006 (m), 910 (s), 830 (s), 807 (s), 779 (s) cm
-1
; 
1
H NMR (400 
MHz, CDCl3)  11.42 (br. s, 1H, -OH), 11.2 (br. s, 1H, -OH), 7.35 (d, J = 8.8 Hz, 2H, ArH), 
7.32 (d, J = 8.8 Hz, 2H, ArH), 7.06 (d, J = 8.8 Hz, 4H, ArH), 7.05 (d, J = 8.8 Hz, 2H, ArH), 
6.99 (d, J = 8.8 Hz, 2H, ArH),  6.87 – 6.77 (m, 12H, ArH), 6.52 – 6.48 (m, 1H, ArCO2CH-), 
6.43 (dd, J = 8.3, 5.4 Hz, 1H, ArCO2CH-), 6.27 (d, J = 2.4 Hz, 1H, ArH), 6.26 (d, J = 2.4 Hz, 
1H, ArH), 5.99 (d, J = 2.9 Hz, 1H, ArH), 5.94 (d, J = 2.9 Hz, 1H, ArH), 5.35 (br. s, 1H, -
OH), 5.23 (br. s, 1H, -OH), 4.49 (dd, J = 8.3, 5.8 Hz, 1H, ArCHO-), 4.37 (dd, J = 8.3, 5.4 
Hz, 1H, ArCHO-), 4.30 (d, J = 11.2 Hz, 1H, ArCH2O-), 4.29 (d, J = 11.2 Hz, 1H, ArCH2O-), 
4.10 (d, J = 11.2 Hz, 1H, ArCH2O-), 4.04 (d, J = 11.2 Hz, 1H, ArCH2O-), 3.82 (s, 3H, -
OCH3), 3.81 (s, 3H, -OCH3), 3.80 (s, 3H, -OCH3), 3.79 (s, 3H, -OCH3), 3.56 (s, 3H, -
NOCH3), 3.54 – 3.40 (m, 2H, -CH2), 3.51 (s, 3H, -NOCH3), 3.27 – 3.18 (m, 2H, -CH2), 3.15 
(s, 3H, -NCH3), 3.13 (s, 3H, -NCH3), 3.10 – 2.95 (m, 4H, -CH2 × 2), 1.02 (s, 9H, -(CH3)3), 
1.01 (s, 9H, -(CH3)3), 0.23 (s, 6H, -Si-CH3 × 2), 0.22 (s, 6H, -Si-CH3 × 2) (d.r = 1:1); 
13
C 
NMR (100 MHz, CDCl3) 170.7, 170.6, 170.5, 170.0, 169.9, 164.8, 164.5, 160.5, 160.4, 
159.6, 158.9, 155.1, 155.0, 143.4, 134.4, 131.4, 131.1, 130.6, 130.4, 129.3 (2C), 129.2 (2C), 
128.3 (4C), 128.2 (2C), 128.1 (2C), 119.8 (4C), 114.0 (4C), 113.6 (4C), 112.7, 112.2, 105.7, 
105.5, 101.9, 101.8, 81.4, 80.6, 73.2, 69.8, 61.3, 61.2, 55.3 (4C), 44.1, 38.7, 38.5, 32.2, 25.7 
(6C), 18.2 (2C), -4.4 (4C) (contains both diastereoisomers); MS (ESI) m/z 768 (M Na)+; 
HRMS (ESI): (M Na)+, found 768.3205; C41H51NNaO10Si requires 768.3180; Elem. 
Anal., found C, 66.19; H, 6.97; N, 1.75; C41H51NO10Si requires C, 66.02; H, 6.89; N, 1.88%.   
203 
 
3-(Methoxy(methyl)amino)-1-(4-methoxyphenyl)-3-oxopropyl 2-(2-(4-(tert-butyldimeth 
ylsilyloxy)phenyl)-2-(4-methoxybenzyloxy)ethyl)-4,6-dimethoxybenzoate rac-303 
 
 
 
 
 
 
 
 
 
 
 
Save for the use of resorcylate rac-292 instead of rac-14, bis-methylated resorcylate rac-303 
(190 mg, 73%, colourless gum) was prepared following the conditions described for the 
synthesis of resorcylate rac-286: Rf 0.46 (Et2O); IR max (neat) 2944 (w), 1721 (s), 1671 (s), 
1606 (s), 1511 (s), 1250 (m), 1159 (s), 1093 (m) cm
-1
; 
1
H NMR (500 MHz, CDCl3)  7.46 – 
7.42 (m, 4H, ArH), 7.08 (d, J = 8.8 Hz, 2H, ArH), 7.05 (d, J = 8.8 Hz, 2H, ArH), 7.04 (d, J = 
8.8 Hz, 2H, ArH), 6.97 (d, J = 8.8 Hz, 2H, ArH), 6.87 (d, J = 8.8 Hz, 2H, ArH), 6.84 (d, J = 
8.8 Hz, 2H, ArH), 6.82 – 6.79 (m, 4H, ArH), 6.75 (d, J = 8.8 Hz, 2H, ArH), 6.74 (d, J = 8.8 
Hz, 2H, ArH), 6.49 – 6.45 (m, 2H, ArCO2CH- × 2), 6.33 (d, J = 2.4 Hz, 1H, ArH), 6.31 (d, J 
= 2.4 Hz, 1H, ArH), 6.24 (d, J = 2.4 Hz, 1H, ArH), 6.14 (d, J = 2.4 Hz, 1H, ArH), 4.45 (dd, J 
= 8.2, 5.2 Hz, 1H, ArCHO-), 4.37 (dd, J = 8.8, 4.9 Hz, 1H, ArCHO-), 4.25 (d, J = 11.3 Hz, 
1H, ArCH2O-), 4.23 (d, J = 11.3 Hz, 1H, ArCH2O-), 4.06 (d, J = 11.7 Hz, 1H, ArCH2O-), 
4.04 (d, J = 11.7 Hz, 1H, ArCH2O-), 3.80 (s, 6H, -OCH3 × 2), 3.79 (s, 3H, -OCH3), 3.77 (s, 
3H, -OCH3), 3.76 (s, 6H, -OCH3 × 2), 3.68 (s, 3H, -OCH3), 3.65 (s, 3H, -OCH3), 3.61 (s, 3H, 
-NOCH3), 3.60 (s, 3H, -NOCH3), 3.29 – 3.19 (m, 2H, -CH2), 3.13 (s, 3H, -NCH3), 3.09 (s, 
3H, -NCH3), 3.04 – 2.92 (m, 4H, -CH2 × 2), 2.83 (dd, J = 13.5, 4.4 Hz, 1H, -CH2), 2.73 (dd, J 
= 13.7, 4.9 Hz, 1H, -CH2), 1.01 (s, 18H, -(CH3)3 × 2), 0.22 (s, 12H, -Si-CH3 × 4) (d.r = 1:1); 
13
C NMR (125 MHz, CDCl3) 170.5, 170.4, 167.2, 167.1, 160.8, 160.7, 159.4, 159.3, 
158.9, 158.2, 158.0, 154.8, 139.6, 139.2, 134.8, 134.7, 132.2, 132.1, 131.0, 129.1 (2C), 129.0 
(2C), 128.5 (2C), 128.4 (2C), 127.7 (4C), 125.5, 119.6 (4C), 116.9, 116.8, 113.7 (2C), 113.6 
(2C), 113.5 (4C), 107.5, 107.3, 97.2, 97.1, 81.4, 81.3, 73.0, 72.8, 70.2, 70.1, 61.2, 55.7, 55.3, 
55.2 (4C), 55.1, 42.6, 39.0, 38.9, 32.0 (2C), 30.3, 25.7 (6C), 18.1 (2C), -4.4 (4C) (contains 
both diastereoisomers); MS (ESI) m/z 796 (M Na)+; HRMS (ESI): (M Na)+, found 
796.3505; C43H55NNaO10Si requires 796.3493. 
 
 
204 
 
6-(2,2-Dimethyl-4-oxo-4H-1,3-dioxin-6-yl)-1-(4-methoxyphenyl)-3,5-dioxohexyl 2-(2-(4-
(tert-butyldimethylsilyloxy)phenyl)-2-(4-methoxybenzyloxy)ethyl)-4,6-dimethoxybenzoate 
rac-305 
 
 
 
 
 
 
 
Save for the use of Weinreb amide rac-303 instead of rac-265, diketo-dioxinone rac-305 
(81.7 mg, 76%, yellow oil) was prepared following the conditions described for the synthesis 
of diketo-dioxinone 275: Rf 0.51 (EtOAc/PE 1:1); IR max (neat) 2953 (w), 1726 (s), 1605 
(s), 1511 (s), 1250 (s), 1202 (m), 1159 (m), 1091 (m) cm
-1
;
 1
H NMR (400 MHz, CDCl3)  
14.9 (br. s, 2H, -OH), 7.36 – 7.32 (m, 4H, ArH), 7.05 (d, J = 8.6 Hz, 2H, ArH), 7.01 (d, J = 
8.5 Hz, 2H, ArH), 6.97 (d, J = 8.5 Hz, 2H, ArH), 6.91 (d, J = 8.3 Hz, 2H, ArH), 6.85 (d, J = 
8.8 Hz, 2H, ArH), 6.80 (d, J = 8.8 Hz, 2H, ArH), 6.79 – 6.77 (m, 4H, ArH), 6.72 (d, J = 8.8 
Hz, 4H, ArH), 6.35 – 6.29 (m, 2H, ArCO2CH- × 2), 6.32 (d, J = 2.0 Hz, 1H, ArH), 6.29 (d, J 
= 2.0 Hz, 1H, ArH), 6.21 (d, J = 2.0 Hz, 1H, ArH), 6.11 (d, J = 2.0 Hz, 1H, ArH), 5.53 (s, 
1H, -HC=COH), 5.50 (s, 1H, -HC=COH), 5.32 (s, 1H, -O2CCHCO-), 5.31 (s, 1H, -
O2CCHCO-), 4.38 (dd, J = 8.1, 5.0 Hz, 1H, ArCHO-), 4.29 (dd, J = 8.9, 4.6 Hz, 1H, 
ArCHO-), 4.22 (d, J = 11.4 Hz, 1H, ArCH2O-), 4.20 (d, J = 11.4 Hz, 1H, ArCH2O-), 4.00 (d, 
J = 11.4 Hz, 1H, ArCH2O-), 3.99 (d, J = 11.4 Hz, 1H, ArCH2O-), 3.78 (s, 6H, -OCH3 × 2), 
3.77 (s, 3H, -OCH3), 3.75 (s, 3H, -OCH3), 3.71 (s, 6H, -OCH3 × 2), 3.66 (s, 3H, -OCH3), 
3.63 (s, 3H, -OCH3), 3.14 (s, 2H, -CH2), 3.10 (s, 2H, -CH2), 3.07 – 2.88 (m, 4H, -CH2 × 2), 
2.82 – 2.73 (m, 3H), 2.63 (dd, J = 13.8, 5.5 Hz, 1H, -CH2), 1.64 (s, 6H, dioxinone -CH3 × 2), 
1.63 (s, 6H, dioxinone -CH3 × 2), 0.99 (s, 18H, -(CH3)3 × 2), 0.20 (s, 12H, -Si-CH3 × 4) (d.r 
= 1:1); 
13
C NMR (100 MHz, CDCl3) 188.3, 188.2, 188.1, 188.0, 167.3, 167.2, 164.7, 
160.9, 160.8, 160.6, 159.6, 159.5, 158.9, 158.8, 158.1, 157.9, 155.0, 154.9, 139.4, 139.0, 
135.0, 134.6, 134.5, 131.2, 131.1, 130.9, 130.8, 129.1 (2C), 129.0 (2C), 128.4 (2C), 128.3 
(2C), 127.7 (4C), 119.7 (4C), 116.6, 116.4, 113.9 (2C), 113.8 (2C), 113.5 (4C), 107.4, 107.2, 
107.1, 100.7 (2C), 97.2, 97.1, 96.3 (2C), 81.3, 81.1, 72.6, 72.5, 70.2, 70.1, 55.7 (2C), 55.3, 
55.2 (4C), 55.1, 44.4, 44.3, 43.3, 43.2, 42.6, 25.6 (6C), 24.9 (2C), 24.8 (2C), 18.2 (2C), -4.4 
205 
 
(4C) (contains both diastereoisomers, keto-form); MS (ESI) m/z 919 (M Na)+; HRMS 
(ESI): (M Na)+, found 919.3732; C50H60NaO13Si requires 919.3701. 
 
3-(4-(tert-Butyldimethylsilyloxy)phenyl)-6,8-dimethoxyisochroman-1-one rac-289 
 
 
 
 
 
 
 
 
Yellow solid: Rf 0.41 (EtOAc/PE 1:1); IR max (neat) 2930 (m), 2861 (m), 1717 (s), 1601 (s), 
1581 (m), 1512 (m), 1469 (m), 1460 (m), 1339 (s), 1254 (s), 1235 (s), 1219 (s), 1157 (s), 
1099 (s), 1073 (s), 1033 (s), 906 (s), 838 (s) cm
-1
; 
1
H NMR (500 MHz, CDCl3)  7.31 (d, J = 
8.8 Hz, 2H, ArH), 6.84 (d, J = 8.8 Hz, 2H, ArH), 6.43 (d, J = 2.2 Hz, 1H, ArH), 6.33 (d, J = 
2.2 Hz, 1H, ArH), 5.32 (dd, J = 12.1, 2.7 Hz, 1H, ArCHO-), 3.94 (s, 3H, -OCH3), 3.87 (s, 
3H, -OCH3), 3.25 (dd, J = 16.5, 12.4 Hz, 1H, -CH2), 2.97 (dd, J = 16.5, 2.2 Hz, 1H, -CH2), 
0.98 (s, 9H, -(CH3)3), 0.19 (s, 6H, -Si-CH3 × 2); 
13
C NMR (125 MHz, CDCl3)  164.5, 
163.2, 162.5, 155.9, 143.8, 131.3, 127.7 (2C), 120.1 (2C), 106.9, 103.8, 97.8, 78.5, 56.2, 
55.5, 37.0, 25.6 (3C), 18.2, -4.4 (2C); MS (ESI) m/z 851 (2M + Na)
+
, 415 (M H)+; HRMS 
(ESI): (M H)+, found 415.1958; C23H31O5Si requires 415.1941.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
206 
 
6-(3-Chloro-2-oxopropyl)-2,2-dimethyl-4H-1,3-dioxin-4-one 101
69
 
 
 
 
 
 
 
 
To a stirred solution of LDA (42.6 mmol) in Et2O (80 mL) at 78 ºC, HMPA (13.4 mL, 84.5 
mmol) was added and the mixture was stirred for 30 min. Dioxinone 65 (5.5 g, 38.7 mmol) in 
Et2O (5 mL) was then added dropwise and the resulting mixture was stirred for 30 min at 78 
ºC. Chloroacetyl chloride 100 (1.54 mL, 19.4 mmol) in Et2O (64 mL) was added dropwise to 
the reaction mixture and the reaction temperature was raised gradually to 23 ºC over 2 h. The 
reaction was quenched with 1 M aq. HCl solution (80 mL) and the separated aqueous layer 
was extracted with Et2O (150 mL). The organic layer was dried (MgSO4), rotary evaporated 
and chromatographed (Et2O/PE 1:2) to afford chloro-keto-dioxinone 101 (950 mg, 23%) as a 
pale yellow solid: Rf 0.45 (EtOAc/PE 1:4); IR max (neat) 1730 (s), 1645 (s) cm-1; 1H NMR 
(400 MHz, CDCl3) 5.40 (s, 1H, -O2CCHCO-), 4.18 (s, 2H, -CH2Cl), 3.59 (s, 2H, -CH2), 
1.73 (s, 6H, -CH3 × 2); MS (ESI) m/z 219 (M + H)
+
. This data is in accordance with the 
literature.
69
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Triphenyl(2,2,2-trifluoroethyl)phosphonium trifluoromethanesulfonate 318
70
 
 
 
 
 
To a stirred solution of trifluoroethanol 316 (7.5 g, 74.9 mmol) and Et3N (9 mL, 74.9 mmol) 
in CH2Cl2 (50 mL), trifluoroacetic anhydride (14 mL, 82.4 mmol) was added dropwise at –20 
ºC. The resulting red solution was stirred at 23 ºC for 4.5 h. The reaction was quenched with 
H2O (150 mL) and the separated aqueous layer was extracted with Et2O (200 mL × 2). The 
combined organic layers were washed with saturated aq. NaHCO3 solution (100 mL) and 
then with 1 M aq. HCl solution (100 mL). The organic layer was dried (MgSO4) and rotary 
evaporated to afford triflate intermediate 317 as a red oil (5.5 g, ~28%). This material was 
used in the following step without further purification. Triflate 317 (5.5 g) was dissolved in 
PhMe (28 mL) and treated with triphenylphosphine (8.2 g, 31.5 mmol) at 23 ºC. The 
resulting mixture was heated at reflux for 72 h. The reaction was cooled to 23 ºC and the 
precipitate was filtered and washed with Et2O (100 mL) to afford phosphonium salt 318 (7.7 
g, 22% over 2 steps) as an off-white solid: Rf 0.23 (EtOAc); IR max (neat) 1439 (m), 1325 
(m), 1253 (s), 1143 (s), 1109 (s), 1028 (s), 686 (s), 635 (s) cm
-1
; 
1
H NMR (400 MHz, 
CD3CN)  7.99 – 7.96 (m, 3H, ArH), 7.87 – 7.76 (m, 12H, ArH), 4.69 (dq, J = 15.2, 10.3 Hz, 
2H, -CH2); 
19
F NMR (100 MHz, CD3CN) δ 54.7 (dt, J  = 9.8, 7.9 Hz, 3F), 79.7 (s, 3F); 
MS (ESI) m/z 345 (M f)+; HRMS (ESI): (M f)+, found 345.1012; C20H17F3P 
requires 345.1014. This data is in accordance with the literature.
70
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((1,3-Dioxolan-2-ylidene)methyl)triphenylphosphonium trifluoromethanesulfonate 314
70
 
 
 
 
 
 
To a stirred solution of phosphonium triflate salt 318 (2 g, 4 mmol) in ethylene glycol (55 
mL, 980 mmol) at 0 ºC, 1 M sodium hydroxide solution (200 mL) was added and stirred for 
12 h at 23 ºC. The aqueous layer was extracted with CH2Cl2 (350 mL × 2) and the combined 
organic layers were dried (Na2SO4), rotary evaporated and chromatographed 
(CH2Cl2/Me2CO, 4:1) to afford the ketal-phosphonium triflate salt 314 (750 mg, 38%) as a 
pale yellow solid: Rf 0.07 (EtOAc); 
1
H NMR (400 MHz, CDCl3)  7.82 – 7.77 (m, 3H, 
ArH), 7.71 – 7.59 (m, 12H, ArH), 4.80 (t, J = 7.8 Hz, 2H, -OCH2-), 4.65 (t, J = 7.8 Hz, 2H, -
OCH2-), 4.17 (d, J = 10.8 Hz, 1H, -C=CH-); MS (ESI) m/z 347 (M f)
+
; HRMS (ESI): 
(M f)+, found 347.1198; C22H20O2P requires 347.1195. This data is in accordance with 
the literature.
70
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Ethyl 5-(tert-butyldimethylsilyloxy)-5-(4-methoxyphenyl)-3-oxopentanoate 322 
 
 
 
 
 
 
 
 
EtOAc (1.0 mL, 9.9 mmol) was added dropwise to a solution of LDA (9.9 mmol) in THF (11 
mL) at 78 ºC and stirred for 45 min where white precipitate was formed. Weinreb amide 
rac-265 (1.4 g, 3.97 mmol) in THF (2.5 mL) was then added dropwise and the reaction 
mixture was slowly warmed to 0 ºC. The reaction was quenched with saturated aq. NH4Cl 
solution (20 mL) and the separated aqueous layer was acidified to pH 1-2 using 1 M aq. HCl 
solution. The resulting aqueous layer was extracted with Et2O (50 mL × 2) and the combined 
organic layers were dried (MgSO4), rotary evaporated and chromatographed (Et2O/PE 1:9 to 
1:4) to afford -ketoester 322 (1.21 g, 81%) as a pale yellow oil: Rf 0.76 (Et2O/PE 1:1); IR 
max (neat) 1745 (m), 1717 (m), 1612 (w), 1512 (m), 1302 (w), 1246 (s), 1172 (m), 1076 (s), 
1033 (s), 834 (s), 777 (s) cm
-1
; 
1
H NMR (400 MHz, CDCl3)  12.1 (br. s, enol form -OH), 
7.26 (d, J = 8.8 Hz, 2H, ArH), 6.86 (d, J = 8.8 Hz, 2H, ArH), 5.13 (dd, J = 8.8, 4.4 Hz, 1H, 
ArCHO-), 5.02 (dd, J = 8.8, 4.4 Hz, enol form – ArCHO-), 5.00 (s, enol form – HC=COH), 
4.19 (q, J = 6.8 Hz, 2H, -OCH2CH3), 3.81 (s, 3H, -OCH3), 3.46 (s, 2H, -CH2), 3.02 (dd, J = 
15.2, 8.8 Hz, 1H, -CH2), 2.65 (dd, J = 15.2, 3.9 Hz, 1H, -CH2), 2.50 – 2.41 (m, enol form -
CH2), 1.27 (t, J = 7.3, 3H, -OCH2CH3), 0.85 (s, 9H, -(CH3)3), 0.03 (s, 3H, -Si-CH3), 0.17 (s, 
3H, -Si-CH3) (exists as a mixture of keto-enol forms, 9:1); 
13
C NMR (100 MHz, CDCl3)  
201.3, 175.0 (enol), 172.6 (enol), 166.9, 158.9, 136.1, 126.9 (2C), 113.6 (2C), 71.5, 61.2, 
55.2, 53.6, 51.0, 25.7 (3C), 18.0, 14.1, 4.7, 5.2; MS (ESI) m/z 444 (M Na + MeCN)+, 
403 (M + Na)
+
; HRMS (ESI): (M Na)+, found 403.1913; C20H32NaO5Si requires 403.1917. 
 
 
 
 
 
 
 
 
 
 
 
 
210 
 
2-Chloroethyl 5-(tert-butyldimethylsilyloxy)-5-(4-methoxyphenyl)-3-oxopentanoate 321 
 
 
 
 
 
 
 
A mixture of -ketoester 322 (300 mg, 0.79 mmol), 1-chloroethanol (0.159 mL, 2.37 mmol) 
and triphenylphosphine (21 mg, 0.79 mmol) in PhMe (4.5 mL) was heated at reflux for 15 h. 
The volatiles were removed by rotary evaporation and the resulting residue was 
chromatographed (Et2O/PE 1:4 to 1:3) to afford 1-chloro-ketoester 321 (205 mg, 64%) as a 
yellow oil: Rf 0.71 (Et2O/PE 1:1); IR max (neat) 1749 (s), 1719 (m), 1612 (m), 1512 (s), 
1247 (s), 1172 (m), 1076 (s), 1032 (s), 834 (s), 778 (s) cm
-1
; 
1
H NMR (400 MHz, CDCl3)  
11.9 (br. s, enol form -OH), 7.26 (d, J = 8.8 Hz, 2H, ArH), 6.87 (d, J = 8.8 Hz, 2H, ArH), 
5.13 (dd, J = 8.8, 4.4 Hz, 1H, ArCHO-), 5.07 (s, enol form – HC=COH), 5.01 (dd, J = 8.8, 
4.9 Hz, enol form – ArCHO-), 4.39 (t, J = 6.4 Hz, 2H, ClCH2-), 3.82 (s, 3H, -OCH3), 3.69 (t, 
J = 6.4 Hz, 2H, -CH2CO2-), 3.55 (d, J = 16.1 Hz, 1H, -COCH2CO-), 3.50 (d, J = 16.1 Hz, 
1H, -COCH2CO-), 3.03 (dd, J = 15.2, 8.8 Hz, 1H, -CH2), 2.66 (dd, J = 15.2, 4.4 Hz, 1H, -
CH2), 2.51 – 2.43 (m, enol form -CH2), 0.86 (s, 9H, -(CH3)3), 0.03 (s, 3H, -Si-CH3), 0.17 (s, 
3H, -Si-CH3) (exists as a mixture of keto-enol forms, 5:1); 
13
C NMR (100 MHz, CDCl3)  
200.9, 176.1 (enol), 171.9 (enol), 166.5, 158.9, 136.0, 126.9 (2C), 113.7 (2C), 71.5, 64.6, 
55.2, 53.6, 50.7, 41.2, 25.7 (3C), 18.1, 4.7, 5.2; Unstable under Mass spectrometry 
conditions. 
 
 
 
 
 
 
 
 
 
 
 
 
211 
 
4-(tert-Butyldimethylsilyloxy)-1-(1,3-dioxolan-2-ylidene)- 
4-(4 methoxyphenyl)butan-2-one 320 
 
 
 
 
 
 
 
To a stirred solution of 1-chloro-ketoester 321 (140 mg, 0.34 mmol) in DMF (1.6 mL) at 23 
ºC, K2CO3 (54 mg, 0.4 mmol) was added and the resulting mixture was stirred for 2.5 h. The 
reaction was quenched with brine (20 mL) and the separated aqueous layer was extracted 
with EtOAc (35 mL). The organic layer was washed with brine (20 mL) and 20% aq. LiCl 
solution (20 mL), dried (MgSO4) and rotary evaporated to afford acylketene acetyl 320 (111 
mg, 90%) as a yellow oil: Rf 0.44 (EtOAc); IR max (neat) 1669 (m), 1579 (s), 1511 (s), 1412 
(w), 1246 (s), 1170 (m), 1077 (m), 1038 (s), 965 (m), 831 (s), 776 (s) cm
-1
; 
1
H NMR (400 
MHz, CDCl3)  7.27 (d, J = 8.3 Hz, 2H, ArH), 6.84 (d, J = 8.3 Hz, 2H, ArH), 5.17 (dd, J = 
8.3, 4.9 Hz, 1H, ArCHO-), 4.99 (s, 1H, -C=CHCO-), 4.59 (t, J = 7.8 Hz, 2H, -OCH2-), 4.38 
(t, J = 7.8 Hz, 2H, -OCH2-), 3.80 (s, 3H, -OCH3), 2.92 (dd, J = 14.7, 8.3 Hz, 1H, -CH2), 2.59 
(dd, J = 14.2, 4.9 Hz, 1H, -CH2), 0.84 (s, 9H, -(CH3)3), 0.02 (s, 3H, -Si-CH3), 0.14 (s, 3H, -
Si-CH3); 
13
C NMR (100 MHz, CDCl3)  195.5, 168.1, 158.5, 137.6, 127.0 (2C), 113.3 (2C), 
79.9, 71.9, 68.2, 65.4, 55.2, 54.1, 25.8 (3C), 18.1, 4,7, 5.1; MS (ESI) m/z 779 (2M Na)+, 
401 (M Na)+, 379 (M H)+; HRMS (ESI): (M H)+, found 379.1938; C20H31O5Si requires 
379.1941.  
 
 
 
 
 
 
 
 
 
 
 
 
212 
 
Benzyl 1H-imidazole-1-carboxylate 332
73
 
 
 
 
 
 
To a stirred solution of imidazole (3.75 g, 55 mmol) in THF (50 mL) at 0 ºC, benzyl 
chloroformate 331 (3.93 mL, 27.5 mL) was added. A precipitate was immediately formed 
and the resulting mixture was stirred for 4 h at 23 ºC. The precipitate was filtered and the 
filtrate was rotary evaporated under and the resulting residue was re-dissolved in Et2O (150 
mL) and washed with H2O (60 mL × 2). The organic layer was dried (MgSO4) and rotary 
evaporated to afford carbamate 332 (4.2 g, 82%) as a white solid: IR max (neat) 1754 (s), 
1479 (m), 1403 (s), 1368 (s), 1293 (s), 1254 (s), 1179 (s), 1003 (s), 845 (m) cm
-1
; 
1
H NMR 
(400 MHz, CDCl3)  8.17 (s, 1H, ArH), 7.46 – 7.42 (m, 6H, ArH), 7.08 (s, 1H, ArH), 5.44 
(s, 2H, -CH2); 
13
C NMR (100 MHz, CDCl3)  148.6, 137.2, 133.9, 130.7, 129.2, 128.8 (2C), 
128.7 (2C), 117.2, 69.8; MS (ESI) m/z 203 (M H)+; HRMS (ESI): (M H)+, found 
203.0828; C11H11N2O2 requires 203.0821. This data is in accordance with the literature.
73
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Benzyl 2-(2,2-dimethyl-4-oxo-4H-1,3-dioxin-6-yl)acetate 330 
 
 
 
 
 
 
 
 
n-Butyllithium (2.5 M in hexane; 2.5 mL) was added dropwise to a solution of HMDS (1.3 
mL, 6.18 mmol) in THF (18 mL) at 78 ºC. After 20 min, dioxinone 65 (878 mg, 6.18 mmol) 
in THF (2 mL) was added dropwise and stirred for 1 h. The reaction mixture was then 
allowed to warm up to 20 ºC. Carbamate 332 (500 mg, 2.5 mmol) in THF (2 mL) was added 
and the resulting mixture was immediately warmed up to 10 ºC and stirred for another 2.5 h. 
The reaction was quenched with 1 M aq. HCl solution (45 mL) and the separated aqueous 
layer was acidified to pH 1‒2 using 1 M aq. HCl solution. The resulting aqueous layer was 
extracted with Et2O (65 mL × 2) and the combined organic layers were dried (MgSO4), 
rotary evaporated and chromatographed (Et2O/PE 1:2 to 1:1) to afford benzyl ester-dioxinone 
330 (300 mg, 44%) as a colourless oil: Rf 0.46 (Et2O/PE 1:1);IRmax (neat) 1727 (s), 1640 
(m), 1391 (m), 1376 (m), 1272 (s), 1203 (m), 1155 (m), 1016 (m), 902 (m) cm
-1
; 
1
H NMR 
(400 MHz, CDCl3)  7.41 – 7.37 (m, 5H, ArH), 5.42 (s, 1H, -O2CCHCO-), 5.20 (s, 2H, -
ArCH2), 3.34 (s, 2H, -CH2), 1.66 (s, 6H, dioxinone -CH3 × 2); 
13
C NMR (100 MHz, CDCl3) 
166.9, 163.5, 160.7, 135.0, 128.7 (2C), 128.6 (2C), 128.4, 107.2, 96.5, 67.4, 39.4, 24.8 
(2C); MS (ESI) m/z 277 (M H)+; HRMS (ESI): (M H)+, found 277.1080; C15H17O5 
requires 277.1076. 
 
Dioxinone 333 (115 mg, 17%, white solid) was also isolated as a byproduct: Rf 0.48 
(EtOAc/PE 1:1); Mp 38 – 41 ºC; IR max (neat) 1736 (s), 1718 (s), 1605 (m), 1391 (s), 1379 
(s), 1351 (s), 1268 (s), 1206 (s), 1079 (s), 1055 (m), 1030 (w) cm
-1
; 
1
H NMR (400 MHz, 
CDCl3)  7.49 – 7.47 (m, 2H, ArH), 7.42 – 7.34 (m, 3H, ArH), 5.32 (s, 2H, -CH2), 2.32 (s, 
3H, -CH3), 1.74 (s, 6H, dioxinone -CH3 × 2); 
13
C NMR (100 MHz, CDCl3) 175.2, 163.8, 
157.4, 135.7, 128.5 (2C), 128.2, 128.1 (2C), 106.3, 93.8, 66.9, 25.1 (2C), 20.1; MS (ESI) m/z 
575 (2M + Na)
+
, 340 (M Na + MeCN)+, 277 (M + H)+; HRMS (ESI): (M H)+, found 
277.1075; C15H17O5 requires 277.1076 . 
 
 
214 
 
2-(2,2-Dimethyl-4-oxo-4H-1,3-dioxin-6-yl)acetic acid 334 
 
 
 
 
 
 
Palladium on charcoal (10%wt, 30 mg) was added to benzyl ester-dioxinone 330 (300 mg, 
1.09 mmol) in EtOAc (15 mL) under a nitrogen atmosphere. The ensuing mixture was stirred 
under a hydrogen atmosphere for 25 min at 23 ºC. The reaction mixture was filtered through 
Celite and rotary evaporated. The resulting residue was triturated with a PE/Et2O (1:1 v/v) 
mixture to afford carboxylic acid 334 (143 mg, 71%) as an off-white solid: Rf 0.38 (Et2O); 
Mp 94 – 96 ºC; IR max (neat) 3106 (m), 1742 (s), 1696 (s), 1651 (s), 1393 (s), 1368 (s), 
1282 (m), 1237 (s), 1196 (s), 1009 (s), 944 (m), 832 (s) cm
-1
; 
1
H NMR (400 MHz, 
CO(CD3)2) 11.28 (br. s, 1H, -CO2H), 5.49 (s, 1H, -O2CCHCO-), 3.43 (s, 2H, -CH2), 1.69 
(s, 6H, dioxinone -CH3 × 2); 
13
C NMR (100 MHz, CO(CD3)2)  168.1, 164.7, 159.8, 106.6, 
96.1, 38.4, 24.1 (2C); MS (CI) m/z 204 (M NH4)
+
; HRMS (CI): (M NH4)
+
, found 
204.0873; C8H14NO5 requires 204.0872; Elem. Anal., found C, 51.52; H, 5.38; C8H10O5 
requires C, 51.61; H, 5.41%.  
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(3S,4R,5S)-5-((S)-2,2-dimethyl-1,3-dioxolan-4-yl)-3,4- 
dihydroxydihydrofuran-2(3H)-one 363
91
 
 
 
 
 
 
 
 
L-(+)-Gulonic acid gamma-lactone 362 (20 g, 112 mmol) was dissolved in DMF (180 mL) 
and the resulting solution was cooled to  ºC. 2-Methoxypropene 219 (14 mL, 146 mmol) 
was added dropwise followed by the addition of catalytic amount of p-TSA (172 mg, 0.92 
mmol). The resulting mixture was stirred at 23 ºC for 24 h. Na2CO3 (20 g) was then added 
and the resulting mixture was stirred vigorously for 2 h. The mixture was filtered through 
Celite and the filtrate diluted with EtOAc (400 mL) and washed with H2O (350 mL). The 
aqueous layer was further extracted with EtOAc (500 mL × 8) and the combined organic 
layers were dried (MgSO4) and rotary evaporated to give an off-white solid. Trituration with 
Et2O afforded acetonide 363 (24.5 g, 64%) as a white powder: Rf 0.41 (Et2O); IR max (neat) 
3513 (m), 3451 (m), 1757 (s), 1375 (m), 1220 (s), 1197 (s), 1146 (s), 1075 (s), 983 (s), 840 
(s) cm
-1
; 
1
H NMR (400 MHz, CD3CN)  4.44 (br. d, J = 4.9 Hz, 1H, -OCHCO2), 4.42 – 4.30 
(m, 3H), 4.16 (dd, J = 8.3, 6.4 Hz, 1H), 3.89 (br. s, 1H, -OH), 3.82 (dd, J = 8.8, 6.4 Hz, 1H), 
3.58 (br. s, 1H, -OH), 1.42 (s, 3H, -CH3), 1.36 (s, 3H, -CH3); 
13
C NMR (100 MHz, CD3CN) 
 MS (CI) m/z 236 (M NH4)
+
; HRMS 
(CI): (M H)+, found 219.0873; C19H15O6 requires 219.0869. This data is in accordance with 
the literature.
91
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(S)-2,2-Dimethyl-1,3-dioxolane-4-carbaldehyde 354
91
 
 
 
 
 
 
 
 
NaIO4 (981 mg, 4.59 mmol) was added portion-wise to a solution of acetonide 363 (500 mg, 
2.30 mmol) in H2O (4 mL) at  ºC while maintaining the pH of the solution at 5.5 – 6.0 using 
1 M aq. NaOH solution. A precipitate started to form after half of the NaIO4 had been added. 
The resulting mixture was stirred at 23 ºC for 2 h where saturated aq. NaCl solution (4 mL) 
was added and the insolubles were filtered. The pH of the filtrate was adjusted to 6.5 – 7.0 
using 1 M aq. NaOH solution. The resulting aqueous layer was extracted with CH2Cl2 (50 
mL × 3) and the combined organic layers were dried (MgSO4) and rotary evaporated to 
afford L-(S)-glyceraldehyde acetonide 354 (170 mg, 52%) as a colourless liquid. This 
material was used in the following step without further purification. 
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(R)-Ethyl 3-((S)-2,2-dimethyl-1,3-dioxolan-4-yl)-3-hydroxypropanoate 364 
 
 
 
 
 
 
 
To a stirred solution of LDA (6.2 mmol) in THF (13.5 mL) at 78 ºC, EtOAc (0.6 mL, 6.5 
mmol) was added dropwise and the resulting mixture was stirred for 45 min. (S)-
Glyceraldehyde acetonide (354) (700 mg, 5.4 mmol) in THF (1.5 mL) was added dropwise 
and stirred for 20 min at 78 ºC. The reaction was quenched with saturated aq. NaHCO3 
solution (25 mL) and the separated aqueous layer was extracted with Et2O (40 mL × 2). The 
combined organic layers were dried (MgSO4), rotary evaporated and chromatographed 
(Et2O/PE 1:2 to 1:1) to afford -hydroxy-ester 364 (875 mg, 25% over 2 steps, d.r = 7.2:1) as 
a pale yellow oil: Rf 0.40 (Et2O/PE 1:1); 
25
D][ .2 (c 0.16 CHCl3); IR max (neat) 3467 
(m), 1735 (s), 1372 (m), 1255 (m), 1215 (m), 1067 (s), 851 (w) cm
-1
; 
1
H NMR (400 MHz, 
CDCl3)  4.20 (q, J = 6.8 Hz, 2H, -CO2CH2CH3), 4.13 – 4.09 (m, 1H), 4.01 – 3.96 (m, 3H), 
3.20 (d, J = 3.4 Hz, 1H, -OH), 2.71 (dd, J = 16.6, 2.9 Hz, 1H, -CH2), 2.49 (dd, J = 16.6, 8.8 
Hz, 1H, -CH2), 1.42 (s, 3H, -CH3), 1.36 (s, 3H, -CH3), 1.30 (t, J = 7.3Hz, 3H, -CO2CH2CH3); 
13
C NMR (100 MHz, CDCl3) 172.8, 109.5, 77.5, 69.2, 66.6, 60.9, 37.6, 26.7, 25.1, 14.1; 
MS (CI) m/z 236 (M NH4)
+
; HRMS (CI): (M H)+, found 219.1232; C10H19O5 requires 
219.1232. 
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(R)-3-(tert-Butyldimethylsilyloxy)-3-((S)-2,2-dimethyl-1,3-dioxolan-4-yl)-N-methoxy-N-
methylpropanamide 366 
 
 
 
 
 
 
 
 
To a stirred solution of β-hydroxy-ester 364 (700 mg, 3.2 mmol) and imidazole (966 mg, 14.2 
mmol) in CH2Cl2 (18 mL) at 23 ºC, TBSCl (1.46 g, 9.69 mmol) in CH2Cl2 (2 mL) was added 
and the resulting mixture was stirred for 18 h. The reaction was quenched with saturated aq. 
NH4Cl solution (30 mL) and the separated aqueous layer was extracted with CH2Cl2 (35 mL 
× 2). The combined organic layers were dried (MgSO4) and rotary evaporated to afford TBS-
protected ester intermediate (1.7 g) as a colourless oil. This material was used in the next step 
without further purification; Rf 0.59 (Et2O/PE 1:3); 
25
D][  (c 0.33 CHCl3); IR max (neat) 
1738 (s), 1476 (w), 1371 (m), 1258 (s), 1175 (m), 1077 (s), 837 (s) cm
-1
; 
1
H NMR (400 
MHz, CDCl3) 4.13 (q, J = 7.8 Hz, 2H, -CO2CH2CH3), 4.12 – 4.10 (m, 1H), 4.06 – 4.00 (m, 
2H), 3.86 – 3.81 (m, 1H), 2.61 (dd, J = 15.2, 4.9 Hz, 1H, -CH2), 2.48 (dd, J = 15.2, 6.4 Hz, 
1H, -CH2), 1.40 (s, 3H, -CH3), 1.33 (s, 3H, -CH3), 1.27 (t, J = 7.3 Hz, 3H, -CO2CH2CH3), 
0.86 (s, 9H, -(CH3)3), 0.11 (s, 3H, -Si-CH3), 0.06 (s, 3H, -Si-CH3); 
13
C NMR (100 MHz, 
CDCl3)  171.2, 109.3, 78.4, 70.5, 66.7, 60.4, 40.3, 26.6, 25.7 (3C), 25.2, 17.9, 14.1, -4.5, -
4.7; MS (ESI) m/z 333 (M H)+, 275 (M t-Bu)+; HRMS (ESI): (M H)+, found 333.2086; 
C16H33O5Si requires 333.2097; Elem. Anal., found C, 57.90; H, 9.57; C16H32O5Si requires C, 
57.79; H, 9.70%. 
 
To a stirred solution of N,O-dimethylhydroxylamine hydrochloride salt 222 (630 mg, 6.46 
mmol) and TBS-protected ester (1.7 g) in THF (29 mL) at ºC, i-PrMgCl (2 M in THF; 
7.26 mL) was added and the resulting mixture was stirred for 1 h at –15 ºC. The reaction was 
quenched with saturated aq. NH4Cl solution (40 mL) and the separated aqueous layer was 
extracted with Et2O (40 mL × 3). The combined organic layers were dried (MgSO4), rotary 
evaporated and chromatographed (Et2O/PE 1:2 to 1:1) to afford Weinreb amide 366 (750 mg, 
67% over 2 steps) as a colourless oil: Rf 0.52 (Et2O/PE 1:1); 
25
D][ 12.0 (c 0.17 CHCl3); IR 
max (neat) 1745 (w), 1665 (s), 1471 (m), 1381 (m), 1252 (m), 1106 (m), 1074 (s), 837 (s) 
cm
-1
; 
1
H NMR (400 MHz, CDCl3) 4.32 – 4.27 (m, 1H), 4.07 – 4.00 (m, 2H), 3.87 – 3.84 
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(m, 1H), 3.70 (s, 3H, -NOCH3), 3.19 (s, 3H, -NCH3), 2.71 (dd, J = 15.1, 6.8 Hz, 1H, -CH2), 
2.61 (dd, J = 15.1, 4.4 Hz, 1H, -CH2), 1.41 (s, 3H, -CH3), 1.34 (s, 3H, -CH3), 0.86 (s, 9H, -
(CH3)3), 0.12 (s, 3H, -Si-CH3), 0.05 (s, 3H, -Si-CH3); 
13
C NMR (100 MHz, CDCl3)  171.9, 
109.2, 78.8, 70.0, 66.6, 61.3, 37.3, 32.0, 26.6, 25.8 (3C), 25.3, 18.0, -4.4, -4.8; MS (ESI) m/z 
370 (M Na)+; HRMS (ESI): (M Na)+, found 370.2008; C16H33NNaO5Si requires 
370.2026; Elem. Anal., found C, 55.26; H, 9.55; N, 3.93; C16H33NO5Si requires C, 55.30; H, 
9.57; N, 4.03%. 
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(E)-1,1-Dibromopenta-1,3-diene 368
92
 
 
 
 
To a stirred solution of CBr4 (7.7 g, 23.3 mmol) in CH2Cl2 (15 mL) at 0 ºC, 
triphenylphosphine (12.2 g, 46.5 mmol) was added portion-wise. The resulting orange slurry 
was stirred for 10 min. Crotonaldehyde (367) (0.96 mL, 11.7 mmol) in CH2Cl2 (15 mL) was 
added dropwise and the resulting mixture was stirred for 45 min at 0 ºC. Pentane (150 mL) 
was then added and the insolubles were filtered. The filtrate was rotary evaporated and 
chromatographed (PE) using neutral alumina to afford dibromo-pentadiene 368 (950 mg, 
37%) as an amber liquid: Rf 0.99 (PE); 
1
H NMR (400 MHz, CDCl3)  6.91 (d, J = 10.3 Hz, 
1H, CH3CH=CH-CH=C-), 6.17 – 6.10 (m, 1H, CH3CH=CH-), 5.94 (dq, J = 15.6, 6.8 Hz, 1H, 
CH3CH=CH-), 1.80 (dd, J = 6.8, 1.5 Hz, 3H, -CH3). This data is in accordance with the 
literature.
92
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(1E,3E)-1-Bromopenta-1,3-diene 352
76
 
 
 
 
 
Sodium hydride (60% in mineral oil, 750 mg, 22.4 mmol) was suspended in absolute EtOH 
(45 mL) and the resulting slurry was treated with diethylphosphite (2.89 mL, 22.4 mmol) at  
0 ºC. Dibromo-pentadiene 368 (1.68 g, 7.5 mmol) in EtOH (10 mL) was added and the 
resulting yellow mixture was heated to reflux for 1.5 h. The reaction mixture was allowed to 
cool to 23 ºC and H2O (80 mL) was added. The separated aqueous layer was extracted with 
Et2O (150 mL) and washed with H2O (50 mL × 3). The resulting organic layer was dried 
(MgSO4) and rotary evaporated to afford 1-bromo-pentadiene 369 as a mixture of cis- and 
trans-isomers (1.8 g, E:Z = 1:1). This material was used in the following step without further 
putification. 
 
A solution of diene 369 (1.8 g) and NaOH (385 mg, 9.7 mmol) in absolute EtOH (15 mL) 
was heated at reflux for 4 h. The reaction mixture was allowed to cool to 23 ºC and the 
reaction was quenched with H2O (80 mL). The separated aqueous layer was extracted with 
Et2O (100 mL) and washed with H2O (40 mL × 3). The resulting organic layer was dried 
(MgSO4), rotary evaporated and chromatographed (PE) using neutral alumina to afford (E)-1-
bromo-pentadiene 352 (420 mg, 37% over 2 steps) as a colourless liquid: Rf 0.99 (PE); 
1
H 
NMR (400 MHz, CDCl3) 6.70 (dd, J = 13.7, 5.4 Hz, 1H, -CH=CHBr), 6.16 (d, J = 13.7 
Hz, 1H, -CH=CHBr), 5.97 (ddd, J = 14.7, 11.2, 1.5 Hz, 1H, CH3CH=CH-), 5.74 (dq, J = 
15.2, 6.8 Hz, 1H, CH3CH=CH-), 1.73 (d, J = 6.8 Hz, 3H, -CH3). This data is in accordance 
with the literature.
76
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(E)-1,1-Diiodopent-3-en-2-yl acetate 373
77
 
 
 
 
 
 
A solution of LDA (57 mmol) in THF (60 mL) was added dropwise via a syringe to a stirred 
solution of crotonaldehyde (367) (2.4 mL, 28.5 mmol) and diiodomethane (4.6 mL, 57 mmol) 
in THF (60 mL) at 78 ºC. The resulting yellow-brown solution was stirred for 1.5 h. The 
reaction was quenched with saturated aq. NH4Cl solution (100 mL) and the aqueous layer 
was extracted with Et2O (100 mL × 2). The combined organic layers were dried (MgSO4) and 
rotary evaporated to give alcohol intermediate 372 as a dark brown oil. This material was 
used in the following step without further purification.  
 
The alcohol 372 was treated with pyridine (120 mL), DMAP (100 mg) and Ac2O (100 mL) 
and the resulting red solution was stirred for 15 h at 23 ºC. The reaction was quenched 
carefully with cold H2O (200 mL) and the separated aqueous layer was extracted with Et2O 
(200 mL × 2). The combined organic layers were washed with H2O (100 mL × 2), dried 
(MgSO4), rotary evaporated and chromatographed (Et2O/PE 1:2) to afford diiodo-acetate 373 
(9.0 g, 83% over 2 steps) as a dark-brown liquid: Rf 0.87 (Et2O/PE 1:1); IR max (neat) 1741 
(s), 1667 (w), 1438 (w), 1369 (m), 1222 (s), 1076 (w), 1016 (m), 961 (m) cm
-1
; 
1
H NMR 
(400 MHz, CDCl3)  5.97 (dq, J = 15.2, 6.8 Hz, 1H, CH3CH=CH-), 5.48 (ddq, J = 15.2, 7.3, 
1.5 Hz, 1H, CH3CH=CH-), 5.17 (d, J = 3.9 Hz, 1H, -CHI2), 5.02 (dd, J = 6.8, 3.9 Hz, 1H, -
CHCHI2), 2.15 (s, 3H, -CH3), 1.78 (dd, J = 6.4, 1.5 Hz, 3H, CH3C=CH-); 
13
C NMR (100 
MHz, CDCl3)  169.4, 134.2, 126.5, 77.8, 21.0, 17.9, 20.7; This data is in accordance with 
the literature.
77
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1-Iodopenta-1,3-diene 374
77
 
 
 
 
 
 
 
To a mixture of Sm powder (2.2 g, 14.4 mmol) and diiodo-acetate 373 (2.0 g, 5.3 mmol) in 
THF (200 mL) at 0 ºC, diiodomethane (1.1 mL, 13.0 mmol) was added dropwise and the 
resulting mixture was stirred at 23 ºC for 2 h. The reaction mixture turned light green from 
dark brown. The reaction was quenched with H2O (150 mL) and the separated aqueous layer 
was extracted with Et2O (120 mL × 2). The combined organic layers were dried (MgSO4), 
rotary evaporated and chromatographed (PE) using neutral alumina to afford 1-iodo-
pentadiene 374 (250 mg, 24%, E:Z = 2:3) as a yellow liquid: Rf 0.99 (PE); 
1
H NMR (400 
MHz, CDCl3) - E isomer  7.01 (dd, J = 14.3, 10.2 Hz, 1H, -CH=CHI), 6.17 (d, J = 14.2 Hz, 
1H, -CH=CHI), 6.03 – 5.98 (m, 1H, CH3CH=CH-), 5.76 (dq, J = 15.2, 6.4 Hz, 1H, 
CH3CH=CH-), 1.74 (dd, J = 6.4, 1.5 Hz, 3H, -CH3); Z isomer  6.70 (dd, J = 10.3, 7.8 Hz, 
1H, -CH=CHI), 6.34 – 6.23 (m, 1H), 6.12 – 5.95 (m, 2H), 1.84 (dd, J = 6.8, 1.5 Hz, 3H, -
CH3). This data is in accordance with the literature.
77
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(S)-1-Methoxy-4-((pent-4-en-2-yloxy)methyl)benzene 346
74
 
 
 
 
 
 
 
 
Vinyl magnesium chloride (1 M in THF; 32 mL, 32 mmol) was added carefully to a stirred 
slurry of CuI (615 mg, 3.23 mmol) in THF (160 mL) at 78 ºC. The resulting mixture was 
stirred for 15 min and (S)-propylene oxide (223) (1.3 mL, 19 mmol) was added. The yellow 
mixture was stirred for 30 min and the cooling bath was replaced with an acetonitrile/CO2 
bath and the reaction temperature was kept at 35 ºC to 25 ºC for 1 h. The black mixture 
was then stirred for 1 h at  ºC. The reaction was quenched with a saturated NH4Cl solution 
(50 mL) and H2O (50 mL) and the separated aqueous layer was extracted with Et2O            
(50 mL × 2). The combined organic layers were dried (MgSO4) and rotary evaporated to give 
alcohol intermediate 356 as a dark-brown oil. This material was used in the following step 
without further purification. 
 
To a stirred solution of alcohol 356 in CH2Cl2 (25 mL) at 23 ºC, acetimidate 226 (4.9 g, 17.4 
mmol) in CH2Cl2 (5 mL) was added dropwise followed by the addition of CSA (404 mg, 1.7 
mmol). The resulting mixture was stirred for 18 h at 23 ºC. The reaction was quenched with a 
saturated aq. NH4Cl solution (40 mL) and the aqueous layer was extracted with Et2O            
(50 mL × 2). The combined organic layers were dried (MgSO4), rotary evaporated and 
chromatographed (Et2O/PE 1:4 to 1:3) to afford olefin 346 (2.0 g, 58% over 2 steps) as an 
amber liquid: Rf 0.83 (Et2O/PE 1:1); 
25
D][ +11.0 (c 0.75 MeOH), lit
93
 +10.1 (c 1.0 MeOH); 
IR max (neat) 1612 (m), 1512 (s), 1462 (w), 1301 (w), 1245 (s), 1172 (m), 1085 (m), 1035 
(s), 913 (m), 819 (m) cm
-1
; 
1
H NMR (400 MHz, CDCl3)  7.30 (d, J = 8.8 Hz, 2H, ArH), 
6.90 (d, J = 8.8 Hz, 2H, ArH), 5.92 – 5.81 (m, 1H, -CH=CH2), 5.14 – 5.06 (m, 2H, -
CH=CH2), 4.53 (d, J = 11.7 Hz, 1H, ArCH2O-), 4.46 (d, J = 11.7 Hz, 1H, ArCH2O-), 3.83 (s, 
3H, -OCH3), 3.60 (st, J = 5.8 Hz, 1H, ArCH2OCH-), 2.44 – 2.37 (m, 1H, -CH2), 2.29 – 2.22 
(m, 1H, -CH2), 1.21 (d, J = 6.4 Hz, 3H, -CH3); 
13
C NMR (100 MHz, CDCl3)  159.0, 135.1, 
131.0, 129.2 (2C), 116.8, 113.7 (2C), 74.1, 70.0, 55.3, 40.9, 19.5; MS (CI) m/z 224 (M + 
NH4)
+
; HRMS (CI): (M NH4)
+
, found 224.1650; C13H22NO2 requires 224.1651.  
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(3E,5E)-Hepta-3,5-dien-2-one 355
78
 
 
 
 
 
 
 
A mixture of 1-(triphenylphosphoranylidene)-2-propanone (25 g, 78.6 mmol) and 
crotonaldehyde (367) (5.4 mL, 65.5 mmol) in PhMe (280 mL) was heated at 100 ºC for 15 h. 
The volatiles were rotary evaporated and the solid filtered. The resulting filtrate was 
chromatographed (Et2O/PE 1:9) to afford enone 355 (3.45 g, 48%) as a pale yellow liquid: Rf 
0.68 (Et2O/PE 1:1); IR max (neat) 1664 (s), 1642 (s), 1592 (s), 1434 (w), 1357 (m), 1325 
(w), 1251 (s), 1148 (m), 992 (s), 962 (m) cm
-1
; 
1
H NMR (400 MHz, CDCl3)  7.13 – 7.07 
(m, 1H, -COCH=CH-), 6.22 – 6.19 (m, 2H, -COCH=CH-CH=CHCH3), 6.04 (d, J = 15.6 Hz, 
1H, -COCH=CH-), 2.27 (s, 3H, -COCH3), 1.87 (d, J = 4.9 Hz, 3H, -CH=CHCH3); 
13
C NMR 
(100 MHz, CDCl3)  198.8, 143.8, 140.3, 130.2, 128.6, 27.2, 18.8; MS (CI) m/z 128 (M + 
NH4)
+
; HRMS (CI): (M  NH4)
+
, found 128.1078; C7H14NO requires 128.1075. This data is 
in accordance with the literature.
78 
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(R,4E,6E)-1-((S)-2,2-Dimethyl-1,3-dioxolan-4-yl)-1-hydroxyocta-4,6-dien-3-one 376 
 
 
 
 
 
 
A solution of DMSO (7 mL) in CH2Cl2 (10 mL) was added dropwise to a stirred solution of 
oxalyl chloride (3.5 mL, 41.6 mmol) in CH2Cl2 (90 mL) at 78 ºC. A solution of (R)-()-2,2-
dimethyl-1,3-dioxolane-4-methanol (17) (5 g, 37.8 mmol) in CH2Cl2 (20 mL) was added and 
the resulting mixture was stirred for 15 min at 78 ºC. Et3N (26.4 mL, 189 mmol) was added 
dropwise and the reaction mixture warmed to 23 ºC over 2 h. The reaction was quenched with 
H2O (90 mL) and the aqueous layer was extracted with CH2Cl2 (120 mL × 3). The combined 
organic layers were dried (MgSO4) and rotary evaporated to 10 mL of CH2Cl2 (to minimize 
polymerization). This solution containing aldehyde 354 was used in the next step without 
further purification. 
 
Enone 355 (4.5 g, 40.2 mmol) in THF (20 mL) was added dropwise to a solution of LDA 
(44.0 mmol) in THF (100 mL) at 78 ºC and the resulting bright yellow mixture was stirred for 
35 min. Aldehyde 354 in CH2Cl2 (10 mL) was added dropwise and the resulting mixture was 
stirred for 30 min at 78 ºC. The reaction was quenched with saturated aq. NH4Cl solution (60 
mL) and H2O (60 mL) and the separated aqueous layer was extracted with Et2O                
(150 mL × 2). The combined organic layers were dried (MgSO4), rotary evaporated and 
chromatographed (Et2O/PE 1:2 to 2:1) to afford -hydroxy-ester 376 (3.02 g, 38% over 2 
steps, d.r = 7.2:1) as a pale yellow oil: Rf 0.59 (Et2O); 
25
D][ 50.0 (c 0.52 CHCl3); IR max 
(neat) 3458 (m), 1637 (s), 1594 (m), 1372 (m), 1254 (m), 1213 (m), 1154 (m), 1064 (s), 998 
(m), 851 (m) cm
-1
; 
1
H NMR (400 MHz, CDCl3)  7.21 (dd, J = 16.1 9.8 Hz, 1H, -
COCH=CH-), 6.32 – 6.20 (m, 2H, -COCH=CH-CH=CHCH3), 6.08 (d, J = 16.1 Hz, 1H, -
COCH=CH-), 4.16 – 4.10 (m, 1H), 4.03 – 4.00 (m, 3H), 3.49 (d, J = 2.4 Hz, 1H, -OH), 3.03 
(dd, J = 17.1, 2.0 Hz, 1H, -CH2), 2.72 (dd, J = 17.1, 8.3 Hz, 1H, -CH2), 1.90 (d, J = 5.9 Hz, 
3H, -C=CHCH3), 1.43 (s, 3H, -CH3), 1.37 (s, 3H, -CH3); 
13
C NMR (100 MHz, CDCl3)  
201.2, 144.5, 141.7, 130.1, 127.6, 109.4, 77.5, 69.5, 67.1, 42.5, 26.7, 25.2, 18.9; MS (ESI) 
m/z 241 (M + H)
+
; HRMS (ESI): (M H)+, found 241.1445; C13H21O4 requires 241.1440. 
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(R,4E,6E)-1-(tert-Butyldimethylsilyloxy)-1-((S)-2,2-dimethyl-1,3- 
dioxolan-4-yl)octa-4,6-dien-3-one 370 
 
 
 
 
 
 
 
To a stirred solution of β-hydroxy ester 376 (2.8 g, 11.67 mmol) and imidazole (7.0 g, 102.8 
mmol) in CH2Cl2 (80 mL) at 23 ºC, TBSCl (10.6 g, 70 mmol) in CH2Cl2 (10 mL) was added 
and the resulting mixture was stirred for 68 h. The reaction was quenched with saturated aq. 
NH4Cl solution (80 mL) and the aqueous layer was extracted with CH2Cl2 (80 mL × 3). The 
combined organic layers were dried (MgSO4), rotary evaporated and chromatographed 
(Et2O/PE 1:9) to afford TBS-protected ester 370 (7.0 g, mixture with TBSOH, 5:3) as a 
colourless oil: Rf 0.85 (Et2O/PE 1:1); 
25
D][ 16.6 (c 0.12 CHCl3); IR max (neat) 1745 (m), 
1672 (m), 1637 (s), 1595 (m), 1467 (w), 1376 (s), 1248 (s), 1073 (s), 832 (s) cm
-1
; 
1
H NMR 
(400 MHz, CDCl3)  7.18 – 7.12 (m, 1H, -COCH=CH-), 6.23 – 6.20 (m, 2H, -COCH=CH-
CH=CHCH3), 6.09 (d, J = 15.2 Hz, 1H, -COCH=CH-), 4.31 – 4.26 (m, 1H, -OCHCH2CO-), 
4.06 – 3.97 (m, 2H, -OCHaHbCHO-, -OCHaHbCHO-), 3.84 (dd, J = 7.8, 5.9 Hz, 1H, -
OCHaHbCHO-), 2.78 – 2.77 (m, 2H, -CH2), 1.89 (d, J = 5.4 Hz, 3H, -CH=CHCH3), 1.41 (s, 
3H, -CH3), 1.34 (s, 3H, -CH3), 0.85 (s, 9H, -(CH3)3), 0.12 (s, 3H, -Si-CH3), 0.01 (s, 3H, -Si-
CH3); 
13
C NMR (100 MHz, CDCl3)  198.6, 143.4, 140.6, 130.3, 128.5, 109.3, 78.7, 69.9, 
66.7, 45.5, 26.6, 25.8 (3C), 25.2, 18.8, 18.0, 3.5, 4.3; MS (ESI) m/z 731 (2M Na)+; 
HRMS (ESI): (2M Na)+, found 731.4365; C38H68NaO8Si2 requires 731.4350. 
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(1R,3S,4E,6E)-1-(tert-Butyldimethylsilyloxy)-1-((S)-2,2- 
cdimethyl-1,3-dioxolan-4-yl)octa-4,6-dien-3-ol 380 
 
 
 
 
 
 
 
 
 
 
A mixture of (R)-Me-CBS 379 (391 mg, 1.4 mmol) and BH3.THF (1 M in THF; 2.1 mL) in 
THF (5 mL) was stirred for 25 min at 23 ºC. The resulting colourless solution was cooled to 
20 ºC and enone 370 (500 mg, 5:3 mixture with TBSOH, 1.4 mmol) in THF (20 mL) was 
added dropwise maintaining the internal temperature between 15 – 20 ºC. The reaction 
mixture was stirred for 1.5 h at 20 ºC. The reaction was quenched with saturated aq. NH4Cl 
(40 mL) and the separated aqueous layer was extracted with Et2O (35 mL × 3). The combined 
organic layers were dried (MgSO4), rotary evaporated and chromatographed (Et2O/PE 1:3 to 
1:2) to afford alcohol 380 (410 mg, 90%, d.r = 95:5) as a colourless oil: Rf 0.34 (Et2O/PE 
1:2); 25D][ 10.2 (c 0.39 CHCl3); IR max (neat) 3449 (m), 1370 (m), 1252 (s), 1213 (m), 
1070 (s), 986 (s), 834 (s) cm
-1
; 
1
H NMR (500 MHz, CDCl3)  6.22 (dd, J = 15.2, 10.3 Hz, 
1H, -OCHCH=CH-), 6.10 – 6.03 (m, 1H, -CH=CHCH3), 5.74 (dq, 1H, J = 14.8, 6.8 Hz, 1H, 
-CH=CHCH3), 5.59 (dd, J = 15.2, 6.4 Hz, 1H, -OCHCH=CH-), 4.47 – 4.42 (br. m, 1H, 
HOCHCH=CH-), 4.15 – 4.06 (m, 2H, -OCHaHbCHO-, -OCHaHbCHO-), 3.90 – 3.86 (m, 1H, 
-SiOCHCH2CH-), 3.82 (dd, J = 7.8, 6.4 Hz, 1H, -OCHaHbCHO-), 2.62 (d, J = 4.4 Hz, 1H, -
OH), 1.88 (ddd, J = 14.2, 8.3, 4.9 Hz, 1H, -CH2), 1.82 – 1.75 (m, 1H, -CH2), 1.78 (d, J = 7.3 
Hz, 3H, -CH=CHCH3), 1.44 (s, 3H, -CH3), 1.38 (s, 3H, -CH3), 0.91 (s, 9H, -(CH3)3), 0.11 (s, 
6H, -Si-CH3 × 2); 
13
C NMR (125 MHz, CDCl3) 133.1, 130.8, 130.1, 129.6, 109.3, 78.7, 
70.9, 68.8, 67.2, 42.8, 26.5, 25.7 (3C), 25.3, 18.0, 17.9, 4.1, 4.5; MS (CI) m/z 374 (M 
H4)
+
; HRMS (CI): (M NH4)
+
, found 374.2718; C19H40NO4Si requires 374.2727.  
  
 
 
 
 
 
 
229 
 
(4R,6S)-4-((S)-2,2-Dimethyl-1,3-dioxolan-4-yl)-2,2-dimethyl- 
6-((1E,3E)-penta-1,3-dienyl)-1,3-dioxane 382 
 
 
 
 
 
 
To a stirred solution alcohol 380 (80 mg, 0.23 mmol) in THF (3.5 mL) at 23 ºC, TBAF (1 M 
in THF; 0.33 mL) was added and the resulting mixture was stirred for 1 h. The reaction was 
quenched with H2O (10 mL) and the aqueous layer was extracted with Et2O (15 mL × 2). The 
combined organic layers were dried (MgSO4) and rotary evaporated to afford syn-diol 381 
(53 mg) as a colourless oil. This material was used in the next step without further 
purification: 
1
H NMR (400 MHz, CDCl3)  6.24 (dd, J = 15.6, 10.8 Hz, 1H, -OCHCH=CH-
), 6.06 (ddd, J = 15.6, 10.8, 1.5 Hz, 1H, -CH=CHCH3), 5.80 – 5.72 (dq, J = 15.2, 6.4 Hz, 1H, 
-CH=CHCH3), 5.59 (dd, J = 15.2, 7.2 Hz, 1H, -OCHCH=CH-), 4.49 – 4.44 (m, 1H, -
OCHCH=C-), 4.08 – 4.03 (m, 1H), 4.02 – 3.93 (m, 3H), 3.18 (br. s, 1H, -OH), 2.56 (br. s, 
1H, -OH), 1.85 – 1.82 (m, 1H, -CH2), 1.79 (dd, J = 7.2, 1.5 Hz, 3H, -C=CHCH3), 1.60 – 1.55 
(m, 1H, -CH2), 1.45 (s, 3H, -CH3), 1.39 (s, 3H, -CH3). 
 
To a stirred solution of diol 381 (53 mg) and 2,2-DMP (1.2 mL) in CH2Cl2 (1.2 mL), p-TSA 
(4.4 mg, 0.023 mmol) was added and the resulting mixture was stirred for 1.5 h at 23 ºC. The 
reaction was quenched with saturated aq. NaHCO3 solution (10 mL) and the insolubles were 
filtered. The filtrate was rotary evaporated and the resulting residue was chromatographed 
(Et2O/PE 3:17 to 1:4) to afford acetonide 382 (32 mg, 50% over 2 steps) as a colourless solid: 
Rf 0.87 (Et2O/PE 1:1); Mp 44 – 46 ºC; 
25
D][ 0.0 (c 0.15 CHCl3); IR max (neat) 1459 (w), 
1380 (s), 1256 (s), 1200 (s), 1155 (s), 1079 (s), 988 (s), 844 (m) cm
-1
; 
1
H NMR (400 MHz, 
CDCl3) 6.23 (dd, J = 15.2, 10.3 Hz, 1H, -OCHCH=CH-), 6.08 – 6.01 (m, 1H, -
CH=CHCH3), 5.76 – 5.68 (dq, J = 15.2, 6.4 Hz, 1H, -CH=CHCH3), 5.54 (dd, J = 15.6, 5.9 
Hz, 1H, -OCHCH=CH-), 4.42 – 4.38 (m, 1H, -OCHCH=C-), 4.11 – 4.05 (m, 1H), 3.94 – 
3.88 (m, 2H), 3.81 – 3.76 (m, 1H), 1.81 (dt, J = 13.2, 2.9 Hz, 1H, -CH2), 1.79 (dd, J = 6.4, 
1.5 Hz, 3H, -CH=CHCH3), 1.50 – 1.45 (m, 1H, -CH2), 1.48 (s, 3H, -CH3), 1.44 (s, 3H, -
CH3), 1.42 (s, 3H, -CH3), 1.36 (s, 3H, -CH3); 
13
C NMR (100 MHz, CDCl3) 131.4, 130.8, 
130.3, 130.2, 109.3, 98.7, 78.3, 70.4, 69.4, 67.1, 33.9, 30.0, 26.8, 25.1, 19.9, 18.1; MS (CI) 
m/z 300 (M + NH4)
+
; HRMS (CI): (M NH4)
+
, found 300.2169; C16H30NO4 requires 
300.2175. 
230 
 
(1S,3R)-3-(tert-Butyldimethylsilyloxy)-3-((S)-2,2-dimethyl-1,3-dioxolan-4-yl)-1-((2R,3R)-3-
((E)-prop-enyl)oxiran-2-yl)propan-1-ol 383 
 
 
 
 
 
 
To a stirred solution of allylic alcohol 380 (300 mg, 0.84 mmol) in CH2Cl2 (8.5 mL) at 10 
ºC, VO(acac)2 (16 mg, 0.06 mmol) and t-BuOOH (5.5 M in decane; 0.49 mL) were added 
and the resulting solution was stirred for 3 h at 10 ºC. The reaction was quenched with 
saturated aq. Na2SO3 solution (20 mL) and the separated aqueous layer was extracted with 
Et2O (30 mL × 2). The combined organic layers were dried (MgSO4), rotary evaporated and 
chromatographed (Et2O/PE 1:3 to 1:2) to afford epoxide 383 (270 mg, 86%, d.r = 6:1, 
inseparable mixture) as a colourless oil: Rf 0.68 (Et2O/PE 1:1); 
25
D][ 40.0 (c 0.15 CHCl3); 
IR max (neat) 3474 (m), 1737 (m), 1459 (m), 1368 (m), 1252 (s), 1206 (s), 1070 (s), 964 
(m), 832 (s), 777 (m) cm
-1
; 
1
H NMR (400 MHz, CDCl3)  5.98 (dq, J = 15.6, 6.8 Hz, 1H, -
CH=CHCH3), 5.28 – 5.20 (m, 1H, -CH=CHCH3), 4.16 – 4.10 (m, 2H), 4.03 – 3.98 (m, 1H), 
3.95 – 3.91 (m, 1H), 3.85 – 3.80 (m, 1H), 3.42 (dd, J = 8.3, 2.0 Hz, 1H, -CHOCHCH=C-), 
2.91 (dd, J = 3.9, 2.0 Hz, 1H, -CHOCHCH=C-), 2.60 (d, J = 2.9 Hz, 1H, -OH), 1.89 – 1.81 
(m, 2H, -CH2), 1.76 (dd, J = 6.8, 1.5 Hz, 3H, -CH=CHCH3), 1.43 (s, 3H, -CH3), 1.37 (s, 3H, 
-CH3), 0.90 (s, 9H, -(CH3)3), 0.11 (s, 6H, -Si-CH3 × 2); 
13
C NMR (100 MHz, CDCl3)  
132.3, 127.9, 109.4, 78.5, 70.8, 67.3, 66.0, 62.3, 55.9, 38.8, 26.6, 25.7 (3C), 25.3, 17.9 (2C), 
4.1, 4.6; MS (ESI) m/z 395 (M + Na)+; HRMS (ESI): (M Na)+, found 395.2228; 
C19H36NaO5Si requires 395.2230. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
231 
 
(5R,7S)-5-((S)-2,2-Dimethyl-1,3-dioxolan-4-yl)-2,2,3,3,9,9,10,10-octamethyl-7-((2S,3R)-3-
((E)-prop-1-enyl)oxiran-2-yl)-4,8-dioxa-3,9-disilaundecane 384 
 
 
 
 
 
 
To a stirred solution of epoxide 383 (150 mg, 0.40 mmol, d.r = 6:1) and imidazole (180 mg, 
2.8 mmol) in CH2Cl2 (6 mL) at 23 ºC, TBSCl (270 mg, 1.8 mmol) in CH2Cl2 (1 mL) was 
added and the resulting mixture was stirred for 68 h. The reaction was quenched with 
saturated aq. NH4Cl solution (20 mL) and the aqueous layer was extracted with CH2Cl2 (15 
mL × 2). The combined organic layers were dried (MgSO4), rotary evaporated  and 
chromatographed (Et2O/PE 1:10) to afford bis-TBS-protected diol 384 (82 mg, 65%, 
diastereoisomers were now separable) as a colourless oil: Rf 0.75 (Et2O/PE 1:10); 
1
H NMR 
(500 MHz, CDCl3) 5.95 (dq, J = 15.6, 6.4 Hz, 1H, -HC=CHCH3), 5.22 (ddq, J = 15.6, 8.3, 
2.0 Hz, 1H, -CH=CHCH3), 4.13 – 4.08 (m, 1H), 4.03 – 3.97 (m, 2H), 3.83 – 3.78 (m, 2H), 
3.25 (dd, J = 8.8, 2.0 Hz, 1H, -CHOCHCH=CH-), 2.83 (dd, J = 5.4, 2.0 Hz, 1H, -
CHOCHCH=CH-), 1.85 – 1.82 (m, 2H, -CH2), 1.75 (dd, J = 6.4, 1.5 Hz, 3H, -CH=CHCH3), 
1.42 (s, 3H, -CH3), 1.35 (s, 3H, -CH3), 0.91 (s, 9H, -(CH3)3), 0.90 (s, 9H, -(CH3)3), 0.10 (s, 
6H, -Si-CH3 × 2), 0.09 (s, 3H, -Si-CH3), 0.08 (s, 3H, -Si-CH3); 
13
C NMR (125 MHz, CDCl3) 
 131.6, 128.1, 109.0, 78.8, 69.2, 68.5, 66.5, 62.5, 56.9, 41.4, 26.6, 25.8 (6C), 25.4, 18.1, 
17.9, 17.8, 4.2, 4.3, 4.6, 4.7; MS (ESI) m/z 509 (M + Na)+, 487 (M H)+, 429 (M t-
Bu)
+
; HRMS (ESI): (M H)+, found 487.3268; C25H51O5Si2 requires 487.3275. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
232 
 
(E)-5-(But-2-enyl)-4-(tert-butyldimethylsilyloxy)-6,8-dioxabicyclo[3.2.1]octan-2-ol 386 
 
 
 
 
 
 
To a stirred solution of acetonide 384 (230 mg, 0.5 mmol) in CH2Cl2 (20 mL), anhydrous 
tin(II) chloride (422 mg, 2.2 mmol) was added and the resulting mixture was stirred for 18 h 
at 23 ºC. A white precipirate gradually formed after 10 min of stirring. The solvent was 
removed by rotary evaporation and the resulting residue was chromatographed (Et2O/PE 1:3) 
to afford bicycle 386 (60 mg, 38%) as a colourless oil; Rf 0.39 (Et2O/PE 1:1); 
1
H NMR (500 
MHz, CDCl3) 5.57 (dq, J = 15.4, 6.4 Hz, 1H, -HC=CHCH3), 5.46 (dt, J = 15.4, 7.7 Hz, 1H, 
-CH=CHCH3), 4.53 – 4.51 (m, 1H, bridge-H), 3.85 (dd, J = 8.0, 5.5 Hz, 1H, -CHCH2O-), 
3.72 (br. d, J = 7.7 Hz, 1H, -CHCH2O-), 3.63 – 3.62 (m, 1H, -CHOTBS), 3.59 – 3.57 (br. m, 
1H, HOCH-), 3.28 (br. d, J = 11.8 Hz, 1H, -OH), 2.54 (dd, J = 14.9, 6.9 Hz, 1H, -CH2C=CH-
), 2.43 (dd, J = 14.9, 6.9 Hz, 1H, -CH2C=CH-), 2.03 (dt, J = 15.2, 3.9 Hz, 1H, -CH2), 1.79 
(app. dq, J = 15.1, 1.9 Hz, 1H, -CH2), 1.68 (dd, J = 6.4, 1.4 Hz, 3H, -CH=CHCH3), 0.93 (s, 
9H, -(CH3)3), 0.12 (s, 3H, -Si-CH3), 0.08 (s, 3H, -Si-CH3); 
13
C NMR (125 MHz, CDCl3)  
129.0, 123.9, 108.3, 78.8, 69.6, 67.0, 66.4, 36.6, 32.2, 25.8 (3C), 18.1, 17.8, -4.3, -5.0; 
HRMS (ESI): (M Na)+, found 337.1801; C16H30NaO4Si requires 337.1811. 
 
The use of tin(II) chloride dihydrate instead of anhydrous tin(II) chloride resulted in the 
formation of bicycle 386 in 82% yield. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
233 
 
(E)-5-(But-2-enyl)-4-(tert-butyldimethylsilyloxy)-6,8-dioxabicyclo[3.2.1]octan-2-yl 3,5-
dinitrobenzoate 388 
 
 
 
 
 
 
 
 
 
 
To a stirred solution of bicycle 386 (45 mg, 0.14 mmol), 3,5-dinitrobenzoyl chloride (64 mg, 
0.28 mmol), and DMAP (1.7 mg, 0.014 mmol) in CH2Cl2 (2.5 mL) at 23 ºC, Et3N (0.04 mL, 
0.28 mmol) was added dropwise and the resulting solution was stirred for 15 h. The reaction 
was quenched with 1 M aq. HCl solution (15 mL) and the aqueous layer was extracted with 
Et2O (10 mL × 2). The combined organic layers were dried (MgSO4), rotary evaporated and 
chromatographed (Et2O/PE 1:3) to afford bicycle 388 as a white solid. Recrystallization from 
a mixture of Et2O/hexanes (1:1 v/v) afforded bicycle 388 (60 mg, 83%) as colourless needles; 
Rf 0.41 (Et2O/PE 1:1); 
25
D][ 55.1 (c 0.33 CHCl3); IR max (neat) 3097 (m), 2944 (m), 2891 
(m), 1723 (s), 1628 (m), 1542 (s), 1461 (m), 1344 (s), 1279 (s), 1171 (s), 1105 (s) cm
-1
; 
1
H 
NMR (500 MHz, CDCl3) 9.23 (t, J = 2.2 Hz, 1H, ArH), 9.20 (d, J = 2.2 Hz, 2H, ArH), 
5.60 (dq, J = 15.4, 6.6 Hz, 1H, -HC=CHCH3), 5.46 (dt, J = 15.4, 8.0 Hz, 1H, -CH=CHCH3), 
5.02 (dt, J = 5.5, 1.9 Hz, 1H, ArCO2CH-), 4.77 – 4.76 (m, 1H, bridge-H), 3.91 (dd, J = 8.0, 
5.5 Hz, 1H, -CHCH2O-), 3.86 (br. d, J = 7.7 Hz, 1H, -CHCH2O-), 3.64 (br. m, 1H, -
CHOTBS), 2.66 (dd, J = 14.9, 6.6 Hz, 1H, -CH2C=CH-), 2.47 (dd, J = 14.6, 6.9 Hz, 1H, -
CH2C=CH-), 2.37 (dt, J = 15.7, 5.5 Hz, 1H, -CH2), 2.00 (app. dq, J = 15.1, 1.9 Hz, 1H, -
CH2), 1.69 (dd, J = 6.3, 1.4 Hz, 3H, -CH=CHCH3), 0.83 (s, 9H, -(CH3)3), 0.09 (s, 3H, -Si-
CH3), 0.02 (s, 3H, -Si-CH3); 
13
C NMR (125 MHz, CDCl3)  162.6, 148.6 (2C), 134.0, 129.6 
(2C), 129.2, 123.7, 122.5, 108.9, 75.5, 70.7, 67.5, 66.2, 36.5, 30.3, 25.7 (3C), 18.1, 17.9, -4.1, 
-5.0; MS (CI) m/z 526 (M + NH4)
+
; HRMS (ESI): (M H4)
+
, found 526.2237; 
C23H36N3O9Si requires 526.2221; Elem. Anal., found C, 54.41; H, 6.22; N, 5.59; 
C23H32N2O9Si requires C, 54.32; H, 6.34; N, 5.51%. The absolute structure was 
unambiguously determined by X-ray crystallography (Appendix 1). 
 
 
 
 
234 
 
(5R,7S)-5-((S)-2,2-Dimethyl-1,3-dioxolan-4-yl)-2,2,3,3,10,10-hexamethyl-9,9-diphenyl-7-
((2S,3R)-3-((E)-prop-1-enyl)oxiran-2-yl)-4,8-dioxa-3,9-disilaundecane 385 
 
 
 
 
 
 
 
To a stirred solution of epoxide 383 (280 mg, 0.75 mmol, d.r = 6:1) and imidazole (115 mg, 
1.65 mmol) in CH2Cl2 (10 mL) at 23 ºC, TBDPSCl (0.3 mL, 1.13 mmol) in CH2Cl2 (1.5 mL) 
was added and the resulting mixture was stirred for 20 h. The reaction was quenched with 
saturated aq. NH4Cl solution (30 mL) and the aqueous layer was extracted with CH2Cl2        
(20 mL × 3). The combined organic layers were dried (MgSO4), rotary evaporated and 
chromatographed (Et2O/PE 1:10) to afford bis-protected diol 385 (400 mg, 86%, 
diastereoisomers were now separable) as a colourless oil: Rf 0.82 (Et2O/PE 1:2); 
25
D][ 25.5 
(c 0.47 CHCl3); IR max (neat) 2959 (s), 2931 (s), 2857 (s), 1472 (m), 1428 (m), 1254 (s), 
1111 (s), 1073 (s), 836 (s) cm
-1
; 
1
H NMR (500 MHz, CDCl3) 7.70 (br. d, J = 6.8 Hz, 4H, 
ArH), 7.46 – 7.36 (m, 6H, ArH), 5.54 (dq, J = 15.2, 6.4 Hz, 1H, -HC=CHCH3), 5.22 (ddq, J 
= 15.2, 8.3, 1.5 Hz, 1H, -CH=CHCH3), 4.14 – 4.10 (m, 1H), 4.02 – 3.98 (m, 1H), 3.91 – 3.87 
(m, 1H), 3.80 – 3.77 (m, 1H), 3.63 – 3.58 (m, 1H), 2.82 (dd, J = 6.8, 2.4 Hz, 1H, -
CHOCHCH=CH-), 2.58 (dd, J = 7.8, 1.5 Hz, 1H, -CHOCHCH=CH-), 1.98 – 1.82 (m, 2H, -
CH2), 1.62 (dd, J = 6.8, 1.5 Hz, 3H, -CH=CHCH3), 1.39 (s, 3H, -CH3), 1.33 (s, 3H, -CH3), 
1.07 (s, 9H, -(CH3)3), 0.86 (s, 9H, -(CH3)3), 0.08 (s, 3H, -Si-CH3), -0.01 (s, 3H, -Si-CH3); 
13
C NMR (125 MHz, CDCl3)  136.0 (2C), 135.9 (2C), 133.5, 133.4, 131.4, 129.8 (2C), 
129.5, 127.7 (2C), 127.4 (2C), 108.8, 78.7, 70.6, 68.7, 65.6, 62.4, 57.9, 41.6, 26.9 (3C), 26.5, 
25.8 (3C), 25.4, 19.3, 18.0, 17.8, -4.3, -4.5; MS (ESI) m/z 633 (M + Na)
+
; HRMS (ESI): (M 
Na)+, found 633.3394; C35H54NaO5Si2 requires 633.3407. 
 
 
 
 
 
 
 
 
235 
 
(E)-5-(But-2-enyl)-4-(tert-butyldiphenylsilyloxy)-6,8-dioxabicyclo[3.2.1]octan-2-ol 387 
 
 
 
 
 
 
Save for the use of epoxide 385 and the reaction time of 15 h, bicycle 387 (70 mg, 48%, 
colourless oil) was prepared following the conditions described for the synthesis of bicycle 
386: Rf 0.19 (Et2O/PE 3:7); 
25
D][ 13.0 (c 1.53 CHCl3); IR max (neat) 3552 (m), 2933 (m), 
2857 (m), 1427 (s), 1175 (m), 1105 (s), 1084 (s), 998 (s) cm
-1
; 
1
H NMR (400 MHz, CDCl3) 
7.75 – 7.72 (m, 4H, ArH), 7.50 – 7.39 (m, 6H, ArH), 5.26 (dq, J = 15.2, 6.8 Hz, 1H, -
HC=CHCH3), 5.46 (dt, J = 15.6, 6.8 Hz, 1H, -CH=CHCH3), 4.60 – 4.58 (m, 1H, bridge-H), 
3.82 (dd, J = 7.8, 5.4 Hz, 1H, -CHCH2O-), 3.69 – 3.62 (br. m, 3H, -CHCH2O-, -
CHOTBDPS, -OH), 3.50 – 3.48 (br. m, 1H, HOCH-), 2.45 (dd, J = 14.7, 7.8 Hz, 1H, -
CH2C=CH-), 2.11 (dd, J = 14.7, 5.8 Hz, 1H, -CH2C=CH-), 1.98 (dq, J = 15.2, 2.0 Hz, 1H, -
CH2), 1.92 (dt, J = 15.2, 3.4 Hz, 1H, -CH2), 1.54 (dd, J = 6.8, 1.5 Hz, 3H, -CH=CHCH3), 
1.13 (s, 9H, -(CH3)3); 
13
C NMR (100 MHz, CDCl3)  136.4 (2C), 136.2 (2C), 132.8, 130.0, 
129.9 (2C), 128.7, 127.8 (2C), 127.7 (2C), 123.6, 108.3, 79.2, 70.2, 67.2, 66.3, 36.5, 31.7, 
27.1 (3C), 19.4, 18.1; MS (ESI) m/z 461 (M + Na)
+
; HRMS (ESI): (M H)+, found 
439.2284; C26H35O4Si requires 461.2226. 
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(R,4E,6E)-1-(tert-butyldiphenylsilyloxy)-1-((S)-2,2-dimethyl-1,3- 
 dioxolan-4-yl)octa-4,6-dien-3-one 401   
 
 
 
 
 
 
To a stirred solution of β-hydroxy ester 376 (1.4 g, 5.8 mmol) and imidazole (1.07 g, 15.8 
mmol) in CH2Cl2 (45 mL) at 23 ºC, TBDPSCl (3.0 mL, 11.7 mmol) in CH2Cl2 (5 mL) was 
added and the resulting mixture was stirred for 20 h. The reaction was quenched with 
saturated aq. NH4Cl solution (40 mL) and the aqueous layer was extracted with CH2Cl2        
(80 mL × 3). The combined organic layers were dried (MgSO4), rotary evaporated and 
chromatographed (Et2O/PE 1:9) to afford TBDPS-protected ester 401 (2.49 g, 90%) as a 
colourless oil: Rf 0.68 (Et2O/PE 2:3); 
25
D][ 2.6 (c 0.77 CHCl3); IR max (neat) 2931 (m), 
2857 (m), 1661 (w), 1637 (s), 1592 (s), 1427 (s), 1370 (m), 1107 (s), 1069 (s), 996 (s) cm
-1
; 
1
H NMR (400 MHz, CDCl3)  7.78 – 7.70 (m, 4H, ArH), 7.48 – 7.37 (m, 6H, ArH), 6.99 – 
6.92 (m, 1H, -COCH=CH-), 6.20 – 6.09 (m, 2H, -COCH=CH-CH=CHCH3), 5.86 (d, J = 
15.2 Hz, 1H, -COCH=CH-), 4.37 (app. q, J = 5.4 Hz, 1H), 4.11 (app. q, J = 5.4 Hz, 1H), 3.89 
(dd, J = 8.3, 6.8 Hz, 1H, -OCHaHbCHO-), 3.66 (dd, J = 8.3, 6.8 Hz, 1H, -OCHaHbCHO-), 
2.85 (dd, J = 15.6, 6.4 Hz, 1H, -CH2), 2.63 (dd, J = 15.6, 5.8 Hz, 1H, -CH2), 1.89 (d, J = 5.9 
Hz, 3H, -CH=CHCH3), 1.33 (s, 3H, -CH3), 1.30 (s, 3H, -CH3), 1.04 (s, 9H, -(CH3)3); 
13
C 
NMR (100 MHz, CDCl3) 197.9, 143.0, 140.3, 136.0 (2C), 134.8, 133.5, 133.4, 130.3, 
129.8, 129.7, 128.1, 127.7, 127.6 (2C), 127.6 (2C), 109.2, 78.6, 70.6, 66.4, 45.0, 26.9 (3C), 
26.6, 25.2, 19.4, 18.8; MS (ESI) m/z 501 (M Na)+; HRMS (ESI): (M Na)+, found 
501.2413; C29H38NaO4Si requires 501.2437. 
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(1R,3S,4E,6E)-1-(tert-butyldiphenylsilyloxy)-1-((S)-2,2- 
dimethyl-1,3-dioxolan-4-yl)octa-4,6-dien-3-ol 402 
 
 
 
 
 
 
 
 
 
 
A mixture of (R)-Me-CBS 379 (580 mg, 2.09 mmol) and BH3.THF (1 M in THF; 3.1 mL) in 
THF (16 mL) was stirred for 25 min at 23 ºC. The resulting colourless solution was cooled to 
20 ºC and enone 401 (1.0 g, 2.09 mmol) in THF (21 mL) was added dropwise and the 
ensuing mixture was stirred for 12 h at 20 ºC. The reaction was quenched with saturated aq. 
NH4Cl (40 mL) and the aqueous layer was extracted with Et2O (35 mL × 3). The combined 
organic layers were dried (MgSO4), rotary evaporated and chromatographed (Et2O/PE 1:3 to 
1:2) to afford alcohol 402 (854 mg, 82%, d.r = 10:1) as a colourless oil: Rf 0.58 (Et2O/PE 
2:3); 25D][ 16.2 (c 0.74 CHCl3); IR max (neat) 3449 (m), 2932 (m), 2857 (m), 1427 (s), 
1210 (s), 1106 (s), 1067 (s), 987 (s) cm
-1
; 
1
H NMR (400 MHz, CDCl3)  7.72 – 7.68 (m, 4H, 
ArH), 7.49 – 7.39 (m, 6H, ArH), 6.02 – 5.89 (m, 2H, -OCHCH=CH-, -CH=CHCH3), 5.62 
(dq, J = 14.6, 6.4 Hz, 1H, -CH=CHCH3), 5.23 (dd, J = 14.2, 6.4 Hz, 1H, -OCHCH=CH-), 
4.35 – 4.30 (br. m, 1H, HOCHCH=CH-), 4.18 (app. q, J = 6.4 Hz, 1H), 3.99 (dd, J = 8.3, 6.4 
Hz, 1H, -OCHaHbCHO-), 3.85 (app. q, J = 6.4 Hz, 1H), 3.64 (dd, J = 8.4, 6.8 Hz, 1H, -
OCHaHbCHO-), 2.52 (d, J = 5.4 Hz, 1H, -OH), 1.88 – 1.77 (m, 2H, -CH2), 1.76 (d, J = 7.3 
Hz, 3H, -CH=CHCH3), 1.32 (s, 3H, -CH3), 1.31 (s, 3H, -CH3), 1.06 (s, 9H, -(CH3)3); 
13
C 
NMR (100 MHz, CDCl3) 136.0 (4C), 133.6, 133.3, 132.9, 130.9, 130.0, 129.9 (2C), 129.3, 
127.7 (4C), 109.4, 78.7, 72.0, 68.6, 67.7, 42.2, 26.9 (3C), 26.3, 25.3, 19.4, 18.1; MS (ESI) 
m/z 503 (M a)+, 423 (M t-Bu)+; HRMS (ESI): (M Na)+, found 503.2606; 
C29H40NaO4Si requires 503.2594.  
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(1R,3S,4E,6E)-1-(tert-butyldiphenylsilyloxy)-1-((S)-2,2-dimethyl- 
1,3-dioxolan-4-yl)octa-4,6-dien-3-yl pivalate 403 
 
 
 
 
 
 
 
To a stirred solution of alcohol 402 (400 mg, 0.83 mmol) and DMAP (10 mg, 0.08 mmol) in 
CH2Cl2 (15 mL) at 23 ºC, PivCl (0.55 mL, 4.2 mmol) and Et3N (0.64 mL, 4.6 mmol) were 
added and the resulting mixture was stirred for 48 h. The reaction was quenched with 1 M aq. 
HCl solution (30 mL) and the aqueous layer was extracted with Et2O (35 mL × 3). The 
combined organic layers were dried (MgSO4), rotary evaporated and chromatographed 
(Et2O/PE 1:9) to afford acetonide 403 (340 mg, 72%) as a colourless oil: Rf 0.79 (Et2O/PE 
1:2); 25D][ 42.1 (c 0.38 CHCl3); IR max (neat) 2960 (m), 2932 (m), 2859 (m), 1727 (s), 
1427 (m), 1279 (m), 1151 (s), 1107 (s), 1070 (s), 987 (s) cm
-1
; 
1
H NMR (400 MHz, CDCl3) 
 7.70 – 7.68 (m, 4H, ArH), 7.45 – 7.35 (m, 6H, ArH), 5.92 – 5.83 (m, 2H, -OCHCH=CH-, -
CH=CHCH3), 5.61 (dq, J = 14.7, 7.2 Hz, 1H, -CH=CHCH3), 5.39 – 5.33 (m, 1H, 
PivOCHCH=CH-), 5.18 – 5.10 (m, 1H, PivOCHCH=CH-), 4.07 (app. q, J = 5.8 Hz, 1H), 
3.87 (dd, J = 8.3, 6.4 Hz, 1H, -OCHaHbCHO-), 3.78 (app. q, J = 5.8 Hz, 1H), 3.62 (dd, J = 
8.2, 6.9 Hz, 1H, -OCHaHbCHO-), 1.95 (ddd, J = 14.4, 7.7, 5.5 Hz, 1H, -CH2), 1.75 – 1.68 (m, 
1H, -CH2), 1.72 (d, J = 6.7 Hz, 3H, -CH=CHCH3), 1.28 (s, 6H, -CH3 × 2), 1.08 (s, 9H, -
(CH3)3), 1.06 (s, 9H, -(CH3)3); 
13
C NMR (100 MHz, CDCl3) 177.1, 136.1 (2C), 136.0 
(2C), 133.6, 133.5, 133.1, 130.7, 130.6, 129.8, 129.7, 128.1, 127.6 (2C), 127.5 (2C), 109.2, 
78.6, 71.0, 70.8, 66.7, 39.2, 38.6, 27.0 (3C), 26.9 (3C), 26.3, 25.2, 19.4, 18.1; MS (ESI) m/z 
587 (M a)+; HRMS (ESI): (M Na)+, found 587.3168; C34H48NaO5Si requires 587.3169. 
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(2S,3R,5S,6E,8E)-3-(tert-butyldiphenylsilyloxy)-1,2- 
dihydroxydeca-6,8-dien-5-yl pivalate 404 
 
 
 
 
 
 
To a stirred solution of acetonide 403 (160 mg, 0.3 mmol) in MeOH (4.4 mL) at 0 ºC, p-TSA 
(18 mg, 0.1 mmol) was added and the resulting mixture was stirred for 2 h at 23 ºC. The 
reaction was quenched with H2O (10 mL) and the aqueous layer was extracted with Et2O   
(20 mL × 2). The combined organic layers were dried (MgSO4), rotary evaporated and 
chromatographed (Et2O/PE 1:4 to 1:2) to afford diol 404 (75 mg, 50%, 13% of acetonide 403 
recovered) as a colourless oil: Rf 0.46 (Et2O/PE 4:1); 
25
D][ 41.1 (c 0.34 CHCl3); IR max 
(neat) 3446 (s), 2960 (s), 2932 (s), 2859 (m), 1726 (s), 1430 (m), 1280 (m), 1157 (s), 1110 
(s), 1082 (s), 989 (s) cm
-1
; 
1
H NMR (500 MHz, CDCl3)  7.70 – 7.67 (m, 4H, ArH), 7.47 – 
7.43 (m, 2H, ArH), 7.41 – 7.37 (m, 4H, ArH), 5.91 – 5.82 (m, 2H, -OCHCH=CH-, -
CH=CHCH3), 5.62 (dq, J = 14.7, 7.2 Hz, 1H, -CH=CHCH3), 5.31 – 5.27 (m, 1H, 
PivOCHCH=CH-), 5.16 – 5.07 (m, 1H, PivOCHCH=CH-), 3.92 – 3.89 (m, 1H, 
TBDPSOCH-), 3.69 – 3.61 (br. m, 2H), 1.95 (ddd, J = 14.4, 7.7, 5.5 Hz, 1H, -CH2), 2.46 (br. 
s, 1H, -OH), 1.99 (br. s, 1H, -OH), 1.94 (ddd, J = 14.2, 7.7, 5.5 Hz, 1H, -CH2), 1.79 – 1.74 
(m, 1H, -CH2), 1.73 (d, J = 6.3 Hz, 3H, -CH=CHCH3), 1.08 (s, 9H, -(CH3)3), 1.07 (s, 9H, -
(CH3)3); 
13
C NMR (125 MHz, CDCl3) 177.4, 136.0 (2C), 135.9 (2C), 133.2, 133.1, 132.9, 
131.0, 130.4, 130.0, 129.9, 127.8 (2C), 127.7 (2C), 127.6, 73.6, 72.3, 71.1, 62.9, 38.7, 38.0, 
27.1 (3C), 27.0 (3C), 19.4, 18.1; MS (ESI) m/z 547 (M a)+; HRMS (ESI): (M Na)+, 
found 547.2858; C31H44NaO5Si requires 547.2856.     
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(2S,3R,5S,6E,8E)-3-(tert-butyldiphenylsilyloxy)-2-hydroxy-1- 
(methoxymethoxy)deca-6,8-dien-5-yl pivalate 407 
 
 
 
 
 
 
To a stirred solution of diol 404 (110 mg, 0.21 mmol) in CH2Cl2 (4.5 mL) at 0 ºC, MOMCl 
(0.1 mL, 1.3 mmol) and i-Pr2NEt (0.24 mL, 1.4 mmol) were added and the resulting mixture 
was stirred for 1 h. The reaction was quenched with saturated aq. NH4Cl solution (15 mL) 
and the aqueous layer was extracted with Et2O (15 mL × 2). The combined organic layers 
were dried (MgSO4), rotary evaporated and chromatographed (Et2O/PE 2:3 to 1:1) to afford 
secondary alcohol 407 (97 mg, 80%) as a colourless oil: Rf 0.74 (Et2O/PE 4:1); 
25
D][ 32.0  
(c 1 CHCl3); IR max (neat) 3491 (m), 2956 (s), 2932 (s), 2858 (m), 1726 (s), 1476 (m), 1427 
(s), 1281 (m), 1153 (s), 1109 (s), 1037 (s), 988 (s) cm
-1
; 
1
H NMR (500 MHz, CDCl3)  7.72 
(br. d, J = 6.8 Hz, 4H, ArH), 7.49 – 7.37 (m, 6H, ArH), 5.91 – 5.81 (m, 2H, -OCHCH=CH-, 
-CH=CHCH3), 5.60 (dq, J = 14.6, 6.8 Hz, 1H, -CH=CHCH3), 5.39 – 5.34 (m, 1H, 
PivOCHCH=CH-), 5.14 (dd, J = 14.6, 7.8 Hz, 1H, PivOCHCH=CH-), 4.57 (s, 2H, -OCH2O-
), 3.87 – 3.84 (m, 1H, TBDPSOCH-), 3.81 – 3.76 (m, 1H, HOCH-), 3.60 (dd, J = 10.3, 3.4 
Hz, 1H, -OCHaHbCHO-), 3.48 (dd, J = 10.3, 7.3 Hz, 1H, -OCHaHbCHO-), 3.33 (s, 3H, -
CH3), 2.49 (d, J = 4.4 Hz, 1H, -OH), 2.04 – 1.97 (m, 1H, -CH2), 1.75 (d, J = 6.8 Hz, 3H, -
CH=CHCH3), 1.75 – 1.66 (m, 1H, -CH2), 1.12 (s, 9H, -(CH3)3), 1.10 (s, 9H, -(CH3)3); 
13
C 
NMR (125 MHz, CDCl3) 177.2, 136.1 (2C), 136.0 (2C), 133.5, 133.4, 133.3, 130.7, 130.6, 
129.7 (2C), 128.0, 127.7 (4C), 96.8, 73.2, 71.4, 71.3, 68.9, 55.3, 38.6, 37.8, 27.0 (6C), 19.4, 
18.0; MS (ESI) m/z 591 (M a)+; HRMS (ESI): (M Na)+, found 591.3115; 
C33H48NaO6Si requires 591.3118.     
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(1S,3R,4S)-3-(tert-butyldiphenylsilyloxy)-5-(methoxymethoxy)-1-((2R,3R)-3-((E)-prop-1-
enyl)oxiran-2-yl)pentane-1,4-diol 409 
 
 
 
 
 
 
To a stirred solution of secondary alcohol 407 (60 mg, 0.11 mmol) in CH2Cl2 (4.0 mL) at 78 
ºC, DIBAL-H (1 M in CH2Cl2; 0.32 mmol) was added dropwise and the resulting mixture 
was stirred for 1.5 h. The reaction was quenched with saturated aq. NH4Cl solution (10 mL) 
and the aqueous layer was extracted with Et2O (10 mL × 2). The combined organic layers 
were dried (MgSO4) and rotary evaporated to give diol 408 (50 mg, 94%) as a colourless oil. 
This material was used in the following step without further purification; 
1
H NMR (400 
MHz, CD2Cl2)  7.75 – 7.70 (m, 4H, ArH), 7.51 – 7.42 (m, 6H, ArH), 6.05 – 5.94 (m, 2H, -
OCHCH=CH-, -CH=CHCH3), 5.67 (dq, J = 15.2, 7.4 Hz, 1H, -CH=CHCH3), 5.14 (dd, J = 
14.8, 6.8 Hz, 1H, -OCHCH=CH-), 4.55 (s, 2H, -OCH2O-), 4.45 – 4.43 (m, 1H, -
OCHCH=CH-), 3.95 – 3.85 (m, 2H, TBDPSOCH-, HOCH-), 3.63 (dd, J = 10.3, 3.4 Hz, 1H, 
-OCHaHbCHO-), 3.46 (dd, J = 10.3, 6.8 Hz, 1H, -OCHaHbCHO-), 3.31 (d, J = 3.9 Hz, 1H, -
OH), 3.29 (s, 3H, -CH3), 2.88 (d, J = 3.9 Hz, 1H, -OH), 1.82 – 1.67 (m, 2H, -CH2), 1.78 (d, J 
= 6.8 Hz, 3H, -CH=CHCH3), 1.11 (s, 9H, -(CH3)3). 
 
To a stirred solution of allylic alcohol 408 (50 mg, 0.10 mmol) in CH2Cl2 (3.0 mL) at 10 ºC, 
VO(acac)2 (2.6 mg, 0.01 mmol) and t-BuOOH (5.5 M in decane; 0.06 mL) were added and 
the resulting dark red coloured solution was stirred for 3 h at 10 ºC. The reaction was 
quenched with saturated aq. Na2SO3 solution (10 mL) and the aqueous layer was extracted 
with Et2O (15 mL × 2). The combined organic layers were dried (MgSO4), rotary evaporated 
and chromatographed (Et2O/PE 1:1) to afford epoxide 409 (37 mg, 73%, d.r = 4.8:1, 
separable by chromatography) as a colourless oil: Rf 0.19 (Et2O/PE 1:1); IR max (neat) 3405 
(m), 3071 (w), 2931 (s), 2857 (m), 1472 (w), 1427 (s), 1105 (s), 1037 (s), 963 (m) cm
-1
; 
1
H 
NMR (500 MHz, CD3CN)  7.75 – 7.70 (m, 4H, ArH), 7.52 – 7.42 (m, 6H, ArH), 5.93 (dq, 
J = 15.6, 6.8 Hz, 1H, -CH=CHCH3), 5.14 (ddq, J = 15.6, 8.3, 2.0 Hz, 1H, -CH=CHCH3), 
4.49 (s, 2H, -OCH2O-), 4.05 – 4.01 (m, 1H, TBDPSOCH-), 3.82 – 3.78 (m, 2H, HOCH- × 
2), 3.66 (d, J = 4.4 Hz, 1H, -OH), 3.58 (d, J = 3.4 Hz, 1H, -OH), 3.55 (dd, J = 10.3, 4.4 Hz, 
1H, -OCHaHbCHO-), 3.36 (dd, J = 10.3, 6.8 Hz, 1H, -OCHaHbCHO-), 3.23 (s, 3H, -CH3), 
3.19 – 3.16 (m, 1H, -CHOCHCH=C-), 2.55 (dd, J = 4.9, 2.0 Hz, 1H, -CHOCHCH=C-), 1.79 
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– 1.64 (m, 2H, -CH2), 1.72 (dd, J = 6.8, 2.0 Hz, 3H, -CH=CHCH3), 1.08 (s, 9H, -(CH3)3); 
13
C 
NMR (125 MHz, CD3CN) 136.9 (4C), 134.8, 134.7, 132.4, 130.8 (2C), 129.4, 128.7 (2C), 
128.6 (2C), 97.3, 74.0, 72.5, 69.9, 66.6, 62.9, 56.7, 55.4, 37.4, 27.4 (3C), 19.9, 18.0; MS 
(ESI) m/z 523 (M a)+; HRMS (ESI): (M Na)+, found 523.2487; C28H40NaO6Si requires 
523.2492.      
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Appendix 1  X-ray crystal structure of bicycle 388 
 
 
 
 
 
Crystal data and structure refinement for 388 
 
Identification code AB1201 
Formula C23H32N2O9Si 
Formula weight 508.60 
Temperature 173 K 
Diffractometer, wavelength OD Xcalibur PX Ultra, 1.54184 Å 
Crystal system, space group Orthorhombic, P2 (1) 2 (1) 2 (1) 
Unit cell dimensions a = 6.46067(9) Å  = 90° 
 b = 18.2163(3) Å  = 90° 
 c = 45.4399(9) Å  = 90° 
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Volume, Z 5347.80(16) Å
3
, 8 
Density (calculated) 1.263 Mg/m
3
 
Absorption coefficient 1.218 mm-1 
F(000) 2160 
Crystal colour / morphology Colourless platy needles 
Crystal size 0.28 x 0.12 x 0.03 mm
3
 
 range for data collection 1.94 to 72.49° 
Index ranges -7<=h<=5, -22<=k<=21, -55<=l<=56 
Reflns collected / unique 39383 / 10411 [R(int) = 0.0389] 
Reflns observed [F>4(F)] 9748 
Absorption correction Analytical 
Max. and min. transmission 0.962 and 0.817 
Refinement method Full-matrix least-squares on F
2
 
Data / restraints / parameters 10411 / 88 / 676 
Goodness-of-fit on F
2
 1.132 
Final R indices [F>4(F)] R1 = 0.0456, wR2 = 0.1201 
 R1+ = 0.0456, wR2+ = 0.1201 
 R1- = 0.0501, wR2- = 0.1284 
R indices (all data) R1 = 0.0492, wR2 = 0.1219 
Absolute structure parameter x+ = 0.00(3), x- = 1.00(3) 
Largest diff. peak, hole 0.287, -0.255 eÅ
-3
 
Mean and maximum shift/error 0.000 and 0.002 
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Table 1. Bond lengths [Å] for 388. 
 
 
Bond   lengths  Bond   lengths  
Si(1A)-O(13A) 1.6536(19) C(9B)-C(10B) 1.486(4) 
Si(1A)-C(15A) 1.862(3) C(9B)-C(10E) 1.499(10) 
Si(1A)-C(14A) 1.864(3) C(10B)-C(11B) 1.324(5) 
Si(1A)-C(16A) 1.881(3) C(11B)-C(12B) 1.516(6) 
O(1A)-C(7A) 1.436(4) C(10E)-C(11E) 1.340(11) 
O(1A)-C(2A) 1.439(3) C(11E)-C(12E) 1.541(10) 
C(2A)-O(8A) 1.414(3) C(16B)-C(19B) 1.528(4) 
C(2A)-C(9A) 1.522(4) C(16B)-C(17B) 1.536(5) 
C(2A)-C(3A) 1.533(4) C(16B)-C(18B) 1.539(4) 
C(3A)-O(13A) 1.414(3) O(20B)-C(21B) 1.336(3) 
C(3A)-C(4A) 1.527(4) C(21B)-O(21B) 1.201(4) 
C(4A)-C(5A) 1.523(4) C(21B)-C(22B) 1.503(4) 
C(5A)-O(20A) 1.466(3) C(22B)-C(23B) 1.385(4) 
C(5A)-C(6A) 1.507(4) C(22B)-C(27B) 1.393(4) 
C(6A)-O(8A) 1.434(3) C(23B)-C(24B) 1.381(4) 
C(6A)-C(7A) 1.529(4) C(24B)-C(25B) 1.366(4) 
C(9A)-C(10A) 1.490(7) C(24B)-N(28B) 1.481(4) 
C(9A)-C(10D) 1.499(10) C(25B)-C(26B) 1.386(4) 
C(9A)-C(10C) 1.508(9) C(26B)-C(27B) 1.383(4) 
C(10A)-C(11A) 1.339(8) C(26B)-N(31B) 1.468(4) 
C(11A)-C(12A) 1.525(7) N(28B)-O(29B) 1.210(4) 
C(10C)-C(11C) 1.339(10) N(28B)-O(30B) 1.218(4) 
C(11C)-C(12C) 1.534(9) N(31B)-O(32B) 1.220(3) 
C(10D)-C(11D) 1.338(10) N(31B)-O(33B) 1.220(4) 
C(11D)-C(12D) 1.543(10) N(31A)-O(32A) 1.227(3) 
C(16A)-C(19A) 1.527(4) Si(1B)-O(13B) 1.649(2) 
C(16A)-C(17A) 1.531(5) Si(1B)-C(15B) 1.864(3) 
C(16A)-C(18A) 1.535(4) Si(1B)-C(14B) 1.872(3) 
O(20A)-C(21A) 1.331(3) Si(1B)-C(16B) 1.887(3) 
C(21A)-O(21A) 1.203(3) O(1B)-C(7B) 1.434(4) 
C(21A)-C(22A) 1.496(4) O(1B)-C(2B) 1.437(3) 
C(22A)-C(27A) 1.387(4) C(2B)-O(8B) 1.423(3) 
C(22A)-C(23A) 1.391(4) C(2B)-C(9B) 1.514(4) 
C(23A)-C(24A) 1.379(4) C(2B)-C(3B) 1.524(4) 
C(24A)-C(25A) 1.376(4) C(3B)-O(13B) 1.416(3) 
C(24A)-N(28A) 1.470(3) C(3B)-C(4B) 1.534(4) 
C(25A)-C(26A) 1.375(4) C(4B)-C(5B) 1.521(4) 
C(26A)-C(27A) 1.390(4) C(5B)-O(20B) 1.459(3) 
C(26A)-N(31A) 1.475(4) C(5B)-C(6B) 1.504(4) 
N(28A)-O(29A) 1.221(3) C(6B)-O(8B) 1.437(4) 
N(28A)-O(30A) 1.224(3) C(6B)-C(7B) 1.524(4) 
N(31A)-O(33A) 1.218(3)     
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Table 2. Bond angles [°] for 388. 
 
Bond   Angles  Bond   Angles 
O(13A)-Si(1A)-C(15A) 111.07(13) O(21A)-C(21A)-O(20A) 125.1(2) 
O(13A)-Si(1A)-C(14A) 110.01(15) O(21A)-C(21A)-C(22A) 122.3(3) 
C(15A)-Si(1A)-C(14A) 109.54(19) O(20A)-C(21A)-C(22A) 112.5(2) 
O(13A)-Si(1A)-C(16A) 104.05(12) C(27A)-C(22A)-C(23A) 120.0(2) 
C(15A)-Si(1A)-C(16A) 110.13(15) C(27A)-C(22A)-C(21A) 123.4(2) 
C(14A)-Si(1A)-C(16A) 111.96(17) C(23A)-C(22A)-C(21A) 116.6(3) 
C(7A)-O(1A)-C(2A) 107.3(2) C(24A)-C(23A)-C(22A) 119.0(3) 
O(8A)-C(2A)-O(1A) 105.2(2) C(25A)-C(24A)-C(23A) 122.9(2) 
O(8A)-C(2A)-C(9A) 108.7(2) C(25A)-C(24A)-N(28A) 118.6(2) 
O(1A)-C(2A)-C(9A) 109.9(2) C(23A)-C(24A)-N(28A) 118.5(2) 
O(8A)-C(2A)-C(3A) 108.8(2) C(26A)-C(25A)-C(24A) 116.7(2) 
O(1A)-C(2A)-C(3A) 108.6(2) C(25A)-C(26A)-C(27A) 123.1(3) 
C(9A)-C(2A)-C(3A) 115.2(2) C(25A)-C(26A)-N(31A) 117.6(2) 
O(13A)-C(3A)-C(4A) 112.3(2) C(27A)-C(26A)-N(31A) 119.2(2) 
O(13A)-C(3A)-C(2A) 107.2(2) C(22A)-C(27A)-C(26A) 118.3(2) 
C(4A)-C(3A)-C(2A) 109.6(2) O(29A)-N(28A)-O(30A) 123.7(3) 
C(5A)-C(4A)-C(3A) 113.5(2) O(29A)-N(28A)-C(24A) 118.1(2) 
O(20A)-C(5A)-C(6A) 106.1(2) O(30A)-N(28A)-C(24A) 118.3(3) 
O(20A)-C(5A)-C(4A) 111.6(2) O(33A)-N(31A)-O(32A) 124.2(3) 
C(6A)-C(5A)-C(4A) 110.9(2) O(33A)-N(31A)-C(26A) 118.1(2) 
O(8A)-C(6A)-C(5A) 110.5(2) O(32A)-N(31A)-C(26A) 117.7(2) 
O(8A)-C(6A)-C(7A) 101.1(2) O(13B)-Si(1B)-C(15B) 111.07(12) 
C(5A)-C(6A)-C(7A) 110.9(3) O(13B)-Si(1B)-C(14B) 110.34(13) 
O(1A)-C(7A)-C(6A) 103.4(2) C(15B)-Si(1B)-C(14B) 110.71(16) 
C(2A)-O(8A)-C(6A) 103.0(2) O(13B)-Si(1B)-C(16B) 103.30(12) 
C(10A)-C(9A)-C(2A) 113.6(5) C(15B)-Si(1B)-C(16B) 109.94(15) 
C(10D)-C(9A)-C(2A) 111.4(13) C(14B)-Si(1B)-C(16B) 111.28(14) 
C(10C)-C(9A)-C(2A) 114.0(11) C(7B)-O(1B)-C(2B) 107.5(2) 
C(11A)-C(10A)-C(9A) 121.8(8) O(8B)-C(2B)-O(1B) 105.0(2) 
C(10A)-C(11A)-C(12A) 120.5(8) O(8B)-C(2B)-C(9B) 108.3(2) 
C(11C)-C(10C)-C(9A) 129.6(15) O(1B)-C(2B)-C(9B) 110.1(2) 
C(10C)-C(11C)-C(12C) 131.1(14) O(8B)-C(2B)-C(3B) 108.6(2) 
C(11D)-C(10D)-C(9A) 123.5(18) O(1B)-C(2B)-C(3B) 108.9(2) 
C(10D)-C(11D)-C(12D) 122.2(17) C(9B)-C(2B)-C(3B) 115.4(2) 
C(3A)-O(13A)-Si(1A) 127.37(18) O(13B)-C(3B)-C(2B) 107.3(2) 
C(19A)-C(16A)-C(17A) 109.2(3) O(13B)-C(3B)-C(4B) 112.5(2) 
C(19A)-C(16A)-C(18A) 108.7(3) C(2B)-C(3B)-C(4B) 109.7(2) 
C(17A)-C(16A)-C(18A) 109.5(3) C(5B)-C(4B)-C(3B) 113.2(2) 
C(19A)-C(16A)-Si(1A) 108.72(18) O(20B)-C(5B)-C(6B) 104.9(2) 
C(17A)-C(16A)-Si(1A) 110.9(2) O(20B)-C(5B)-C(4B) 113.2(2) 
C(18A)-C(16A)-Si(1A) 109.8(2) C(6B)-C(5B)-C(4B) 111.5(2) 
C(21A)-O(20A)-C(5A) 115.2(2) O(8B)-C(6B)-C(5B) 109.8(2) 
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Bond   Angles  Bond   Angles 
O(8B)-C(6B)-C(7B) 100.9(2) O(20B)-C(21B)-C(22B) 110.7(2) 
C(5B)-C(6B)-C(7B) 111.6(3) C(23B)-C(22B)-C(27B) 120.1(3) 
O(1B)-C(7B)-C(6B) 103.7(2) C(23B)-C(22B)-C(21B) 118.0(3) 
C(2B)-O(8B)-C(6B) 102.9(2) C(27B)-C(22B)-C(21B) 121.9(3) 
C(10B)-C(9B)-C(2B) 113.3(3) C(24B)-C(23B)-C(22B) 118.7(3) 
C(10E)-C(9B)-C(2B) 112.3(15) C(25B)-C(24B)-C(23B) 123.5(3) 
C(11B)-C(10B)-C(9B) 123.9(4) C(25B)-C(24B)-N(28B) 118.5(3) 
C(10B)-C(11B)-C(12B) 124.3(5) C(23B)-C(24B)-N(28B) 118.0(3) 
C(11E)-C(10E)-C(9B) 123(2) C(24B)-C(25B)-C(26B) 116.4(3) 
C(10E)-C(11E)-C(12E) 123(2) C(27B)-C(26B)-C(25B) 122.9(3) 
C(3B)-O(13B)-Si(1B) 129.19(18) C(27B)-C(26B)-N(31B) 118.9(3) 
C(19B)-C(16B)-C(17B) 109.1(3) C(25B)-C(26B)-N(31B) 118.2(3) 
C(19B)-C(16B)-C(18B) 109.8(3) C(26B)-C(27B)-C(22B) 118.5(3) 
C(17B)-C(16B)-C(18B) 108.9(3) O(29B)-N(28B)-O(30B) 124.4(3) 
C(19B)-C(16B)-Si(1B) 108.5(2) O(29B)-N(28B)-C(24B) 118.1(3) 
C(17B)-C(16B)-Si(1B) 109.9(2) O(30B)-N(28B)-C(24B) 117.5(3) 
C(18B)-C(16B)-Si(1B) 110.6(2) O(32B)-N(31B)-O(33B) 123.5(3) 
C(21B)-O(20B)-C(5B) 117.5(2) O(32B)-N(31B)-C(26B) 118.5(3) 
O(21B)-C(21B)-O(20B) 125.7(3) O(33B)-N(31B)-C(26B) 118.0(3) 
O(21B)-C(21B)-C(22B) 123.6(3)     
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Appendix 2  NMR spectra of (S)-zearalenone (5) – Synthetic sample  
 
1
H NMR (400 MHz, CDCl3): Identical to those reported in the literature
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13
C NMR (125 MHz, CDCl3): Identical to those reported in the literature
20 
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Appendix 3  NMR spectra of LL-Z1640-2 (9) – Authentic sample from Aldrich Chemical Co. 
1
H NMR (400 MHz, CDCl3) 
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13
C NMR (125 MHz, CDCl3) 
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Appendix 4  NMR spectra of LL-Z1640-2 (9) – Synthetic sample 
1
H NMR (400 MHz, CDCl3) 
 ppm (t1)
2.03.04.05.06.07.0
6
.9
2
8
6
.8
8
9
6
.4
3
1
6
.4
1
5
6
.3
5
2
6
.3
4
4
6
.2
6
3
6
.2
4
2
6
.2
3
5
6
.0
2
8
6
.0
1
7
5
.2
8
8
5
.2
8
3
5
.2
7
5
5
.2
6
9
4
.5
4
2
4
.0
1
9
3
.8
4
0
3
.7
6
4
3
.6
3
3
3
.5
9
0
2
.5
6
6
2
.5
2
3
2
.4
3
9
2
.2
3
8
2
.1
3
6
2
.0
7
6
1
.5
1
1
1
.4
9
6
1
.1
0
2
.1
1
1
.1
8
1
.1
4
1
.0
4
1
.1
0
1
.1
9
1
.1
4
1
.0
5
1
.2
3
3
.1
8
1
.1
4
1
.0
8
2
.2
5
3
.3
6
ppm (t1)
12.145012.150012.155012.160012.1650
1
2
.1
5
2
0
.8
5
Chemical Shif t
254 
 
13
C NMR (125 MHz, CDCl3) 
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